1	AAPS	NN	O	aap	nn	6	SENT_1	0/4
2	JAAPS	NN	O	jaap	nn	6	SENT_1	5/10
3	JThe	NN	O	jthe	nn	6	SENT_1	11/15
4	AAPS	NN	O	aap	nn	6	SENT_1	16/20
5	Journal1550-7416Springer	NN	O	journal1550-7416springer	nn	6	SENT_1	21/45
6	USBoston221898993282010931610	NN	O	usboston221898993282010931610		-1	SENT_1	46/75
7	.1208	CD	NUMBER	.1208	dep	6	SENT_1	75/80
8	/	:	O	/	punct	10	SENT_1	80/81
9	s12248-011-9316-3Research	JJ	O	s12248-011-9316-3research	amod	10	SENT_1	81/106
10	ArticleEffect	NN	O	articleeffect	dep	7	SENT_1	107/120
11	of	IN	O	of		-1	SENT_1	121/123
12	Cyclosporine	NN	O	cyclosporine	prep_of	10	SENT_1	124/136
13	and	CC	O	and		-1	SENT_1	137/140
14	Rifampin	NN	O	rifampin	conj_and	12	SENT_1	141/149
15	on	IN	O	on		-1	SENT_1	150/152
16	the	DT	O	the	det	17	SENT_1	153/156
17	Pharmacokinetics	NNS	O	pharmacokinetic	prep_on	10	SENT_1	157/173
18	of	IN	O	of		-1	SENT_1	174/176
19	Macitentan	NNP	LOCATION	Macitentan	prep_of	17	SENT_1	177/187
20	,	,	O	,		-1	SENT_1	187/188
21	a	DT	O	a	det	22	SENT_1	189/190
22	Tissue	NN	O	tissue	appos	19	SENT_1	191/197
23	-	:	O	-		-1	SENT_1	197/198
24	Targeting	NN	O	targeting	dep	6	SENT_1	199/208
25	Dual	JJ	O	dual	amod	28	SENT_1	209/213
26	Endothelin	NN	O	endothelin	nn	28	SENT_1	214/224
27	Receptor	NN	O	receptor	nn	28	SENT_1	225/233
28	AntagonistBrudererShirin+41-61-5656668+41-61-5656200shirin.bruderer@actelion	NN	O	antagonistbruderershirin+41-61-5656668+41-61-5656200shirin.bruderer@actelion	dep	24	SENT_1	234/310
29	.	.	O	.		-1	SENT_1	311/312

1	com	NN	O	com	nn	2	SENT_2	312/315
2	anismaaPaiviHomeryMarie	NN	O	anismaapaivihomerymarie		-1	SENT_2	317/340
3	-	:	O	-		-1	SENT_2	340/341
4	ClaudeHauslerStephanieLandskronerKyleSidhartaPatricia	NNP	ORGANIZATION	ClaudeHauslerStephanieLandskronerKyleSidhartaPatricia	nn	7	SENT_2	342/395
5	N.	NNP	ORGANIZATION	N.	nn	7	SENT_2	396/398
6	TreiberAlexanderDingemanseJasperClinical	NNP	ORGANIZATION	TreiberAlexanderDingemanseJasperClinical	nn	7	SENT_2	398/438
7	Pharmacology	NNP	ORGANIZATION	Pharmacology	dep	2	SENT_2	439/451
8	,	,	O	,		-1	SENT_2	451/452
9	Actelion	NNP	ORGANIZATION	Actelion	nn	11	SENT_2	453/461
10	Pharmaceuticals	NNPS	ORGANIZATION	Pharmaceuticals	nn	11	SENT_2	462/477
11	Ltd	NNP	ORGANIZATION	Ltd	appos	7	SENT_2	478/481
12	,	,	O	,		-1	SENT_2	481/482
13	Gewerbestrasse	NNP	ORGANIZATION	Gewerbestrasse	appos	7	SENT_2	483/497
14	16	CD	NUMBER	16	num	13	SENT_2	498/500
15	,	,	O	,		-1	SENT_2	500/501
16	4123	CD	NUMBER	4123	num	13	SENT_2	502/506
17	Allschwil	NNP	O	Allschwil	dep	13	SENT_2	507/516
18	,	,	O	,		-1	SENT_2	516/517
19	Switzerland	NNP	LOCATION	Switzerland	appos	7	SENT_2	518/529
20	Preclinical	JJ	O	preclinical	amod	21	SENT_2	530/541
21	Pharmacokinetics	NNS	O	pharmacokinetic	dep	46	SENT_2	542/558
22	and	CC	O	and		-1	SENT_2	559/562
23	Metabolism	NN	O	metabolism	conj_and	21	SENT_2	563/573
24	,	,	O	,		-1	SENT_2	573/574
25	Actelion	NNP	ORGANIZATION	Actelion	nn	27	SENT_2	575/583
26	Pharmaceuticals	NNPS	ORGANIZATION	Pharmaceuticals	nn	27	SENT_2	584/599
27	Ltd	NNP	ORGANIZATION	Ltd	appos	21	SENT_2	600/603
28	,	,	O	,		-1	SENT_2	603/604
29	Allschwil	NNP	O	Allschwil	appos	21	SENT_2	605/614
30	,	,	O	,		-1	SENT_2	614/615
31	Switzerland	NNP	LOCATION	Switzerland	nn	32	SENT_2	616/627
32	BIOTRIAL	NNP	LOCATION	BIOTRIAL	appos	21	SENT_2	628/636
33	,	,	O	,		-1	SENT_2	636/637
34	7-9	CD	NUMBER	7-9	num	37	SENT_2	638/641
35	Rue	NNP	O	Rue	nn	37	SENT_2	642/645
36	Jean-Louis	NNP	PERSON	Jean-Louis	nn	37	SENT_2	646/656
37	Bertrand	NNP	PERSON	Bertrand	appos	21	SENT_2	657/665
38	,	,	O	,		-1	SENT_2	665/666
39	35000	CD	NUMBER	35000	num	41	SENT_2	667/672
40	Rennes	NNP	ORGANIZATION	Rennes	nn	41	SENT_2	673/679
41	Cedex	NNP	ORGANIZATION	Cedex	appos	21	SENT_2	680/685
42	,	,	O	,		-1	SENT_2	685/686
43	France	NNP	LOCATION	France	appos	21	SENT_2	687/693
44	2212201132012141687820920111122011	CD	NUMBER	2212201132012141687820920111122011	dep	46	SENT_2	694/728
45	(	CD	NUMBER	(	num	46	SENT_2	728/729
46	C	NN	O	c	dep	53	SENT_2	729/730
47	)	CD	NUMBER	)	dep	46	SENT_2	730/731
48	The	DT	O	the	det	50	SENT_2	732/735
49	Author	NN	O	author	nn	50	SENT_2	736/742
50	(	NN	O	(	nsubj	53	SENT_2	742/743
51	s	VBZ	O	s	cop	53	SENT_2	743/744
52	)	CD	NUMBER	)	num	53	SENT_2	744/745
53	2011	CD	DATE	2011	dep	2	SENT_2	746/750

1	Macitentan	NNP	O	Macitentan	nsubj	7	SENT_3	767/777
2	is	VBZ	O	be	cop	7	SENT_3	778/780
3	a	DT	O	a	det	7	SENT_3	781/782
4	dual	JJ	O	dual	amod	7	SENT_3	783/787
5	endothelin	NN	O	endothelin	nn	7	SENT_3	788/798
6	receptor	NN	O	receptor	nn	7	SENT_3	799/807
7	antagonist	NN	O	antagonist		-1	SENT_3	808/818
8	under	IN	O	under		-1	SENT_3	819/824
9	phase	NN	O	phase	nn	11	SENT_3	825/830
10	3	CD	NUMBER	3	num	11	SENT_3	831/832
11	investigation	NN	O	investigation	prep_under	7	SENT_3	833/846
12	in	IN	O	in		-1	SENT_3	847/849
13	pulmonary	JJ	O	pulmonary	amod	15	SENT_3	850/859
14	arterial	JJ	O	arterial	amod	15	SENT_3	860/868
15	hypertension	NN	O	hypertension	prep_in	11	SENT_3	869/881
16	.	.	O	.		-1	SENT_3	881/882

1	We	PRP	O	we	nsubj	2	SENT_4	883/885
2	investigated	VBD	O	investigate		-1	SENT_4	886/898
3	the	DT	O	the	det	4	SENT_4	899/902
4	effect	NN	O	effect	dep	9	SENT_4	903/909
5	of	IN	O	of		-1	SENT_4	910/912
6	cyclosporine	NN	O	cyclosporine	prep_of	4	SENT_4	913/925
7	(	CD	NUMBER	(	num	8	SENT_4	926/927
8	Cs	NNS	O	c	dep	9	SENT_4	927/929
9	)	CD	NUMBER	)	dep	2	SENT_4	929/930
10	and	CC	O	and		-1	SENT_4	931/934
11	rifampin	NN	O	rifampin	conj_and	9	SENT_4	935/943
12	on	IN	O	on		-1	SENT_4	944/946
13	the	DT	O	the	det	14	SENT_4	947/950
14	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	9	SENT_4	951/967
15	of	IN	O	of		-1	SENT_4	968/970
16	macitentan	NN	O	macitentan	prep_of	14	SENT_4	971/981
17	and	CC	O	and		-1	SENT_4	982/985
18	its	PRP$	O	its	poss	19	SENT_4	986/989
19	metabolites	NNS	O	metabolite	conj_and	16	SENT_4	990/1001
20	ACT-132577	NN	O	act-132577	dobj	2	SENT_4	1002/1012
21	and	CC	O	and		-1	SENT_4	1013/1016
22	ACT-373898	NN	O	act-373898	conj_and	20	SENT_4	1017/1027
23	in	IN	O	in		-1	SENT_4	1028/1030
24	healthy	JJ	O	healthy	amod	26	SENT_4	1031/1038
25	male	JJ	O	male	amod	26	SENT_4	1039/1043
26	subjects	NNS	O	subject	prep_in	20	SENT_4	1044/1052
27	.	.	O	.		-1	SENT_4	1052/1053

1	In	IN	O	in	dep	6	SENT_5	1054/1056
2	addition	NN	O	addition	pobj	1	SENT_5	1057/1065
3	,	,	O	,		-1	SENT_5	1065/1066
4	in	FW	O	in	nn	5	SENT_5	1067/1069
5	vitro	FW	O	vitro	dep	1	SENT_5	1070/1075
6	studies	NNS	O	study	nsubjpass	8	SENT_5	1076/1083
7	were	VBD	O	be	auxpass	8	SENT_5	1084/1088
8	performed	VBN	O	perform		-1	SENT_5	1089/1098
9	to	TO	O	to	aux	10	SENT_5	1099/1101
10	investigate	VB	O	investigate	xcomp	8	SENT_5	1102/1113
11	interactions	NNS	O	interaction	dobj	10	SENT_5	1114/1126
12	between	IN	O	between		-1	SENT_5	1127/1134
13	macitentan	NN	O	macitentan	prep_between	11	SENT_5	1135/1145
14	and	CC	O	and		-1	SENT_5	1146/1149
15	its	PRP$	O	its	poss	18	SENT_5	1150/1153
16	active	JJ	O	active	amod	18	SENT_5	1154/1160
17	metabolite	NN	O	metabolite	nn	18	SENT_5	1161/1171
18	ACT-132577	NN	O	act-132577	conj_and	11	SENT_5	1172/1182
19	with	IN	O	with		-1	SENT_5	1183/1187
20	human	JJ	O	human	amod	22	SENT_5	1188/1193
21	organic	JJ	O	organic	amod	22	SENT_5	1194/1201
22	anion	NN	O	anion	prep_with	18	SENT_5	1202/1207
23	-	:	O	-		-1	SENT_5	1207/1208
24	transporting	VBG	O	transport	parataxis	8	SENT_5	1209/1221
25	polypeptides	NNS	O	polypeptide	nsubj	27	SENT_5	1222/1234
26	(	CD	NUMBER	(	num	27	SENT_5	1235/1236
27	OATPs	NNS	O	oatp	xcomp	24	SENT_5	1236/1241
28	)	CD	NUMBER	)	dep	27	SENT_5	1241/1242
29	.	.	O	.		-1	SENT_5	1242/1243

1	The	DT	O	the	det	6	SENT_6	1244/1247
2	clinical	JJ	O	clinical	amod	6	SENT_6	1248/1256
3	study	NN	O	study	nn	6	SENT_6	1257/1262
4	(	CD	NUMBER	(	num	6	SENT_6	1263/1264
5	AC-055-111	NN	O	ac-055-111	nn	6	SENT_6	1264/1274
6	)	NN	O	)	nsubjpass	8	SENT_6	1274/1275
7	was	VBD	O	be	auxpass	8	SENT_6	1276/1279
8	conducted	VBN	O	conduct		-1	SENT_6	1280/1289
9	as	IN	O	as		-1	SENT_6	1290/1292
10	a	DT	O	a	det	16	SENT_6	1293/1294
11	two-part	JJ	O	two-part	amod	16	SENT_6	1295/1303
12	,	,	O	,		-1	SENT_6	1303/1304
13	one-sequence	NN	O	one-sequence	dep	16	SENT_6	1305/1317
14	,	,	O	,		-1	SENT_6	1317/1318
15	crossover	NN	O	crossover	dep	16	SENT_6	1319/1328
16	study	NN	O	study	prep_as	8	SENT_6	1329/1334
17	.	.	O	.		-1	SENT_6	1334/1335

1	Ten	CD	NUMBER	ten	num	2	SENT_7	1336/1339
2	subjects	NNS	O	subject	nsubj	6	SENT_7	1340/1348
3	in	IN	O	in		-1	SENT_7	1349/1351
4	each	DT	O	each	det	5	SENT_7	1352/1356
5	part	NN	O	part	prep_in	2	SENT_7	1357/1361
6	received	VBD	O	receive		-1	SENT_7	1362/1370
7	multiple-dose	JJ	O	multiple-dose	amod	8	SENT_7	1371/1384
8	macitentan	NN	O	macitentan	dobj	6	SENT_7	1385/1395
9	followed	VBN	O	follow		-1	SENT_7	1396/1404
10	by	IN	O	by	prepc_followed_by	6	SENT_7	1405/1407
11	multiple-dose	JJ	O	multiple-dose	amod	12	SENT_7	1408/1421
12	co	NN	O	co	pobj	6	SENT_7	1422/1424
13	-	:	O	-		-1	SENT_7	1424/1425
14	administration	NN	O	administration	dep	20	SENT_7	1426/1440
15	of	IN	O	of		-1	SENT_7	1441/1443
16	Cs	NNP	O	Cs	nn	18	SENT_7	1444/1446
17	(	CD	NUMBER	(	num	18	SENT_7	1447/1448
18	part	NN	O	part	prep_of	14	SENT_7	1448/1452
19	A	DT	O	a	det	20	SENT_7	1453/1454
20	)	NN	O	)	parataxis	6	SENT_7	1454/1455
21	or	CC	O	or		-1	SENT_7	1456/1458
22	rifampin	NN	O	rifampin	nn	26	SENT_7	1459/1467
23	(	CD	NUMBER	(	num	26	SENT_7	1468/1469
24	part	NN	O	part	nn	26	SENT_7	1469/1473
25	B	NN	O	b	nn	26	SENT_7	1474/1475
26	)	NN	O	)	conj_or	20	SENT_7	1475/1476
27	.	.	O	.		-1	SENT_7	1476/1477

1	In	IN	O	in		-1	SENT_8	1478/1480
2	the	DT	O	the	det	3	SENT_8	1481/1484
3	presence	NN	O	presence	prep_in	25	SENT_8	1485/1493
4	of	IN	O	of		-1	SENT_8	1494/1496
5	Cs	NNP	O	Cs	prep_of	3	SENT_8	1497/1499
6	,	,	O	,		-1	SENT_8	1499/1500
7	steady-state	JJ	O	steady-state	amod	8	SENT_8	1501/1513
8	area	NN	O	area	nsubj	25	SENT_8	1514/1518
9	under	IN	O	under		-1	SENT_8	1519/1524
10	the	DT	O	the	det	13	SENT_8	1525/1528
11	plasma	NN	O	plasma	nn	13	SENT_8	1529/1535
12	concentration-time	NN	O	concentration-time	nn	13	SENT_8	1536/1554
13	profiles	NNS	O	profile	prep_under	8	SENT_8	1555/1563
14	during	IN	O	during		-1	SENT_8	1564/1570
15	a	DT	O	a	det	20	SENT_8	1571/1572
16	dose	NN	O	dose	nn	20	SENT_8	1573/1577
17	interval	NN	O	interval	nn	20	SENT_8	1578/1586
18	(	CD	NUMBER	(	num	20	SENT_8	1587/1588
19	AUC	NN	O	auc	nn	20	SENT_8	1588/1591
20	)	NN	O	)	prep_during	13	SENT_8	1593/1594
21	for	IN	O	for		-1	SENT_8	1595/1598
22	macitentan	NN	O	macitentan	prep_for	20	SENT_8	1599/1609
23	and	CC	O	and		-1	SENT_8	1610/1613
24	ACT-373898	NN	O	act-373898	conj_and	22	SENT_8	1614/1624
25	increased	VBD	O	increase		-1	SENT_8	1625/1634
26	10	CD	PERCENT	10	num	27	SENT_8	1635/1637
27	%	NN	PERCENT	%	dobj	25	SENT_8	1637/1638
28	and	CC	O	and		-1	SENT_8	1639/1642
29	7	CD	PERCENT	7	num	30	SENT_8	1643/1644
30	%	NN	PERCENT	%	conj_and	27	SENT_8	1644/1645
31	,	,	O	,		-1	SENT_8	1645/1646
32	respectively	RB	O	respectively	advmod	27	SENT_8	1647/1659
33	,	,	O	,		-1	SENT_8	1659/1660
34	and	CC	O	and		-1	SENT_8	1661/1664
35	decreased	VBD	O	decrease	conj_and	25	SENT_8	1665/1674
36	3	CD	PERCENT	3	num	37	SENT_8	1675/1676
37	%	NN	PERCENT	%	dobj	35	SENT_8	1676/1677
38	for	IN	O	for		-1	SENT_8	1678/1681
39	ACT-132577	NN	O	act-132577	prep_for	35	SENT_8	1682/1692
40	.	.	O	.		-1	SENT_8	1692/1693

1	Steady-state	JJ	O	steady-state	amod	2	SENT_9	1694/1706
2	AUC	NN	O	auc	nsubj	12	SENT_9	1707/1710
3	of	IN	O	of		-1	SENT_9	1713/1715
4	macitentan	NN	O	macitentan	prep_of	2	SENT_9	1716/1726
5	and	CC	O	and		-1	SENT_9	1727/1730
6	ACT-373898	NN	O	act-373898	conj_and	4	SENT_9	1731/1741
7	in	IN	O	in		-1	SENT_9	1742/1744
8	the	DT	O	the	det	9	SENT_9	1745/1748
9	presence	NN	O	presence	prep_in	4	SENT_9	1749/1757
10	of	IN	O	of		-1	SENT_9	1758/1760
11	rifampin	NN	O	rifampin	prep_of	9	SENT_9	1761/1769
12	decreased	VBD	O	decrease		-1	SENT_9	1770/1779
13	79	CD	PERCENT	79	num	14	SENT_9	1780/1782
14	%	NN	PERCENT	%	dobj	12	SENT_9	1782/1783
15	and	CC	O	and		-1	SENT_9	1784/1787
16	64	CD	PERCENT	64	num	17	SENT_9	1788/1790
17	%	NN	PERCENT	%	conj_and	14	SENT_9	1790/1791
18	,	,	O	,		-1	SENT_9	1791/1792
19	respectively	RB	O	respectively	advmod	12	SENT_9	1793/1805
20	.	.	O	.		-1	SENT_9	1805/1806

1	For	IN	O	for		-1	SENT_10	1807/1810
2	ACT-132577	NN	O	act-132577	prep_for	14	SENT_10	1811/1821
3	,	,	O	,		-1	SENT_10	1821/1822
4	no	DT	O	no	det	6	SENT_10	1823/1825
5	relevant	JJ	O	relevant	amod	6	SENT_10	1826/1834
6	difference	NN	O	difference	nsubjpass	14	SENT_10	1835/1845
7	in	IN	O	in		-1	SENT_10	1846/1848
8	AUC	NN	O	auc	prep_in	6	SENT_10	1849/1852
9	between	IN	O	between		-1	SENT_10	1855/1862
10	the	DT	O	the	det	12	SENT_10	1863/1866
11	two	CD	NUMBER	two	num	12	SENT_10	1867/1870
12	treatments	NNS	O	treatment	prep_between	8	SENT_10	1871/1881
13	was	VBD	O	be	auxpass	14	SENT_10	1882/1885
14	observed	VBN	O	observe		-1	SENT_10	1886/1894
15	.	.	O	.		-1	SENT_10	1894/1895

1	Macitentan	NNP	O	Macitentan	nsubjpass	9	SENT_11	1896/1906
2	co-administered	JJ	O	co-administered	amod	1	SENT_11	1907/1922
3	with	IN	O	with		-1	SENT_11	1923/1927
4	Cs	NNS	O	c	prep_with	2	SENT_11	1928/1930
5	or	CC	O	or		-1	SENT_11	1931/1933
6	rifampin	NN	O	rifampin	conj_or	4	SENT_11	1934/1942
7	was	VBD	O	be	auxpass	9	SENT_11	1943/1946
8	well	RB	O	well	advmod	9	SENT_11	1947/1951
9	tolerated	VBN	O	tolerate		-1	SENT_11	1952/1961
10	.	.	O	.		-1	SENT_11	1961/1962

1	The	DT	O	the	det	2	SENT_12	1963/1966
2	complementary	JJ	O	complementary	nsubj	6	SENT_12	1967/1980
3	in	FW	O	in	nn	5	SENT_12	1981/1983
4	vitro	FW	O	vitro	dep	5	SENT_12	1984/1989
5	studies	NNS	O	study	advmod	6	SENT_12	1990/1997
6	demonstrated	VBD	O	demonstrate		-1	SENT_12	1998/2010
7	no	DT	O	no	det	9	SENT_12	2011/2013
8	marked	JJ	O	marked	amod	9	SENT_12	2014/2020
9	differences	NNS	O	difference	dobj	6	SENT_12	2021/2032
10	in	IN	O	in		-1	SENT_12	2033/2035
11	uptake	NN	O	uptake	nn	12	SENT_12	2036/2042
12	rates	NNS	O	rate	prep_in	9	SENT_12	2043/2048
13	of	IN	O	of		-1	SENT_12	2049/2051
14	macitentan	NN	O	macitentan	prep_of	12	SENT_12	2052/2062
15	and	CC	O	and		-1	SENT_12	2063/2066
16	ACT-132577	NN	O	act-132577	conj_and	14	SENT_12	2067/2077
17	between	IN	O	between		-1	SENT_12	2078/2085
18	the	DT	O	the	dep	19	SENT_12	2086/2089
19	wild-type	JJ	O	wild-type	prep_between	9	SENT_12	2090/2099
20	and	CC	O	and		-1	SENT_12	2100/2103
21	OATP	NN	O	oatp	nn	23	SENT_12	2104/2108
22	over-expressing	NN	O	over-expressing	nn	23	SENT_12	2109/2124
23	cells	NNS	O	cell	conj_and	19	SENT_12	2125/2130
24	over	IN	O	over		-1	SENT_12	2131/2135
25	the	DT	O	the	det	27	SENT_12	2136/2139
26	concentration	NN	O	concentration	nn	27	SENT_12	2140/2153
27	range	NN	O	range	prep_over	19	SENT_12	2154/2159
28	tested	VBN	O	test	partmod	27	SENT_12	2160/2166
29	.	.	O	.		-1	SENT_12	2166/2167

1	Concomitant	JJ	O	concomitant	amod	2	SENT_13	2168/2179
2	treatment	NN	O	treatment	nsubj	7	SENT_13	2180/2189
3	with	IN	O	with		-1	SENT_13	2190/2194
4	Cs	NNS	PERSON	c	prep_with	2	SENT_13	2195/2197
5	did	VBD	O	do	aux	7	SENT_13	2198/2201
6	not	RB	O	not	neg	7	SENT_13	2202/2205
7	have	VB	O	have		-1	SENT_13	2206/2210
8	any	DT	O	any	det	11	SENT_13	2211/2214
9	clinically	RB	O	clinically	advmod	10	SENT_13	2215/2225
10	relevant	JJ	O	relevant	amod	11	SENT_13	2226/2234
11	effect	NN	O	effect	dobj	7	SENT_13	2235/2241
12	on	IN	O	on		-1	SENT_13	2242/2244
13	the	DT	O	the	det	14	SENT_13	2245/2248
14	exposure	NN	O	exposure	prep_on	11	SENT_13	2249/2257
15	to	TO	O	to		-1	SENT_13	2258/2260
16	macitentan	NN	O	macitentan	prep_to	7	SENT_13	2261/2271
17	or	CC	O	or		-1	SENT_13	2272/2274
18	its	PRP$	O	its	poss	19	SENT_13	2275/2278
19	metabolites	NNS	O	metabolite	conj_or	16	SENT_13	2279/2290
20	,	,	O	,		-1	SENT_13	2290/2291
21	at	IN	O	at		-1	SENT_13	2292/2294
22	steady-state	JJ	O	steady-state	prep_at	7	SENT_13	2295/2307
23	.	.	O	.		-1	SENT_13	2307/2308

1	Concomitant	JJ	O	concomitant	amod	2	SENT_14	2309/2320
2	treatment	NN	O	treatment	nsubj	5	SENT_14	2321/2330
3	with	IN	O	with		-1	SENT_14	2331/2335
4	rifampin	NN	O	rifampin	prep_with	2	SENT_14	2336/2344
5	reduced	VBD	O	reduce		-1	SENT_14	2345/2352
6	significantly	RB	O	significantly	advmod	5	SENT_14	2353/2366
7	the	DT	O	the	det	8	SENT_14	2367/2370
8	exposure	NN	O	exposure	pobj	6	SENT_14	2371/2379
9	to	TO	O	to		-1	SENT_14	2380/2382
10	macitentan	NN	O	macitentan	prep_to	6	SENT_14	2383/2393
11	and	CC	O	and		-1	SENT_14	2394/2397
12	its	PRP$	O	its	poss	14	SENT_14	2398/2401
13	metabolite	NN	O	metabolite	nn	14	SENT_14	2402/2412
14	ACT-373898	NN	O	act-373898	conj_and	10	SENT_14	2413/2423
15	at	IN	O	at		-1	SENT_14	2424/2426
16	steady-state	JJ	O	steady-state	prep_at	5	SENT_14	2427/2439
17	but	CC	O	but		-1	SENT_14	2440/2443
18	did	VBD	O	do	aux	20	SENT_14	2444/2447
19	not	RB	O	not	neg	20	SENT_14	2448/2451
20	affect	VB	O	affect	conj_but	5	SENT_14	2452/2458
21	the	DT	O	the	det	22	SENT_14	2459/2462
22	exposure	NN	O	exposure	dobj	20	SENT_14	2463/2471
23	to	TO	O	to		-1	SENT_14	2472/2474
24	the	DT	O	the	det	27	SENT_14	2475/2478
25	active	JJ	O	active	amod	27	SENT_14	2479/2485
26	metabolite	NN	O	metabolite	nn	27	SENT_14	2486/2496
27	ACT-132577	NN	O	act-132577	prep_to	20	SENT_14	2497/2507
28	to	TO	O	to		-1	SENT_14	2508/2510
29	a	DT	O	a	det	32	SENT_14	2511/2512
30	clinically	RB	O	clinically	advmod	31	SENT_14	2513/2523
31	relevant	JJ	O	relevant	amod	32	SENT_14	2524/2532
32	extent	NN	O	extent	prep_to	20	SENT_14	2533/2539
33	.	.	O	.		-1	SENT_14	2539/2540

1	KEY	JJ	O	key	amod	2	SENT_15	2576/2579
2	WORDS	NNS	O	word		-1	SENT_15	2580/2585

1	cyclosporine	NN	O	cyclosporine	dep	12	SENT_16	2602/2614
2	(	CD	NUMBER	(	num	3	SENT_16	2615/2616
3	Cs	NNS	O	c	dep	1	SENT_16	2616/2618
4	)	CD	NUMBER	)	num	5	SENT_16	2618/2619
5	endothelinmacitentanpharmacokineticsrifampinissue-copyright	NN	O	endothelinmacitentanpharmacokineticsrifampinissue-copyright	dep	3	SENT_16	2619/2678
6	-	:	O	-		-1	SENT_16	2678/2679
7	statement	NN	O	statement	dep	3	SENT_16	2680/2689
8	(	CD	NUMBER	(	num	7	SENT_16	2689/2690
9	C	NN	O	c	dep	12	SENT_16	2690/2691
10	)	CD	NUMBER	)	num	9	SENT_16	2691/2692
11	American	NNP	O	American	nn	12	SENT_16	2693/2701
12	Association	NNP	O	Association	dep	16	SENT_16	2702/2713
13	of	IN	O	of		-1	SENT_16	2714/2716
14	Pharmaceutical	NNP	O	Pharmaceutical	nn	15	SENT_16	2717/2731
15	Scientists	NNS	O	scientist	prep_of	12	SENT_16	2732/2742
16	2012	CD	DATE	2012		-1	SENT_16	2743/2747

1	INTRODUCTION	NN	O	introduction		-1	SENT_17	2764/2776

1	Macitentan	NNP	O	Macitentan	nsubj	13	SENT_18	2812/2822
2	(	CD	NUMBER	(	num	4	SENT_18	2823/2824
3	ACT-064992	NN	O	act-064992	nn	4	SENT_18	2824/2834
4	)	NN	O	)	dep	1	SENT_18	2834/2835
5	is	VBZ	O	be	cop	13	SENT_18	2836/2838
6	an	DT	O	a	det	13	SENT_18	2839/2841
7	orally	RB	O	orally	advmod	8	SENT_18	2842/2848
8	active	JJ	O	active	amod	13	SENT_18	2849/2855
9	,	,	O	,		-1	SENT_18	2855/2856
10	tissue-targeting	JJ	O	tissue-targeting	amod	13	SENT_18	2857/2873
11	dual	JJ	O	dual	amod	13	SENT_18	2874/2878
12	endothelin	JJ	O	endothelin	amod	13	SENT_18	2879/2889
13	ETA	NNP	ORGANIZATION	ETA		-1	SENT_18	2890/2893
14	and	CC	O	and		-1	SENT_18	2894/2897
15	ETB	NN	O	etb	nn	17	SENT_18	2898/2901
16	receptor	NN	O	receptor	nn	17	SENT_18	2902/2910
17	antagonist	NN	O	antagonist	conj_and	13	SENT_18	2911/2921
18	(	CD	NUMBER	(	num	20	SENT_18	2922/2923
19	ERA	NN	O	era	nn	20	SENT_18	2923/2926
20	)	NN	O	)	dep	13	SENT_18	2926/2927
21	under	IN	O	under		-1	SENT_18	2928/2933
22	phase	NN	O	phase	nn	24	SENT_18	2934/2939
23	3	CD	NUMBER	3	num	24	SENT_18	2940/2941
24	investigation	NN	O	investigation	prep_under	20	SENT_18	2942/2955
25	in	IN	O	in		-1	SENT_18	2956/2958
26	pulmonary	JJ	O	pulmonary	amod	29	SENT_18	2959/2968
27	arterial	JJ	O	arterial	amod	29	SENT_18	2969/2977
28	hypertension	NN	O	hypertension	nn	29	SENT_18	2978/2990
29	(	NN	O	(	prep_in	24	SENT_18	2991/2992
30	1	CD	NUMBER	1	dep	29	SENT_18	2992/2993
31	,	,	O	,		-1	SENT_18	2993/2994
32	2	CD	NUMBER	2	num	33	SENT_18	2995/2996
33	)	NN	O	)	appos	29	SENT_18	2996/2997
34	.	.	O	.		-1	SENT_18	2997/2998

1	In	IN	O	in		-1	SENT_19	2999/3001
2	humans	NNS	O	human	prep_in	5	SENT_19	3002/3008
3	,	,	O	,		-1	SENT_19	3008/3009
4	macitentan	NN	O	macitentan	nsubj	5	SENT_19	3010/3020
5	shows	VBZ	O	show		-1	SENT_19	3021/3026
6	a	DT	O	a	det	8	SENT_19	3027/3028
7	slow	JJ	O	slow	amod	8	SENT_19	3029/3033
8	absorption	NN	O	absorption	dobj	5	SENT_19	3034/3044
9	;	:	O	;		-1	SENT_19	3044/3045
10	maximum	NN	O	maximum	nn	12	SENT_19	3046/3053
11	plasma	NN	O	plasma	nn	12	SENT_19	3054/3060
12	concentrations	NNS	O	concentration	nsubjpass	14	SENT_19	3061/3075
13	are	VBP	O	be	auxpass	14	SENT_19	3076/3079
14	achieved	VBN	O	achieve	parataxis	5	SENT_19	3080/3088
15	approximately	RB	O	approximately	quantmod	16	SENT_19	3089/3102
16	8	CD	NUMBER	8	num	17	SENT_19	3103/3104
17	h	NN	O	h	dobj	14	SENT_19	3105/3106
18	after	IN	O	after		-1	SENT_19	3107/3112
19	administration	NN	O	administration	prep_after	14	SENT_19	3113/3127
20	.	.	O	.		-1	SENT_19	3127/3128

1	In	IN	O	in		-1	SENT_20	3129/3131
2	addition	NN	O	addition		-1	SENT_20	3132/3140
3	to	TO	O	to		-1	SENT_20	3141/3143
4	macitentan	NN	O	macitentan	prep_in_addition_to	24	SENT_20	3144/3154
5	,	,	O	,		-1	SENT_20	3154/3155
6	two	CD	NUMBER	two	num	7	SENT_20	3156/3159
7	metabolites	NNS	O	metabolite	nsubjpass	24	SENT_20	3160/3171
8	,	,	O	,		-1	SENT_20	3171/3172
9	ACT-132577	NN	O	act-132577	nn	10	SENT_20	3173/3183
10	(	NN	O	(	appos	7	SENT_20	3184/3185
11	depropylated	VBN	O	depropylate	partmod	10	SENT_20	3185/3197
12	metabolite	NN	O	metabolite	nn	13	SENT_20	3198/3208
13	)	NN	O	)	dobj	11	SENT_20	3208/3209
14	and	CC	O	and		-1	SENT_20	3210/3213
15	ACT-373898	NN	O	act-373898	conj_and	13	SENT_20	3214/3224
16	(	CD	NUMBER	(	num	15	SENT_20	3225/3226
17	carboxylic	JJ	O	carboxylic	amod	20	SENT_20	3226/3236
18	acid	NN	O	acid	nn	20	SENT_20	3237/3241
19	metabolite	NN	O	metabolite	nn	20	SENT_20	3242/3252
20	)	NN	O	)	dep	15	SENT_20	3252/3253
21	,	,	O	,		-1	SENT_20	3253/3254
22	have	VBP	O	have	aux	24	SENT_20	3255/3259
23	been	VBN	O	be	auxpass	24	SENT_20	3260/3264
24	identified	VBN	O	identify		-1	SENT_20	3265/3275
25	in	IN	O	in		-1	SENT_20	3276/3278
26	plasma	NN	O	plasma	prep_in	24	SENT_20	3279/3285
27	with	IN	O	with		-1	SENT_20	3286/3290
28	ACT-132577	NN	O	act-132577	prep_with	26	SENT_20	3291/3301
29	being	VBG	O	be	cop	31	SENT_20	3302/3307
30	pharmacologically	RB	O	pharmacologically	advmod	31	SENT_20	3308/3325
31	active	JJ	O	active	xcomp	24	SENT_20	3326/3332
32	.	.	O	.		-1	SENT_20	3332/3333

1	While	IN	O	while	mark	11	SENT_21	3334/3339
2	the	DT	O	the	det	7	SENT_21	3340/3343
3	elimination	NN	O	elimination	nn	7	SENT_21	3344/3355
4	half-life	NN	O	half-life	nn	7	SENT_21	3356/3365
5	(	CD	NUMBER	(	num	7	SENT_21	3366/3367
6	t1/2	NN	O	t1/2	nn	7	SENT_21	3367/3371
7	)	NN	O	)	nsubj	11	SENT_21	3371/3372
8	is	VBZ	O	be	cop	11	SENT_21	3373/3375
9	approximately	RB	O	approximately	quantmod	10	SENT_21	3376/3389
10	16	CD	NUMBER	16	num	11	SENT_21	3390/3392
11	h	NN	O	h	advcl	16	SENT_21	3393/3394
12	for	IN	O	for		-1	SENT_21	3395/3398
13	macitentan	NN	O	macitentan	prep_for	11	SENT_21	3399/3409
14	,	,	O	,		-1	SENT_21	3409/3410
15	ACT-132577	NN	O	act-132577	nsubj	16	SENT_21	3411/3421
16	has	VBZ	O	have		-1	SENT_21	3422/3425
17	a	DT	O	a	det	18	SENT_21	3426/3427
18	t1/2	NN	O	t1/2	dobj	16	SENT_21	3428/3432
19	of	IN	O	of		-1	SENT_21	3433/3435
20	approximately	RB	O	approximately	quantmod	21	SENT_21	3436/3449
21	48	CD	NUMBER	48	prep_of	18	SENT_21	3450/3452
22	h.	NN	O	h.	nn	23	SENT_21	3453/3455
23	ACT-373898	NN	O	act-373898	nsubj	24	SENT_21	3456/3466
24	has	VBZ	O	have	rcmod	21	SENT_21	3467/3470
25	a	DT	O	a	det	31	SENT_21	3471/3472
26	similar	JJ	O	similar	amod	31	SENT_21	3473/3480
27	pharmacokinetic	JJ	O	pharmacokinetic	amod	31	SENT_21	3481/3496
28	(	NN	O	(	nn	31	SENT_21	3497/3498
29	PK	NN	O	pk	nn	31	SENT_21	3498/3500
30	)	NN	O	)	nn	31	SENT_21	3500/3501
31	profile	NN	O	profile	dobj	24	SENT_21	3502/3509
32	to	TO	O	to		-1	SENT_21	3510/3512
33	macitentan	NN	O	macitentan	prep_to	31	SENT_21	3513/3523
34	.	.	O	.		-1	SENT_21	3523/3524

1	There	EX	O	there	expl	2	SENT_22	3525/3530
2	are	VBP	O	be		-1	SENT_22	3531/3534
3	no	DT	O	no	det	5	SENT_22	3535/3537
4	notable	JJ	O	notable	amod	5	SENT_22	3538/3545
5	differences	NNS	O	difference	nn	27	SENT_22	3546/3557
6	in	IN	O	in		-1	SENT_22	3558/3560
7	PK	NN	O	pk	nn	8	SENT_22	3561/3563
8	parameters	NNS	O	parameter	prep_in	5	SENT_22	3564/3574
9	of	IN	O	of		-1	SENT_22	3575/3577
10	macitentan	NN	O	macitentan	prep_of	8	SENT_22	3578/3588
11	and	CC	O	and		-1	SENT_22	3589/3592
12	its	PRP$	O	its	poss	14	SENT_22	3593/3596
13	active	JJ	O	active	amod	14	SENT_22	3597/3603
14	metabolite	NN	O	metabolite	conj_and	8	SENT_22	3604/3614
15	between	IN	O	between		-1	SENT_22	3615/3622
16	males	NNS	O	male	prep_between	14	SENT_22	3623/3628
17	and	CC	O	and		-1	SENT_22	3629/3632
18	females	NNS	O	female	conj_and	16	SENT_22	3633/3640
19	and/or	RB	O	and/or	advmod	16	SENT_22	3641/3647
20	between	IN	O	between		-1	SENT_22	3648/3655
21	Caucasian	JJ	LOCATION	caucasian	amod	24	SENT_22	3656/3665
22	and	CC	O	and		-1	SENT_22	3666/3669
23	Japanese	JJ	O	japanese	conj_and	21	SENT_22	3670/3678
24	subjects	NNS	O	subject	prep_between	16	SENT_22	3679/3687
25	(	JJ	O	(	amod	27	SENT_22	3688/3689
26	3	CD	NUMBER	3	tmod	25	SENT_22	3689/3690
27	)	NN	O	)	nsubj	2	SENT_22	3690/3691
28	.	.	O	.		-1	SENT_22	3691/3692

1	In	IN	O	in		-1	SENT_23	3693/3695
2	addition	NN	O	addition	prep_in	7	SENT_23	3696/3704
3	,	,	O	,		-1	SENT_23	3704/3705
4	macitentan	NN	O	macitentan	nsubjpass	7	SENT_23	3706/3716
5	can	MD	O	can	aux	7	SENT_23	3717/3720
6	be	VB	O	be	auxpass	7	SENT_23	3721/3723
7	given	VBN	O	give		-1	SENT_23	3724/3729
8	to	TO	O	to		-1	SENT_23	3730/3732
9	subjects	NNS	O	subject	prep_to	7	SENT_23	3733/3741
10	irrespective	JJ	O	irrespective	amod	9	SENT_23	3742/3754
11	of	IN	O	of		-1	SENT_23	3755/3757
12	food	NN	O	food	nn	13	SENT_23	3758/3762
13	intake	NN	O	intake	prep_of	9	SENT_23	3763/3769
14	.	.	O	.		-1	SENT_23	3769/3770

1	Early	JJ	O	early	amod	3	SENT_24	3806/3811
2	phase	NN	O	phase	nn	3	SENT_24	3812/3817
3	studies	NNS	O	study	nsubj	5	SENT_24	3818/3825
4	have	VBP	O	have	aux	5	SENT_24	3826/3830
5	shown	VBN	O	show		-1	SENT_24	3831/3836
6	macitentan	NN	O	macitentan	dobj	5	SENT_24	3837/3847
7	to	TO	O	to	aux	8	SENT_24	3848/3850
8	have	VB	O	have	xcomp	5	SENT_24	3851/3855
9	a	DT	O	a	det	11	SENT_24	3856/3857
10	good	JJ	O	good	amod	11	SENT_24	3858/3862
11	safety	NN	O	safety	dobj	8	SENT_24	3863/3869
12	and	CC	O	and		-1	SENT_24	3870/3873
13	tolerability	NN	O	tolerability	nn	14	SENT_24	3874/3886
14	profile	NN	O	profile	conj_and	11	SENT_24	3887/3894
15	.	.	O	.		-1	SENT_24	3894/3895

1	The	DT	O	the	det	6	SENT_25	3896/3899
2	most	RBS	O	most	advmod	3	SENT_25	3900/3904
3	frequently	RB	O	frequently	advmod	4	SENT_25	3905/3915
4	reported	VBN	O	report	amod	6	SENT_25	3916/3924
5	adverse	JJ	O	adverse	amod	6	SENT_25	3925/3932
6	event	NN	O	event		-1	SENT_25	3933/3938
7	(	NN	O	(	nn	9	SENT_25	3939/3940
8	AE	NN	O	ae	nn	9	SENT_25	3940/3942
9	)	NN	O	)	dep	6	SENT_25	3942/3943
10	is	VBZ	O	be	cop	11	SENT_25	3944/3946
11	headache	NN	O	headache	rcmod	9	SENT_25	3947/3955
12	(	CD	NUMBER	(	num	11	SENT_25	3956/3957
13	2,4	CD	NUMBER	2,4	num	14	SENT_25	3957/3960
14	)	NN	O	)	dep	11	SENT_25	3960/3961
15	.	.	O	.		-1	SENT_25	3961/3962

1	Cyclosporine	NN	O	cyclosporine	nsubjpass	8	SENT_26	3998/4010
2	(	CD	NUMBER	(	num	3	SENT_26	4011/4012
3	Cs	NNS	O	c	dep	1	SENT_26	4012/4014
4	)	CD	NUMBER	)	dep	1	SENT_26	4014/4015
5	and	CC	O	and		-1	SENT_26	4016/4019
6	rifampin	NN	O	rifampin	conj_and	4	SENT_26	4020/4028
7	were	VBD	O	be	auxpass	8	SENT_26	4029/4033
8	used	VBN	O	use		-1	SENT_26	4034/4038
9	to	TO	O	to	aux	10	SENT_26	4039/4041
10	investigate	VB	O	investigate	xcomp	8	SENT_26	4042/4053
11	the	DT	O	the	det	12	SENT_26	4054/4057
12	role	NN	O	role	dobj	10	SENT_26	4058/4062
13	of	IN	O	of		-1	SENT_26	4063/4065
14	metabolism	NN	O	metabolism	nn	17	SENT_26	4066/4076
15	and	CC	O	and		-1	SENT_26	4077/4080
16	drug	NN	O	drug	conj_and	14	SENT_26	4081/4085
17	transport	NN	O	transport	prep_of	12	SENT_26	4086/4095
18	in	IN	O	in		-1	SENT_26	4096/4098
19	the	DT	O	the	det	20	SENT_26	4099/4102
20	disposition	NN	O	disposition	prep_in	10	SENT_26	4103/4114
21	of	IN	O	of		-1	SENT_26	4115/4117
22	macitentan	NN	O	macitentan	prep_of	20	SENT_26	4118/4128
23	.	.	O	.		-1	SENT_26	4128/4129

1	The	DT	O	the	det	3	SENT_27	4130/4133
2	immunosuppressant	JJ	O	immunosuppressant	amod	3	SENT_27	4134/4151
3	Cs	NN	O	c	nsubj	6	SENT_27	4152/4154
4	is	VBZ	O	be	cop	6	SENT_27	4155/4157
5	an	DT	O	a	det	6	SENT_27	4158/4160
6	inhibitor	NN	O	inhibitor		-1	SENT_27	4161/4170
7	of	IN	O	of		-1	SENT_27	4171/4173
8	CYP3A4	NN	O	cyp3a4	prep_of	6	SENT_27	4174/4180
9	,	,	O	,		-1	SENT_27	4180/4181
10	the	DT	O	the	det	13	SENT_27	4182/4185
11	hepatic	JJ	O	hepatic	amod	13	SENT_27	4186/4193
12	uptake	NN	O	uptake	nn	13	SENT_27	4194/4200
13	transporter	NN	O	transporter	appos	8	SENT_27	4201/4212
14	organic	JJ	O	organic	amod	15	SENT_27	4213/4220
15	anion	NN	O	anion	dep	13	SENT_27	4221/4226
16	-	:	O	-		-1	SENT_27	4226/4227
17	transporting	VBG	O	transport	parataxis	6	SENT_27	4228/4240
18	polypeptide	NN	O	polypeptide	nn	20	SENT_27	4241/4252
19	(	CD	NUMBER	(	num	20	SENT_27	4253/4254
20	OATP	NN	O	oatp	dobj	17	SENT_27	4254/4258
21	)	CD	NUMBER	)	num	22	SENT_27	4258/4259
22	(	NN	O	(	dep	20	SENT_27	4260/4261
23	5	CD	NUMBER	5	num	24	SENT_27	4261/4262
24	)	NN	O	)	dep	20	SENT_27	4262/4263
25	,	,	O	,		-1	SENT_27	4263/4264
26	and	CC	O	and		-1	SENT_27	4265/4268
27	the	DT	O	the	det	30	SENT_27	4269/4272
28	efflux	NN	O	efflux	nn	30	SENT_27	4273/4279
29	transporter	NN	O	transporter	nn	30	SENT_27	4280/4291
30	P-glycoprotein	NN	O	p-glycoprotein	conj_and	20	SENT_27	4292/4306
31	(	CD	NUMBER	(	number	32	SENT_27	4307/4308
32	6	CD	NUMBER	6	num	33	SENT_27	4308/4309
33	)	NN	O	)	dep	30	SENT_27	4309/4310
34	.	.	O	.		-1	SENT_27	4310/4311

1	Rifampin	NNP	O	Rifampin	nsubj	16	SENT_28	4312/4320
2	,	,	O	,		-1	SENT_28	4320/4321
3	an	DT	O	a	det	4	SENT_28	4322/4324
4	antibiotic	JJ	O	antibiotic	appos	1	SENT_28	4325/4335
5	mainly	RB	O	mainly	advmod	6	SENT_28	4336/4342
6	used	VBN	O	use	partmod	4	SENT_28	4343/4347
7	for	IN	O	for		-1	SENT_28	4348/4351
8	the	DT	O	the	det	9	SENT_28	4352/4355
9	treatment	NN	O	treatment	prep_for	6	SENT_28	4356/4365
10	of	IN	O	of		-1	SENT_28	4366/4368
11	tuberculosis	NN	O	tuberculosis	prep_of	9	SENT_28	4369/4381
12	,	,	O	,		-1	SENT_28	4381/4382
13	is	VBZ	O	be	cop	16	SENT_28	4383/4385
14	a	DT	O	a	det	16	SENT_28	4386/4387
15	strong	JJ	O	strong	amod	16	SENT_28	4388/4394
16	inducer	NN	O	inducer		-1	SENT_28	4395/4402
17	of	IN	O	of		-1	SENT_28	4403/4405
18	CYP3A4	NN	O	cyp3a4	prep_of	16	SENT_28	4406/4412
19	and	CC	O	and		-1	SENT_28	4413/4416
20	an	DT	O	a	det	22	SENT_28	4417/4419
21	effective	JJ	O	effective	amod	22	SENT_28	4420/4429
22	inhibitor	NN	O	inhibitor	conj_and	16	SENT_28	4430/4439
23	of	IN	O	of		-1	SENT_28	4440/4442
24	OATP	NN	O	oatp	prep_of	22	SENT_28	4443/4447
25	(	CD	NUMBER	(	num	24	SENT_28	4448/4449
26	7-9	CD	NUMBER	7-9	num	27	SENT_28	4449/4452
27	)	NN	O	)	dep	22	SENT_28	4452/4453
28	.	.	O	.		-1	SENT_28	4453/4454

1	As	IN	O	as	mark	7	SENT_29	4455/4457
2	the	DT	O	the	det	3	SENT_29	4458/4461
3	metabolism	NN	O	metabolism	nsubj	7	SENT_29	4462/4472
4	of	IN	O	of		-1	SENT_29	4473/4475
5	macitentan	NN	O	macitentan	prep_of	3	SENT_29	4476/4486
6	mainly	RB	O	mainly	advmod	7	SENT_29	4487/4493
7	relies	VBZ	O	rely	advcl	22	SENT_29	4494/4500
8	on	IN	O	on		-1	SENT_29	4501/4503
9	CYP3A4	NN	O	cyp3a4	prep_on	7	SENT_29	4504/4510
10	,	,	O	,		-1	SENT_29	4510/4511
11	the	DT	O	the	det	12	SENT_29	4512/4515
12	influence	NN	O	influence	nsubj	22	SENT_29	4516/4525
13	of	IN	O	of		-1	SENT_29	4526/4528
14	these	DT	O	these	det	16	SENT_29	4529/4534
15	two	CD	NUMBER	two	num	16	SENT_29	4535/4538
16	drugs	NNS	O	drug	prep_of	12	SENT_29	4539/4544
17	on	IN	O	on		-1	SENT_29	4545/4547
18	the	DT	O	the	det	19	SENT_29	4548/4551
19	PK	NN	O	pk	prep_on	16	SENT_29	4552/4554
20	of	IN	O	of		-1	SENT_29	4555/4557
21	macitentan	NN	O	macitentan	prep_of	19	SENT_29	4558/4568
22	is	VBZ	O	be		-1	SENT_29	4569/4571
23	of	IN	O	of		-1	SENT_29	4572/4574
24	particular	JJ	O	particular	amod	28	SENT_29	4575/4585
25	interest	NN	O	interest	nn	28	SENT_29	4586/4594
26	(	NN	O	(	nn	28	SENT_29	4595/4596
27	10	CD	NUMBER	10	num	28	SENT_29	4596/4598
28	)	NN	O	)	prep_of	22	SENT_29	4598/4599
29	.	.	O	.		-1	SENT_29	4599/4600

1	In	IN	O	in		-1	SENT_30	4601/4603
2	addition	NN	O	addition	prep_in	6	SENT_30	4604/4612
3	,	,	O	,		-1	SENT_30	4612/4613
4	drug-drug	JJ	O	drug-drug	amod	5	SENT_30	4614/4623
5	interactions	NNS	O	interaction	nsubj	6	SENT_30	4624/4636
6	(	VBP	O	(		-1	SENT_30	4637/4638
7	DDIs	NNS	O	ddi	nsubjpass	17	SENT_30	4638/4642
8	)	CD	NUMBER	)	num	7	SENT_30	4642/4643
9	at	IN	O	at		-1	SENT_30	4644/4646
10	the	DT	O	the	det	11	SENT_30	4647/4650
11	level	NN	O	level	prep_at	7	SENT_30	4651/4656
12	of	IN	O	of		-1	SENT_30	4657/4659
13	hepatic	JJ	O	hepatic	amod	14	SENT_30	4660/4667
14	OATPs	NNS	O	oatp	prep_of	11	SENT_30	4668/4673
15	have	VBP	O	have	aux	17	SENT_30	4674/4678
16	been	VBN	O	be	auxpass	17	SENT_30	4679/4683
17	documented	VBN	O	document	dep	6	SENT_30	4684/4694
18	following	VBG	O	follow		-1	SENT_30	4695/4704
19	co-administration	NN	O	co-administration	prep_following	17	SENT_30	4705/4722
20	of	IN	O	of		-1	SENT_30	4723/4725
21	other	JJ	O	other	amod	24	SENT_30	4726/4731
22	structurally	RB	O	structurally	advmod	23	SENT_30	4732/4744
23	related	JJ	O	related	amod	24	SENT_30	4745/4752
24	ERAs	NNS	O	era	prep_of	19	SENT_30	4753/4757
25	and	CC	O	and		-1	SENT_30	4758/4761
26	Cs	NNS	O	c	nsubj	27	SENT_30	4762/4764
27	(	VBP	O	(	conj_and	17	SENT_30	4765/4766
28	11,12	CD	NUMBER	11,12	number	29	SENT_30	4766/4771
29	)	CD	NUMBER	)	dobj	27	SENT_30	4771/4772
30	.	.	O	.		-1	SENT_30	4772/4773

1	As	IN	O	as	mark	7	SENT_31	4774/4776
2	Cs	NNS	O	c	nsubjpass	7	SENT_31	4777/4779
3	and	CC	O	and		-1	SENT_31	4780/4783
4	rifampin	NN	O	rifampin	conj_and	2	SENT_31	4784/4792
5	may	MD	O	may	aux	7	SENT_31	4793/4796
6	be	VB	O	be	auxpass	7	SENT_31	4797/4799
7	used	VBN	O	use	advcl	16	SENT_31	4800/4804
8	concomitantly	RB	O	concomitantly	advmod	7	SENT_31	4805/4818
9	with	IN	O	with		-1	SENT_31	4819/4823
10	macitentan	NN	O	macitentan	prep_with	7	SENT_31	4824/4834
11	in	IN	O	in		-1	SENT_31	4835/4837
12	clinical	JJ	O	clinical	amod	13	SENT_31	4838/4846
13	practice	NN	O	practice	prep_in	10	SENT_31	4847/4855
14	,	,	O	,		-1	SENT_31	4855/4856
15	we	PRP	O	we	nsubj	16	SENT_31	4857/4859
16	investigated	VBD	O	investigate		-1	SENT_31	4860/4872
17	in	IN	O	in		-1	SENT_31	4873/4875
18	a	DT	O	a	det	24	SENT_31	4876/4877
19	two-part	JJ	O	two-part	amod	24	SENT_31	4878/4886
20	,	,	O	,		-1	SENT_31	4886/4887
21	one-sequence	NN	O	one-sequence	dep	24	SENT_31	4888/4900
22	,	,	O	,		-1	SENT_31	4900/4901
23	crossover	NN	O	crossover	dep	24	SENT_31	4902/4911
24	study	NN	O	study	prep_in	16	SENT_31	4912/4917
25	the	DT	O	the	det	26	SENT_31	4918/4921
26	effect	NN	O	effect	nsubj	30	SENT_31	4922/4928
27	of	IN	O	of		-1	SENT_31	4929/4931
28	multiple-dose	JJ	O	multiple-dose	amod	29	SENT_31	4932/4945
29	Cs	NNS	O	c	prep_of	26	SENT_31	4946/4948
30	(	VBD	O	(	ccomp	16	SENT_31	4949/4950
31	part	NN	O	part	nsubj	33	SENT_31	4950/4954
32	A	DT	O	a	det	33	SENT_31	4955/4956
33	)	NN	O	)	xcomp	30	SENT_31	4956/4957
34	and	CC	O	and		-1	SENT_31	4958/4961
35	rifampin	NN	O	rifampin	nn	39	SENT_31	4962/4970
36	(	CD	NUMBER	(	num	39	SENT_31	4971/4972
37	part	NN	O	part	nn	39	SENT_31	4972/4976
38	B	NN	O	b	nn	39	SENT_31	4977/4978
39	)	NN	O	)	conj_and	33	SENT_31	4978/4979
40	on	IN	O	on		-1	SENT_31	4980/4982
41	the	DT	O	the	det	42	SENT_31	4983/4986
42	PK	NN	O	pk	prep_on	30	SENT_31	4987/4989
43	of	IN	O	of		-1	SENT_31	4990/4992
44	macitentan	NN	O	macitentan	prep_of	42	SENT_31	4993/5003
45	and	CC	O	and		-1	SENT_31	5004/5007
46	its	PRP$	O	its	poss	47	SENT_31	5008/5011
47	metabolites	NNS	O	metabolite	conj_and	44	SENT_31	5012/5023
48	.	.	O	.		-1	SENT_31	5023/5024

1	In	IN	O	in	dep	6	SENT_32	5025/5027
2	addition	NN	O	addition	pobj	1	SENT_32	5028/5036
3	,	,	O	,		-1	SENT_32	5036/5037
4	in	FW	O	in	nn	5	SENT_32	5038/5040
5	vitro	FW	O	vitro	dep	1	SENT_32	5041/5046
6	studies	NNS	O	study	nsubjpass	8	SENT_32	5047/5054
7	were	VBD	O	be	auxpass	8	SENT_32	5055/5059
8	performed	VBN	O	perform		-1	SENT_32	5060/5069
9	to	TO	O	to	aux	10	SENT_32	5070/5072
10	investigate	VB	O	investigate	xcomp	8	SENT_32	5073/5084
11	interactions	NNS	O	interaction	dobj	10	SENT_32	5085/5097
12	between	IN	O	between		-1	SENT_32	5098/5105
13	macitentan	NN	O	macitentan	prep_between	11	SENT_32	5106/5116
14	and	CC	O	and		-1	SENT_32	5117/5120
15	its	PRP$	O	its	poss	18	SENT_32	5121/5124
16	active	JJ	O	active	amod	18	SENT_32	5125/5131
17	metabolite	NN	O	metabolite	nn	18	SENT_32	5132/5142
18	ACT-132577	NN	O	act-132577	conj_and	11	SENT_32	5143/5153
19	with	IN	O	with		-1	SENT_32	5154/5158
20	human	JJ	O	human	amod	22	SENT_32	5159/5164
21	OATP	NN	O	oatp	nn	22	SENT_32	5165/5169
22	transporters	NNS	O	transporter	prep_with	18	SENT_32	5170/5182
23	.	.	O	.		-1	SENT_32	5182/5183

1	MATERIALS	NNS	O	material		-1	SENT_33	5219/5228
2	AND	CC	O	and		-1	SENT_33	5229/5232
3	METHODS	NNS	O	method	conj_and	1	SENT_33	5233/5240

1	Subjects	NNS	O	subject		-1	SENT_34	5276/5284

1	It	PRP	O	it	nsubjpass	3	SENT_35	5320/5322
2	was	VBD	O	be	auxpass	3	SENT_35	5323/5326
3	planned	VBN	O	plan		-1	SENT_35	5327/5334
4	to	TO	O	to	aux	5	SENT_35	5335/5337
5	enroll	VB	O	enroll	xcomp	3	SENT_35	5338/5344
6	a	DT	O	a	det	7	SENT_35	5345/5346
7	total	NN	O	total	dobj	5	SENT_35	5347/5352
8	of	IN	O	of		-1	SENT_35	5353/5355
9	20	CD	NUMBER	20	num	10	SENT_35	5356/5358
10	subjects	NNS	O	subject	prep_of	7	SENT_35	5359/5367
11	,	,	O	,		-1	SENT_35	5367/5368
12	10	CD	NUMBER	10	conj_and	7	SENT_35	5369/5371
13	in	IN	O	in		-1	SENT_35	5372/5374
14	part	NN	O	part	nn	15	SENT_35	5375/5379
15	A	NN	O	a	prep_in	12	SENT_35	5380/5381
16	and	CC	O	and		-1	SENT_35	5382/5385
17	10	CD	NUMBER	10	conj_and	7	SENT_35	5386/5388
18	in	IN	O	in		-1	SENT_35	5389/5391
19	part	NN	O	part	nn	20	SENT_35	5392/5396
20	B.	NNP	O	B.	nn	23	SENT_35	5397/5399
21	Healthy	JJ	O	healthy	amod	23	SENT_35	5400/5407
22	male	JJ	O	male	amod	23	SENT_35	5408/5412
23	subjects	NNS	O	subject	prep_in	17	SENT_35	5413/5421
24	(	JJ	O	(	amod	23	SENT_35	5422/5423
25	based	VBN	O	base		-1	SENT_35	5423/5428
26	on	IN	O	on	prepc_based_on	5	SENT_35	5429/5431
27	medical	JJ	O	medical	amod	28	SENT_35	5432/5439
28	history	NN	O	history	pobj	5	SENT_35	5440/5447
29	and	CC	O	and		-1	SENT_35	5448/5451
30	screening	NN	O	screening	nn	31	SENT_35	5452/5461
31	examination	NN	O	examination	conj_and	28	SENT_35	5462/5473
32	)	CD	NUMBER	)	num	38	SENT_35	5473/5474
33	aged	JJ	O	aged	amod	38	SENT_35	5475/5479
34	between	IN	O	between	amod	35	SENT_35	5480/5487
35	18	CD	NUMBER	18	num	38	SENT_35	5488/5490
36	and	CC	O	and		-1	SENT_35	5491/5494
37	45	CD	DURATION	45	conj_and	35	SENT_35	5495/5497
38	years	NNS	NUMBER	year	nsubj	54	SENT_35	5498/5503
39	,	,	O	,		-1	SENT_35	5503/5504
40	with	IN	O	with		-1	SENT_35	5505/5509
41	body	NN	O	body	nn	46	SENT_35	5510/5514
42	mass	NN	O	mass	nn	46	SENT_35	5515/5519
43	index	NN	O	index	nn	46	SENT_35	5520/5525
44	(	CD	NUMBER	(	num	46	SENT_35	5526/5527
45	BMI	NN	O	bmus	nn	46	SENT_35	5527/5530
46	)	NN	O	)	prep_with	38	SENT_35	5530/5531
47	between	IN	O	between		-1	SENT_35	5532/5539
48	18	CD	NUMBER	18	prep_between	46	SENT_35	5540/5542
49	and	CC	NUMBER	and		-1	SENT_35	5543/5546
50	28	CD	NUMBER	28	num	51	SENT_35	5547/5549
51	kg/m2	NN	O	kg/m2	conj_and	48	SENT_35	5550/5555
52	,	,	O	,		-1	SENT_35	5555/5556
53	were	VBD	O	be	cop	54	SENT_35	5557/5561
54	eligible	JJ	O	eligible	rcmod	28	SENT_35	5562/5570
55	for	IN	O	for		-1	SENT_35	5571/5574
56	this	DT	O	this	det	57	SENT_35	5575/5579
57	study	NN	O	study	prep_for	54	SENT_35	5580/5585
58	.	.	O	.		-1	SENT_35	5585/5586

1	In	IN	O	in		-1	SENT_36	5587/5589
2	addition	NN	O	addition	prep_in	6	SENT_36	5590/5598
3	,	,	O	,		-1	SENT_36	5598/5599
4	eligible	JJ	O	eligible	amod	5	SENT_36	5600/5608
5	subjects	NNS	O	subject	nsubj	6	SENT_36	5609/5617
6	had	VBD	O	have		-1	SENT_36	5618/5621
7	to	TO	O	to	aux	8	SENT_36	5622/5624
8	have	VB	O	have	xcomp	6	SENT_36	5625/5629
9	hematology	NN	O	hematology	dobj	8	SENT_36	5630/5640
10	and	CC	O	and		-1	SENT_36	5641/5644
11	clinical	JJ	O	clinical	amod	12	SENT_36	5645/5653
12	chemistry	NN	O	chemistry	nsubj	13	SENT_36	5654/5663
13	results	VBZ	O	result	conj_and	6	SENT_36	5664/5671
14	within	IN	O	within		-1	SENT_36	5672/5678
15	the	DT	O	the	det	17	SENT_36	5679/5682
16	normal	JJ	O	normal	amod	17	SENT_36	5683/5689
17	range	NN	O	range	prep_within	13	SENT_36	5690/5695
18	and	CC	O	and		-1	SENT_36	5696/5699
19	negative	JJ	O	negative	amod	20	SENT_36	5700/5708
20	results	NNS	O	result	conj_and	17	SENT_36	5709/5716
21	for	IN	O	for		-1	SENT_36	5717/5720
22	drug	NN	O	drug	nn	25	SENT_36	5721/5725
23	and	CC	O	and		-1	SENT_36	5726/5729
24	alcohol	NN	O	alcohol	conj_and	22	SENT_36	5730/5737
25	use	NN	O	use	prep_for	20	SENT_36	5738/5741
26	at	IN	O	at		-1	SENT_36	5742/5744
27	screening	NN	O	screening	prep_at	13	SENT_36	5745/5754
28	.	.	O	.		-1	SENT_36	5754/5755

1	Subjects	NNS	O	subject	nsubjpass	3	SENT_37	5756/5764
2	were	VBD	O	be	auxpass	3	SENT_37	5765/5769
3	excluded	VBN	O	exclude		-1	SENT_37	5770/5778
4	from	IN	O	from		-1	SENT_37	5779/5783
5	the	DT	O	the	det	6	SENT_37	5784/5787
6	study	NN	O	study	prep_from	3	SENT_37	5788/5793
7	if	IN	O	if	mark	10	SENT_37	5794/5796
8	they	PRP	O	they	nsubj	10	SENT_37	5797/5801
9	had	VBD	O	have	aux	10	SENT_37	5802/5805
10	received	VBN	O	receive	dep	3	SENT_37	5806/5814
11	any	DT	O	any	det	12	SENT_37	5815/5818
12	drug	NN	O	drug	dobj	10	SENT_37	5819/5823
13	with	IN	O	with		-1	SENT_37	5824/5828
14	immunosuppressive	JJ	O	immunosuppressive	amod	15	SENT_37	5829/5846
15	potential	NN	O	potential	prep_with	12	SENT_37	5847/5856
16	within	IN	O	within		-1	SENT_37	5857/5863
17	6	CD	DURATION	6	num	18	SENT_37	5864/5865
18	months	NNS	NUMBER	month	prep_within	10	SENT_37	5866/5872
19	preceding	VBG	O	precede	partmod	18	SENT_37	5873/5882
20	the	DT	O	the	det	22	SENT_37	5883/5886
21	screening	NN	O	screening	nn	22	SENT_37	5887/5896
22	examination	NN	O	examination	dobj	19	SENT_37	5897/5908
23	or	CC	O	or		-1	SENT_37	5909/5911
24	if	IN	O	if	mark	27	SENT_37	5912/5914
25	they	PRP	O	they	nsubjpass	27	SENT_37	5915/5919
26	were	VBD	O	be	auxpass	27	SENT_37	5920/5924
27	administered	VBN	O	administer	conj_or	10	SENT_37	5925/5937
28	any	DT	O	any	dep	30	SENT_37	5938/5941
29	metabolic	JJ	O	metabolic	amod	30	SENT_37	5942/5951
30	enzyme-inducing	JJ	O	enzyme-inducing	npadvmod	27	SENT_37	5952/5967
31	or	CC	O	or		-1	SENT_37	5968/5970
32	enzyme-inhibiting	JJ	O	enzyme-inhibiting	amod	33	SENT_37	5971/5988
33	drugs	NNS	O	drug	conj_or	30	SENT_37	5989/5994
34	within	IN	O	within		-1	SENT_37	5995/6001
35	the	DT	DURATION	the	det	38	SENT_37	6002/6005
36	last	JJ	DURATION	last	amod	38	SENT_37	6006/6010
37	4	CD	DURATION	4	num	38	SENT_37	6011/6012
38	weeks	NNS	NUMBER	week	prep_within	27	SENT_37	6013/6018
39	prior	RB	O	prior		-1	SENT_37	6019/6024
40	to	TO	O	to		-1	SENT_37	6025/6027
41	the	DT	O	the	det	43	SENT_37	6028/6031
42	screening	NN	O	screening	nn	43	SENT_37	6032/6041
43	examination	NN	O	examination	prep_prior_to	27	SENT_37	6042/6053
44	.	.	O	.		-1	SENT_37	6053/6054

1	The	DT	O	the	det	3	SENT_38	6090/6093
2	ethics	NNS	O	ethic	nn	3	SENT_38	6094/6100
3	committee	NN	O	committee	nsubj	20	SENT_38	6101/6110
4	,	,	O	,		-1	SENT_38	6110/6111
5	Comite	NNP	ORGANIZATION	Comite	nn	11	SENT_38	6112/6118
6	de	NNP	ORGANIZATION	de	nn	11	SENT_38	6119/6121
7	Protection	NNP	ORGANIZATION	Protection	nn	11	SENT_38	6122/6132
8	des	NNP	ORGANIZATION	des	nn	11	SENT_38	6133/6136
9	Personnes	NNP	ORGANIZATION	Personnes	nn	11	SENT_38	6137/6146
10	Ouest	NNP	ORGANIZATION	Ouest	nn	11	SENT_38	6147/6152
11	VI	NNP	ORGANIZATION	VI	appos	3	SENT_38	6153/6155
12	,	,	O	,		-1	SENT_38	6155/6156
13	located	JJ	O	located	amod	18	SENT_38	6157/6164
14	in	IN	O	in		-1	SENT_38	6165/6167
15	Brest	NNP	LOCATION	Brest	nn	17	SENT_38	6168/6173
16	(	NNP	O	(	nn	17	SENT_38	6174/6175
17	France	NNP	LOCATION	France	prep_in	13	SENT_38	6175/6181
18	)	NN	O	)	appos	11	SENT_38	6181/6182
19	,	,	O	,		-1	SENT_38	6182/6183
20	approved	VBD	O	approve		-1	SENT_38	6184/6192
21	the	DT	O	the	det	26	SENT_38	6193/6196
22	study	NN	O	study	nn	26	SENT_38	6197/6202
23	protocol	NN	O	protocol	nn	26	SENT_38	6203/6211
24	(	CD	NUMBER	(	num	26	SENT_38	6212/6213
25	study	NN	O	study	nn	26	SENT_38	6213/6218
26	number	NN	O	number	nsubj	28	SENT_38	6219/6225
27	AC-055-111	NN	O	ac-055-111	nn	28	SENT_38	6226/6236
28	)	NN	O	)	xcomp	20	SENT_38	6236/6237
29	,	,	O	,		-1	SENT_38	6237/6238
30	and	CC	O	and		-1	SENT_38	6239/6242
31	all	DT	O	all	det	32	SENT_38	6243/6246
32	subjects	NNS	O	subject	nsubj	33	SENT_38	6247/6255
33	gave	VBD	O	give	conj_and	20	SENT_38	6256/6260
34	written	VBN	O	write	amod	36	SENT_38	6261/6268
35	informed	VBN	O	inform	amod	36	SENT_38	6269/6277
36	consent	NN	O	consent	dobj	33	SENT_38	6278/6285
37	before	IN	O	before	mark	42	SENT_38	6286/6292
38	any	DT	O	any	det	40	SENT_38	6293/6296
39	screening	JJ	O	screening	amod	40	SENT_38	6297/6306
40	procedures	NNS	O	procedure	nsubjpass	42	SENT_38	6307/6317
41	were	VBD	O	be	auxpass	42	SENT_38	6318/6322
42	performed	VBN	O	perform	advcl	33	SENT_38	6323/6332
43	.	.	O	.		-1	SENT_38	6332/6333

1	The	DT	O	the	det	2	SENT_39	6334/6337
2	study	NN	O	study	nsubjpass	4	SENT_39	6338/6343
3	was	VBD	O	be	auxpass	4	SENT_39	6344/6347
4	conducted	VBN	O	conduct		-1	SENT_39	6348/6357
5	in	IN	O	in		-1	SENT_39	6358/6360
6	full	JJ	O	full	amod	7	SENT_39	6361/6365
7	conformity	NN	O	conformity	prep_in	4	SENT_39	6366/6376
8	with	IN	O	with		-1	SENT_39	6377/6381
9	the	DT	O	the	det	10	SENT_39	6382/6385
10	principles	NNS	O	principle	prep_with	7	SENT_39	6386/6396
11	of	IN	O	of		-1	SENT_39	6397/6399
12	the	DT	O	the	det	13	SENT_39	6400/6403
13	Declaration	NN	O	declaration	prep_of	10	SENT_39	6404/6415
14	of	IN	O	of		-1	SENT_39	6416/6418
15	Helsinki	NNP	LOCATION	Helsinki	prep_of	13	SENT_39	6419/6427
16	,	,	O	,		-1	SENT_39	6427/6428
17	the	DT	O	the	det	18	SENT_39	6429/6432
18	EMEA	NNP	ORGANIZATION	EMEA	appos	15	SENT_39	6433/6437
19	Note	VB	O	note	tmod	4	SENT_39	6438/6442
20	for	IN	O	for		-1	SENT_39	6443/6446
21	Guidance	NN	O	guidance	prep_for	19	SENT_39	6447/6455
22	on	IN	O	on		-1	SENT_39	6456/6458
23	Good	JJ	O	good	amod	35	SENT_39	6459/6463
24	Clinical	JJ	O	clinical	amod	35	SENT_39	6464/6472
25	Practice	NN	O	practice	nn	35	SENT_39	6473/6481
26	(	NN	O	(	nn	35	SENT_39	6482/6483
27	CPMP/ICH/135	NN	O	cpmp/ich/135	nn	35	SENT_39	6483/6495
28	/	:	O	/	punct	29	SENT_39	6495/6496
29	95	CD	NUMBER	95	dep	35	SENT_39	6496/6498
30	)	NN	O	)	dep	29	SENT_39	6498/6499
31	,	,	O	,		-1	SENT_39	6499/6500
32	and	CC	O	and		-1	SENT_39	6501/6504
33	International	NNP	ORGANIZATION	International	nn	34	SENT_39	6505/6518
34	Ethical	NNP	ORGANIZATION	Ethical	conj_and	29	SENT_39	6519/6526
35	Guidelines	NNS	ORGANIZATION	guideline	prep_on	19	SENT_39	6527/6537
36	for	IN	ORGANIZATION	for		-1	SENT_39	6538/6541
37	Biomedical	NNP	ORGANIZATION	Biomedical	nn	43	SENT_39	6542/6552
38	Research	NNP	ORGANIZATION	Research	nn	43	SENT_39	6553/6561
39	Involving	NNP	ORGANIZATION	Involving	nn	43	SENT_39	6562/6571
40	Human	NNP	ORGANIZATION	Human	nn	43	SENT_39	6572/6577
41	Subjects	NNPS	ORGANIZATION	Subjects	nn	43	SENT_39	6578/6586
42	(	NNP	O	(	nn	43	SENT_39	6587/6588
43	Council	NNP	ORGANIZATION	Council	prep_for	35	SENT_39	6588/6595
44	for	IN	ORGANIZATION	for		-1	SENT_39	6596/6599
45	International	NNP	ORGANIZATION	International	nn	46	SENT_39	6600/6613
46	Organizations	NNP	ORGANIZATION	Organizations	prep_for	19	SENT_39	6614/6627
47	of	IN	ORGANIZATION	of		-1	SENT_39	6628/6630
48	Medical	NNP	ORGANIZATION	Medical	nn	49	SENT_39	6631/6638
49	Sciences	NNPS	O	Sciences	prep_of	46	SENT_39	6639/6647
50	2002	CD	DATE	2002	num	51	SENT_39	6648/6652
51	)	CD	NUMBER	)	dep	19	SENT_39	6652/6653
52	.	.	O	.		-1	SENT_39	6653/6654

1	Clinical	JJ	O	clinical	amod	3	SENT_40	6690/6698
2	Study	NN	O	study	nn	3	SENT_40	6699/6704
3	Design	NN	O	design		-1	SENT_40	6705/6711

1	This	DT	O	this	det	2	SENT_41	6747/6751
2	phase	NN	O	phase	nsubj	14	SENT_41	6752/6757
3	1	CD	NUMBER	1	num	2	SENT_41	6758/6759
4	,	,	O	,		-1	SENT_41	6759/6760
5	single-center	NN	O	single-center	appos	2	SENT_41	6761/6774
6	,	,	O	,		-1	SENT_41	6774/6775
7	open-label	JJ	O	open-label	amod	13	SENT_41	6776/6786
8	,	,	O	,		-1	SENT_41	6786/6787
9	two-part	JJ	O	two-part	amod	13	SENT_41	6788/6796
10	,	,	O	,		-1	SENT_41	6796/6797
11	one-sequence	JJ	O	one-sequence	amod	13	SENT_41	6798/6810
12	crossover	NN	O	crossover	nn	13	SENT_41	6811/6820
13	study	NN	O	study	appos	5	SENT_41	6821/6826
14	consisted	VBD	O	consist		-1	SENT_41	6827/6836
15	of	IN	O	of		-1	SENT_41	6837/6839
16	two	CD	NUMBER	two	num	17	SENT_41	6840/6843
17	parts	NNS	O	part	prep_of	14	SENT_41	6844/6849
18	.	.	O	.		-1	SENT_41	6849/6850

1	Each	DT	O	each	det	2	SENT_42	6851/6855
2	part	NN	O	part	nsubj	3	SENT_42	6856/6860
3	comprised	VBD	O	comprise		-1	SENT_42	6861/6870
4	two	CD	NUMBER	two	num	5	SENT_42	6871/6874
5	periods	NNS	O	period	dep	7	SENT_42	6875/6882
6	:	:	O	:		-1	SENT_42	6882/6883
7	period	NN	O	period	dep	3	SENT_42	6884/6890
8	1	CD	NUMBER	1	num	7	SENT_42	6891/6892
9	,	,	O	,		-1	SENT_42	6892/6893
10	multiple-dose	JJ	O	multiple-dose	amod	11	SENT_42	6894/6907
11	treatment	NN	O	treatment	appos	7	SENT_42	6908/6917
12	with	IN	O	with		-1	SENT_42	6918/6922
13	macitentan	NN	O	macitentan	prep_with	11	SENT_42	6923/6933
14	,	,	O	,		-1	SENT_42	6933/6934
15	and	CC	O	and		-1	SENT_42	6935/6938
16	period	NN	O	period	dep	39	SENT_42	6939/6945
17	2	CD	NUMBER	2	num	16	SENT_42	6946/6947
18	,	,	O	,		-1	SENT_42	6947/6948
19	multiple-dose	JJ	O	multiple-dose	amod	20	SENT_42	6949/6962
20	treatment	NN	O	treatment	dep	31	SENT_42	6963/6972
21	with	IN	O	with		-1	SENT_42	6973/6977
22	macitentan	NN	O	macitentan	prep_with	20	SENT_42	6978/6988
23	and	CC	O	and		-1	SENT_42	6989/6992
24	Cs	NN	O	c	conj_and	22	SENT_42	6993/6995
25	(	CD	NUMBER	(	num	26	SENT_42	6996/6997
26	part	NN	O	part	dep	31	SENT_42	6997/7001
27	A	DT	O	a	det	31	SENT_42	7002/7003
28	)	NN	O	)	nn	31	SENT_42	7003/7004
29	or	CC	O	or		-1	SENT_42	7005/7007
30	multiple-dose	JJ	O	multiple-dose	conj_or	28	SENT_42	7008/7021
31	treatment	NN	O	treatment	dep	16	SENT_42	7022/7031
32	with	IN	O	with		-1	SENT_42	7032/7036
33	macitentan	NN	O	macitentan	prep_with	31	SENT_42	7037/7047
34	and	CC	O	and		-1	SENT_42	7048/7051
35	rifampin	NN	O	rifampin	conj_and	33	SENT_42	7052/7060
36	(	CD	NUMBER	(	num	39	SENT_42	7061/7062
37	part	NN	O	part	nn	39	SENT_42	7062/7066
38	B	NN	O	b	nn	39	SENT_42	7067/7068
39	)	NN	O	)	conj_and	7	SENT_42	7068/7069
40	.	.	O	.		-1	SENT_42	7069/7070

1	An	DT	O	a	det	3	SENT_43	7106/7108
2	oral	JJ	O	oral	amod	3	SENT_43	7109/7113
3	dose	NN	O	dose	nsubjpass	11	SENT_43	7114/7118
4	of	IN	O	of		-1	SENT_43	7119/7121
5	10	CD	NUMBER	10	num	7	SENT_43	7122/7124
6	mg	NN	O	mg	nn	7	SENT_43	7125/7127
7	macitentan	NN	O	macitentan	prep_of	3	SENT_43	7128/7138
8	once	RB	DATE	once	advmod	11	SENT_43	7139/7143
9	daily	RB	SET	daily	advmod	11	SENT_43	7144/7149
10	was	VBD	O	be	auxpass	11	SENT_43	7150/7153
11	assessed	VBN	O	assess		-1	SENT_43	7154/7162
12	in	IN	O	in		-1	SENT_43	7163/7165
13	this	DT	O	this	det	14	SENT_43	7166/7170
14	study	NN	O	study	prep_in	11	SENT_43	7171/7176
15	,	,	O	,		-1	SENT_43	7176/7177
16	which	WDT	O	which	nsubj	17	SENT_43	7178/7183
17	corresponds	VBZ	O	correspond	rcmod	14	SENT_43	7184/7195
18	to	TO	O	to		-1	SENT_43	7196/7198
19	the	DT	O	the	det	21	SENT_43	7199/7202
20	maximum	NN	O	maximum	nn	21	SENT_43	7203/7210
21	dose	NN	O	dose	prep_to	17	SENT_43	7211/7215
22	used	VBN	O	use	partmod	21	SENT_43	7216/7220
23	in	IN	O	in		-1	SENT_43	7221/7223
24	the	DT	O	the	det	28	SENT_43	7224/7227
25	ongoing	JJ	O	ongoing	amod	28	SENT_43	7228/7235
26	phase	NN	O	phase	nn	28	SENT_43	7236/7241
27	3	CD	NUMBER	3	num	28	SENT_43	7242/7243
28	program	NN	O	program	prep_in	22	SENT_43	7244/7251
29	.	.	O	.		-1	SENT_43	7251/7252

1	The	DT	O	the	det	2	SENT_44	7253/7256
2	use	NN	O	use	nsubj	11	SENT_44	7257/7260
3	of	IN	O	of		-1	SENT_44	7261/7263
4	a	DT	O	a	det	7	SENT_44	7264/7265
5	30-mg	JJ	O	30-mg	amod	7	SENT_44	7266/7271
6	loading	NN	O	loading	nn	7	SENT_44	7272/7279
7	dose	NN	O	dose	prep_of	2	SENT_44	7280/7284
8	on	IN	O	on		-1	SENT_44	7285/7287
9	day	NN	DURATION	day	prep_on	7	SENT_44	7288/7291
10	1	CD	NUMBER	1	num	9	SENT_44	7292/7293
11	reduced	VBD	O	reduce		-1	SENT_44	7294/7301
12	the	DT	O	the	det	13	SENT_44	7302/7305
13	time	NN	O	time	dobj	11	SENT_44	7306/7310
14	to	TO	O	to	aux	15	SENT_44	7311/7313
15	reach	VB	O	reach	infmod	13	SENT_44	7314/7319
16	steady-state	JJ	O	steady-state	amod	17	SENT_44	7320/7332
17	conditions	NNS	O	condition	dobj	15	SENT_44	7333/7343
18	of	IN	O	of		-1	SENT_44	7344/7346
19	ACT-132577	NN	O	act-132577	nn	21	SENT_44	7347/7357
20	(	CD	NUMBER	(	num	21	SENT_44	7358/7359
21	day	NN	NUMBER	day	prep_of	17	SENT_44	7359/7362
22	4	CD	NUMBER	4	num	21	SENT_44	7363/7364
23	instead	RB	O	instead		-1	SENT_44	7365/7372
24	of	IN	O	of		-1	SENT_44	7373/7375
25	day	NN	DURATION	day	nn	27	SENT_44	7376/7379
26	7	CD	NUMBER	7	num	27	SENT_44	7380/7381
27	)	NN	O	)	prep_instead_of	17	SENT_44	7381/7382
28	.	.	O	.		-1	SENT_44	7382/7383

1	In	IN	O	in		-1	SENT_45	7384/7386
2	the	DT	O	the	det	5	SENT_45	7387/7390
3	single-ascending	JJ	O	single-ascending	amod	5	SENT_45	7391/7407
4	dose	NN	O	dose	nn	5	SENT_45	7408/7412
5	study	NN	O	study	prep_in	16	SENT_45	7413/7418
6	,	,	O	,		-1	SENT_45	7418/7419
7	doses	NNS	O	dose	nsubjpass	16	SENT_45	7420/7425
8	of	IN	O	of		-1	SENT_45	7426/7428
9	up	RB	O	up	quantmod	11	SENT_45	7429/7431
10	to	TO	O	to	dep	11	SENT_45	7432/7434
11	300	CD	NUMBER	300	num	12	SENT_45	7435/7438
12	mg	NN	O	mg	prep_of	7	SENT_45	7439/7441
13	had	VBD	O	have	aux	16	SENT_45	7442/7445
14	been	VBN	O	be	auxpass	16	SENT_45	7446/7450
15	well	RB	O	well	advmod	16	SENT_45	7451/7455
16	tolerated	VBN	O	tolerate		-1	SENT_45	7456/7465
17	(	NN	O	(	nn	19	SENT_45	7466/7467
18	2	CD	NUMBER	2	num	19	SENT_45	7467/7468
19	)	NN	O	)	dobj	16	SENT_45	7468/7469
20	.	.	O	.		-1	SENT_45	7469/7470

1	In	IN	O	in		-1	SENT_46	7471/7473
2	part	NN	O	part	nn	3	SENT_46	7474/7478
3	A	NN	O	a	prep_in	14	SENT_46	7479/7480
4	,	,	O	,		-1	SENT_46	7480/7481
5	after	IN	O	after		-1	SENT_46	7482/7487
6	5	CD	DURATION	5	num	7	SENT_46	7488/7489
7	days	NNS	NUMBER	day	nn	8	SENT_46	7490/7494
8	administration	NN	O	administration	prep_after	14	SENT_46	7495/7509
9	of	IN	O	of		-1	SENT_46	7510/7512
10	macitentan	NN	O	macitentan	prep_of	8	SENT_46	7513/7523
11	,	,	O	,		-1	SENT_46	7523/7524
12	subjects	NNS	O	subject	nsubjpass	14	SENT_46	7525/7533
13	were	VBD	O	be	auxpass	14	SENT_46	7534/7538
14	co-administered	VBN	O	co-administer		-1	SENT_46	7539/7554
15	oral	JJ	O	oral	amod	16	SENT_46	7555/7559
16	doses	NNS	O	dose	dobj	14	SENT_46	7560/7565
17	of	IN	O	of		-1	SENT_46	7566/7568
18	100	CD	NUMBER	100	num	19	SENT_46	7569/7572
19	mg	NN	O	mg	prep_of	16	SENT_46	7573/7575
20	of	IN	O	of		-1	SENT_46	7576/7578
21	Cs	NNP	O	Cs	prep_of	19	SENT_46	7579/7581
22	(	CD	NUMBER	(	num	21	SENT_46	7582/7583
23	1	CD	NUMBER	1	number	24	SENT_46	7583/7584
24	100	CD	NUMBER	100	num	26	SENT_46	7592/7595
25	mg	NN	O	mg	nn	26	SENT_46	7596/7598
26	capsule	NN	O	capsule	dep	32	SENT_46	7599/7606
27	of	IN	O	of		-1	SENT_46	7607/7609
28	Neoral	NNP	O	Neoral	prep_of	26	SENT_46	7610/7616
29	)	CD	NUMBER	)	num	28	SENT_46	7618/7619
30	every	DT	O	every	det	31	SENT_46	7620/7625
31	12	CD	NUMBER	12	dep	32	SENT_46	7626/7628
32	h	NN	O	h	dep	35	SENT_46	7629/7630
33	on	IN	O	on		-1	SENT_46	7631/7633
34	days	NNS	DURATION	day	prep_on	32	SENT_46	7634/7638
35	6	CD	NUMBER	6	dep	16	SENT_46	7639/7640
36	through	IN	O	through		-1	SENT_46	7641/7648
37	17	CD	NUMBER	17	prep_through	14	SENT_46	7649/7651
38	.	.	O	.		-1	SENT_46	7651/7652

1	The	DT	O	the	det	2	SENT_47	7653/7656
2	dose	NN	O	dose	nsubj	13	SENT_47	7657/7661
3	of	IN	O	of		-1	SENT_47	7662/7664
4	2	CD	NUMBER	2	number	5	SENT_47	7665/7666
5	100	CD	NUMBER	100	num	6	SENT_47	7674/7677
6	mg/day	NN	O	mg/day	prep_of	2	SENT_47	7678/7684
7	of	IN	O	of		-1	SENT_47	7685/7687
8	Cs	NNS	O	c	prep_of	6	SENT_47	7688/7690
9	used	VBN	O	use	partmod	8	SENT_47	7691/7695
10	in	IN	O	in		-1	SENT_47	7696/7698
11	this	DT	O	this	det	12	SENT_47	7699/7703
12	study	NN	O	study	prep_in	9	SENT_47	7704/7709
13	corresponds	VBZ	O	correspond		-1	SENT_47	7710/7721
14	to	TO	O	to		-1	SENT_47	7722/7724
15	approximately	RB	O	approximately	quantmod	16	SENT_47	7725/7738
16	2.9	CD	NUMBER	2.9	num	17	SENT_47	7739/7742
17	mg/kg/day	NN	O	mg/kg/day	prep_to	13	SENT_47	7743/7752
18	for	IN	O	for		-1	SENT_47	7753/7756
19	a	DT	O	a	det	21	SENT_47	7757/7758
20	70-kg	JJ	O	70-kg	amod	21	SENT_47	7759/7764
21	man	NN	O	man	prep_for	13	SENT_47	7765/7768
22	.	.	O	.		-1	SENT_47	7768/7769

1	This	DT	O	this	nsubj	36	SENT_48	7770/7774
2	is	VBZ	O	be	dep	1	SENT_48	7775/7777
3	within	IN	O	within		-1	SENT_48	7778/7784
4	the	DT	O	the	det	6	SENT_48	7785/7788
5	recommended	VBN	O	recommend	amod	6	SENT_48	7789/7800
6	range	NN	O	range	prep_within	2	SENT_48	7801/7806
7	for	IN	O	for		-1	SENT_48	7807/7810
8	transplantation	NN	O	transplantation	nn	9	SENT_48	7811/7826
9	indications	NNS	O	indication	prep_for	6	SENT_48	7827/7838
10	,	,	O	,		-1	SENT_48	7838/7839
11	i.e.	FW	O	i.e.	dep	2	SENT_48	7840/7844
12	,	,	O	,		-1	SENT_48	7844/7845
13	2	CD	NUMBER	2	dep	14	SENT_48	7846/7847
14	to	TO	O	to	parataxis	2	SENT_48	7848/7850
15	6	CD	NUMBER	6	num	16	SENT_48	7851/7852
16	mg/kg/day	NN	O	mg/kg/day	pobj	14	SENT_48	7853/7862
17	,	,	O	,		-1	SENT_48	7862/7863
18	and	CC	O	and		-1	SENT_48	7864/7867
19	is	VBZ	O	be	conj_and	14	SENT_48	7868/7870
20	below	IN	O	below		-1	SENT_48	7871/7876
21	the	DT	O	the	det	23	SENT_48	7877/7880
22	dose	NN	O	dose	nn	23	SENT_48	7881/7885
23	level	NN	O	level	prep_below	19	SENT_48	7886/7891
24	of	IN	O	of		-1	SENT_48	7892/7894
25	5	CD	NUMBER	5	num	26	SENT_48	7895/7896
26	mg/kg/day	NN	O	mg/kg/day	prep_of	23	SENT_48	7897/7906
27	known	VBN	O	know	partmod	26	SENT_48	7907/7912
28	to	TO	O	to	aux	30	SENT_48	7913/7915
29	potentially	RB	O	potentially	advmod	30	SENT_48	7916/7927
30	increase	VB	O	increase	xcomp	27	SENT_48	7928/7936
31	creatinine	NN	O	creatinine	iobj	30	SENT_48	7937/7947
32	and	CC	O	and		-1	SENT_48	7948/7951
33	hypertension	NN	O	hypertension	conj_and	31	SENT_48	7952/7964
34	side	JJ	O	side	amod	35	SENT_48	7965/7969
35	effects	NNS	O	effect	dobj	30	SENT_48	7970/7977
36	(	VBP	O	(		-1	SENT_48	7978/7979
37	13	CD	NUMBER	13	num	38	SENT_48	7979/7981
38	)	CD	NUMBER	)	dobj	36	SENT_48	7981/7982
39	.	.	O	.		-1	SENT_48	7982/7983

1	Both	DT	O	both	det	2	SENT_49	7984/7988
2	drugs	NNS	O	drug	nsubjpass	4	SENT_49	7989/7994
3	were	VBD	O	be	auxpass	4	SENT_49	7995/7999
4	administered	VBN	O	administer		-1	SENT_49	8000/8012
5	after	IN	O	after		-1	SENT_49	8013/8018
6	food	NN	O	food	prep_after	4	SENT_49	8019/8023
7	.	.	O	.		-1	SENT_49	8023/8024

1	In	IN	O	in		-1	SENT_50	8060/8062
2	part	NN	O	part	nn	3	SENT_50	8063/8067
3	B	NN	O	b	prep_in	27	SENT_50	8068/8069
4	,	,	O	,		-1	SENT_50	8069/8070
5	after	IN	O	after		-1	SENT_50	8071/8076
6	5	CD	DURATION	5	num	7	SENT_50	8077/8078
7	days	NNS	NUMBER	day	nn	8	SENT_50	8079/8083
8	administration	NN	O	administration	prep_after	27	SENT_50	8084/8098
9	of	IN	O	of		-1	SENT_50	8099/8101
10	macitentan	NN	O	macitentan	prep_of	8	SENT_50	8102/8112
11	,	,	O	,		-1	SENT_50	8112/8113
12	oral	JJ	O	oral	amod	13	SENT_50	8114/8118
13	doses	NNS	O	dose	dep	20	SENT_50	8119/8124
14	of	IN	O	of		-1	SENT_50	8125/8127
15	600	CD	NUMBER	600	num	16	SENT_50	8128/8131
16	mg	NN	O	mg	prep_of	13	SENT_50	8132/8134
17	rifampin	NN	O	rifampin	dep	20	SENT_50	8135/8143
18	(	CD	NUMBER	(	num	17	SENT_50	8144/8145
19	two	CD	NUMBER	two	num	20	SENT_50	8145/8148
20	capsules	NNS	O	capsule	dep	27	SENT_50	8149/8157
21	of	IN	O	of		-1	SENT_50	8158/8160
22	300	CD	NUMBER	300	num	23	SENT_50	8161/8164
23	mg	NN	O	mg	prep_of	20	SENT_50	8165/8167
24	Rifadin	NN	LOCATION	rifadin	nn	25	SENT_50	8168/8175
25	)	NN	O	)	nsubj	27	SENT_50	8177/8178
26	were	VBD	O	be	cop	27	SENT_50	8179/8183
27	co-administered	JJ	O	co-administered		-1	SENT_50	8184/8199
28	once	RB	DATE	once	advmod	27	SENT_50	8200/8204
29	daily	RB	SET	daily	advmod	27	SENT_50	8205/8210
30	for	IN	O	for		-1	SENT_50	8211/8214
31	7	CD	DURATION	7	num	32	SENT_50	8215/8216
32	days	NNS	NUMBER	day	prep_for	27	SENT_50	8217/8221
33	,	,	O	,		-1	SENT_50	8221/8222
34	on	IN	O	on		-1	SENT_50	8223/8225
35	days	NNS	DURATION	day	prep_on	27	SENT_50	8226/8230
36	6	CD	NUMBER	6	tmod	27	SENT_50	8231/8232
37	through	IN	O	through		-1	SENT_50	8233/8240
38	12	CD	NUMBER	12	prep_through	27	SENT_50	8241/8243
39	.	.	O	.		-1	SENT_50	8243/8244

1	This	DT	O	this	det	3	SENT_51	8245/8249
2	dosing	NN	O	dosing	nn	3	SENT_51	8250/8256
3	regimen	NN	O	regimen	nsubjpass	5	SENT_51	8257/8264
4	is	VBZ	O	be	auxpass	5	SENT_51	8265/8267
5	approved	VBN	O	approve		-1	SENT_51	8268/8276
6	for	IN	O	for		-1	SENT_51	8277/8280
7	the	DT	O	the	det	8	SENT_51	8281/8284
8	treatment	NN	O	treatment	prep_for	5	SENT_51	8285/8294
9	of	IN	O	of		-1	SENT_51	8295/8297
10	tuberculosis	NN	O	tuberculosis	prep_of	8	SENT_51	8298/8310
11	and	CC	O	and		-1	SENT_51	8311/8314
12	is	VBZ	O	be	auxpass	13	SENT_51	8315/8317
13	recommended	VBN	O	recommend	conj_and	5	SENT_51	8318/8329
14	by	IN	O	by		-1	SENT_51	8330/8332
15	the	DT	O	the	det	16	SENT_51	8333/8336
16	Food	NNP	ORGANIZATION	Food	agent	13	SENT_51	8337/8341
17	and	CC	ORGANIZATION	and		-1	SENT_51	8342/8345
18	Drug	NNP	ORGANIZATION	Drug	nn	22	SENT_51	8346/8350
19	Administration	NNP	ORGANIZATION	Administration	nn	22	SENT_51	8351/8365
20	(	CD	NUMBER	(	num	22	SENT_51	8366/8367
21	FDA	NNP	ORGANIZATION	FDA	nn	22	SENT_51	8367/8370
22	)	NN	O	)	conj_and	16	SENT_51	8370/8371
23	for	IN	O	for		-1	SENT_51	8372/8375
24	assessment	NN	O	assessment	prep_for	16	SENT_51	8376/8386
25	of	IN	O	of		-1	SENT_51	8387/8389
26	its	PRP$	O	its	poss	28	SENT_51	8390/8393
27	enzyme-inducing	JJ	O	enzyme-inducing	amod	28	SENT_51	8394/8409
28	effect	NN	O	effect	prep_of	24	SENT_51	8410/8416
29	(	CD	NUMBER	(	number	30	SENT_51	8417/8418
30	14,15	CD	NUMBER	14,15	num	31	SENT_51	8418/8423
31	)	NN	O	)	dobj	5	SENT_51	8423/8424
32	.	.	O	.		-1	SENT_51	8424/8425

1	Since	IN	O	since	mark	4	SENT_52	8426/8431
2	food	NN	O	food	nn	3	SENT_52	8432/8436
3	intake	NN	O	intake	nsubj	4	SENT_52	8437/8443
4	has	VBZ	O	have	advcl	16	SENT_52	8444/8447
5	a	DT	O	a	det	7	SENT_52	8448/8449
6	significant	JJ	O	significant	amod	7	SENT_52	8450/8461
7	effect	NN	O	effect	dobj	4	SENT_52	8462/8468
8	on	IN	O	on		-1	SENT_52	8469/8471
9	the	DT	O	the	det	10	SENT_52	8472/8475
10	PK	NN	O	pk	prep_on	7	SENT_52	8476/8478
11	of	IN	O	of		-1	SENT_52	8479/8481
12	rifampin	NN	O	rifampin	prep_of	10	SENT_52	8482/8490
13	,	,	O	,		-1	SENT_52	8490/8491
14	drugs	NNS	O	drug	nsubjpass	16	SENT_52	8492/8497
15	were	VBD	O	be	auxpass	16	SENT_52	8498/8502
16	administered	VBN	O	administer		-1	SENT_52	8503/8515
17	under	IN	O	under		-1	SENT_52	8516/8521
18	fasted	JJ	O	fasted	amod	19	SENT_52	8522/8528
19	conditions	NNS	O	condition	prep_under	16	SENT_52	8529/8539
20	(	VBP	O	(	rcmod	19	SENT_52	8540/8541
21	1	CD	NUMBER	1	num	22	SENT_52	8541/8542
22	h	NN	O	h	dobj	20	SENT_52	8543/8544
23	before	IN	O	before		-1	SENT_52	8545/8551
24	a	DT	O	a	det	26	SENT_52	8552/8553
25	meal	NN	O	meal	nn	26	SENT_52	8554/8558
26	)	NN	O	)	prep_before	22	SENT_52	8558/8559
27	.	.	O	.		-1	SENT_52	8559/8560

1	An	DT	O	a	det	2	SENT_53	8596/8598
2	End	NN	O	end	nsubj	21	SENT_53	8599/8602
3	of	IN	O	of		-1	SENT_53	8603/8605
4	Study	NNP	O	Study	nn	5	SENT_53	8606/8611
5	examination	NN	O	examination	prep_of	2	SENT_53	8612/8623
6	,	,	O	,		-1	SENT_53	8623/8624
7	including	VBG	O	include		-1	SENT_53	8625/8634
8	vital	JJ	O	vital	amod	9	SENT_53	8635/8640
9	signs	NNS	O	sign	prep_including	2	SENT_53	8641/8646
10	,	,	O	,		-1	SENT_53	8646/8647
11	electrocardiogram	NN	O	electrocardiogram	nn	14	SENT_53	8648/8665
12	(	CD	NUMBER	(	num	14	SENT_53	8666/8667
13	ECG	NN	O	ecg	nn	14	SENT_53	8667/8670
14	)	NN	O	)	conj_and	9	SENT_53	8670/8671
15	,	,	O	,		-1	SENT_53	8671/8672
16	and	CC	O	and		-1	SENT_53	8673/8676
17	clinical	JJ	O	clinical	amod	19	SENT_53	8677/8685
18	laboratory	NN	O	laboratory	nn	19	SENT_53	8686/8696
19	tests	NNS	O	test	conj_and	9	SENT_53	8697/8702
20	,	,	O	,		-1	SENT_53	8702/8703
21	took	VBD	O	take		-1	SENT_53	8704/8708
22	place	NN	O	place	dobj	21	SENT_53	8709/8714
23	2	CD	DURATION	2	num	24	SENT_53	8715/8716
24	weeks	NNS	NUMBER	week	tmod	21	SENT_53	8717/8722
25	after	IN	O	after	mark	66	SENT_53	8723/8728
26	the	DT	O	the	det	28	SENT_53	8729/8732
27	last	JJ	O	last	amod	28	SENT_53	8733/8737
28	PK	NN	O	pk	nsubj	66	SENT_53	8738/8740
29	blood	NN	O	blood	nn	30	SENT_53	8741/8746
30	sampling	NN	O	sampling	dep	28	SENT_53	8747/8755
31	,	,	O	,		-1	SENT_53	8755/8756
32	i.e.	FW	O	i.e.	dep	28	SENT_53	8757/8761
33	,	,	O	,		-1	SENT_53	8761/8762
34	on	IN	O	on		-1	SENT_53	8763/8765
35	day	NN	DURATION	day	nn	37	SENT_53	8766/8769
36	32	CD	NUMBER	32	num	37	SENT_53	8770/8772
37	(	NN	O	(	prep_on	28	SENT_53	8773/8774
38	2	CD	DURATION	2	num	39	SENT_53	8776/8777
39	days	NNS	NUMBER	day	tmod	28	SENT_53	8778/8782
40	)	NN	O	)	nn	51	SENT_53	8782/8783
41	of	IN	O	of		-1	SENT_53	8784/8786
42	part	NN	O	part	nn	43	SENT_53	8787/8791
43	A	NN	O	a	prep_of	40	SENT_53	8792/8793
44	and	CC	O	and		-1	SENT_53	8794/8797
45	on	IN	O	on	conj_and	40	SENT_53	8798/8800
46	day	NN	DURATION	day	nn	48	SENT_53	8801/8804
47	27	CD	NUMBER	27	num	48	SENT_53	8805/8807
48	(	NN	O	(	pobj	45	SENT_53	8808/8809
49	2	CD	DURATION	2	num	50	SENT_53	8811/8812
50	days	NNS	NUMBER	day	tmod	48	SENT_53	8813/8817
51	)	NN	O	)	nsubj	63	SENT_53	8817/8818
52	of	IN	O	of		-1	SENT_53	8819/8821
53	part	NN	O	part	nn	58	SENT_53	8822/8826
54	B.	NNP	O	B.	nn	58	SENT_53	8827/8829
55	A	NNP	O	A	nn	58	SENT_53	8830/8831
56	telephone	NN	O	telephone	nn	58	SENT_53	8832/8841
57	safety	NN	O	safety	nn	58	SENT_53	8842/8848
58	follow-up	NN	O	follow-up	prep_of	51	SENT_53	8849/8858
59	for	IN	O	for		-1	SENT_53	8859/8862
60	serious	JJ	O	serious	amod	62	SENT_53	8863/8870
61	adverse	JJ	O	adverse	amod	62	SENT_53	8871/8878
62	events	NNS	O	event	prep_for	51	SENT_53	8879/8885
63	(	VBP	O	(	rcmod	28	SENT_53	8886/8887
64	SAEs	NNS	O	sae	dobj	63	SENT_53	8887/8891
65	)	CD	NUMBER	)	tmod	63	SENT_53	8891/8892
66	took	VBD	O	take	advcl	21	SENT_53	8893/8897
67	place	NN	O	place	dobj	66	SENT_53	8898/8903
68	30	CD	DURATION	30	num	69	SENT_53	8904/8906
69	days	NNS	NUMBER	day	tmod	66	SENT_53	8907/8911
70	after	IN	O	after		-1	SENT_53	8912/8917
71	the	DT	O	the	det	75	SENT_53	8918/8921
72	last	JJ	O	last	amod	75	SENT_53	8922/8926
73	study	NN	O	study	nn	75	SENT_53	8927/8932
74	drug	NN	O	drug	nn	75	SENT_53	8933/8937
75	administration	NN	O	administration	prep_after	66	SENT_53	8938/8952
76	.	.	O	.		-1	SENT_53	8952/8953

1	Trough	NN	O	trough	nn	2	SENT_54	8989/8995
2	concentrations	NNS	O	concentration	nsubjpass	9	SENT_54	8996/9010
3	of	IN	O	of		-1	SENT_54	9011/9013
4	macitentan	NN	O	macitentan	prep_of	2	SENT_54	9014/9024
5	and	CC	O	and		-1	SENT_54	9025/9028
6	its	PRP$	O	its	poss	7	SENT_54	9029/9032
7	metabolites	NNS	O	metabolite	conj_and	4	SENT_54	9033/9044
8	were	VBD	O	be	auxpass	9	SENT_54	9045/9049
9	determined	VBN	O	determine		-1	SENT_54	9050/9060
10	in	IN	O	in		-1	SENT_54	9061/9063
11	blood	NN	O	blood	nn	12	SENT_54	9064/9069
12	samples	NNS	O	sample	prep_in	9	SENT_54	9070/9077
13	taken	VBN	O	take	partmod	12	SENT_54	9078/9083
14	from	IN	O	from		-1	SENT_54	9084/9088
15	days	NNS	DATE	day	conj_and	15	SENT_54	9089/9093
16	1	CD	DATE	1	num	15	SENT_54	9094/9095
17	to	TO	DATE	to		-1	SENT_54	9096/9098
18	17	CD	DATE	17	number	19	SENT_54	9099/9101
19	(	CD	NUMBER	(	num	20	SENT_54	9102/9103
20	part	NN	O	part	prep_to	15	SENT_54	9103/9107
21	A	DT	O	a	det	22	SENT_54	9108/9109
22	)	NN	O	)	dep	20	SENT_54	9109/9110
23	and	CC	O	and		-1	SENT_54	9111/9114
24	from	IN	O	from		-1	SENT_54	9115/9119
25	days	NNS	DATE	day	prep_from	15	SENT_54	9120/9124
26	1	CD	DATE	1	num	25	SENT_54	9125/9126
27	to	TO	DATE	to	dep	25	SENT_54	9127/9129
28	12	CD	DATE	12	num	25	SENT_54	9130/9132
29	(	CD	NUMBER	(	num	31	SENT_54	9133/9134
30	part	NN	O	part	nn	31	SENT_54	9134/9138
31	B	NN	O	b	dep	15	SENT_54	9139/9140
32	)	CD	NUMBER	)	npadvmod	31	SENT_54	9140/9141
33	prior	JJ	O	prior		-1	SENT_54	9142/9147
34	to	TO	O	to		-1	SENT_54	9148/9150
35	daily	JJ	SET	daily	amod	37	SENT_54	9151/9156
36	macitentan	NN	O	macitentan	nn	37	SENT_54	9157/9167
37	administration	NN	O	administration	prep_prior_to	31	SENT_54	9168/9182
38	.	.	O	.		-1	SENT_54	9182/9183

1	Twenty-four-hour	CD	DURATION	twenty-four-hour	num	3	SENT_55	9184/9200
2	concentration-time	JJ	O	concentration-time	amod	3	SENT_55	9201/9219
3	profiles	NNS	O	profile	nsubj	24	SENT_55	9220/9228
4	of	IN	O	of		-1	SENT_55	9229/9231
5	macitentan	NN	O	macitentan	prep_of	3	SENT_55	9232/9242
6	and	CC	O	and		-1	SENT_55	9243/9246
7	its	PRP$	O	its	poss	8	SENT_55	9247/9250
8	metabolites	NNS	O	metabolite	conj_and	5	SENT_55	9251/9262
9	on	IN	O	on		-1	SENT_55	9263/9265
10	day	NN	DURATION	day	prep_on	8	SENT_55	9266/9269
11	5	CD	NUMBER	5	number	12	SENT_55	9270/9271
12	(	CD	NUMBER	(	dep	5	SENT_55	9272/9273
13	96-120	CD	NUMBER	96-120	num	15	SENT_55	9273/9279
14	h	NN	O	h	nn	15	SENT_55	9280/9281
15	)	NN	O	)	dep	12	SENT_55	9281/9282
16	and	CC	O	and		-1	SENT_55	9283/9286
17	day	NN	DURATION	day	conj_and	5	SENT_55	9287/9290
18	17	CD	NUMBER	17	number	19	SENT_55	9291/9293
19	(	CD	NUMBER	(	dep	17	SENT_55	9294/9295
20	384-408	CD	NUMBER	384-408	num	21	SENT_55	9295/9302
21	h	NN	O	h	dep	19	SENT_55	9303/9304
22	)	CD	NUMBER	)	number	23	SENT_55	9304/9305
23	(	CD	NUMBER	(	num	24	SENT_55	9306/9307
24	part	NN	O	part		-1	SENT_55	9307/9311
25	A	DT	O	a	det	26	SENT_55	9312/9313
26	)	NN	O	)	nsubjpass	39	SENT_55	9313/9314
27	or	CC	O	or		-1	SENT_55	9315/9317
28	day	NN	DURATION	day	nn	37	SENT_55	9318/9321
29	12	CD	NUMBER	12	num	37	SENT_55	9322/9324
30	(	CD	NUMBER	(	num	37	SENT_55	9325/9326
31	264-288	CD	NUMBER	264-288	num	37	SENT_55	9326/9333
32	h	NN	O	h	nn	37	SENT_55	9334/9335
33	)	CD	NUMBER	)	num	37	SENT_55	9335/9336
34	(	CD	NUMBER	(	num	37	SENT_55	9337/9338
35	part	NN	O	part	nn	37	SENT_55	9338/9342
36	B	NN	O	b	nn	37	SENT_55	9343/9344
37	)	NN	O	)	conj_or	26	SENT_55	9344/9345
38	were	VBD	O	be	auxpass	39	SENT_55	9346/9350
39	determined	VBN	O	determine	rcmod	24	SENT_55	9351/9361
40	in	IN	O	in		-1	SENT_55	9362/9364
41	blood	NN	O	blood	nn	42	SENT_55	9365/9370
42	samples	NNS	O	sample	prep_in	39	SENT_55	9371/9378
43	drawn	VBN	O	draw	conj_and	43	SENT_55	9379/9384
44	immediately	RB	O	immediately	advmod	43	SENT_55	9385/9396
45	before	IN	O	before		-1	SENT_55	9397/9403
46	and	CC	O	and		-1	SENT_55	9404/9407
47	at	IN	O	at		-1	SENT_55	9408/9410
48	1	CD	NUMBER	1	prep_before	43	SENT_55	9411/9412
49	,	,	O	,		-1	SENT_55	9412/9413
50	3	CD	NUMBER	3	dobj	24	SENT_55	9414/9415
51	,	,	O	,		-1	SENT_55	9415/9416
52	5	CD	NUMBER	5	rcmod	50	SENT_55	9417/9418
53	,	,	O	,		-1	SENT_55	9418/9419
54	6	CD	NUMBER	6	conj_and	52	SENT_55	9420/9421
55	,	,	O	,		-1	SENT_55	9421/9422
56	7	CD	NUMBER	7	conj_and	52	SENT_55	9423/9424
57	,	,	O	,		-1	SENT_55	9424/9425
58	8	CD	NUMBER	8	conj_and	52	SENT_55	9426/9427
59	,	,	O	,		-1	SENT_55	9427/9428
60	9	CD	NUMBER	9	conj_and	52	SENT_55	9429/9430
61	,	,	O	,		-1	SENT_55	9430/9431
62	10	CD	NUMBER	10	conj_and	52	SENT_55	9432/9434
63	,	,	O	,		-1	SENT_55	9434/9435
64	11	CD	NUMBER	11	conj_and	52	SENT_55	9436/9438
65	,	,	O	,		-1	SENT_55	9438/9439
66	12	CD	NUMBER	12	conj_and	52	SENT_55	9440/9442
67	,	,	O	,		-1	SENT_55	9442/9443
68	13	CD	NUMBER	13	conj_and	52	SENT_55	9444/9446
69	,	,	O	,		-1	SENT_55	9446/9447
70	14	CD	NUMBER	14	conj_and	52	SENT_55	9448/9450
71	,	,	O	,		-1	SENT_55	9450/9451
72	16	CD	NUMBER	16	conj_and	52	SENT_55	9452/9454
73	,	,	O	,		-1	SENT_55	9454/9455
74	and	CC	NUMBER	and		-1	SENT_55	9456/9459
75	24	CD	NUMBER	24	num	76	SENT_55	9460/9462
76	h	NN	O	h	conj_and	52	SENT_55	9463/9464
77	after	IN	O	after	dep	52	SENT_55	9465/9470
78	macitentan	NN	O	macitentan	nn	79	SENT_55	9471/9481
79	administration	NN	O	administration	pobj	77	SENT_55	9482/9496
80	.	.	O	.		-1	SENT_55	9496/9497

1	For	IN	O	for		-1	SENT_56	9533/9536
2	each	DT	O	each	det	4	SENT_56	9537/9541
3	time	NN	O	time	nn	4	SENT_56	9542/9546
4	point	NN	O	point	prep_for	12	SENT_56	9547/9552
5	,	,	O	,		-1	SENT_56	9552/9553
6	approximately	RB	O	approximately	quantmod	7	SENT_56	9554/9567
7	3	CD	NUMBER	3	num	8	SENT_56	9568/9569
8	mL	NN	O	ml	nsubjpass	12	SENT_56	9570/9572
9	of	IN	O	of		-1	SENT_56	9573/9575
10	blood	NN	O	blood	prep_of	8	SENT_56	9576/9581
11	was	VBD	O	be	auxpass	12	SENT_56	9582/9585
12	collected	VBN	O	collect		-1	SENT_56	9586/9595
13	from	IN	O	from		-1	SENT_56	9596/9600
14	the	DT	O	the	det	15	SENT_56	9601/9604
15	subject	NN	O	subject	prep_from	12	SENT_56	9605/9612
16	in	IN	O	in		-1	SENT_56	9613/9615
17	tubes	NNS	O	tube	nsubj	18	SENT_56	9616/9621
18	containing	VBG	O	contain	dep	22	SENT_56	9622/9632
19	ethylene	NN	O	ethylene	nn	20	SENT_56	9633/9641
20	diamine	NN	O	diamine	dobj	18	SENT_56	9642/9649
21	tetra-acetic	JJ	O	tetra-acetic	amod	22	SENT_56	9650/9662
22	acid	NN	O	acid	prep_in	15	SENT_56	9663/9667
23	.	.	O	.		-1	SENT_56	9667/9668

1	Within	IN	O	within		-1	SENT_57	9669/9675
2	30	CD	DURATION	30	num	3	SENT_57	9676/9678
3	min	NN	DURATION	min	prep_within	10	SENT_57	9679/9682
4	after	IN	O	after		-1	SENT_57	9683/9688
5	collection	NN	O	collection	prep_after	3	SENT_57	9689/9699
6	,	,	O	,		-1	SENT_57	9699/9700
7	the	DT	O	the	det	8	SENT_57	9701/9704
8	tubes	NNS	O	tube	nsubjpass	10	SENT_57	9705/9710
9	were	VBD	O	be	auxpass	10	SENT_57	9711/9715
10	centrifuged	VBN	O	centrifuge		-1	SENT_57	9716/9727
11	at	IN	O	at		-1	SENT_57	9728/9730
12	approximately	RB	O	approximately	quantmod	13	SENT_57	9731/9744
13	1,500	CD	NUMBER	1,500	num	14	SENT_57	9745/9750
14	g	NN	O	g	prep_at	10	SENT_57	9752/9753
15	for	IN	O	for		-1	SENT_57	9754/9757
16	10	CD	DURATION	10	num	17	SENT_57	9758/9760
17	min	NN	DURATION	min	prep_for	14	SENT_57	9761/9764
18	at	IN	O	at		-1	SENT_57	9765/9767
19	2	CD	NUMBER	2	num	20	SENT_57	9768/9769
20	C	NN	O	c	prep_at	17	SENT_57	9771/9772
21	to	TO	O	to		-1	SENT_57	9773/9775
22	8	CD	NUMBER	8	num	23	SENT_57	9776/9777
23	C.	NN	O	c.	prep_to	10	SENT_57	9779/9781
24	The	DT	O	the	det	25	SENT_57	9782/9785
25	plasma	NN	O	plasma	nsubjpass	27	SENT_57	9786/9792
26	was	VBD	O	be	auxpass	27	SENT_57	9793/9796
27	stored	VBN	O	store	rcmod	23	SENT_57	9797/9803
28	at	IN	O	at		-1	SENT_57	9804/9806
29	20	CD	NUMBER	20	num	30	SENT_57	9810/9812
30	C	NN	O	c	prep_at	27	SENT_57	9814/9815
31	until	IN	O	until		-1	SENT_57	9816/9821
32	analysis	NN	O	analysis	prep_until	27	SENT_57	9822/9830
33	.	.	O	.		-1	SENT_57	9830/9831

1	Bioanalytical	JJ	O	bioanalytical	amod	2	SENT_58	9867/9880
2	Methods	NNS	O	method		-1	SENT_58	9881/9888
3	and	CC	O	and		-1	SENT_58	9889/9892
4	PK	NN	O	pk	nn	5	SENT_58	9893/9895
5	Assessments	NNS	O	assessment	conj_and	2	SENT_58	9896/9907

1	Quantification	NN	O	quantification	nsubjpass	12	SENT_59	9943/9957
2	of	IN	O	of		-1	SENT_59	9958/9960
3	macitentan	NN	O	macitentan	prep_of	1	SENT_59	9961/9971
4	,	,	O	,		-1	SENT_59	9971/9972
5	ACT-132577	NN	O	act-132577	conj_and	3	SENT_59	9973/9983
6	,	,	O	,		-1	SENT_59	9983/9984
7	and	CC	O	and		-1	SENT_59	9985/9988
8	ACT-373898	NN	O	act-373898	conj_and	3	SENT_59	9989/9999
9	in	IN	O	in		-1	SENT_59	10000/10002
10	plasma	NN	O	plasma	prep_in	3	SENT_59	10003/10009
11	was	VBD	O	be	auxpass	12	SENT_59	10010/10013
12	performed	VBN	O	perform		-1	SENT_59	10014/10023
13	by	IN	O	by		-1	SENT_59	10024/10026
14	a	DT	O	a	det	25	SENT_59	10027/10028
15	validated	VBN	O	validate	dep	25	SENT_59	10029/10038
16	liquid	JJ	O	liquid	amod	17	SENT_59	10039/10045
17	chromatography	NN	O	chromatography	dobj	15	SENT_59	10046/10060
18	with	IN	O	with		-1	SENT_59	10061/10065
19	tandem	JJ	O	tandem	amod	21	SENT_59	10066/10072
20	mass	NN	O	mass	nn	21	SENT_59	10073/10077
21	spectrometry	NN	O	spectrometry	prep_with	15	SENT_59	10078/10090
22	(	CD	NUMBER	(	num	24	SENT_59	10091/10092
23	LCMS/MS	NN	O	lcms/ms	nn	24	SENT_59	10092/10099
24	)	NN	O	)	dep	21	SENT_59	10099/10100
25	method	NN	O	method	agent	12	SENT_59	10101/10107
26	.	.	O	.		-1	SENT_59	10107/10108

1	Analytes	NNS	O	analyte	nsubjpass	3	SENT_60	10109/10117
2	were	VBD	O	be	auxpass	3	SENT_60	10118/10122
3	extracted	VBN	O	extract		-1	SENT_60	10123/10132
4	from	IN	O	from		-1	SENT_60	10133/10137
5	plasma	NN	O	plasma	prep_from	3	SENT_60	10138/10144
6	by	IN	O	by		-1	SENT_60	10145/10147
7	protein	NN	O	protein	nn	8	SENT_60	10148/10155
8	precipitation	NN	O	precipitation	agent	3	SENT_60	10156/10169
9	with	IN	O	with		-1	SENT_60	10170/10174
10	ethanol	NN	O	ethanol	nn	12	SENT_60	10175/10182
11	(	CD	NUMBER	(	num	12	SENT_60	10183/10184
12	EtOH	NN	O	etoh	prep_with	3	SENT_60	10184/10188
13	)	CD	NUMBER	)	num	12	SENT_60	10188/10189
14	/	:	O	/	punct	15	SENT_60	10189/10190
15	acetonitrile	NN	O	acetonitrile	dep	3	SENT_60	10190/10202
16	(	CD	NUMBER	(	num	17	SENT_60	10203/10204
17	50:50	CD	NUMBER	50:50	nsubj	25	SENT_60	10204/10209
18	,	,	O	,		-1	SENT_60	10209/10210
19	v/v	NN	O	v/v	nn	20	SENT_60	10211/10214
20	)	NN	O	)	appos	17	SENT_60	10214/10215
21	containing	VBG	O	contain	partmod	20	SENT_60	10216/10226
22	the	DT	O	the	det	24	SENT_60	10227/10230
23	internal	JJ	O	internal	amod	24	SENT_60	10231/10239
24	standards	NNS	O	standard	dobj	21	SENT_60	10240/10249
25	(	VBP	O	(	rcmod	15	SENT_60	10250/10251
26	polydeuterated	JJ	O	polydeuterated	amod	27	SENT_60	10251/10265
27	analogs	NNS	O	analog	dobj	25	SENT_60	10266/10273
28	of	IN	O	of		-1	SENT_60	10274/10276
29	macitentan	NN	O	macitentan	nn	31	SENT_60	10277/10287
30	,	,	O	,		-1	SENT_60	10287/10288
31	ACT-132577	NN	O	act-132577	prep_of	27	SENT_60	10289/10299
32	,	,	O	,		-1	SENT_60	10299/10300
33	and	CC	O	and		-1	SENT_60	10301/10304
34	ACT-373898	NN	O	act-373898	nn	35	SENT_60	10305/10315
35	)	NN	O	)	conj_and	31	SENT_60	10315/10316
36	and	CC	O	and		-1	SENT_60	10317/10320
37	filtered	VBN	O	filter	conj_and	3	SENT_60	10321/10329
38	through	IN	O	through		-1	SENT_60	10330/10337
39	a	DT	O	a	det	42	SENT_60	10338/10339
40	protein	NN	O	protein	nn	42	SENT_60	10340/10347
41	precipitation	NN	O	precipitation	nn	42	SENT_60	10348/10361
42	plate	NN	O	plate	prep_through	37	SENT_60	10362/10367
43	(	CD	NUMBER	(	number	44	SENT_60	10368/10369
44	0.2	CD	NUMBER	0.2	num	48	SENT_60	10369/10372
45	m	NN	O	m	nn	48	SENT_60	10375/10376
46	pore	NN	O	pore	nn	48	SENT_60	10377/10381
47	size	NN	O	size	nn	48	SENT_60	10382/10386
48	)	NN	O	)	dep	42	SENT_60	10386/10387
49	,	,	O	,		-1	SENT_60	10387/10388
50	before	IN	O	before		-1	SENT_60	10389/10395
51	injection	NN	O	injection	prep_before	42	SENT_60	10396/10405
52	into	IN	O	into		-1	SENT_60	10406/10410
53	the	DT	O	the	det	58	SENT_60	10411/10414
54	high	JJ	O	high	amod	58	SENT_60	10415/10419
55	performance	NN	O	performance	nn	58	SENT_60	10420/10431
56	liquid	JJ	O	liquid	amod	58	SENT_60	10432/10438
57	chromatography	NN	O	chromatography	nn	58	SENT_60	10439/10453
58	system	NN	O	system	prep_into	37	SENT_60	10454/10460
59	.	.	O	.		-1	SENT_60	10460/10461

1	The	DT	O	the	det	2	SENT_61	10462/10465
2	samples	NNS	O	sample	nsubjpass	5	SENT_61	10466/10473
3	were	VBD	O	be	auxpass	5	SENT_61	10474/10478
4	subsequently	RB	O	subsequently	advmod	5	SENT_61	10479/10491
5	analyzed	VBN	O	analyze		-1	SENT_61	10492/10500
6	by	IN	O	by		-1	SENT_61	10501/10503
7	triple-stage	JJ	O	triple-stage	amod	8	SENT_61	10504/10516
8	quadrupole	NN	O	quadrupole	agent	5	SENT_61	10517/10527
9	tandem	JJ	O	tandem	amod	14	SENT_61	10528/10534
10	mass	NN	O	mass	nn	14	SENT_61	10535/10539
11	spectrometry	NN	O	spectrometry	nn	14	SENT_61	10540/10552
12	(	CD	NUMBER	(	num	14	SENT_61	10553/10554
13	MS/MS	NN	O	ms/ms	nn	14	SENT_61	10554/10559
14	)	NN	O	)	dep	8	SENT_61	10559/10560
15	.	.	O	.		-1	SENT_61	10560/10561

1	The	DT	O	the	det	2	SENT_62	10562/10565
2	concentrations	NNS	O	concentration	nsubjpass	7	SENT_62	10566/10580
3	of	IN	O	of		-1	SENT_62	10581/10583
4	the	DT	O	the	det	5	SENT_62	10584/10587
5	analytes	NNS	O	analyte	prep_of	2	SENT_62	10588/10596
6	were	VBD	O	be	auxpass	7	SENT_62	10597/10601
7	determined	VBN	O	determine		-1	SENT_62	10602/10612
8	using	VBG	O	use	xcomp	7	SENT_62	10613/10618
9	the	DT	O	the	det	12	SENT_62	10619/10622
10	internal	JJ	O	internal	amod	12	SENT_62	10623/10631
11	standardization	NN	O	standardization	nn	12	SENT_62	10632/10647
12	method	NN	O	method	dobj	8	SENT_62	10648/10654
13	.	.	O	.		-1	SENT_62	10654/10655

1	The	DT	O	the	det	2	SENT_63	10656/10659
2	square	NN	O	square	nsubj	13	SENT_63	10660/10666
3	of	IN	O	of		-1	SENT_63	10667/10669
4	the	DT	O	the	det	9	SENT_63	10670/10673
5	correlation	NN	O	correlation	nn	9	SENT_63	10674/10685
6	coefficient	NN	O	coefficient	nn	9	SENT_63	10686/10697
7	(	NN	O	(	nn	9	SENT_63	10698/10699
8	R2	NN	O	r2	nn	9	SENT_63	10699/10701
9	)	NN	O	)	prep_of	2	SENT_63	10701/10702
10	was	VBD	O	be	cop	13	SENT_63	10703/10706
11	at	IN	O	at	quantmod	13	SENT_63	10707/10709
12	least	JJS	O	least	mwe	11	SENT_63	10710/10715
13	0.9985	CD	NUMBER	0.9985		-1	SENT_63	10716/10722
14	for	IN	O	for		-1	SENT_63	10723/10726
15	macitentan	NN	O	macitentan	prep_for	13	SENT_63	10727/10737
16	,	,	O	,		-1	SENT_63	10737/10738
17	0.9863	CD	NUMBER	0.9863	conj_and	13	SENT_63	10739/10745
18	for	IN	O	for		-1	SENT_63	10746/10749
19	ACT-132577	NN	O	act-132577	prep_for	17	SENT_63	10750/10760
20	,	,	O	,		-1	SENT_63	10760/10761
21	and	CC	O	and		-1	SENT_63	10762/10765
22	0.9932	CD	NUMBER	0.9932	conj_and	13	SENT_63	10766/10772
23	for	IN	O	for		-1	SENT_63	10773/10776
24	ACT-373898	NN	O	act-373898	prep_for	22	SENT_63	10777/10787
25	in	IN	O	in		-1	SENT_63	10788/10790
26	all	DT	O	all	det	27	SENT_63	10791/10794
27	runs	NNS	O	run	prep_in	24	SENT_63	10795/10799
28	.	.	O	.		-1	SENT_63	10799/10800

1	For	IN	O	for		-1	SENT_64	10801/10804
2	macitentan	NN	O	macitentan	prep_for	17	SENT_64	10805/10815
3	,	,	O	,		-1	SENT_64	10815/10816
4	the	DT	O	the	det	8	SENT_64	10817/10820
5	inter-day	JJ	O	inter-day	amod	8	SENT_64	10821/10830
6	precision	NN	O	precision	nn	8	SENT_64	10831/10840
7	(	NN	O	(	nn	8	SENT_64	10841/10842
8	coefficient	NN	O	coefficient	nsubj	17	SENT_64	10842/10853
9	of	IN	O	of		-1	SENT_64	10854/10856
10	variation	NN	O	variation	nn	11	SENT_64	10857/10866
11	)	NN	O	)	prep_of	8	SENT_64	10866/10867
12	of	IN	O	of		-1	SENT_64	10868/10870
13	control	NN	O	control	nn	14	SENT_64	10871/10878
14	samples	NNS	O	sample	prep_of	11	SENT_64	10879/10886
15	was	VBD	O	be	cop	17	SENT_64	10887/10890
16	8.6	CD	PERCENT	8.6	num	17	SENT_64	10894/10897
17	%	NN	PERCENT	%		-1	SENT_64	10897/10898
18	,	,	O	,		-1	SENT_64	10898/10899
19	and	CC	O	and		-1	SENT_64	10900/10903
20	inter-day	JJ	O	inter-day	amod	21	SENT_64	10904/10913
21	inaccuracy	NN	O	inaccuracy	nsubj	22	SENT_64	10914/10924
22	ranged	VBD	O	range	conj_and	17	SENT_64	10925/10931
23	from	IN	O	from		-1	SENT_64	10932/10936
24	4.3	CD	PERCENT	4.3	number	28	SENT_64	10940/10943
25	%	NN	PERCENT	%	dep	28	SENT_64	10943/10944
26	to	TO	O	to	dep	28	SENT_64	10945/10947
27	5.3	CD	PERCENT	5.3	number	28	SENT_64	10948/10951
28	%	NN	PERCENT	%	prep_from	22	SENT_64	10951/10952
29	.	.	O	.		-1	SENT_64	10952/10953

1	For	IN	O	for		-1	SENT_65	10954/10957
2	ACT-132577	NN	O	act-132577	prep_for	8	SENT_65	10958/10968
3	,	,	O	,		-1	SENT_65	10968/10969
4	inter-day	JJ	O	inter-day	amod	5	SENT_65	10970/10979
5	precision	NN	O	precision	nsubj	8	SENT_65	10980/10989
6	was	VBD	O	be	cop	8	SENT_65	10990/10993
7	7.0	CD	PERCENT	7.0	num	8	SENT_65	10997/11000
8	%	NN	PERCENT	%		-1	SENT_65	11000/11001
9	,	,	O	,		-1	SENT_65	11001/11002
10	and	CC	O	and		-1	SENT_65	11003/11006
11	inter-day	JJ	O	inter-day	amod	12	SENT_65	11007/11016
12	inaccuracy	NN	O	inaccuracy	nsubj	13	SENT_65	11017/11027
13	ranged	VBD	O	range	conj_and	8	SENT_65	11028/11034
14	from	IN	O	from		-1	SENT_65	11035/11039
15	5.7	CD	PERCENT	5.7	number	19	SENT_65	11043/11046
16	%	NN	PERCENT	%	dep	19	SENT_65	11046/11047
17	to	TO	O	to	dep	19	SENT_65	11048/11050
18	2.0	CD	PERCENT	2.0	number	19	SENT_65	11054/11057
19	%	NN	PERCENT	%	prep_from	13	SENT_65	11057/11058
20	.	.	O	.		-1	SENT_65	11058/11059

1	For	IN	O	for		-1	SENT_66	11060/11063
2	ACT-373898	NN	O	act-373898	prep_for	8	SENT_66	11064/11074
3	,	,	O	,		-1	SENT_66	11074/11075
4	inter-day	JJ	O	inter-day	amod	5	SENT_66	11076/11085
5	precision	NN	O	precision	nsubj	8	SENT_66	11086/11095
6	was	VBD	O	be	cop	8	SENT_66	11096/11099
7	10.1	CD	PERCENT	10.1	num	8	SENT_66	11103/11107
8	%	NN	PERCENT	%		-1	SENT_66	11107/11108
9	,	,	O	,		-1	SENT_66	11108/11109
10	and	CC	O	and		-1	SENT_66	11110/11113
11	inter-day	JJ	O	inter-day	amod	12	SENT_66	11114/11123
12	inaccuracy	NN	O	inaccuracy	nsubj	13	SENT_66	11124/11134
13	was	VBD	O	be	conj_and	8	SENT_66	11135/11138
14	in	IN	O	in		-1	SENT_66	11139/11141
15	the	DT	O	the	det	16	SENT_66	11142/11145
16	range	NN	O	range	prep_in	13	SENT_66	11146/11151
17	of	IN	O	of		-1	SENT_66	11152/11154
18	9.3	CD	PERCENT	9.3	number	22	SENT_66	11158/11161
19	%	NN	PERCENT	%	dep	22	SENT_66	11161/11162
20	to	TO	O	to	dep	22	SENT_66	11163/11165
21	1.8	CD	PERCENT	1.8	number	22	SENT_66	11166/11169
22	%	NN	PERCENT	%	prep_of	16	SENT_66	11169/11170
23	.	.	O	.		-1	SENT_66	11170/11171

1	The	DT	O	the	det	3	SENT_67	11172/11175
2	lower	JJR	O	lower	amod	3	SENT_67	11176/11181
3	limit	NN	O	limit	nsubj	11	SENT_67	11182/11187
4	of	IN	O	of		-1	SENT_67	11188/11190
5	quantification	NN	O	quantification	nn	8	SENT_67	11191/11205
6	(	CD	NUMBER	(	num	8	SENT_67	11206/11207
7	LLOQ	NN	O	lloq	nn	8	SENT_67	11207/11211
8	)	NN	O	)	prep_of	3	SENT_67	11211/11212
9	was	VBD	O	be	cop	11	SENT_67	11213/11216
10	1	CD	NUMBER	1	num	11	SENT_67	11217/11218
11	ng/mL	NN	O	ng/ml		-1	SENT_67	11219/11224
12	for	IN	O	for		-1	SENT_67	11225/11228
13	macitentan	NN	O	macitentan	prep_for	11	SENT_67	11229/11239
14	and	CC	O	and		-1	SENT_67	11240/11243
15	ACT-132577	NN	O	act-132577	conj_and	13	SENT_67	11244/11254
16	,	,	O	,		-1	SENT_67	11254/11255
17	and	CC	O	and		-1	SENT_67	11256/11259
18	0.5	CD	NUMBER	0.5	num	19	SENT_67	11260/11263
19	ng/mL	NN	O	ng/ml	conj_and	11	SENT_67	11264/11269
20	for	IN	O	for		-1	SENT_67	11270/11273
21	ACT-373898	NN	O	act-373898	prep_for	19	SENT_67	11274/11284
22	.	.	O	.		-1	SENT_67	11284/11285

1	The	DT	O	the	nsubj	31	SENT_68	11321/11324
2	measured	VBN	O	measure	dep	1	SENT_68	11325/11333
3	individual	JJ	O	individual	amod	5	SENT_68	11334/11344
4	plasma	NN	O	plasma	nn	5	SENT_68	11345/11351
5	concentrations	NNS	O	concentration	dobj	2	SENT_68	11352/11366
6	of	IN	O	of		-1	SENT_68	11367/11369
7	macitentan	NN	O	macitentan	prep_of	5	SENT_68	11370/11380
8	,	,	O	,		-1	SENT_68	11380/11381
9	ACT-132577	NN	O	act-132577	appos	7	SENT_68	11382/11392
10	,	,	O	,		-1	SENT_68	11392/11393
11	and	CC	O	and		-1	SENT_68	11394/11397
12	ACT-373898	NN	O	act-373898	nsubjpass	14	SENT_68	11398/11408
13	were	VBD	O	be	auxpass	14	SENT_68	11409/11413
14	used	VBN	O	use	conj_and	2	SENT_68	11414/11418
15	to	TO	O	to	aux	16	SENT_68	11419/11421
16	calculate	VB	O	calculate	xcomp	14	SENT_68	11422/11431
17	PK	NN	O	pk	nn	18	SENT_68	11432/11434
18	parameters	NNS	O	parameter	dobj	16	SENT_68	11435/11445
19	by	IN	O	by		-1	SENT_68	11446/11448
20	model-independent	JJ	O	model-independent	amod	21	SENT_68	11449/11466
21	analysis	NN	O	analysis	prep_by	16	SENT_68	11467/11475
22	,	,	O	,		-1	SENT_68	11475/11476
23	using	VBG	O	use	partmod	16	SENT_68	11477/11482
24	the	DT	O	the	det	25	SENT_68	11483/11486
25	WinNonlin	NNP	O	WinNonlin	dobj	23	SENT_68	11487/11496
26	6.1	CD	NUMBER	6.1	num	25	SENT_68	11497/11500
27	or	CC	O	or		-1	SENT_68	11501/11503
28	Phoenix	NNP	LOCATION	Phoenix	nn	30	SENT_68	11504/11511
29	software	NN	O	software	nn	30	SENT_68	11512/11520
30	packages	NNS	O	package	conj_or	25	SENT_68	11521/11529
31	(	VBP	O	(		-1	SENT_68	11530/11531
32	Pharsight	NNP	ORGANIZATION	Pharsight	nn	33	SENT_68	11531/11540
33	Corporation	NNP	ORGANIZATION	Corporation	dobj	31	SENT_68	11541/11552
34	,	,	O	,		-1	SENT_68	11552/11553
35	Mountain	NNP	ORGANIZATION	Mountain	nn	40	SENT_68	11554/11562
36	View	NNP	ORGANIZATION	View	nn	40	SENT_68	11563/11567
37	,	,	O	,		-1	SENT_68	11567/11568
38	CA	NNP	O	CA	appos	40	SENT_68	11569/11571
39	,	,	O	,		-1	SENT_68	11571/11572
40	USA	NNP	LOCATION	USA	appos	33	SENT_68	11573/11576
41	)	CD	NUMBER	)	num	40	SENT_68	11576/11577
42	.	.	O	.		-1	SENT_68	11577/11578

1	The	DT	O	the	nsubj	2	SENT_69	11579/11582
2	measured	VBN	O	measure	dep	14	SENT_69	11583/11591
3	individual	JJ	O	individual	amod	5	SENT_69	11592/11602
4	plasma	NN	O	plasma	nn	5	SENT_69	11603/11609
5	concentrations	NNS	O	concentration	dobj	2	SENT_69	11610/11624
6	immediately	RB	O	immediately	advmod	2	SENT_69	11625/11636
7	before	IN	O	before		-1	SENT_69	11637/11643
8	the	DT	O	the	det	10	SENT_69	11644/11647
9	morning	NN	TIME	morning	nn	10	SENT_69	11648/11655
10	dose	NN	O	dose	prep_before	2	SENT_69	11656/11660
11	of	IN	O	of		-1	SENT_69	11661/11663
12	macitentan	NN	O	macitentan	prep_of	10	SENT_69	11664/11674
13	were	VBD	O	be	auxpass	14	SENT_69	11675/11679
14	used	VBN	O	use		-1	SENT_69	11680/11684
15	to	TO	O	to	aux	17	SENT_69	11685/11687
16	directly	RB	O	directly	advmod	17	SENT_69	11688/11696
17	obtain	VB	O	obtain	xcomp	14	SENT_69	11697/11703
18	trough	NN	O	trough	nn	19	SENT_69	11704/11710
19	concentrations	NNS	O	concentration	dobj	17	SENT_69	11711/11725
20	(	CD	NUMBER	(	num	22	SENT_69	11726/11727
21	Ctr	NN	O	ctr	nn	22	SENT_69	11727/11730
22	)	NN	O	)	nsubjpass	14	SENT_69	11730/11731
23	.	.	O	.		-1	SENT_69	11731/11732

1	The	DT	O	the	det	2	SENT_70	11733/11736
2	area	NN	O	area	nsubj	7	SENT_70	11737/11741
3	under	IN	O	under		-1	SENT_70	11742/11747
4	the	DT	O	the	det	6	SENT_70	11748/11751
5	plasma	NN	O	plasma	nn	6	SENT_70	11752/11758
6	concentration-time	NN	O	concentration-time	prep_under	2	SENT_70	11759/11777
7	curve	NN	O	curve		-1	SENT_70	11778/11783
8	(	CD	NUMBER	(	num	10	SENT_70	11784/11785
9	AUC	NN	O	auc	nn	10	SENT_70	11785/11788
10	)	NN	O	)	nsubjpass	12	SENT_70	11788/11789
11	was	VBD	O	be	auxpass	12	SENT_70	11790/11793
12	calculated	VBN	O	calculate	ccomp	7	SENT_70	11794/11804
13	according	VBG	O	accord		-1	SENT_70	11805/11814
14	to	TO	O	to	prepc_according_to	12	SENT_70	11815/11817
15	the	DT	O	the	det	18	SENT_70	11818/11821
16	linear	JJ	O	linear	amod	18	SENT_70	11822/11828
17	trapezoidal	JJ	O	trapezoidal	amod	18	SENT_70	11829/11840
18	rule	NN	O	rule	pobj	12	SENT_70	11841/11845
19	,	,	O	,		-1	SENT_70	11845/11846
20	using	VBG	O	use	partmod	18	SENT_70	11847/11852
21	the	DT	O	the	det	24	SENT_70	11853/11856
22	measured	VBN	O	measure	amod	24	SENT_70	11857/11865
23	concentration-time	NN	O	concentration-time	nn	24	SENT_70	11866/11884
24	values	NNS	O	value	dobj	20	SENT_70	11885/11891
25	above	IN	O	above		-1	SENT_70	11892/11897
26	the	DT	O	the	det	27	SENT_70	11898/11901
27	LLOQ	NNP	O	LLOQ	prep_above	20	SENT_70	11902/11906
28	.	.	O	.		-1	SENT_70	11906/11907

1	Safety	NNP	O	Safety	nn	2	SENT_71	11943/11949
2	Assessments	NNS	O	assessment		-1	SENT_71	11950/11961

1	Tolerability	NN	O	tolerability	nsubjpass	5	SENT_72	11997/12009
2	and	CC	O	and		-1	SENT_72	12010/12013
3	safety	NN	O	safety	conj_and	1	SENT_72	12014/12020
4	were	VBD	O	be	auxpass	5	SENT_72	12021/12025
5	evaluated	VBN	O	evaluate		-1	SENT_72	12026/12035
6	by	IN	O	by		-1	SENT_72	12036/12038
7	recording	VBG	O	record	agent	5	SENT_72	12039/12048
8	SAEs	NNS	O	sae	dobj	7	SENT_72	12049/12053
9	,	,	O	,		-1	SENT_72	12053/12054
10	AEs	NNS	O	ae	conj_and	8	SENT_72	12055/12058
11	,	,	O	,		-1	SENT_72	12058/12059
12	clinical	JJ	O	clinical	amod	14	SENT_72	12060/12068
13	laboratory	NN	O	laboratory	nn	14	SENT_72	12069/12079
14	variables	NNS	O	variable	conj_and	8	SENT_72	12080/12089
15	,	,	O	,		-1	SENT_72	12089/12090
16	vital	JJ	O	vital	amod	17	SENT_72	12091/12096
17	signs	NNS	O	sign	conj_and	8	SENT_72	12097/12102
18	,	,	O	,		-1	SENT_72	12102/12103
19	and	CC	O	and		-1	SENT_72	12104/12107
20	12-lead	JJ	O	12-lead	amod	21	SENT_72	12108/12115
21	ECG	NN	O	ecg	conj_and	8	SENT_72	12116/12119
22	during	IN	O	during		-1	SENT_72	12120/12126
23	the	DT	O	the	det	24	SENT_72	12127/12130
24	study	NN	O	study	prep_during	7	SENT_72	12131/12136
25	.	.	O	.		-1	SENT_72	12136/12137

1	Statistical	JJ	O	statistical	amod	2	SENT_73	12173/12184
2	Analysis	NN	O	analysis		-1	SENT_73	12185/12193

1	The	DT	O	the	det	2	SENT_74	12229/12232
2	effect	NN	O	effect	nsubjpass	32	SENT_74	12233/12239
3	of	IN	O	of		-1	SENT_74	12240/12242
4	Cs	NNS	O	c	prep_of	2	SENT_74	12243/12245
5	and	CC	O	and		-1	SENT_74	12246/12249
6	rifampin	NN	O	rifampin	conj_and	4	SENT_74	12250/12258
7	on	IN	O	on		-1	SENT_74	12259/12261
8	the	DT	O	the	det	10	SENT_74	12262/12265
9	steady-state	JJ	O	steady-state	amod	10	SENT_74	12266/12278
10	area	NN	O	area	prep_on	2	SENT_74	12279/12283
11	under	IN	O	under		-1	SENT_74	12284/12289
12	the	DT	O	the	det	16	SENT_74	12290/12293
13	plasma	NN	O	plasma	nn	16	SENT_74	12294/12300
14	concentration	NN	O	concentration	nn	16	SENT_74	12301/12314
15	time	NN	O	time	nn	16	SENT_74	12315/12319
16	curve	NN	O	curve	prep_under	10	SENT_74	12320/12325
17	during	IN	O	during		-1	SENT_74	12326/12332
18	a	DT	O	a	det	23	SENT_74	12333/12334
19	dose	NN	O	dose	nn	23	SENT_74	12335/12339
20	interval	NN	O	interval	nn	23	SENT_74	12340/12348
21	(	CD	NUMBER	(	num	23	SENT_74	12349/12350
22	AUC	NN	O	auc	nn	23	SENT_74	12350/12353
23	)	NN	O	)	prep_during	16	SENT_74	12355/12356
24	and	CC	O	and		-1	SENT_74	12357/12360
25	Ctr	NN	O	ctr	conj_and	23	SENT_74	12361/12364
26	of	IN	O	of		-1	SENT_74	12365/12367
27	macitentan	NN	O	macitentan	prep_of	25	SENT_74	12368/12378
28	and	CC	O	and		-1	SENT_74	12379/12382
29	its	PRP$	O	its	poss	30	SENT_74	12383/12386
30	metabolites	NNS	O	metabolite	conj_and	27	SENT_74	12387/12398
31	were	VBD	O	be	auxpass	32	SENT_74	12399/12403
32	explored	VBN	O	explore		-1	SENT_74	12404/12412
33	using	VBG	O	use	xcomp	32	SENT_74	12413/12418
34	the	DT	O	the	det	35	SENT_74	12419/12422
35	ratio	NN	O	ratio	dobj	33	SENT_74	12423/12428
36	of	IN	O	of		-1	SENT_74	12429/12431
37	geometric	JJ	O	geometric	amod	38	SENT_74	12432/12441
38	means	NNS	O	means	prep_of	35	SENT_74	12442/12447
39	and	CC	O	and		-1	SENT_74	12448/12451
40	its	PRP$	O	its	poss	44	SENT_74	12452/12455
41	90	CD	PERCENT	90	number	42	SENT_74	12456/12458
42	%	NN	PERCENT	%	amod	44	SENT_74	12458/12459
43	confidence	NN	O	confidence	nn	44	SENT_74	12460/12470
44	intervals	NNS	O	interval	conj_and	35	SENT_74	12471/12480
45	of	IN	O	of		-1	SENT_74	12481/12483
46	macitentan	NN	O	macitentan	prep_of	44	SENT_74	12484/12494
47	+	CC	O	+		-1	SENT_74	12495/12496
48	Cs	NN	O	c	conj_+	35	SENT_74	12497/12499
49	(	CD	NUMBER	(	num	48	SENT_74	12500/12501
50	or	CC	O	or		-1	SENT_74	12501/12503
51	macitentan	NN	O	macitentan	conj_or	48	SENT_74	12504/12514
52	+	CC	O	+		-1	SENT_74	12515/12516
53	rifampin	NN	O	rifampin	conj_+	48	SENT_74	12517/12525
54	)	CD	NUMBER	)	num	53	SENT_74	12525/12526
55	versus	CC	O	versus	prep	53	SENT_74	12527/12533
56	macitentan	NN	O	macitentan	dep	55	SENT_74	12534/12544
57	.	.	O	.		-1	SENT_74	12544/12545

1	Tolerability	NN	O	tolerability	nn	4	SENT_75	12546/12558
2	and	CC	O	and		-1	SENT_75	12559/12562
3	safety	NN	O	safety	conj_and	1	SENT_75	12563/12569
4	endpoints	NNS	O	endpoint	nsubjpass	6	SENT_75	12570/12579
5	were	VBD	O	be	auxpass	6	SENT_75	12580/12584
6	analyzed	VBN	O	analyze		-1	SENT_75	12585/12593
7	descriptively	RB	O	descriptively	advmod	6	SENT_75	12594/12607
8	.	.	O	.		-1	SENT_75	12607/12608

1	In	IN	O	in		-1	SENT_76	12644/12646
2	Vitro	NNP	O	Vitro	nn	3	SENT_76	12647/12652
3	Experiments	NNS	O	experiment	pobj	1	SENT_76	12653/12664

1	Chinese	JJ	O	chinese	amod	3	SENT_77	12700/12707
2	Hamster	NN	O	hamster	nn	3	SENT_77	12708/12715
3	Ovary	NN	O	ovary		-1	SENT_77	12716/12721
4	Cell	NN	O	cell	nn	5	SENT_77	12722/12726
5	Culture	NN	O	culture	dep	3	SENT_77	12727/12734

1	Wild-type	JJ	O	wild-type	nsubjpass	15	SENT_78	12770/12779
2	and	CC	O	and		-1	SENT_78	12780/12783
3	Chinese	JJ	O	chinese	amod	8	SENT_78	12784/12791
4	hamster	NN	O	hamster	nn	8	SENT_78	12792/12799
5	ovary	NN	O	ovary	nn	8	SENT_78	12800/12805
6	(	CD	NUMBER	(	num	8	SENT_78	12806/12807
7	CHO	NN	O	cho	nn	8	SENT_78	12807/12810
8	)	NN	O	)	conj_and	1	SENT_78	12810/12811
9	cells	NNS	O	cell	nn	11	SENT_78	12812/12817
10	over-expressing	NN	O	over-expressing	nn	11	SENT_78	12818/12833
11	OATP1B1	NN	O	oatp1b1	dep	8	SENT_78	12834/12841
12	and	CC	O	and		-1	SENT_78	12842/12845
13	OATP1B3	NN	O	oatp1b3	conj_and	11	SENT_78	12846/12853
14	were	VBD	O	be	auxpass	15	SENT_78	12854/12858
15	maintained	VBN	O	maintain		-1	SENT_78	12859/12869
16	in	IN	O	in		-1	SENT_78	12870/12872
17	Dulbecco	NNP	PERSON	Dulbecco	prep_in	15	SENT_78	12873/12881
18	's	POS	O	's	possessive	17	SENT_78	12881/12883
19	modified	VBN	O	modify	amod	20	SENT_78	12884/12892
20	eagle	NN	O	eagle	poss	22	SENT_78	12893/12898
21	's	POS	O	's		-1	SENT_78	12898/12900
22	medium	NN	O	medium	dep	17	SENT_78	12901/12907
23	supplemented	VBN	O	supplement	partmod	22	SENT_78	12908/12920
24	with	IN	O	with		-1	SENT_78	12921/12925
25	10	CD	PERCENT	10	num	26	SENT_78	12926/12928
26	%	NN	PERCENT	%	prep_with	23	SENT_78	12928/12929
27	(	CD	NUMBER	(	num	28	SENT_78	12930/12931
28	v/v	NN	O	v/v	dep	26	SENT_78	12931/12934
29	)	CD	NUMBER	)	num	32	SENT_78	12934/12935
30	fetal	JJ	O	fetal	amod	32	SENT_78	12936/12941
31	calf	NN	O	calf	nn	32	SENT_78	12942/12946
32	serum	NN	O	serum	dep	26	SENT_78	12947/12952
33	,	,	O	,		-1	SENT_78	12952/12953
34	penicillin/streptomycin	NN	O	penicillin/streptomycin	nn	35	SENT_78	12954/12977
35	(	NN	O	(	conj_and	26	SENT_78	12978/12979
36	100	CD	NUMBER	100	num	38	SENT_78	12979/12982
37	IU/mL	NN	O	iu/ml	nn	38	SENT_78	12983/12988
38	)	NN	O	)	dep	35	SENT_78	12988/12989
39	,	,	O	,		-1	SENT_78	12989/12990
40	and	CC	O	and		-1	SENT_78	12991/12994
41	l-proline	JJ	O	l-proline	amod	42	SENT_78	12995/13004
42	(	NN	O	(	conj_and	26	SENT_78	13005/13006
43	0.05	CD	NUMBER	0.05	num	45	SENT_78	13006/13010
44	mg/mL	NN	O	mg/ml	nn	45	SENT_78	13011/13016
45	)	NN	O	)	dep	42	SENT_78	13016/13017
46	at	IN	O	at		-1	SENT_78	13018/13020
47	37	CD	NUMBER	37	num	48	SENT_78	13021/13023
48	C	NN	O	c	prep_at	23	SENT_78	13025/13026
49	in	IN	O	in		-1	SENT_78	13027/13029
50	a	DT	O	a	det	52	SENT_78	13030/13031
51	humidified	JJ	O	humidified	amod	52	SENT_78	13032/13042
52	atmosphere	NN	O	atmosphere	prep_in	48	SENT_78	13043/13053
53	containing	VBG	O	contain	partmod	52	SENT_78	13054/13064
54	5	CD	PERCENT	5	number	55	SENT_78	13065/13066
55	%	NN	PERCENT	%	amod	56	SENT_78	13066/13067
56	CO2	NN	O	co2	dobj	53	SENT_78	13068/13071
57	.	.	O	.		-1	SENT_78	13071/13072

1	The	DT	O	the	det	3	SENT_79	13073/13076
2	culture	NN	O	culture	nn	3	SENT_79	13077/13084
3	medium	NN	O	medium	nsubj	8	SENT_79	13085/13091
4	for	IN	O	for		-1	SENT_79	13092/13095
5	transfected	VBN	O	transfect	prepc_for	3	SENT_79	13096/13107
6	cells	NNS	O	cell	dobj	5	SENT_79	13108/13113
7	also	RB	O	also	advmod	8	SENT_79	13114/13118
8	contained	VBD	O	contain		-1	SENT_79	13119/13128
9	geneticin	NN	O	geneticin	nn	10	SENT_79	13129/13138
10	(	NN	O	(	nsubj	13	SENT_79	13139/13140
11	500	CD	NUMBER	500	num	13	SENT_79	13140/13143
12	g/mL	NN	O	g/ml	nn	13	SENT_79	13146/13150
13	)	NN	O	)	xcomp	8	SENT_79	13150/13151
14	.	.	O	.		-1	SENT_79	13151/13152

1	For	IN	O	for		-1	SENT_80	13153/13156
2	transport	NN	O	transport	nn	3	SENT_80	13157/13166
3	experiments	NNS	O	experiment	prep_for	7	SENT_80	13167/13178
4	,	,	O	,		-1	SENT_80	13178/13179
5	cells	NNS	O	cell	nsubjpass	7	SENT_80	13180/13185
6	were	VBD	O	be	auxpass	7	SENT_80	13186/13190
7	seeded	VBN	O	seed		-1	SENT_80	13191/13197
8	1:10	CD	TIME	1:10	dobj	7	SENT_80	13198/13202
9	or	CC	O	or		-1	SENT_80	13203/13205
10	1:20	CD	TIME	1:20	conj_or	8	SENT_80	13206/13210
11	on	IN	O	on		-1	SENT_80	13211/13213
12	8-cm2	JJ	O	8-cm2	amod	15	SENT_80	13214/13219
13	tissue	NN	O	tissue	nn	15	SENT_80	13220/13226
14	culture	NN	O	culture	nn	15	SENT_80	13227/13234
15	dishes	NNS	O	dish	prep_on	7	SENT_80	13235/13241
16	(	CD	NUMBER	(	dep	15	SENT_80	13242/13243
17	Vitaris	NNP	PERSON	Vitaris	nn	21	SENT_80	13243/13250
18	,	,	O	,		-1	SENT_80	13250/13251
19	Zug	NNP	LOCATION	Zug	appos	21	SENT_80	13252/13255
20	,	,	O	,		-1	SENT_80	13255/13256
21	Switzerland	NNP	LOCATION	Switzerland	dep	16	SENT_80	13257/13268
22	)	CD	NUMBER	)	num	21	SENT_80	13268/13269
23	3	CD	DURATION	3	number	25	SENT_80	13270/13271
24	to	TO	DURATION	to	dep	25	SENT_80	13272/13274
25	4	CD	DURATION	4	num	26	SENT_80	13275/13276
26	days	NNS	NUMBER	day	npadvmod	7	SENT_80	13277/13281
27	before	IN	O	before		-1	SENT_80	13282/13288
28	assaying	VBG	O	assay	prep_before	7	SENT_80	13289/13297
29	.	.	O	.		-1	SENT_80	13297/13298

1	One	CD	DURATION	one	num	2	SENT_81	13299/13302
2	day	NN	DURATION	day	npadvmod	20	SENT_81	13303/13306
3	before	IN	O	before		-1	SENT_81	13307/13313
4	the	DT	O	the	det	5	SENT_81	13314/13317
5	experiments	NNS	O	experiment	prep_before	20	SENT_81	13318/13329
6	,	,	O	,		-1	SENT_81	13329/13330
7	5	CD	NUMBER	5	num	10	SENT_81	13331/13332
8	M	NN	O	m	nn	10	SENT_81	13335/13336
9	sodium	NN	O	sodium	nn	10	SENT_81	13337/13343
10	butyrate	NN	O	butyrate	appos	5	SENT_81	13344/13352
11	(	CD	NUMBER	(	num	14	SENT_81	13353/13354
12	Sigma-Aldrich	NNP	ORGANIZATION	Sigma-Aldrich	nn	14	SENT_81	13354/13367
13	,	,	O	,		-1	SENT_81	13367/13368
14	Buchs	NNP	PERSON	Buchs	dep	10	SENT_81	13369/13374
15	,	,	O	,		-1	SENT_81	13374/13375
16	Switzerland	NNP	LOCATION	Switzerland	nn	17	SENT_81	13376/13387
17	)	NN	O	)	nsubjpass	20	SENT_81	13387/13388
18	was	VBD	O	be	auxpass	20	SENT_81	13389/13392
19	also	RB	O	also	advmod	20	SENT_81	13393/13397
20	added	VBN	O	add		-1	SENT_81	13398/13403
21	.	.	O	.		-1	SENT_81	13403/13404

1	Transport	NN	O	transport	nn	2	SENT_82	13440/13449
2	Experiments	NNS	O	experiment		-1	SENT_82	13450/13461

1	Transport	NN	O	transport	nn	2	SENT_83	13497/13506
2	experiments	NNS	O	experiment	nsubjpass	10	SENT_83	13507/13518
3	with	IN	O	with		-1	SENT_83	13519/13523
4	wild-type	JJ	O	wild-type	amod	8	SENT_83	13524/13533
5	and	CC	O	and		-1	SENT_83	13534/13537
6	transfected	VBN	O	transfect	conj_and	4	SENT_83	13538/13549
7	CHO	NN	O	cho	dobj	6	SENT_83	13550/13553
8	cells	NNS	O	cell	prep_with	2	SENT_83	13554/13559
9	were	VBD	O	be	auxpass	10	SENT_83	13560/13564
10	performed	VBN	O	perform		-1	SENT_83	13565/13574
11	in	IN	O	in		-1	SENT_83	13575/13577
12	parallel	NN	O	parallel	prep_in	10	SENT_83	13578/13586
13	using	VBG	O	use	xcomp	10	SENT_83	13587/13592
14	two	CD	NUMBER	two	dobj	13	SENT_83	13593/13596
15	to	TO	O	to		-1	SENT_83	13597/13599
16	three	CD	NUMBER	three	num	20	SENT_83	13600/13605
17	8-cm2	JJ	O	8-cm2	amod	20	SENT_83	13606/13611
18	tissue	NN	O	tissue	nn	20	SENT_83	13612/13618
19	culture	NN	O	culture	nn	20	SENT_83	13619/13626
20	dishes	NNS	O	dish	prep_to	13	SENT_83	13627/13633
21	for	IN	O	for		-1	SENT_83	13634/13637
22	each	DT	O	each	det	23	SENT_83	13638/13642
23	concentration	NN	O	concentration	prep_for	20	SENT_83	13643/13656
24	.	.	O	.		-1	SENT_83	13656/13657

1	After	IN	O	after		-1	SENT_84	13658/13663
2	washing	VBG	O	wash	prepc_after	53	SENT_84	13664/13671
3	the	DT	O	the	det	4	SENT_84	13672/13675
4	cells	NNS	O	cell	dobj	2	SENT_84	13676/13681
5	three	CD	NUMBER	three	num	6	SENT_84	13682/13687
6	times	NNS	O	time	dep	18	SENT_84	13688/13693
7	with	IN	O	with		-1	SENT_84	13694/13698
8	a	DT	O	a	det	10	SENT_84	13699/13700
9	pre-warmed	JJ	O	pre-warmed	amod	10	SENT_84	13701/13711
10	(	NN	O	(	prep_with	6	SENT_84	13712/13713
11	37	CD	NUMBER	37	num	12	SENT_84	13713/13715
12	C	NN	O	c	dep	18	SENT_84	13717/13718
13	)	JJ	O	)	amod	18	SENT_84	13718/13719
14	buffer	NN	O	buffer	nn	18	SENT_84	13720/13726
15	(	NN	O	(	nn	18	SENT_84	13727/13728
16	5.3	CD	NUMBER	5.3	num	18	SENT_84	13728/13731
17	mM	NN	O	mm	nn	18	SENT_84	13732/13734
18	KCl	NN	O	kcl	dep	41	SENT_84	13735/13738
19	,	,	O	,		-1	SENT_84	13738/13739
20	1	CD	NUMBER	1	num	22	SENT_84	13740/13741
21	mM	NN	O	mm	nn	22	SENT_84	13742/13744
22	NaH2PO4	NN	O	nah2po4	appos	18	SENT_84	13745/13752
23	,	,	O	,		-1	SENT_84	13752/13753
24	0.8	CD	NUMBER	0.8	num	26	SENT_84	13754/13757
25	mM	NN	O	mm	nn	26	SENT_84	13758/13760
26	MgSO4	NN	O	mgso4	appos	18	SENT_84	13761/13766
27	,	,	O	,		-1	SENT_84	13766/13767
28	5.5	CD	NUMBER	5.5	num	30	SENT_84	13768/13771
29	mM	NN	O	mm	nn	30	SENT_84	13772/13774
30	d-glucose	NN	O	d-glucose	appos	18	SENT_84	13775/13784
31	,	,	O	,		-1	SENT_84	13784/13785
32	20	CD	NUMBER	20	num	34	SENT_84	13786/13788
33	mM	NN	O	mm	nn	34	SENT_84	13789/13791
34	HEPES	NN	O	hepe	appos	18	SENT_84	13792/13797
35	,	,	O	,		-1	SENT_84	13797/13798
36	116.4	CD	NUMBER	116.4	num	38	SENT_84	13799/13804
37	mM	NN	O	mm	nn	38	SENT_84	13805/13807
38	NaCl	NN	O	nacl	appos	18	SENT_84	13808/13812
39	,	,	O	,		-1	SENT_84	13812/13813
40	pH	NN	O	ph	appos	18	SENT_84	13814/13816
41	7.4	CD	NUMBER	7.4	dep	2	SENT_84	13817/13820
42	at	IN	O	at		-1	SENT_84	13821/13823
43	room	NN	O	room	nn	45	SENT_84	13824/13828
44	temperature	NN	O	temperature	nn	45	SENT_84	13829/13840
45	)	NN	O	)	prep_at	41	SENT_84	13840/13841
46	,	,	O	,		-1	SENT_84	13841/13842
47	uptake	NN	O	uptake	nsubjpass	53	SENT_84	13843/13849
48	of	IN	O	of		-1	SENT_84	13850/13852
49	a	DT	O	a	det	51	SENT_84	13853/13854
50	test	NN	O	test	nn	51	SENT_84	13855/13859
51	compound	NN	O	compound	prep_of	47	SENT_84	13860/13868
52	was	VBD	O	be	auxpass	53	SENT_84	13869/13872
53	initiated	VBN	O	initiate		-1	SENT_84	13873/13882
54	by	IN	O	by		-1	SENT_84	13883/13885
55	adding	VBG	O	add	agent	53	SENT_84	13886/13892
56	1	CD	NUMBER	1	num	57	SENT_84	13893/13894
57	mL	NN	O	ml	dobj	55	SENT_84	13895/13897
58	of	IN	O	of		-1	SENT_84	13898/13900
59	the	DT	O	the	det	61	SENT_84	13901/13904
60	same	JJ	O	same	amod	61	SENT_84	13905/13909
61	buffer	NN	O	buffer	prep_of	57	SENT_84	13910/13916
62	containing	VBG	O	contain	partmod	61	SENT_84	13917/13927
63	the	DT	O	the	det	65	SENT_84	13928/13931
64	test	NN	O	test	nn	65	SENT_84	13932/13936
65	compound	NN	O	compound	dobj	62	SENT_84	13937/13945
66	at	IN	O	at		-1	SENT_84	13946/13948
67	desired	VBN	O	desire	amod	69	SENT_84	13949/13956
68	concentration	NN	O	concentration	nn	69	SENT_84	13957/13970
69	(	NN	O	(	prep_at	62	SENT_84	13971/13972
70	as	IN	O	as		-1	SENT_84	13972/13974
71	14C-labeled	JJ	O	14c-labeled	amod	81	SENT_84	13975/13986
72	alone	RB	O	alone	advmod	71	SENT_84	13987/13992
73	or	CC	O	or		-1	SENT_84	13993/13995
74	as	IN	O	as	conj_or	71	SENT_84	13996/13998
75	a	DT	O	a	det	76	SENT_84	13999/14000
76	mixture	NN	O	mixture	pobj	74	SENT_84	14001/14008
77	with	IN	O	with		-1	SENT_84	14009/14013
78	non-labeled	JJ	O	non-labeled	amod	79	SENT_84	14014/14025
79	test	NN	O	test	prep_with	76	SENT_84	14026/14030
80	compound	NN	O	compound	nn	81	SENT_84	14031/14039
81	)	NN	O	)	prep_as	69	SENT_84	14039/14040
82	.	.	O	.		-1	SENT_84	14040/14041

1	The	DT	O	the	det	3	SENT_85	14042/14045
2	final	JJ	O	final	amod	3	SENT_85	14046/14051
3	concentration	NN	O	concentration	nsubj	9	SENT_85	14052/14065
4	of	IN	O	of		-1	SENT_85	14066/14068
5	organic	JJ	O	organic	amod	6	SENT_85	14069/14076
6	solvent	JJ	O	solvent	prep_of	3	SENT_85	14077/14084
7	was	VBD	O	be	cop	9	SENT_85	14085/14088
8	1	CD	PERCENT	1	num	9	SENT_85	14089/14090
9	%	NN	PERCENT	%		-1	SENT_85	14090/14091
10	(	CD	NUMBER	(	num	12	SENT_85	14092/14093
11	v/v	NN	O	v/v	nn	12	SENT_85	14093/14096
12	)	NN	O	)	dep	9	SENT_85	14096/14097
13	.	.	O	.		-1	SENT_85	14097/14098

1	Uptake	NN	O	uptake	nsubjpass	7	SENT_86	14099/14105
2	of	IN	O	of		-1	SENT_86	14106/14108
3	a	DT	O	a	det	5	SENT_86	14109/14110
4	test	NN	O	test	nn	5	SENT_86	14111/14115
5	compound	NN	O	compound	prep_of	1	SENT_86	14116/14124
6	was	VBD	O	be	auxpass	7	SENT_86	14125/14128
7	stopped	VBN	O	stop		-1	SENT_86	14129/14136
8	after	RB	O	after	prep	7	SENT_86	14137/14142
9	incubation	NN	O	incubation	pobj	8	SENT_86	14143/14153
10	at	IN	O	at		-1	SENT_86	14154/14156
11	37	CD	NUMBER	37	num	12	SENT_86	14157/14159
12	C	NN	O	c	prep_at	7	SENT_86	14161/14162
13	for	IN	O	for		-1	SENT_86	14163/14166
14	the	DT	O	the	det	16	SENT_86	14167/14170
15	desired	VBN	O	desire	amod	16	SENT_86	14171/14178
16	duration	NN	O	duration	prep_for	7	SENT_86	14179/14187
17	by	IN	O	by		-1	SENT_86	14188/14190
18	twice	RB	O	twice	advmod	19	SENT_86	14191/14196
19	adding	VBG	O	add	agent	7	SENT_86	14197/14203
20	2-mL	JJ	O	2-ml	amod	21	SENT_86	14204/14208
21	aliquots	NNS	O	aliquot	dobj	19	SENT_86	14209/14217
22	of	IN	O	of		-1	SENT_86	14218/14220
23	ice-cold	JJ	O	ice-cold	amod	24	SENT_86	14221/14229
24	buffer	NN	O	buffer	prep_of	21	SENT_86	14230/14236
25	containing	VBG	O	contain	xcomp	19	SENT_86	14237/14247
26	0.5	CD	PERCENT	0.5	num	27	SENT_86	14248/14251
27	%	NN	PERCENT	%	dobj	25	SENT_86	14251/14252
28	(	CD	NUMBER	(	num	29	SENT_86	14253/14254
29	w/v	NN	O	w/v	dep	37	SENT_86	14254/14257
30	)	CD	NUMBER	)	num	33	SENT_86	14257/14258
31	bovine	JJ	O	bovine	amod	33	SENT_86	14259/14265
32	serum	NN	O	serum	nn	33	SENT_86	14266/14271
33	albumin	NN	O	albumin	dep	29	SENT_86	14272/14279
34	(	CD	NUMBER	(	num	35	SENT_86	14280/14281
35	BSA	NN	ORGANIZATION	bsa	dep	37	SENT_86	14281/14284
36	)	CD	NUMBER	)	num	37	SENT_86	14284/14285
37	(	CD	NUMBER	(	dep	25	SENT_86	14286/14287
38	Sigma	NNP	O	Sigma	nn	42	SENT_86	14287/14292
39	,	,	O	,		-1	SENT_86	14292/14293
40	Buchs	NNP	PERSON	Buchs	appos	42	SENT_86	14294/14299
41	,	,	O	,		-1	SENT_86	14299/14300
42	Switzerland	NNP	LOCATION	Switzerland	dep	37	SENT_86	14301/14312
43	)	CD	NUMBER	)	num	42	SENT_86	14312/14313
44	.	.	O	.		-1	SENT_86	14313/14314

1	Cells	NNS	O	cell	nsubjpass	5	SENT_87	14315/14320
2	were	VBD	O	be	auxpass	5	SENT_87	14321/14325
3	then	RB	O	then	advmod	5	SENT_87	14326/14330
4	rapidly	RB	O	rapidly	advmod	5	SENT_87	14331/14338
5	washed	VBN	O	wash		-1	SENT_87	14339/14345
6	four	CD	NUMBER	four	num	7	SENT_87	14346/14350
7	times	NNS	O	time	tmod	5	SENT_87	14351/14356
8	with	IN	O	with		-1	SENT_87	14357/14361
9	approximately	RB	O	approximately	quantmod	10	SENT_87	14362/14375
10	2	CD	NUMBER	2	num	11	SENT_87	14376/14377
11	mL	NN	O	ml	prep_with	5	SENT_87	14378/14380
12	of	IN	O	of		-1	SENT_87	14381/14383
13	ice-cold	JJ	O	ice-cold	amod	14	SENT_87	14384/14392
14	buffer	NN	O	buffer	prep_of	11	SENT_87	14393/14399
15	and	CC	O	and		-1	SENT_87	14400/14403
16	solubilized	VBN	O	solubilize	conj_and	5	SENT_87	14404/14415
17	by	IN	O	by		-1	SENT_87	14416/14418
18	the	DT	O	the	det	19	SENT_87	14419/14422
19	addition	NN	O	addition	prep_by	16	SENT_87	14423/14431
20	of	IN	O	of		-1	SENT_87	14432/14434
21	1	CD	NUMBER	1	num	22	SENT_87	14435/14436
22	mL	NN	O	ml	prep_of	19	SENT_87	14437/14439
23	of	IN	O	of		-1	SENT_87	14440/14442
24	1	CD	PERCENT	1	num	25	SENT_87	14443/14444
25	%	NN	PERCENT	%	prep_of	22	SENT_87	14444/14445
26	(	CD	NUMBER	(	num	27	SENT_87	14446/14447
27	w/v	NN	O	w/v	dep	25	SENT_87	14447/14450
28	)	CD	NUMBER	)	num	30	SENT_87	14450/14451
29	Triton	NNP	ORGANIZATION	Triton	nn	30	SENT_87	14452/14458
30	X-100	NN	O	x-100	dobj	5	SENT_87	14459/14464
31	.	.	O	.		-1	SENT_87	14464/14465

1	After	IN	O	after		-1	SENT_88	14466/14471
2	incubation	NN	O	incubation	prep_after	16	SENT_88	14472/14482
3	for	IN	O	for		-1	SENT_88	14483/14486
4	at	IN	DURATION	at	quantmod	6	SENT_88	14487/14489
5	least	JJS	DURATION	least	mwe	4	SENT_88	14490/14495
6	20	CD	DURATION	20	num	7	SENT_88	14496/14498
7	min	NN	DURATION	min	prep_for	2	SENT_88	14499/14502
8	,	,	O	,		-1	SENT_88	14502/14503
9	cell	NN	O	cell	nn	10	SENT_88	14504/14508
10	lysate	NN	O	lysate	appos	7	SENT_88	14509/14515
11	(	CD	NUMBER	(	number	12	SENT_88	14516/14517
12	0.5	CD	NUMBER	0.5	num	14	SENT_88	14517/14520
13	mL	NN	O	ml	nn	14	SENT_88	14521/14523
14	)	NN	O	)	dep	10	SENT_88	14523/14524
15	was	VBD	O	be	auxpass	16	SENT_88	14525/14528
16	mixed	VBN	O	mix		-1	SENT_88	14529/14534
17	with	IN	O	with		-1	SENT_88	14535/14539
18	5	CD	NUMBER	5	num	19	SENT_88	14540/14541
19	mL	NN	O	ml	prep_with	16	SENT_88	14542/14544
20	of	IN	O	of		-1	SENT_88	14545/14547
21	scintillation	NN	O	scintillation	nn	24	SENT_88	14548/14561
22	cocktail	NN	O	cocktail	nn	24	SENT_88	14562/14570
23	IRGA	NN	O	irga	nn	24	SENT_88	14571/14575
24	Safe	NN	O	safe	prep_of	19	SENT_88	14576/14580
25	Plus	NN	O	plus	nn	27	SENT_88	14581/14585
26	(	CD	NUMBER	(	num	27	SENT_88	14586/14587
27	PerkinElmer	NNP	ORGANIZATION	PerkinElmer	nsubjpass	37	SENT_88	14587/14598
28	,	,	O	,		-1	SENT_88	14598/14599
29	Zurich	NNP	LOCATION	Zurich	conj_and	27	SENT_88	14600/14606
30	,	,	O	,		-1	SENT_88	14606/14607
31	Switzerland	NNP	LOCATION	Switzerland	nn	32	SENT_88	14608/14619
32	)	NNP	O	)	conj_and	27	SENT_88	14619/14620
33	,	,	O	,		-1	SENT_88	14620/14621
34	and	CC	O	and		-1	SENT_88	14622/14625
35	radioactivity	NN	O	radioactivity	conj_and	27	SENT_88	14626/14639
36	was	VBD	O	be	auxpass	37	SENT_88	14640/14643
37	determined	VBN	O	determine	rcmod	24	SENT_88	14644/14654
38	using	VBG	O	use	xcomp	37	SENT_88	14655/14660
39	a	DT	O	a	det	45	SENT_88	14661/14662
40	Tri-Carb	JJ	O	tri-carb	amod	45	SENT_88	14663/14671
41	2300	CD	DATE	2300	num	45	SENT_88	14672/14676
42	TR	NN	O	tr	nn	45	SENT_88	14677/14679
43	liquid	JJ	O	liquid	amod	45	SENT_88	14680/14686
44	scintillation	NN	O	scintillation	nn	45	SENT_88	14687/14700
45	analyzer	NN	O	analyzer	dobj	38	SENT_88	14701/14709
46	(	CD	NUMBER	(	num	48	SENT_88	14710/14711
47	Packard	NNP	ORGANIZATION	Packard	nn	48	SENT_88	14711/14718
48	Bioscience	NNP	ORGANIZATION	Bioscience	nsubjpass	16	SENT_88	14719/14729
49	,	,	O	,		-1	SENT_88	14729/14730
50	Zurich	NNP	LOCATION	Zurich	appos	48	SENT_88	14731/14737
51	,	,	O	,		-1	SENT_88	14737/14738
52	Switzerland	NNP	LOCATION	Switzerland	appos	50	SENT_88	14739/14750
53	)	CD	NUMBER	)	num	52	SENT_88	14750/14751
54	.	.	O	.		-1	SENT_88	14751/14752

1	Aliquots	NNS	O	aliquot	nsubj	5	SENT_89	14753/14761
2	of	IN	O	of		-1	SENT_89	14762/14764
3	cell	NN	O	cell	nn	4	SENT_89	14765/14769
4	lysates	NNS	O	lysate	prep_of	1	SENT_89	14770/14777
5	(	VBP	O	(		-1	SENT_89	14778/14779
6	25	CD	NUMBER	25	num	8	SENT_89	14779/14781
7	L	NN	O	l	nn	8	SENT_89	14784/14785
8	)	NN	O	)	nsubjpass	10	SENT_89	14785/14786
9	were	VBD	O	be	auxpass	10	SENT_89	14787/14791
10	used	VBN	O	use	ccomp	5	SENT_89	14792/14796
11	to	TO	O	to	aux	12	SENT_89	14797/14799
12	determine	VB	O	determine	xcomp	10	SENT_89	14800/14809
13	the	DT	O	the	det	15	SENT_89	14810/14813
14	protein	NN	O	protein	nn	15	SENT_89	14814/14821
15	content	NN	O	content	dobj	12	SENT_89	14822/14829
16	of	IN	O	of		-1	SENT_89	14830/14832
17	each	DT	O	each	det	18	SENT_89	14833/14837
18	sample	NN	O	sample	prep_of	15	SENT_89	14838/14844
19	using	VBG	O	use	partmod	18	SENT_89	14845/14850
20	the	DT	O	the	det	27	SENT_89	14851/14854
21	Pierce	NNP	O	Pierce	nn	27	SENT_89	14855/14861
22	BCA	NNP	O	BCA	nn	27	SENT_89	14862/14865
23	(	NN	O	(	nn	27	SENT_89	14866/14867
24	bicinchoninic	JJ	O	bicinchoninic	amod	27	SENT_89	14867/14880
25	acid	NN	O	acid	nn	27	SENT_89	14881/14885
26	)	NN	O	)	nn	27	SENT_89	14885/14886
27	assay	NN	O	assay	nsubj	28	SENT_89	14887/14892
28	(	CD	NUMBER	(	xcomp	19	SENT_89	14893/14894
29	Pierce	NNP	O	Pierce	nn	34	SENT_89	14894/14900
30	Science	NNP	O	Science	nn	34	SENT_89	14901/14908
31	,	,	O	,		-1	SENT_89	14908/14909
32	Lausanne	NNP	LOCATION	Lausanne	appos	34	SENT_89	14910/14918
33	,	,	O	,		-1	SENT_89	14918/14919
34	Switzerland	NNP	LOCATION	Switzerland	dep	28	SENT_89	14920/14931
35	)	CD	NUMBER	)	num	34	SENT_89	14931/14932
36	according	VBG	O	accord		-1	SENT_89	14933/14942
37	to	TO	O	to	prepc_according_to	19	SENT_89	14943/14945
38	the	DT	O	the	det	39	SENT_89	14946/14949
39	supplier	NN	O	supplier	poss	41	SENT_89	14950/14958
40	's	POS	O	's		-1	SENT_89	14958/14960
41	protocol	NN	O	protocol	pobj	19	SENT_89	14961/14969
42	.	.	O	.		-1	SENT_89	14969/14970

1	BSA	NN	ORGANIZATION	bsa	nsubjpass	3	SENT_90	14971/14974
2	was	VBD	O	be	auxpass	3	SENT_90	14975/14978
3	used	VBN	O	use		-1	SENT_90	14979/14983
4	as	IN	O	as		-1	SENT_90	14984/14986
5	standard	NN	O	standard	prep_as	3	SENT_90	14987/14995
6	.	.	O	.		-1	SENT_90	14995/14996

1	The	DT	O	the	det	3	SENT_91	15032/15035
2	inhibitory	JJ	O	inhibitory	amod	3	SENT_91	15036/15046
3	potential	NN	O	potential	nsubjpass	17	SENT_91	15047/15056
4	of	IN	O	of		-1	SENT_91	15057/15059
5	macitentan	NN	O	macitentan	prep_of	3	SENT_91	15060/15070
6	and	CC	O	and		-1	SENT_91	15071/15074
7	ACT-132577	NN	O	act-132577	conj_and	5	SENT_91	15075/15085
8	on	IN	O	on		-1	SENT_91	15086/15088
9	the	DT	O	the	det	11	SENT_91	15089/15092
10	cellular	JJ	O	cellular	amod	11	SENT_91	15093/15101
11	uptake	NN	O	uptake	prep_on	5	SENT_91	15102/15108
12	of	IN	O	of		-1	SENT_91	15109/15111
13	prototypical	JJ	O	prototypical	amod	15	SENT_91	15112/15124
14	OATP	NN	O	oatp	nn	15	SENT_91	15125/15129
15	substrates	NNS	O	substrate	prep_of	11	SENT_91	15130/15140
16	was	VBD	O	be	auxpass	17	SENT_91	15141/15144
17	investigated	VBN	O	investigate		-1	SENT_91	15145/15157
18	at	IN	O	at		-1	SENT_91	15158/15160
19	a	DT	O	a	det	25	SENT_91	15161/15162
20	single	JJ	O	single	amod	25	SENT_91	15163/15169
21	substrate	NN	O	substrate	nn	25	SENT_91	15170/15179
22	concentration	NN	O	concentration	nn	25	SENT_91	15180/15193
23	(	CD	NUMBER	(	num	25	SENT_91	15194/15195
24	Km	NN	O	km	nn	25	SENT_91	15198/15200
25	)	NN	O	)	prep_at	17	SENT_91	15200/15201
26	of	IN	O	of		-1	SENT_91	15202/15204
27	1	CD	NUMBER	1	num	29	SENT_91	15205/15206
28	M	NN	O	m	nn	29	SENT_91	15209/15210
29	atorvastatin	NN	O	atorvastatin	prep_of	25	SENT_91	15211/15223
30	for	IN	O	for		-1	SENT_91	15224/15227
31	OATP1B1	NN	O	oatp1b1	prep_for	29	SENT_91	15228/15235
32	and	CC	O	and		-1	SENT_91	15236/15239
33	5	CD	NUMBER	5	num	35	SENT_91	15240/15241
34	M	NN	O	m	nn	35	SENT_91	15244/15245
35	estrone-3-sulfate	NN	O	estrone-3-sulfate	conj_and	29	SENT_91	15246/15263
36	for	IN	O	for		-1	SENT_91	15264/15267
37	OATP1B3	NN	O	oatp1b3	prep_for	35	SENT_91	15268/15275
38	.	.	O	.		-1	SENT_91	15275/15276

1	After	IN	O	after		-1	SENT_92	15277/15282
2	incubation	NN	O	incubation	prep_after	22	SENT_92	15283/15293
3	at	IN	O	at		-1	SENT_92	15294/15296
4	37	CD	NUMBER	37	num	5	SENT_92	15297/15299
5	C	NN	O	c	prep_at	2	SENT_92	15301/15302
6	for	IN	O	for		-1	SENT_92	15303/15306
7	40	CD	NUMBER	40	num	8	SENT_92	15307/15309
8	s	NNS	O	s	prep_for	5	SENT_92	15310/15311
9	(	CD	NUMBER	(	num	11	SENT_92	15312/15313
10	OATP1B1	NN	O	oatp1b1	nn	11	SENT_92	15313/15320
11	)	NN	O	)	dep	8	SENT_92	15320/15321
12	and	CC	O	and		-1	SENT_92	15322/15325
13	90	CD	NUMBER	90	num	14	SENT_92	15326/15328
14	s	NNS	O	s	conj_and	8	SENT_92	15329/15330
15	(	CD	NUMBER	(	num	17	SENT_92	15331/15332
16	OATP1B3	NN	O	oatp1b3	nn	17	SENT_92	15332/15339
17	)	NN	O	)	dep	14	SENT_92	15339/15340
18	,	,	O	,		-1	SENT_92	15340/15341
19	the	DT	O	the	det	20	SENT_92	15342/15345
20	uptake	NN	O	uptake	nsubjpass	22	SENT_92	15346/15352
21	was	VBD	O	be	auxpass	22	SENT_92	15353/15356
22	terminated	VBN	O	terminate		-1	SENT_92	15357/15367
23	by	IN	O	by		-1	SENT_92	15368/15370
24	twice	RB	O	twice	advmod	25	SENT_92	15371/15376
25	adding	VBG	O	add	agent	22	SENT_92	15377/15383
26	2	CD	NUMBER	2	num	27	SENT_92	15384/15385
27	mL	NN	O	ml	dobj	25	SENT_92	15386/15388
28	of	IN	O	of		-1	SENT_92	15389/15391
29	ice-cold	JJ	O	ice-cold	amod	30	SENT_92	15392/15400
30	buffer	NN	O	buffer	prep_of	27	SENT_92	15401/15407
31	containing	VBG	O	contain	partmod	30	SENT_92	15408/15418
32	0.5	CD	PERCENT	0.5	num	33	SENT_92	15419/15422
33	%	NN	PERCENT	%	dobj	31	SENT_92	15422/15423
34	(	CD	NUMBER	(	num	35	SENT_92	15424/15425
35	w/v	NN	O	w/v	tmod	31	SENT_92	15425/15428
36	)	CD	NUMBER	)	num	37	SENT_92	15428/15429
37	BSA	NN	ORGANIZATION	bsa	dep	35	SENT_92	15430/15433
38	.	.	O	.		-1	SENT_92	15433/15434

1	Afterwards	RB	O	afterwards	advmod	8	SENT_93	15435/15445
2	,	,	O	,		-1	SENT_93	15445/15446
3	sample	NN	O	sample	nn	4	SENT_93	15447/15453
4	preparation	NN	O	preparation	nsubjpass	8	SENT_93	15454/15465
5	and	CC	O	and		-1	SENT_93	15466/15469
6	analysis	NN	O	analysis	conj_and	4	SENT_93	15470/15478
7	were	VBD	O	be	auxpass	8	SENT_93	15479/15483
8	performed	VBN	O	perform		-1	SENT_93	15484/15493
9	as	IN	O	as	mark	10	SENT_93	15494/15496
10	outlined	VBN	O	outline	advcl	8	SENT_93	15497/15505
11	above	IN	O	above	prep	10	SENT_93	15506/15511
12	.	.	O	.		-1	SENT_93	15511/15512

1	Data	NNS	O	datum		-1	SENT_94	15548/15552
2	Evaluation	NN	O	evaluation	dep	1	SENT_94	15553/15563

1	In	IN	O	in	mark	4	SENT_95	15599/15601
2	order	NN	O	order	dep	4	SENT_95	15602/15607
3	to	TO	O	to	aux	4	SENT_95	15608/15610
4	determine	VB	O	determine	advcl	11	SENT_95	15611/15620
5	uptake	NN	O	uptake	nn	6	SENT_95	15621/15627
6	rates	NNS	O	rate	dobj	4	SENT_95	15628/15633
7	,	,	O	,		-1	SENT_95	15633/15634
8	cellular	JJ	O	cellular	amod	9	SENT_95	15635/15643
9	uptakes	NNS	O	uptake	nsubjpass	11	SENT_95	15644/15651
10	were	VBD	O	be	auxpass	11	SENT_95	15652/15656
11	normalized	VBN	O	normalize		-1	SENT_95	15657/15667
12	to	TO	O	to		-1	SENT_95	15668/15670
13	total	JJ	O	total	amod	15	SENT_95	15671/15676
14	protein	NN	O	protein	nn	15	SENT_95	15677/15684
15	content	NN	O	content	prep_to	11	SENT_95	15685/15692
16	and	CC	O	and		-1	SENT_95	15693/15696
17	incubation	NN	O	incubation	nn	18	SENT_95	15697/15707
18	time	NN	O	time	conj_and	15	SENT_95	15708/15712
19	.	.	O	.		-1	SENT_95	15712/15713

1	Net	JJ	O	net	amod	4	SENT_96	15714/15717
2	OATP-mediated	JJ	O	oatp-mediated	amod	4	SENT_96	15718/15731
3	uptake	NN	O	uptake	nn	4	SENT_96	15732/15738
4	rates	NNS	O	rate	nsubjpass	6	SENT_96	15739/15744
5	were	VBD	O	be	auxpass	6	SENT_96	15745/15749
6	calculated	VBN	O	calculate		-1	SENT_96	15750/15760
7	as	IN	O	as		-1	SENT_96	15761/15763
8	the	DT	O	the	det	9	SENT_96	15764/15767
9	difference	NN	O	difference	prep_as	6	SENT_96	15768/15778
10	in	IN	O	in		-1	SENT_96	15779/15781
11	the	DT	O	the	det	13	SENT_96	15782/15785
12	uptake	NN	O	uptake	nn	13	SENT_96	15786/15792
13	rates	NNS	O	rate	prep_in	9	SENT_96	15793/15798
14	of	IN	O	of		-1	SENT_96	15799/15801
15	the	DT	O	the	prep_of	13	SENT_96	15802/15805
16	transfected	VBN	O	transfect	dep	9	SENT_96	15806/15817
17	and	CC	O	and		-1	SENT_96	15818/15821
18	wild	JJ	O	wild	conj_and	16	SENT_96	15822/15826
19	-	:	O	-		-1	SENT_96	15826/15827
20	type	NN	O	type	nn	21	SENT_96	15828/15832
21	cells	NNS	O	cell	dep	9	SENT_96	15833/15838
22	for	IN	O	for		-1	SENT_96	15839/15842
23	each	DT	O	each	det	25	SENT_96	15843/15847
24	individual	JJ	O	individual	amod	25	SENT_96	15848/15858
25	concentration	NN	O	concentration	prep_for	21	SENT_96	15859/15872
26	.	.	O	.		-1	SENT_96	15872/15873

1	Half	NN	O	half	dep	199	SENT_97	15874/15878
2	maximal	JJ	O	maximal	dep	199	SENT_97	15879/15886
3	inhibitory	JJ	O	inhibitory	dep	199	SENT_97	15887/15897
4	concentration	NN	O	concentration	dep	199	SENT_97	15898/15911
5	(	NN	O	(	dep	199	SENT_97	15912/15913
6	IC50	NN	O	ic50	dep	199	SENT_97	15913/15917
7	)	NN	O	)	dep	199	SENT_97	15917/15918
8	values	NNS	O	value	dep	199	SENT_97	15919/15925
9	for	IN	O	for	dep	199	SENT_97	15926/15929
10	uptake	NN	O	uptake	dep	199	SENT_97	15930/15936
11	inhibition	NN	O	inhibition	dep	199	SENT_97	15937/15947
12	were	VBD	O	be	dep	199	SENT_97	15948/15952
13	determined	VBN	O	determine	dep	199	SENT_97	15953/15963
14	by	IN	O	by	dep	199	SENT_97	15964/15966
15	plotting	VBG	O	plot	dep	199	SENT_97	15967/15975
16	the	DT	O	the	dep	199	SENT_97	15976/15979
17	inhibitor	NN	O	inhibitor	dep	199	SENT_97	15980/15989
18	concentration	NN	O	concentration	dep	199	SENT_97	15990/16003
19	(	CD	NUMBER	(	dep	199	SENT_97	16004/16005
20	logarithmic	JJ	O	logarithmic	dep	199	SENT_97	16005/16016
21	scale	NN	O	scale	dep	199	SENT_97	16017/16022
22	)	NN	O	)	dep	199	SENT_97	16022/16023
23	against	IN	O	against	dep	199	SENT_97	16024/16031
24	the	DT	O	the	dep	199	SENT_97	16032/16035
25	net	JJ	O	net	dep	199	SENT_97	16036/16039
26	uptake	NN	O	uptake	dep	199	SENT_97	16040/16046
27	rates	NNS	O	rate	dep	199	SENT_97	16047/16052
28	and	CC	O	and	dep	199	SENT_97	16053/16056
29	nonlinear	JJ	O	nonlinear	dep	199	SENT_97	16057/16066
30	regression	NN	O	regression	dep	199	SENT_97	16067/16077
31	using	VBG	O	use	dep	199	SENT_97	16078/16083
32	the	DT	O	the	dep	199	SENT_97	16084/16087
33	equation	NN	O	equation	dep	199	SENT_97	16088/16096
34	:	:	O	:		-1	SENT_97	16096/16097
35	\	CD	NUMBER	\	dep	199	SENT_97	16097/16098
36	documentclass	NN	O	documentclass	dep	199	SENT_97	16098/16111
37	[	CD	NUMBER	[	dep	199	SENT_97	16111/16112
38	12pt	JJ	O	12pt	dep	199	SENT_97	16112/16116
39	]	NN	O	]	dep	199	SENT_97	16116/16117
40	{	NN	O	{	dep	199	SENT_97	16117/16118
41	minimal	JJ	O	minimal	dep	199	SENT_97	16118/16125
42	}	CD	NUMBER	}	dep	199	SENT_97	16125/16126
43	\	NN	O	\	dep	199	SENT_97	16127/16128
44	usepackage	NN	O	usepackage	dep	199	SENT_97	16128/16138
45	{	NN	O	{	dep	199	SENT_97	16138/16139
46	amsmath	NN	O	amsmath	dep	199	SENT_97	16139/16146
47	}	CD	NUMBER	}	dep	199	SENT_97	16146/16147
48	\	NN	O	\	dep	199	SENT_97	16148/16149
49	usepackage	NN	O	usepackage	dep	199	SENT_97	16149/16159
50	{	NN	O	{	dep	199	SENT_97	16159/16160
51	wasysym	NN	O	wasysym	dep	199	SENT_97	16160/16167
52	}	CD	NUMBER	}	dep	199	SENT_97	16167/16168
53	\	NN	O	\	dep	199	SENT_97	16169/16170
54	usepackage	NN	O	usepackage	dep	199	SENT_97	16170/16180
55	{	CD	NUMBER	{	dep	199	SENT_97	16180/16181
56	amsfonts	NNS	O	amsfont	dep	199	SENT_97	16181/16189
57	}	CD	NUMBER	}	dep	199	SENT_97	16189/16190
58	\	NN	O	\	dep	199	SENT_97	16191/16192
59	usepackage	NN	O	usepackage	dep	199	SENT_97	16192/16202
60	{	NN	O	{	dep	199	SENT_97	16202/16203
61	amssymb	NN	O	amssymb	dep	199	SENT_97	16203/16210
62	}	CD	NUMBER	}	dep	199	SENT_97	16210/16211
63	\	NN	O	\	dep	199	SENT_97	16212/16213
64	usepackage	NN	O	usepackage	dep	199	SENT_97	16213/16223
65	{	NN	O	{	dep	199	SENT_97	16223/16224
66	amsbsy	NN	O	amsbsy	dep	199	SENT_97	16224/16230
67	}	CD	NUMBER	}	dep	199	SENT_97	16230/16231
68	\	NN	O	\	dep	199	SENT_97	16232/16233
69	usepackage	NN	O	usepackage	dep	199	SENT_97	16233/16243
70	{	CD	NUMBER	{	dep	199	SENT_97	16243/16244
71	mathrsfs	NNS	O	mathrsf	dep	199	SENT_97	16244/16252
72	}	CD	NUMBER	}	dep	199	SENT_97	16252/16253
73	\	NN	O	\	dep	199	SENT_97	16254/16255
74	usepackage	NN	O	usepackage	dep	199	SENT_97	16255/16265
75	{	NN	O	{	dep	199	SENT_97	16265/16266
76	upgreek	NN	O	upgreek	dep	199	SENT_97	16266/16273
77	}	CD	NUMBER	}	dep	199	SENT_97	16273/16274
78	\	NN	O	\	dep	199	SENT_97	16275/16276
79	setlength	NN	O	setlength	dep	199	SENT_97	16276/16285
80	{	CD	NUMBER	{	dep	199	SENT_97	16285/16286
81	\	NN	O	\	dep	199	SENT_97	16286/16287
82	oddsidemargin	NN	O	oddsidemargin	dep	199	SENT_97	16287/16300
83	}	CD	NUMBER	}	dep	199	SENT_97	16300/16301
84	{	CD	NUMBER	{	dep	199	SENT_97	16301/16302
85	-69	CD	NUMBER	-69	dep	199	SENT_97	16302/16305
86	pt	NN	O	pt	dep	199	SENT_97	16305/16307
87	}	CD	NUMBER	}	dep	199	SENT_97	16307/16308
88	\	NN	O	\	dep	199	SENT_97	16309/16310
89	begin	VB	O	begin	dep	199	SENT_97	16310/16315
90	{	NN	O	{	dep	199	SENT_97	16315/16316
91	document	NN	O	document	dep	199	SENT_97	16316/16324
92	}	CD	MONEY	}	dep	199	SENT_97	16324/16325
93	$	$	MONEY	$	dep	199	SENT_97	16325/16326
94	$	$	O	$	dep	199	SENT_97	16326/16327
95	y	JJ	O	y	dep	199	SENT_97	16327/16328
96	=	JJ	O	=	dep	199	SENT_97	16329/16330
97	\	NN	O	\	dep	199	SENT_97	16331/16332
98	frac	NN	O	frac	dep	199	SENT_97	16332/16336
99	{	CD	NUMBER	{	dep	199	SENT_97	16336/16337
100	{	CD	NUMBER	{	dep	199	SENT_97	16337/16338
101	Top	JJ	O	top	dep	199	SENT_97	16338/16341
102	}	CD	NUMBER	}	dep	199	SENT_97	16341/16342
103	}	CD	NUMBER	}	dep	199	SENT_97	16342/16343
104	{	NN	O	{	dep	199	SENT_97	16343/16344
105	{	NN	O	{	dep	199	SENT_97	16344/16345
106	1	CD	NUMBER	1	dep	199	SENT_97	16345/16346
107	+	CC	O	+	dep	199	SENT_97	16347/16348
108	{	CD	NUMBER	{	dep	199	SENT_97	16349/16350
109	\	CD	NUMBER	\	dep	199	SENT_97	16350/16351
110	left	VBD	O	leave	dep	199	SENT_97	16351/16355
111	(	CD	NUMBER	(	dep	199	SENT_97	16355/16356
112	{	CD	NUMBER	{	dep	199	SENT_97	16357/16358
113	\	NN	O	\	dep	199	SENT_97	16358/16359
114	frac	NN	O	frac	dep	199	SENT_97	16359/16363
115	{	CD	NUMBER	{	dep	199	SENT_97	16363/16364
116	x	CC	O	x	dep	199	SENT_97	16364/16365
117	}	CD	NUMBER	}	dep	199	SENT_97	16365/16366
118	{	CD	NUMBER	{	dep	199	SENT_97	16366/16367
119	{	NN	O	{	dep	199	SENT_97	16367/16368
120	IC	NN	O	ic	dep	199	SENT_97	16368/16370
121	_	CD	NUMBER	_	dep	199	SENT_97	16370/16371
122	{	CD	NUMBER	{	dep	199	SENT_97	16371/16372
123	{	NN	O	{	dep	199	SENT_97	16372/16373
124	50	CD	NUMBER	50	dep	199	SENT_97	16373/16375
125	}	CD	NUMBER	}	dep	199	SENT_97	16375/16376
126	}	NN	O	}	dep	199	SENT_97	16376/16377
127	}	CD	NUMBER	}	dep	199	SENT_97	16378/16379
128	}	CD	NUMBER	}	dep	199	SENT_97	16379/16380
129	}	CD	NUMBER	}	dep	199	SENT_97	16380/16381
130	\	RB	O	\	dep	199	SENT_97	16382/16383
131	right	JJ	O	right	dep	199	SENT_97	16383/16388
132	)	NN	O	)	dep	199	SENT_97	16388/16389
133	}	CD	NUMBER	}	dep	199	SENT_97	16389/16390
134	^	CD	NUMBER	^	dep	199	SENT_97	16390/16391
135	{	NN	O	{	dep	199	SENT_97	16391/16392
136	s	NNS	O	s	dep	199	SENT_97	16392/16393
137	}	VBP	O	}	dep	199	SENT_97	16393/16394
138	}	CD	NUMBER	}	dep	199	SENT_97	16395/16396
139	}	CD	NUMBER	}	dep	199	SENT_97	16396/16397
140	+	CC	O	+	dep	199	SENT_97	16398/16399
141	Bottom	NNP	O	Bottom	dep	199	SENT_97	16400/16406
142	$	$	O	$	dep	199	SENT_97	16406/16407
143	$	$	MONEY	$	dep	199	SENT_97	16407/16408
144	\	CD	MONEY	\	dep	199	SENT_97	16408/16409
145	end	NN	O	end	dep	199	SENT_97	16409/16412
146	{	CD	NUMBER	{	dep	199	SENT_97	16412/16413
147	document	NN	O	document	dep	199	SENT_97	16413/16421
148	}	NN	O	}	dep	199	SENT_97	16421/16422
149	where	WRB	O	where	dep	199	SENT_97	16422/16427
150	y	NN	O	y	dep	199	SENT_97	16428/16429
151	is	VBZ	O	be	dep	199	SENT_97	16430/16432
152	the	DT	O	the	dep	199	SENT_97	16433/16436
153	net	JJ	O	net	dep	199	SENT_97	16437/16440
154	uptake	NN	O	uptake	dep	199	SENT_97	16441/16447
155	rate	NN	O	rate	dep	199	SENT_97	16448/16452
156	(	CD	NUMBER	(	dep	199	SENT_97	16453/16454
157	picomoles	NNS	O	picomole	dep	199	SENT_97	16454/16463
158	per	IN	O	per	dep	199	SENT_97	16464/16467
159	milligram	NN	O	milligram	dep	199	SENT_97	16468/16477
160	protein	NN	O	protein	dep	199	SENT_97	16478/16485
161	per	IN	O	per	dep	199	SENT_97	16486/16489
162	minute	NN	DURATION	minute	dep	199	SENT_97	16490/16496
163	)	NN	O	)	dep	199	SENT_97	16496/16497
164	,	,	O	,		-1	SENT_97	16497/16498
165	x	NN	O	x	dep	199	SENT_97	16499/16500
166	is	VBZ	O	be	dep	199	SENT_97	16501/16503
167	the	DT	O	the	dep	199	SENT_97	16504/16507
168	inhibitor	NN	O	inhibitor	dep	199	SENT_97	16508/16517
169	concentration	NN	O	concentration	dep	199	SENT_97	16518/16531
170	(	CD	NUMBER	(	dep	199	SENT_97	16532/16533
171	micromolars	NNS	O	micromolar	dep	199	SENT_97	16533/16544
172	)	RB	O	)	dep	199	SENT_97	16544/16545
173	,	,	O	,		-1	SENT_97	16545/16546
174	s	NNS	O	s	dep	199	SENT_97	16547/16548
175	is	VBZ	O	be	dep	199	SENT_97	16549/16551
176	the	DT	O	the	dep	199	SENT_97	16552/16555
177	slope	NN	O	slope	dep	199	SENT_97	16556/16561
178	at	IN	O	at	dep	199	SENT_97	16562/16564
179	the	DT	O	the	dep	199	SENT_97	16565/16568
180	point	NN	O	point	dep	199	SENT_97	16569/16574
181	of	IN	O	of	dep	199	SENT_97	16575/16577
182	inversion	NN	O	inversion	dep	199	SENT_97	16578/16587
183	,	,	O	,		-1	SENT_97	16587/16588
184	and	CC	O	and	dep	199	SENT_97	16589/16592
185	Top	NNP	PERSON	Top	dep	199	SENT_97	16593/16596
186	and	CC	O	and	dep	199	SENT_97	16597/16600
187	Bottom	NNP	O	Bottom	dep	199	SENT_97	16601/16607
188	are	VBP	O	be	dep	199	SENT_97	16608/16611
189	the	DT	O	the	dep	199	SENT_97	16612/16615
190	maximum	NN	O	maximum	dep	199	SENT_97	16616/16623
191	and	CC	O	and	dep	199	SENT_97	16624/16627
192	minimum	NN	O	minimum	dep	199	SENT_97	16628/16635
193	values	NNS	O	value	dep	199	SENT_97	16636/16642
194	for	IN	O	for	dep	199	SENT_97	16643/16646
195	cellular	JJ	O	cellular	dep	199	SENT_97	16647/16655
196	uptake	NN	O	uptake	dep	199	SENT_97	16656/16662
197	rates	NNS	O	rate	dep	199	SENT_97	16663/16668
198	,	,	O	,		-1	SENT_97	16668/16669
199	respectively	RB	O	respectively		-1	SENT_97	16670/16682
200	.	.	O	.		-1	SENT_97	16682/16683

1	For	IN	O	for		-1	SENT_98	16684/16687
2	all	DT	O	all	det	5	SENT_98	16688/16691
3	graphical	JJ	O	graphical	amod	5	SENT_98	16692/16701
4	data	NNS	O	datum	nn	5	SENT_98	16702/16706
5	evaluations	NNS	O	evaluation	prep_for	26	SENT_98	16707/16718
6	,	,	O	,		-1	SENT_98	16718/16719
7	the	DT	O	the	det	11	SENT_98	16720/16723
8	GraphPad	NNP	O	GraphPad	nn	11	SENT_98	16724/16732
9	Prism	NNP	O	Prism	nn	11	SENT_98	16733/16738
10	software	NN	O	software	nn	11	SENT_98	16739/16747
11	package	NN	O	package	nsubjpass	26	SENT_98	16748/16755
12	(	CD	NUMBER	(	num	13	SENT_98	16756/16757
13	version	NN	O	version	dep	11	SENT_98	16757/16764
14	5.0	CD	NUMBER	5.0	dep	11	SENT_98	16765/16768
15	,	,	O	,		-1	SENT_98	16768/16769
16	GraphPad	NNP	ORGANIZATION	GraphPad	nn	18	SENT_98	16770/16778
17	Software	NNP	ORGANIZATION	Software	nn	18	SENT_98	16779/16787
18	Inc.	NNP	ORGANIZATION	Inc.	appos	14	SENT_98	16788/16792
19	,	,	O	,		-1	SENT_98	16792/16793
20	La	NNP	PERSON	La	nn	21	SENT_98	16794/16796
21	Jolla	NNP	PERSON	Jolla	appos	14	SENT_98	16797/16802
22	,	,	O	,		-1	SENT_98	16802/16803
23	CA	NNP	O	CA	nn	24	SENT_98	16804/16806
24	)	NNP	O	)	appos	14	SENT_98	16806/16807
25	was	VBD	O	be	auxpass	26	SENT_98	16808/16811
26	used	VBN	O	use		-1	SENT_98	16812/16816
27	.	.	O	.		-1	SENT_98	16816/16817

1	The	DT	O	the	det	3	SENT_99	16818/16821
2	fitted	JJ	O	fitted	amod	3	SENT_99	16822/16828
3	parameters	NNS	O	parameter	nsubjpass	5	SENT_99	16829/16839
4	are	VBP	O	be	auxpass	5	SENT_99	16840/16843
5	presented	VBN	O	present		-1	SENT_99	16844/16853
6	as	IN	O	as		-1	SENT_99	16854/16856
7	best-fit	JJ	O	best-fit	amod	8	SENT_99	16857/16865
8	parameter	NN	O	parameter	prep_as	5	SENT_99	16866/16875
9	and	CC	O	and		-1	SENT_99	16876/16879
10	standard	JJ	O	standard	amod	11	SENT_99	16880/16888
11	error	NN	O	error	conj_and	8	SENT_99	16889/16894
12	(	CD	NUMBER	(	num	11	SENT_99	16895/16896
13	SE	NN	O	se	dep	11	SENT_99	16896/16898
14	)	CD	NUMBER	)	num	13	SENT_99	16898/16899
15	.	.	O	.		-1	SENT_99	16899/16900

1	RESULTS	NNS	O	result		-1	SENT_100	16936/16943

1	Demographics	NNS	O	demographic		-1	SENT_101	16979/16991
2	and	CC	O	and		-1	SENT_101	16992/16995
3	Baseline	NN	O	baseline	nn	4	SENT_101	16996/17004
4	Characteristics	NNS	O	characteristic	conj_and	1	SENT_101	17005/17020

1	Ten	CD	NUMBER	ten	num	4	SENT_102	17056/17059
2	healthy	JJ	O	healthy	amod	4	SENT_102	17060/17067
3	male	JJ	O	male	amod	4	SENT_102	17068/17072
4	subjects	NNS	O	subject	nsubjpass	51	SENT_102	17073/17081
5	in	IN	O	in		-1	SENT_102	17082/17084
6	part	NN	O	part	prep_in	4	SENT_102	17085/17089
7	A	DT	O	a	det	11	SENT_102	17090/17091
8	(	JJ	O	(	amod	11	SENT_102	17092/17093
9	age	NN	O	age	nn	11	SENT_102	17093/17096
10	standard	JJ	O	standard	amod	11	SENT_102	17104/17112
11	deviation	NN	O	deviation	dep	6	SENT_102	17113/17122
12	[	CD	NUMBER	[	num	14	SENT_102	17123/17124
13	SD	NN	O	sd	nn	14	SENT_102	17124/17126
14	]	NN	O	]	dep	6	SENT_102	17126/17127
15	,	,	O	,		-1	SENT_102	17127/17128
16	29	CD	NUMBER	29	number	17	SENT_102	17129/17131
17	9	CD	DURATION	9	num	18	SENT_102	17139/17140
18	years	NNS	NUMBER	year	appos	14	SENT_102	17141/17146
19	;	:	O	;		-1	SENT_102	17146/17147
20	BMI	NNP	O	BMI	nn	21	SENT_102	17148/17151
21	SD	NN	O	sd	dep	14	SENT_102	17159/17161
22	,	,	O	,		-1	SENT_102	17161/17162
23	22.1	CD	NUMBER	22.1	number	24	SENT_102	17163/17167
24	2.8	CD	NUMBER	2.8	num	41	SENT_102	17175/17178
25	kg/m2	NN	O	kg/m2	nn	41	SENT_102	17179/17184
26	)	NN	O	)	nn	41	SENT_102	17184/17185
27	and	CC	O	and		-1	SENT_102	17186/17189
28	10	CD	NUMBER	10	num	31	SENT_102	17190/17192
29	healthy	JJ	O	healthy	amod	31	SENT_102	17193/17200
30	male	JJ	O	male	amod	31	SENT_102	17201/17205
31	subjects	NNS	O	subject	conj_and	41	SENT_102	17206/17214
32	in	IN	O	in		-1	SENT_102	17215/17217
33	part	NN	O	part	nn	34	SENT_102	17218/17222
34	B	NN	O	b	prep_in	31	SENT_102	17223/17224
35	(	CD	NUMBER	(	num	37	SENT_102	17225/17226
36	age	NN	O	age	nn	37	SENT_102	17226/17229
37	SD	NN	O	sd	dep	31	SENT_102	17235/17237
38	,	,	O	,		-1	SENT_102	17237/17238
39	33	CD	NUMBER	33	number	40	SENT_102	17239/17241
40	10	CD	DURATION	10	amod	41	SENT_102	17249/17251
41	years	NNS	NUMBER	year	appos	21	SENT_102	17252/17257
42	;	:	O	;		-1	SENT_102	17257/17258
43	BMI	NNP	O	BMI	dep	14	SENT_102	17259/17262
44	SD	NN	O	sd	dep	43	SENT_102	17270/17272
45	,	,	O	,		-1	SENT_102	17272/17273
46	23.0	CD	NUMBER	23.0	number	47	SENT_102	17274/17278
47	1.5	CD	NUMBER	1.5	num	49	SENT_102	17286/17289
48	kg/m2	NN	O	kg/m2	nn	49	SENT_102	17290/17295
49	)	NN	O	)	appos	6	SENT_102	17295/17296
50	were	VBD	O	be	auxpass	51	SENT_102	17297/17301
51	enrolled	VBN	O	enrol		-1	SENT_102	17302/17310
52	.	.	O	.		-1	SENT_102	17310/17311

1	All	DT	O	all	det	2	SENT_103	17312/17315
2	subjects	NNS	O	subject	nsubj	4	SENT_103	17316/17324
3	were	VBD	O	be	cop	4	SENT_103	17325/17329
4	Caucasian	JJ	O	caucasian		-1	SENT_103	17330/17339
5	.	.	O	.		-1	SENT_103	17339/17340

1	All	DT	O	all	nsubj	2	SENT_104	17341/17344
2	completed	VBD	O	complete		-1	SENT_104	17345/17354
3	the	DT	O	the	det	4	SENT_104	17355/17358
4	study	NN	O	study	dobj	2	SENT_104	17359/17364
5	as	IN	O	as		-1	SENT_104	17365/17367
6	per	IN	O	per	prepc_as_per	2	SENT_104	17368/17371
7	protocol	NN	O	protocol	pobj	2	SENT_104	17372/17380
8	.	.	O	.		-1	SENT_104	17380/17381

1	None	NN	O	none	nsubj	24	SENT_105	17382/17386
2	of	IN	O	of		-1	SENT_105	17387/17389
3	the	DT	O	the	det	5	SENT_105	17390/17393
4	subjects	NNS	O	subject	nn	5	SENT_105	17394/17402
5	(	NN	O	(	prep_of	1	SENT_105	17403/17404
6	in	IN	O	in		-1	SENT_105	17404/17406
7	parts	NNS	O	part	prep_in	5	SENT_105	17407/17412
8	A	DT	O	a	nsubjpass	13	SENT_105	17413/17414
9	and	CC	O	and		-1	SENT_105	17415/17418
10	B	NN	O	b	conj_and	8	SENT_105	17419/17420
11	)	NN	O	)	dep	8	SENT_105	17420/17421
12	were	VBD	O	be	auxpass	13	SENT_105	17422/17426
13	exposed	VBN	O	expose	rcmod	7	SENT_105	17427/17434
14	to	TO	O	to		-1	SENT_105	17435/17437
15	any	DT	O	any	prep_to	13	SENT_105	17438/17441
16	prescribed	VBN	O	prescribe	partmod	15	SENT_105	17442/17452
17	or	CC	O	or		-1	SENT_105	17453/17455
18	over-the-counter	JJ	O	over-the-counter	amod	20	SENT_105	17456/17472
19	drug	NN	O	drug	nn	20	SENT_105	17473/17477
20	(	NN	O	(	conj_or	7	SENT_105	17478/17479
21	including	VBG	O	include		-1	SENT_105	17479/17488
22	herbal	JJ	O	herbal	amod	23	SENT_105	17489/17495
23	medicines	NNS	O	medicine	prep_including	20	SENT_105	17496/17505
24	)	VBP	O	)		-1	SENT_105	17505/17506
25	for	IN	O	for	prep	24	SENT_105	17507/17510
26	3	CD	DURATION	3	num	27	SENT_105	17511/17512
27	months	NNS	NUMBER	month	npadvmod	28	SENT_105	17513/17519
28	prior	RB	O	prior	pcomp	25	SENT_105	17520/17525
29	to	TO	O	to		-1	SENT_105	17526/17528
30	screening	NN	O	screening	prep_to	24	SENT_105	17529/17538
31	.	.	O	.		-1	SENT_105	17538/17539

1	Pharmacokinetics	NNS	O	pharmacokinetic		-1	SENT_106	17575/17591

1	Part	NNP	O	Part	nn	2	SENT_107	17627/17631
2	A	NNP	O	A		-1	SENT_107	17632/17633

1	Mean	NN	O	mean	nn	3	SENT_108	17669/17673
2	concentration-time	JJ	O	concentration-time	amod	3	SENT_108	17674/17692
3	profiles	NNS	O	profile	nsubj	19	SENT_108	17693/17701
4	of	IN	O	of		-1	SENT_108	17702/17704
5	macitentan	NN	O	macitentan	prep_of	3	SENT_108	17705/17715
6	,	,	O	,		-1	SENT_108	17715/17716
7	ACT-132577	NN	O	act-132577	conj_and	5	SENT_108	17717/17727
8	,	,	O	,		-1	SENT_108	17727/17728
9	and	CC	O	and		-1	SENT_108	17729/17732
10	ACT-373898	NN	O	act-373898	conj_and	5	SENT_108	17733/17743
11	in	IN	O	in		-1	SENT_108	17744/17746
12	period	NN	O	period	prep_in	5	SENT_108	17747/17753
13	1	CD	NUMBER	1	number	14	SENT_108	17754/17755
14	(	CD	NUMBER	(	dep	12	SENT_108	17756/17757
15	multiple-dose	JJ	O	multiple-dose	amod	18	SENT_108	17757/17770
16	macitentan	NN	O	macitentan	nn	18	SENT_108	17771/17781
17	treatment	NN	O	treatment	nn	18	SENT_108	17782/17791
18	)	NN	O	)	dep	14	SENT_108	17791/17792
19	followed	VBN	O	follow		-1	SENT_108	17793/17801
20	by	IN	O	by		-1	SENT_108	17802/17804
21	period	NN	O	period	prep_by	19	SENT_108	17805/17811
22	2	CD	NUMBER	2	number	23	SENT_108	17812/17813
23	(	CD	NUMBER	(	num	24	SENT_108	17814/17815
24	multiple	JJ	O	multiple	dobj	19	SENT_108	17815/17823
25	-	:	O	-		-1	SENT_108	17823/17824
26	dose	NN	O	dose	nn	27	SENT_108	17825/17829
27	co-administration	NN	O	co-administration	nsubjpass	32	SENT_108	17830/17847
28	of	IN	O	of		-1	SENT_108	17848/17850
29	Cs	NNP	O	Cs	prep_of	27	SENT_108	17851/17853
30	)	CD	NUMBER	)	num	29	SENT_108	17853/17854
31	are	VBP	O	be	auxpass	32	SENT_108	17855/17858
32	shown	VBN	O	show	parataxis	19	SENT_108	17859/17864
33	in	IN	O	in		-1	SENT_108	17865/17867
34	Fig.	NN	O	fig.	prep_in	32	SENT_108	17868/17872
35	1	CD	NUMBER	1	num	34	SENT_108	17873/17874
36	.	.	O	.		-1	SENT_108	17874/17875

1	In	IN	O	in		-1	SENT_109	17876/17878
2	period	NN	O	period	prep_in	14	SENT_109	17879/17885
3	1	CD	NUMBER	1	num	2	SENT_109	17886/17887
4	,	,	O	,		-1	SENT_109	17887/17888
5	plasma	NN	O	plasma	nn	6	SENT_109	17889/17895
6	concentrations	NNS	O	concentration	nsubj	14	SENT_109	17896/17910
7	of	IN	O	of		-1	SENT_109	17911/17913
8	macitentan	NN	O	macitentan	prep_of	6	SENT_109	17914/17924
9	,	,	O	,		-1	SENT_109	17924/17925
10	ACT-132577	NN	O	act-132577	conj_and	8	SENT_109	17926/17936
11	,	,	O	,		-1	SENT_109	17936/17937
12	and	CC	O	and		-1	SENT_109	17938/17941
13	ACT-373898	NN	O	act-373898	conj_and	8	SENT_109	17942/17952
14	approached	VBD	O	approach		-1	SENT_109	17953/17963
15	steady	JJ	O	steady	dobj	14	SENT_109	17964/17970
16	-	:	O	-		-1	SENT_109	17970/17971
17	state	NN	O	state	dep	15	SENT_109	17972/17977
18	on	IN	O	on		-1	SENT_109	17978/17980
19	day	NN	DURATION	day	prep_on	17	SENT_109	17981/17984
20	5	CD	NUMBER	5	num	19	SENT_109	17985/17986
21	(	NN	O	(	nn	24	SENT_109	17987/17988
22	96	CD	NUMBER	96	num	24	SENT_109	17988/17990
23	h	NN	O	h	nn	24	SENT_109	17991/17992
24	)	NN	O	)	tmod	14	SENT_109	17992/17993
25	of	IN	O	of		-1	SENT_109	17994/17996
26	dosing	NN	O	dosing	prep_of	24	SENT_109	17997/18003
27	.	.	O	.		-1	SENT_109	18003/18004

1	In	IN	O	in		-1	SENT_110	18005/18007
2	the	DT	O	the	det	3	SENT_110	18008/18011
3	presence	NN	O	presence	prep_in	22	SENT_110	18012/18020
4	of	IN	O	of		-1	SENT_110	18021/18023
5	Cs	NNP	O	Cs	prep_of	3	SENT_110	18024/18026
6	(	CD	NUMBER	(	num	5	SENT_110	18027/18028
7	period	NN	O	period	tmod	22	SENT_110	18028/18034
8	2	CD	NUMBER	2	num	9	SENT_110	18035/18036
9	)	NN	O	)	nsubjpass	22	SENT_110	18036/18037
10	,	,	O	,		-1	SENT_110	18037/18038
11	no	DT	O	no	det	13	SENT_110	18039/18041
12	relevant	JJ	O	relevant	amod	13	SENT_110	18042/18050
13	changes	NNS	O	change	appos	9	SENT_110	18051/18058
14	in	IN	O	in		-1	SENT_110	18059/18061
15	Ctr	NN	O	ctr	prep_in	13	SENT_110	18062/18065
16	of	IN	O	of		-1	SENT_110	18066/18068
17	macitentan	NN	O	macitentan	prep_of	15	SENT_110	18069/18079
18	and	CC	O	and		-1	SENT_110	18080/18083
19	its	PRP$	O	its	poss	20	SENT_110	18084/18087
20	metabolites	NNS	O	metabolite	conj_and	17	SENT_110	18088/18099
21	were	VBD	O	be	auxpass	22	SENT_110	18100/18104
22	observed	VBN	O	observe		-1	SENT_110	18105/18113
23	compared	VBN	O	compare		-1	SENT_110	18114/18122
24	to	TO	O	to	prepc_compared_to	22	SENT_110	18123/18125
25	macitentan	NN	O	macitentan	nn	26	SENT_110	18126/18136
26	treatment	NN	O	treatment	pobj	22	SENT_110	18137/18146
27	alone	RB	O	alone	advmod	26	SENT_110	18147/18152
28	.	.	O	.		-1	SENT_110	18152/18153

1	The	DT	O	the	det	6	SENT_111	18154/18157
2	mean	NN	O	mean	nn	6	SENT_111	18158/18162
3	24-h	JJ	O	24-h	amod	6	SENT_111	18163/18167
4	plasma	NN	O	plasma	nn	6	SENT_111	18168/18174
5	concentration-time	NN	O	concentration-time	nn	6	SENT_111	18175/18193
6	profiles	NNS	O	profile	nsubj	41	SENT_111	18194/18202
7	at	IN	O	at		-1	SENT_111	18203/18205
8	steady-state	JJ	O	steady-state	prep_at	6	SENT_111	18206/18218
9	in	IN	O	in		-1	SENT_111	18219/18221
10	the	DT	O	the	det	12	SENT_111	18222/18225
11	two	CD	NUMBER	two	num	12	SENT_111	18226/18229
12	periods	NNS	O	period	prep_in	8	SENT_111	18230/18237
13	,	,	O	,		-1	SENT_111	18237/18238
14	i.e.	FW	O	i.e.	dep	6	SENT_111	18239/18243
15	,	,	O	,		-1	SENT_111	18243/18244
16	on	IN	O	on		-1	SENT_111	18245/18247
17	day	NN	DURATION	day	nn	20	SENT_111	18248/18251
18	5	CD	NUMBER	5	num	20	SENT_111	18252/18253
19	(	NN	O	(	nn	20	SENT_111	18254/18255
20	period	NN	O	period	prep_on	6	SENT_111	18255/18261
21	1	CD	NUMBER	1	num	22	SENT_111	18262/18263
22	)	NN	O	)	dep	20	SENT_111	18263/18264
23	and	CC	O	and		-1	SENT_111	18265/18268
24	day	NN	DURATION	day	nn	27	SENT_111	18269/18272
25	17	CD	NUMBER	17	num	27	SENT_111	18273/18275
26	(	NN	O	(	nn	27	SENT_111	18276/18277
27	period	NN	O	period	conj_and	20	SENT_111	18277/18283
28	2	CD	NUMBER	2	num	29	SENT_111	18284/18285
29	)	NN	O	)	dep	27	SENT_111	18285/18286
30	,	,	O	,		-1	SENT_111	18286/18287
31	for	IN	O	for		-1	SENT_111	18288/18291
32	macitentan	NN	O	macitentan	prep_for	6	SENT_111	18292/18302
33	and	CC	O	and		-1	SENT_111	18303/18306
34	its	PRP$	O	its	poss	35	SENT_111	18307/18310
35	metabolites	NNS	O	metabolite	conj_and	32	SENT_111	18311/18322
36	were	VBD	O	be	cop	41	SENT_111	18323/18327
37	similar	JJ	O	similar	amod	41	SENT_111	18328/18335
38	(	NN	O	(	nn	41	SENT_111	18336/18337
39	Fig.	NN	O	fig.	nn	41	SENT_111	18337/18341
40	2	CD	NUMBER	2	num	41	SENT_111	18342/18343
41	)	NN	O	)		-1	SENT_111	18343/18344
42	.	.	O	.		-1	SENT_111	18344/18345

1	Fig.	NN	O	fig.		-1	SENT_112	18345/18349
2	1	CD	NUMBER	1	num	1	SENT_112	18350/18351

1	Part	NNP	O	Part	nn	2	SENT_113	18368/18372
2	A	NNP	O	A		-1	SENT_113	18373/18374
3	:	:	O	:		-1	SENT_113	18374/18375
4	Arithmetic	NNP	O	Arithmetic	nsubj	5	SENT_113	18376/18386
5	mean	VB	O	mean	dep	2	SENT_113	18387/18391
6	SD	NN	O	sd	nn	8	SENT_113	18395/18397
7	plasma	NN	O	plasma	nn	8	SENT_113	18398/18404
8	concentration	NN	O	concentration	dobj	5	SENT_113	18405/18418
9	versus	CC	O	versus	prep	8	SENT_113	18419/18425
10	time	NN	O	time	nn	11	SENT_113	18426/18430
11	profiles	NNS	O	profile	dep	9	SENT_113	18431/18439
12	of	IN	O	of		-1	SENT_113	18440/18442
13	macitentan	NN	O	macitentan	prep_of	11	SENT_113	18443/18453
14	,	,	O	,		-1	SENT_113	18453/18454
15	ACT-132577	NN	O	act-132577	conj_and	13	SENT_113	18455/18465
16	,	,	O	,		-1	SENT_113	18465/18466
17	and	CC	O	and		-1	SENT_113	18467/18470
18	ACT-373898	NN	O	act-373898	conj_and	13	SENT_113	18471/18481
19	from	IN	O	from		-1	SENT_113	18482/18486
20	days	NNS	DATE	day	prep_from	13	SENT_113	18487/18491
21	1	CD	DATE	1	num	20	SENT_113	18492/18493
22	to	TO	DATE	to	dep	20	SENT_113	18494/18496
23	17	CD	DATE	17	num	20	SENT_113	18497/18499
24	.	.	O	.		-1	SENT_113	18499/18500

1	The	DT	DATE	the	det	3	SENT_114	18501/18504
2	last	JJ	DATE	last	amod	3	SENT_114	18505/18509
3	day	NN	DATE	day	dep	14	SENT_114	18510/18513
4	of	IN	O	of		-1	SENT_114	18514/18516
5	treatment	NN	O	treatment	prep_of	3	SENT_114	18517/18526
6	with	IN	O	with		-1	SENT_114	18527/18531
7	macitentan	NN	O	macitentan	prep_with	5	SENT_114	18532/18542
8	in	IN	O	in		-1	SENT_114	18543/18545
9	period	NN	O	period	prep_in	7	SENT_114	18546/18552
10	1	CD	NUMBER	1	num	9	SENT_114	18553/18554
11	(	CD	NUMBER	(	num	12	SENT_114	18555/18556
12	day	NN	NUMBER	day	dep	14	SENT_114	18556/18559
13	5	CD	NUMBER	5	num	14	SENT_114	18560/18561
14	)	NN	O	)	dep	28	SENT_114	18561/18562
15	and	CC	O	and		-1	SENT_114	18563/18566
16	last	JJ	DATE	last	amod	17	SENT_114	18567/18571
17	day	NN	DATE	day	conj_and	14	SENT_114	18572/18575
18	of	IN	O	of		-1	SENT_114	18576/18578
19	treatment	NN	O	treatment	prep_of	14	SENT_114	18579/18588
20	with	IN	O	with		-1	SENT_114	18589/18593
21	macitentan	NN	O	macitentan	prep_with	19	SENT_114	18594/18604
22	+	CC	O	+		-1	SENT_114	18607/18608
23	Cs	NNS	O	c	conj_+	21	SENT_114	18611/18613
24	in	IN	O	in		-1	SENT_114	18614/18616
25	period	NN	O	period	prep_in	21	SENT_114	18617/18623
26	2	CD	NUMBER	2	num	28	SENT_114	18624/18625
27	(	CD	NUMBER	(	num	28	SENT_114	18626/18627
28	day	NN	NUMBER	day		-1	SENT_114	18627/18630
29	17	CD	NUMBER	17	num	30	SENT_114	18631/18633
30	)	NN	O	)	nsubjpass	32	SENT_114	18633/18634
31	are	VBP	O	be	auxpass	32	SENT_114	18635/18638
32	indicated	VBN	O	indicate	rcmod	28	SENT_114	18639/18648
33	in	IN	O	in		-1	SENT_114	18649/18651
34	the	DT	O	the	det	35	SENT_114	18652/18655
35	figure	NN	O	figure	prep_in	32	SENT_114	18656/18662

1	Fig.	NN	O	fig.		-1	SENT_115	18679/18683
2	2	CD	NUMBER	2	num	1	SENT_115	18684/18685

1	Part	NNP	O	Part	nn	2	SENT_116	18702/18706
2	A	NNP	O	A		-1	SENT_116	18707/18708
3	:	:	O	:		-1	SENT_116	18708/18709
4	Arithmetic	NNP	O	Arithmetic	nsubj	5	SENT_116	18710/18720
5	mean	VB	O	mean	dep	2	SENT_116	18721/18725
6	SD	NN	O	sd	nn	8	SENT_116	18729/18731
7	plasma	NN	O	plasma	nn	8	SENT_116	18732/18738
8	concentration	NN	O	concentration	dobj	5	SENT_116	18739/18752
9	versus	CC	O	versus	prep	8	SENT_116	18753/18759
10	time	NN	O	time	nn	11	SENT_116	18760/18764
11	profiles	NNS	O	profile	dep	9	SENT_116	18765/18773
12	of	IN	O	of		-1	SENT_116	18774/18776
13	macitentan	NN	O	macitentan	prep_of	11	SENT_116	18777/18787
14	,	,	O	,		-1	SENT_116	18787/18788
15	ACT-132577	NN	O	act-132577	conj_and	13	SENT_116	18789/18799
16	,	,	O	,		-1	SENT_116	18799/18800
17	and	CC	O	and		-1	SENT_116	18801/18804
18	ACT-373898	NN	O	act-373898	conj_and	13	SENT_116	18805/18815
19	on	IN	O	on		-1	SENT_116	18816/18818
20	day	NN	DURATION	day	nn	23	SENT_116	18819/18822
21	5	CD	NUMBER	5	num	23	SENT_116	18823/18824
22	(	NN	O	(	nn	23	SENT_116	18825/18826
23	period	NN	O	period	prep_on	13	SENT_116	18826/18832
24	1	CD	NUMBER	1	dep	8	SENT_116	18833/18834
25	:	:	O	:		-1	SENT_116	18834/18835
26	macitentan	NN	O	macitentan	nn	27	SENT_116	18836/18846
27	)	NN	O	)	dep	8	SENT_116	18846/18847
28	compared	VBN	O	compare		-1	SENT_116	18848/18856
29	to	TO	O	to	prepc_compared_to	27	SENT_116	18857/18859
30	day	NN	DURATION	day	nn	33	SENT_116	18860/18863
31	17	CD	NUMBER	17	num	33	SENT_116	18864/18866
32	(	NN	O	(	nn	33	SENT_116	18867/18868
33	period	NN	O	period	pobj	27	SENT_116	18868/18874
34	2	CD	NUMBER	2	dep	33	SENT_116	18875/18876
35	:	:	O	:		-1	SENT_116	18876/18877
36	macitentan	NN	O	macitentan	dep	27	SENT_116	18878/18888
37	+	CC	O	+		-1	SENT_116	18891/18892
38	Cs	NN	O	c	nn	39	SENT_116	18895/18897
39	)	NN	O	)	conj_+	36	SENT_116	18897/18898

1	Geometric	JJ	O	geometric	amod	2	SENT_117	18953/18962
2	means	NNS	O	means	nsubj	20	SENT_117	18963/18968
3	of	IN	O	of		-1	SENT_117	18969/18971
4	steady-state	JJ	O	steady-state	amod	5	SENT_117	18972/18984
5	AUC	NN	O	auc	prep_of	2	SENT_117	18985/18988
6	for	IN	O	for		-1	SENT_117	18991/18994
7	macitentan	NN	O	macitentan	prep_for	5	SENT_117	18995/19005
8	,	,	O	,		-1	SENT_117	19005/19006
9	ACT-132577	NN	O	act-132577	conj_and	7	SENT_117	19007/19017
10	,	,	O	,		-1	SENT_117	19017/19018
11	and	CC	O	and		-1	SENT_117	19019/19022
12	ACT-373898	NN	O	act-373898	conj_and	7	SENT_117	19023/19033
13	in	IN	O	in		-1	SENT_117	19034/19036
14	the	DT	O	the	det	15	SENT_117	19037/19040
15	absence	NN	O	absence	prep_in	7	SENT_117	19041/19048
16	of	IN	O	of		-1	SENT_117	19049/19051
17	Cs	NN	O	c	nn	18	SENT_117	19052/19054
18	treatment	NN	O	treatment	prep_of	15	SENT_117	19055/19064
19	were	VBD	O	be	cop	20	SENT_117	19065/19069
20	6,876	CD	NUMBER	6,876	dep	51	SENT_117	19070/19075
21	,	,	O	,		-1	SENT_117	19075/19076
22	16,881	CD	NUMBER	16,881	num	20	SENT_117	19077/19083
23	,	,	O	,		-1	SENT_117	19083/19084
24	and	CC	NUMBER	and		-1	SENT_117	19085/19088
25	530	CD	NUMBER	530	conj_and	20	SENT_117	19089/19092
26	ng	NN	O	ng	nn	28	SENT_117	19093/19095
27	*	NN	O	*	nn	28	SENT_117	19095/19096
28	h/mL	NN	O	h/ml	dep	20	SENT_117	19096/19100
29	,	,	O	,		-1	SENT_117	19100/19101
30	respectively	RB	O	respectively	advmod	20	SENT_117	19102/19114
31	,	,	O	,		-1	SENT_117	19114/19115
32	compared	VBN	O	compare		-1	SENT_117	19116/19124
33	to	TO	O	to	prepc_compared_to	20	SENT_117	19125/19127
34	7,562	CD	NUMBER	7,562	pobj	20	SENT_117	19128/19133
35	,	,	O	,		-1	SENT_117	19133/19134
36	16,428	CD	NUMBER	16,428	conj_and	34	SENT_117	19135/19141
37	,	,	O	,		-1	SENT_117	19141/19142
38	and	CC	NUMBER	and		-1	SENT_117	19143/19146
39	568	CD	NUMBER	568	num	42	SENT_117	19147/19150
40	ng	NN	O	ng	nn	42	SENT_117	19151/19153
41	*	NN	O	*	nn	42	SENT_117	19153/19154
42	h/mL	NN	O	h/ml	conj_and	34	SENT_117	19154/19158
43	in	IN	O	in		-1	SENT_117	19159/19161
44	the	DT	O	the	det	45	SENT_117	19162/19165
45	presence	NN	O	presence	prep_in	42	SENT_117	19166/19174
46	of	IN	O	of		-1	SENT_117	19175/19177
47	Cs	NNP	O	Cs	prep_of	45	SENT_117	19178/19180
48	(	CD	NUMBER	(	num	47	SENT_117	19181/19182
49	Table	NNP	O	Table	dep	42	SENT_117	19182/19187
50	I	PRP	O	I	nsubj	51	SENT_117	19188/19189
51	)	VBP	O	)		-1	SENT_117	19189/19190
52	.	.	O	.		-1	SENT_117	19190/19191

1	The	DT	O	the	det	2	SENT_118	19192/19195
2	comparison	NN	O	comparison	nsubjpass	13	SENT_118	19196/19206
3	of	IN	O	of		-1	SENT_118	19207/19209
4	geometric	JJ	O	geometric	amod	5	SENT_118	19210/19219
5	means	NNS	O	means	prep_of	2	SENT_118	19220/19225
6	of	IN	O	of		-1	SENT_118	19226/19228
7	PK	NN	O	pk	nn	8	SENT_118	19229/19231
8	variables	NNS	O	variable	prep_of	5	SENT_118	19232/19241
9	in	IN	O	in		-1	SENT_118	19242/19244
10	part	NN	O	part	nn	11	SENT_118	19245/19249
11	A	NN	O	a	prep_in	8	SENT_118	19250/19251
12	is	VBZ	O	be	auxpass	13	SENT_118	19252/19254
13	shown	VBN	O	show		-1	SENT_118	19255/19260
14	in	IN	O	in		-1	SENT_118	19261/19263
15	Table	NNP	O	Table	nn	16	SENT_118	19264/19269
16	II	NNP	O	II	prep_in	13	SENT_118	19270/19272
17	.	.	O	.		-1	SENT_118	19272/19273

1	The	DT	O	the	det	2	SENT_119	19274/19277
2	ratio	NN	O	ratio	nsubj	16	SENT_119	19278/19283
3	of	IN	O	of		-1	SENT_119	19284/19286
4	geometric	JJ	O	geometric	amod	5	SENT_119	19287/19296
5	means	NNS	O	means	prep_of	2	SENT_119	19297/19302
6	and	CC	O	and		-1	SENT_119	19303/19306
7	their	PRP$	O	they	poss	11	SENT_119	19307/19312
8	90	CD	PERCENT	90	number	9	SENT_119	19313/19315
9	%	NN	PERCENT	%	amod	11	SENT_119	19315/19316
10	confidence	NN	O	confidence	nn	11	SENT_119	19317/19327
11	limits	NNS	O	limit	conj_and	2	SENT_119	19328/19334
12	of	IN	O	of		-1	SENT_119	19335/19337
13	AUC	NN	O	auc	prep_of	11	SENT_119	19338/19341
14	for	IN	O	for		-1	SENT_119	19344/19347
15	ACT-132577	NN	O	act-132577	prep_for	13	SENT_119	19348/19358
16	fell	VBD	O	fall		-1	SENT_119	19359/19363
17	entirely	RB	O	entirely	advmod	16	SENT_119	19364/19372
18	within	IN	O	within		-1	SENT_119	19373/19379
19	the	DT	O	the	det	22	SENT_119	19380/19383
20	FDA-recommended	JJ	O	fda-recommended	amod	22	SENT_119	19384/19399
21	bioequivalence	NN	O	bioequivalence	nn	22	SENT_119	19400/19414
22	range	NN	O	range	prep_within	16	SENT_119	19415/19420
23	of	IN	O	of		-1	SENT_119	19421/19423
24	0.80-1	CD	NUMBER	0.80-1	num	25	SENT_119	19424/19430
25	.25	CD	NUMBER	.25	prep_of	22	SENT_119	19430/19433
26	,	,	O	,		-1	SENT_119	19433/19434
27	whereas	IN	O	whereas	mark	47	SENT_119	19435/19442
28	for	IN	O	for		-1	SENT_119	19443/19446
29	macitentan	NN	O	macitentan	prep_for	47	SENT_119	19447/19457
30	and	CC	O	and		-1	SENT_119	19458/19461
31	ACT-373898	NN	O	act-373898	conj_and	29	SENT_119	19462/19472
32	,	,	O	,		-1	SENT_119	19472/19473
33	at	IN	O	at	quantmod	35	SENT_119	19474/19476
34	least	JJS	O	least	mwe	33	SENT_119	19477/19482
35	one	CD	NUMBER	one	nsubj	47	SENT_119	19483/19486
36	of	IN	O	of		-1	SENT_119	19487/19489
37	the	DT	O	the	det	39	SENT_119	19490/19493
38	confidence	NN	O	confidence	nn	39	SENT_119	19494/19504
39	limits	NNS	O	limit	prep_of	35	SENT_119	19505/19511
40	were	VBD	O	be	cop	47	SENT_119	19512/19516
41	outside	JJ	O	outside		-1	SENT_119	19517/19524
42	of	IN	O	of		-1	SENT_119	19525/19527
43	this	DT	O	this	det	44	SENT_119	19528/19532
44	range	NN	O	range	prep_outside_of	47	SENT_119	19533/19538
45	(	CD	NUMBER	(	num	44	SENT_119	19539/19540
46	Table	NNP	O	Table	nn	47	SENT_119	19540/19545
47	II	NNP	O	II	advcl	16	SENT_119	19546/19548
48	)	CD	NUMBER	)	number	49	SENT_119	19548/19549
49	(	CD	NUMBER	(	dep	47	SENT_119	19550/19551
50	15	CD	NUMBER	15	num	51	SENT_119	19551/19553
51	)	NN	O	)	dep	49	SENT_119	19553/19554
52	.	.	O	.		-1	SENT_119	19554/19555

1	Table	NNP	O	Table		-1	SENT_120	19555/19560
2	I	PRP	O	I	dep	1	SENT_120	19561/19562

1	Summary	NN	O	summary		-1	SENT_121	19579/19586
2	of	IN	O	of		-1	SENT_121	19587/19589
3	geometric	JJ	O	geometric	amod	4	SENT_121	19590/19599
4	means	NNS	O	means	prep_of	1	SENT_121	19600/19605
5	of	IN	O	of		-1	SENT_121	19606/19608
6	steady-state	JJ	O	steady-state	amod	7	SENT_121	19609/19621
7	AUC	NN	O	auc	prep_of	4	SENT_121	19622/19625
8	and	CC	O	and		-1	SENT_121	19628/19631
9	C	NN	O	c	nn	11	SENT_121	19632/19633
10	tr	NN	O	tr	nn	11	SENT_121	19634/19636
11	values	NNS	O	value	conj_and	7	SENT_121	19637/19643
12	of	IN	O	of		-1	SENT_121	19644/19646
13	macitentan	NN	O	macitentan	prep_of	4	SENT_121	19647/19657
14	and	CC	O	and		-1	SENT_121	19658/19661
15	its	PRP$	O	its	poss	16	SENT_121	19662/19665
16	metabolites	NNS	O	metabolite	conj_and	4	SENT_121	19666/19677
17	in	IN	O	in		-1	SENT_121	19678/19680
18	part	NN	O	part	prep_in	16	SENT_121	19681/19685
19	A	DT	O	a	det	21	SENT_121	19686/19687
20	(	NN	O	(	nn	21	SENT_121	19688/19689
21	macitentan	NN	O	macitentan	dep	1	SENT_121	19689/19699
22	+	CC	O	+		-1	SENT_121	19702/19703
23	Cs	NN	O	c	conj_+	21	SENT_121	19706/19708
24	versus	CC	O	versus		-1	SENT_121	19709/19715
25	macitentan	NN	O	macitentan	nn	26	SENT_121	19716/19726
26	)	NN	O	)	conj_versus	21	SENT_121	19726/19727
27	and	CC	O	and		-1	SENT_121	19728/19731
28	part	NN	O	part	nn	29	SENT_121	19732/19736
29	B	NN	O	b	conj_and	26	SENT_121	19737/19738
30	(	CD	NUMBER	(	num	31	SENT_121	19739/19740
31	macitentan	NN	O	macitentan	dep	26	SENT_121	19740/19750
32	+	CC	O	+		-1	SENT_121	19753/19754
33	rifampin	NN	O	rifampin	conj_+	26	SENT_121	19757/19765
34	versus	CC	O	versus	prep	33	SENT_121	19766/19772
35	macitentan	NN	O	macitentan	nn	36	SENT_121	19773/19783
36	)	NN	O	)	dep	34	SENT_121	19783/19784

1	Part	NNP	O	Part	dep	190	SENT_122	19801/19805
2	APart	NNP	O	APart	dep	190	SENT_122	19806/19811
3	B	NNP	O	B	dep	190	SENT_122	19812/19813
4	AUC	NN	O	auc	dep	190	SENT_122	19815/19818
5	(	CD	NUMBER	(	dep	190	SENT_122	19821/19822
6	ng	NN	O	ng	dep	190	SENT_122	19822/19824
7	*	CD	NUMBER	*	dep	190	SENT_122	19824/19825
8	h/mL	NN	O	h/ml	dep	190	SENT_122	19825/19829
9	)	NN	O	)	dep	190	SENT_122	19829/19830
10	C	NN	O	c	dep	190	SENT_122	19831/19832
11	tr	NN	O	tr	dep	190	SENT_122	19833/19835
12	(	CD	NUMBER	(	dep	190	SENT_122	19836/19837
13	ng/mL	NN	O	ng/ml	dep	190	SENT_122	19837/19842
14	)	CD	NUMBER	)	dep	190	SENT_122	19842/19843
15	AUC	NN	O	auc	dep	190	SENT_122	19843/19846
16	(	CD	NUMBER	(	dep	190	SENT_122	19849/19850
17	ng	NN	O	ng	dep	190	SENT_122	19850/19852
18	*	CD	NUMBER	*	dep	190	SENT_122	19852/19853
19	h/mL	NN	O	h/ml	dep	190	SENT_122	19853/19857
20	)	NN	O	)	dep	190	SENT_122	19857/19858
21	C	NN	O	c	dep	190	SENT_122	19859/19860
22	tr	NN	O	tr	dep	190	SENT_122	19861/19863
23	(	CD	NUMBER	(	dep	190	SENT_122	19864/19865
24	ng/mL	NN	O	ng/ml	dep	190	SENT_122	19865/19870
25	)	NN	O	)	dep	190	SENT_122	19870/19871
26	MacitentanMacitentan	NN	O	macitentanmacitentan	dep	190	SENT_122	19873/19893
27	+	CC	O	+	dep	190	SENT_122	19896/19897
28	CsMacitentanMacitentan	NN	O	csmacitentanmacitentan	dep	190	SENT_122	19900/19922
29	+	CC	O	+	dep	190	SENT_122	19925/19926
30	CsMacitentanMacitentan	NN	O	csmacitentanmacitentan	dep	190	SENT_122	19929/19951
31	+	CC	O	+	dep	190	SENT_122	19954/19955
32	rifampinMacitentanMacitentan	NN	O	rifampinmacitentanmacitentan	dep	190	SENT_122	19956/19984
33	+	CC	O	+	dep	190	SENT_122	19987/19988
34	rifampin	NN	O	rifampin	dep	190	SENT_122	19991/19999
35	96-120	CD	NUMBER	96-120	dep	190	SENT_122	20001/20007
36	h384-408	NN	O	h384-408	dep	190	SENT_122	20008/20016
37	h96-120	NN	O	h96-120	dep	190	SENT_122	20017/20024
38	h384-408	NN	O	h384-408	dep	190	SENT_122	20025/20033
39	h96-120	NN	O	h96-120	dep	190	SENT_122	20034/20041
40	h264-288	NN	O	h264-288	dep	190	SENT_122	20042/20050
41	h96-120	NN	O	h96-120	dep	190	SENT_122	20051/20058
42	h264-288	NN	O	h264-288	dep	190	SENT_122	20059/20067
43	h	NN	O	h	dep	190	SENT_122	20068/20069
44	Macitentan	NNP	O	Macitentan	dep	190	SENT_122	20071/20081
45	6,876	CD	NUMBER	6,876	dep	190	SENT_122	20083/20088
46	(	CD	NUMBER	(	dep	190	SENT_122	20089/20090
47	5,724	CD	NUMBER	5,724	dep	190	SENT_122	20090/20095
48	,	,	O	,		-1	SENT_122	20095/20096
49	8,259	CD	NUMBER	8,259	dep	190	SENT_122	20097/20102
50	)	CD	NUMBER	)	dep	190	SENT_122	20102/20103
51	7,562	CD	NUMBER	7,562	dep	190	SENT_122	20105/20110
52	(	NN	O	(	dep	190	SENT_122	20111/20112
53	6,439	CD	NUMBER	6,439	dep	190	SENT_122	20112/20117
54	,	,	O	,		-1	SENT_122	20117/20118
55	8,881	CD	NUMBER	8,881	dep	190	SENT_122	20119/20124
56	)	NN	O	)	dep	190	SENT_122	20124/20125
57	159	CD	NUMBER	159	dep	190	SENT_122	20127/20130
58	(	NN	O	(	dep	190	SENT_122	20131/20132
59	121	CD	NUMBER	121	dep	190	SENT_122	20132/20135
60	,	,	O	,		-1	SENT_122	20135/20136
61	209	CD	NUMBER	209	dep	190	SENT_122	20137/20140
62	)	NN	O	)	dep	190	SENT_122	20140/20141
63	220	CD	NUMBER	220	dep	190	SENT_122	20143/20146
64	(	NN	O	(	dep	190	SENT_122	20147/20148
65	176	CD	NUMBER	176	dep	190	SENT_122	20148/20151
66	,	,	O	,		-1	SENT_122	20151/20152
67	274	CD	NUMBER	274	dep	190	SENT_122	20153/20156
68	)	NN	O	)	dep	190	SENT_122	20156/20157
69	5,775	CD	NUMBER	5,775	dep	190	SENT_122	20159/20164
70	(	CD	NUMBER	(	dep	190	SENT_122	20165/20166
71	4,648	CD	NUMBER	4,648	dep	190	SENT_122	20166/20171
72	,	,	O	,		-1	SENT_122	20171/20172
73	7,174	CD	NUMBER	7,174	dep	190	SENT_122	20173/20178
74	)	CD	NUMBER	)	dep	190	SENT_122	20178/20179
75	1,240	CD	NUMBER	1,240	dep	190	SENT_122	20181/20186
76	(	NN	O	(	dep	190	SENT_122	20187/20188
77	1,049	CD	NUMBER	1,049	dep	190	SENT_122	20188/20193
78	,	,	O	,		-1	SENT_122	20193/20194
79	1,465	CD	NUMBER	1,465	dep	190	SENT_122	20195/20200
80	)	NN	O	)	dep	190	SENT_122	20200/20201
81	157	CD	NUMBER	157	dep	190	SENT_122	20203/20206
82	(	NN	O	(	dep	190	SENT_122	20207/20208
83	122	CD	NUMBER	122	dep	190	SENT_122	20208/20211
84	,	,	O	,		-1	SENT_122	20211/20212
85	202	CD	NUMBER	202	dep	190	SENT_122	20213/20216
86	)	NN	O	)	dep	190	SENT_122	20216/20217
87	11	CD	NUMBER	11	dep	190	SENT_122	20219/20221
88	(	NN	O	(	dep	190	SENT_122	20222/20223
89	8	CD	NUMBER	8	dep	190	SENT_122	20223/20224
90	,	,	O	,		-1	SENT_122	20224/20225
91	15	CD	NUMBER	15	dep	190	SENT_122	20226/20228
92	)	CD	NUMBER	)	dep	190	SENT_122	20228/20229
93	ACT-132577	NN	O	act-132577	dep	190	SENT_122	20231/20241
94	16,881	CD	NUMBER	16,881	dep	190	SENT_122	20243/20249
95	(	CD	NUMBER	(	dep	190	SENT_122	20250/20251
96	15,120	CD	NUMBER	15,120	dep	190	SENT_122	20251/20257
97	,	,	O	,		-1	SENT_122	20257/20258
98	18,847	CD	NUMBER	18,847	dep	190	SENT_122	20259/20265
99	)	CD	NUMBER	)	dep	190	SENT_122	20265/20266
100	16,428	CD	NUMBER	16,428	dep	190	SENT_122	20268/20274
101	(	CD	NUMBER	(	dep	190	SENT_122	20275/20276
102	14,353	CD	NUMBER	14,353	dep	190	SENT_122	20276/20282
103	,	,	O	,		-1	SENT_122	20282/20283
104	18,802	CD	NUMBER	18,802	dep	190	SENT_122	20284/20290
105	)	NN	O	)	dep	190	SENT_122	20290/20291
106	626	CD	NUMBER	626	dep	190	SENT_122	20293/20296
107	(	NN	O	(	dep	190	SENT_122	20297/20298
108	547	CD	NUMBER	547	dep	190	SENT_122	20298/20301
109	,	,	O	,		-1	SENT_122	20301/20302
110	717	CD	NUMBER	717	dep	190	SENT_122	20303/20306
111	)	NN	O	)	dep	190	SENT_122	20306/20307
112	640	CD	NUMBER	640	dep	190	SENT_122	20309/20312
113	(	NN	O	(	dep	190	SENT_122	20313/20314
114	550	CD	NUMBER	550	dep	190	SENT_122	20314/20317
115	,	,	O	,		-1	SENT_122	20317/20318
116	745	CD	NUMBER	745	dep	190	SENT_122	20319/20322
117	)	NN	O	)	dep	190	SENT_122	20322/20323
118	14,846	CD	NUMBER	14,846	dep	190	SENT_122	20325/20331
119	(	CD	NUMBER	(	dep	190	SENT_122	20332/20333
120	13,384	CD	NUMBER	13,384	dep	190	SENT_122	20333/20339
121	,	,	O	,		-1	SENT_122	20339/20340
122	16,467	CD	NUMBER	16,467	dep	190	SENT_122	20341/20347
123	)	CD	NUMBER	)	dep	190	SENT_122	20347/20348
124	14,798	CD	NUMBER	14,798	dep	190	SENT_122	20350/20356
125	(	CD	NUMBER	(	dep	190	SENT_122	20357/20358
126	13,216	CD	NUMBER	13,216	dep	190	SENT_122	20358/20364
127	,	,	O	,		-1	SENT_122	20364/20365
128	16,569	CD	NUMBER	16,569	dep	190	SENT_122	20366/20372
129	)	NN	O	)	dep	190	SENT_122	20372/20373
130	580	CD	NUMBER	580	dep	190	SENT_122	20375/20378
131	(	NN	O	(	dep	190	SENT_122	20379/20380
132	518	CD	NUMBER	518	dep	190	SENT_122	20380/20383
133	,	,	O	,		-1	SENT_122	20383/20384
134	649	CD	NUMBER	649	dep	190	SENT_122	20385/20388
135	)	NN	O	)	dep	190	SENT_122	20388/20389
136	479	CD	NUMBER	479	dep	190	SENT_122	20391/20394
137	(	NN	O	(	dep	190	SENT_122	20395/20396
138	425	CD	NUMBER	425	dep	190	SENT_122	20396/20399
139	,	,	O	,		-1	SENT_122	20399/20400
140	540	CD	NUMBER	540	dep	190	SENT_122	20401/20404
141	)	NN	O	)	dep	190	SENT_122	20404/20405
142	ACT-373898	NN	O	act-373898	dep	190	SENT_122	20407/20417
143	530	CD	NUMBER	530	dep	190	SENT_122	20419/20422
144	(	NN	O	(	dep	190	SENT_122	20423/20424
145	398	CD	NUMBER	398	dep	190	SENT_122	20424/20427
146	,	,	O	,		-1	SENT_122	20427/20428
147	706	CD	NUMBER	706	dep	190	SENT_122	20429/20432
148	)	NN	O	)	dep	190	SENT_122	20432/20433
149	568	CD	NUMBER	568	dep	190	SENT_122	20435/20438
150	(	NN	O	(	dep	190	SENT_122	20439/20440
151	432	CD	NUMBER	432	dep	190	SENT_122	20440/20443
152	,	,	O	,		-1	SENT_122	20443/20444
153	747	CD	NUMBER	747	dep	190	SENT_122	20445/20448
154	)	NN	O	)	dep	190	SENT_122	20448/20449
155	17	CD	NUMBER	17	dep	190	SENT_122	20451/20453
156	(	CD	NUMBER	(	dep	190	SENT_122	20454/20455
157	13	CD	NUMBER	13	dep	190	SENT_122	20455/20457
158	,	,	O	,		-1	SENT_122	20457/20458
159	24	CD	NUMBER	24	dep	190	SENT_122	20459/20461
160	)	CD	NUMBER	)	dep	190	SENT_122	20461/20462
161	20	CD	NUMBER	20	dep	190	SENT_122	20464/20466
162	(	NN	O	(	dep	190	SENT_122	20467/20468
163	15	CD	NUMBER	15	dep	190	SENT_122	20468/20470
164	,	,	O	,		-1	SENT_122	20470/20471
165	26	CD	NUMBER	26	dep	190	SENT_122	20472/20474
166	)	NN	O	)	dep	190	SENT_122	20474/20475
167	484	CD	NUMBER	484	dep	190	SENT_122	20477/20480
168	(	NN	O	(	dep	190	SENT_122	20481/20482
169	352	CD	NUMBER	352	dep	190	SENT_122	20482/20485
170	,	,	O	,		-1	SENT_122	20485/20486
171	668	CD	NUMBER	668	dep	190	SENT_122	20487/20490
172	)	NN	O	)	dep	190	SENT_122	20490/20491
173	176	CD	NUMBER	176	dep	190	SENT_122	20493/20496
174	(	NN	O	(	dep	190	SENT_122	20497/20498
175	137	CD	NUMBER	137	dep	190	SENT_122	20498/20501
176	,	,	O	,		-1	SENT_122	20501/20502
177	227	CD	NUMBER	227	dep	190	SENT_122	20503/20506
178	)	NN	O	)	dep	190	SENT_122	20506/20507
179	16	CD	NUMBER	16	dep	190	SENT_122	20509/20511
180	(	NN	O	(	dep	190	SENT_122	20512/20513
181	11	CD	NUMBER	11	dep	190	SENT_122	20513/20515
182	,	,	O	,		-1	SENT_122	20515/20516
183	23	CD	NUMBER	23	dep	190	SENT_122	20517/20519
184	)	NN	O	)	dep	190	SENT_122	20519/20520
185	2	CD	NUMBER	2	dep	190	SENT_122	20522/20523
186	(	NN	O	(	dep	190	SENT_122	20524/20525
187	1	CD	NUMBER	1	dep	190	SENT_122	20525/20526
188	,	,	O	,		-1	SENT_122	20526/20527
189	3	CD	NUMBER	3	dep	190	SENT_122	20528/20529
190	)	NN	O	)		-1	SENT_122	20529/20530

1	Data	NNS	O	datum	nsubj	4	SENT_123	20551/20555
2	are	VBP	O	be	cop	4	SENT_123	20556/20559
3	geometric	JJ	O	geometric	amod	4	SENT_123	20560/20569
4	means	NNS	O	means		-1	SENT_123	20570/20575
5	(	NN	O	(	nsubj	11	SENT_123	20576/20577
6	and	CC	O	and		-1	SENT_123	20577/20580
7	95	CD	PERCENT	95	number	8	SENT_123	20581/20583
8	%	NN	PERCENT	%	amod	10	SENT_123	20583/20584
9	confidence	NN	O	confidence	nn	10	SENT_123	20585/20595
10	intervals	NNS	O	interval	conj_and	5	SENT_123	20596/20605
11	)	VBP	O	)	rcmod	4	SENT_123	20605/20606

1	96-120	CD	NUMBER	96-120	num	2	SENT_124	20642/20648
2	h	NN	O	h		-1	SENT_124	20649/20650
3	:	:	O	:		-1	SENT_124	20650/20651
4	day	NN	DURATION	day	dep	2	SENT_124	20652/20655
5	5	CD	NUMBER	5	num	4	SENT_124	20656/20657
6	of	IN	O	of		-1	SENT_124	20658/20660
7	period	NN	O	period	nn	11	SENT_124	20661/20667
8	1	CD	NUMBER	1	num	11	SENT_124	20668/20669
9	(	NN	O	(	nn	11	SENT_124	20670/20671
10	macitentan	NN	O	macitentan	nn	11	SENT_124	20671/20681
11	)	NN	O	)	prep_of	4	SENT_124	20681/20682
12	;	:	O	;		-1	SENT_124	20682/20683
13	384-408	CD	NUMBER	384-408	dep	4	SENT_124	20684/20691
14	h	NN	O	h	dep	13	SENT_124	20692/20693
15	:	:	O	:		-1	SENT_124	20693/20694
16	day	NN	DURATION	day	dep	4	SENT_124	20695/20698
17	17	CD	NUMBER	17	num	16	SENT_124	20699/20701
18	of	IN	O	of		-1	SENT_124	20702/20704
19	period	NN	O	period	nn	22	SENT_124	20705/20711
20	2	CD	NUMBER	2	num	22	SENT_124	20712/20713
21	(	NN	O	(	nn	22	SENT_124	20714/20715
22	macitentan	NN	O	macitentan	prep_of	16	SENT_124	20715/20725
23	+	CC	O	+		-1	SENT_124	20725/20726
24	Cs	NN	O	c	nn	25	SENT_124	20726/20728
25	)	NN	O	)	conj_+	22	SENT_124	20728/20729
26	;	:	O	;		-1	SENT_124	20729/20730
27	96-120	CD	NUMBER	96-120	dep	4	SENT_124	20731/20737
28	h	NN	O	h	dep	27	SENT_124	20738/20739
29	:	:	O	:		-1	SENT_124	20739/20740
30	day	NN	DURATION	day	dep	4	SENT_124	20741/20744
31	5	CD	NUMBER	5	num	30	SENT_124	20745/20746
32	of	IN	O	of		-1	SENT_124	20747/20749
33	period	NN	O	period	nn	37	SENT_124	20750/20756
34	1	CD	NUMBER	1	num	37	SENT_124	20757/20758
35	(	NN	O	(	nn	37	SENT_124	20759/20760
36	macitentan	NN	O	macitentan	nn	37	SENT_124	20760/20770
37	)	NN	O	)	prep_of	30	SENT_124	20770/20771
38	;	:	O	;		-1	SENT_124	20771/20772
39	264-288	CD	NUMBER	264-288	dep	4	SENT_124	20773/20780
40	h	NN	O	h	dep	39	SENT_124	20781/20782
41	:	:	O	:		-1	SENT_124	20782/20783
42	day	NN	DURATION	day	dep	4	SENT_124	20784/20787
43	12	CD	NUMBER	12	num	42	SENT_124	20788/20790
44	of	IN	O	of		-1	SENT_124	20791/20793
45	period	NN	O	period	nn	48	SENT_124	20794/20800
46	2	CD	NUMBER	2	num	48	SENT_124	20801/20802
47	(	NN	O	(	nn	48	SENT_124	20803/20804
48	macitentan	NN	O	macitentan	prep_of	42	SENT_124	20804/20814
49	+	CC	O	+		-1	SENT_124	20814/20815
50	rifampin	NN	O	rifampin	nn	51	SENT_124	20815/20823
51	)	NN	O	)	conj_+	48	SENT_124	20823/20824

1	Table	NNP	O	Table	nn	2	SENT_125	20841/20846
2	II	NNP	O	II		-1	SENT_125	20847/20849

1	Ratios	NNS	O	ratio	dep	27	SENT_126	20866/20872
2	of	IN	O	of		-1	SENT_126	20873/20875
3	geometric	JJ	O	geometric	amod	4	SENT_126	20876/20885
4	means	NNS	O	means	prep_of	1	SENT_126	20886/20891
5	of	IN	O	of		-1	SENT_126	20892/20894
6	steady-state	JJ	O	steady-state	amod	7	SENT_126	20895/20907
7	AUC	NN	O	auc	prep_of	4	SENT_126	20908/20911
8	and	CC	O	and		-1	SENT_126	20914/20917
9	C	NN	O	c	nn	10	SENT_126	20918/20919
10	tr	NN	O	tr	conj_and	7	SENT_126	20920/20922
11	of	IN	O	of		-1	SENT_126	20923/20925
12	macitentan	NN	O	macitentan	prep_of	7	SENT_126	20926/20936
13	and	CC	O	and		-1	SENT_126	20937/20940
14	its	PRP$	O	its	poss	15	SENT_126	20941/20944
15	metabolites	NNS	O	metabolite	conj_and	1	SENT_126	20945/20956
16	in	IN	O	in		-1	SENT_126	20957/20959
17	the	DT	O	the	det	18	SENT_126	20960/20963
18	presence	NN	O	presence	prep_in	15	SENT_126	20964/20972
19	of	IN	O	of		-1	SENT_126	20973/20975
20	cyclosporine	NN	O	cyclosporine	nn	23	SENT_126	20976/20988
21	or	CC	O	or		-1	SENT_126	20989/20991
22	rifampin	NN	O	rifampin	conj_or	20	SENT_126	20992/21000
23	treatment	NN	O	treatment	prep_of	18	SENT_126	21001/21010
24	(	JJ	O	(	amod	25	SENT_126	21011/21012
25	period	NN	O	period	dep	27	SENT_126	21012/21018
26	2	CD	NUMBER	2	number	27	SENT_126	21019/21020
27	)	CD	NUMBER	)	dep	35	SENT_126	21020/21021
28	versus	CC	O	versus	prep	27	SENT_126	21022/21028
29	macitentan	NN	O	macitentan	nn	30	SENT_126	21029/21039
30	treatment	NN	O	treatment	dep	28	SENT_126	21040/21049
31	alone	RB	O	alone	advmod	30	SENT_126	21050/21055
32	(	JJ	O	(	amod	33	SENT_126	21056/21057
33	period	NN	O	period	tmod	30	SENT_126	21057/21063
34	1	CD	NUMBER	1	num	35	SENT_126	21064/21065
35	)	NN	O	)		-1	SENT_126	21065/21066

1	StatisticsPart	NNP	O	StatisticsPart	dep	110	SENT_127	21083/21097
2	APart	RB	O	apart	dep	110	SENT_127	21098/21103
3	B	NN	O	b	dep	110	SENT_127	21104/21105
4	Macitentan	NN	O	macitentan	dep	110	SENT_127	21107/21117
5	+	CC	O	+	dep	110	SENT_127	21120/21121
6	Cs	NN	O	c	dep	110	SENT_127	21124/21126
7	vs	CC	O	vs	dep	110	SENT_127	21127/21129
8	macitentanMacitentan	NN	O	macitentanmacitentan	dep	110	SENT_127	21130/21150
9	+	CC	O	+	dep	110	SENT_127	21153/21154
10	rifampin	NN	O	rifampin	dep	110	SENT_127	21157/21165
11	vs	CC	O	vs	dep	110	SENT_127	21166/21168
12	macitentan	NN	O	macitentan	dep	110	SENT_127	21169/21179
13	AUC	NN	O	auc	dep	110	SENT_127	21181/21184
14	(	CD	NUMBER	(	dep	110	SENT_127	21187/21188
15	ng	NN	O	ng	dep	110	SENT_127	21188/21190
16	*	CD	NUMBER	*	dep	110	SENT_127	21190/21191
17	h/mL	NN	O	h/ml	dep	110	SENT_127	21191/21195
18	)	NN	O	)	dep	110	SENT_127	21195/21196
19	C	NN	O	c	dep	110	SENT_127	21197/21198
20	tr	NN	O	tr	dep	110	SENT_127	21199/21201
21	(	CD	NUMBER	(	dep	110	SENT_127	21202/21203
22	ng	NN	O	ng	dep	110	SENT_127	21203/21205
23	*	NN	O	*	dep	110	SENT_127	21205/21206
24	h/mL	NN	O	h/ml	dep	110	SENT_127	21206/21210
25	)	CD	NUMBER	)	dep	110	SENT_127	21210/21211
26	AUC	NN	O	auc	dep	110	SENT_127	21211/21214
27	(	CD	NUMBER	(	dep	110	SENT_127	21217/21218
28	ng	NN	O	ng	dep	110	SENT_127	21218/21220
29	*	CD	NUMBER	*	dep	110	SENT_127	21220/21221
30	h/mL	NN	O	h/ml	dep	110	SENT_127	21221/21225
31	)	NN	O	)	dep	110	SENT_127	21225/21226
32	C	NN	O	c	dep	110	SENT_127	21227/21228
33	tr	NN	O	tr	dep	110	SENT_127	21229/21231
34	(	CD	NUMBER	(	dep	110	SENT_127	21232/21233
35	ng	NN	O	ng	dep	110	SENT_127	21233/21235
36	*	NN	O	*	dep	110	SENT_127	21235/21236
37	h/mL	NN	O	h/ml	dep	110	SENT_127	21236/21240
38	)	CD	NUMBER	)	dep	110	SENT_127	21240/21241
39	Macitentan	NNP	O	Macitentan	dep	110	SENT_127	21243/21253
40	Ratio	NNP	O	Ratio	dep	110	SENT_127	21255/21260
41	of	IN	O	of	dep	110	SENT_127	21261/21263
42	geometric	JJ	O	geometric	dep	110	SENT_127	21264/21273
43	means	NNS	O	means	dep	110	SENT_127	21274/21279
44	1.10	CD	NUMBER	1.10	dep	110	SENT_127	21281/21285
45	a	DT	O	a	dep	110	SENT_127	21285/21286
46	1.38	CD	NUMBER	1.38	dep	110	SENT_127	21288/21292
47	a	DT	O	a	dep	110	SENT_127	21292/21293
48	0.21	CD	NUMBER	0.21	dep	110	SENT_127	21295/21299
49	a	DT	O	a	dep	110	SENT_127	21299/21300
50	0.07	CD	NUMBER	0.07	dep	110	SENT_127	21302/21306
51	a	DT	O	a	dep	110	SENT_127	21306/21307
52	90	CD	PERCENT	90	dep	110	SENT_127	21309/21311
53	%	NN	PERCENT	%	dep	110	SENT_127	21311/21312
54	confidence	NN	O	confidence	dep	110	SENT_127	21313/21323
55	interval	NN	O	interval	dep	110	SENT_127	21324/21332
56	0.91-1	CD	NUMBER	0.91-1	dep	110	SENT_127	21334/21340
57	.33	CD	NUMBER	.33	dep	110	SENT_127	21340/21343
58	1.06-1	CD	NUMBER	1.06-1	dep	110	SENT_127	21345/21351
59	.81	CD	NUMBER	.81	dep	110	SENT_127	21351/21354
60	0.17-0	CD	NUMBER	0.17-0	dep	110	SENT_127	21356/21362
61	.26	CD	NUMBER	.26	dep	110	SENT_127	21362/21365
62	0.05-0	CD	NUMBER	0.05-0	dep	110	SENT_127	21367/21373
63	.10	CD	NUMBER	.10	dep	110	SENT_127	21373/21376
64	ACT-132577	NN	O	act-132577	dep	110	SENT_127	21378/21388
65	Ratio	NN	O	ratio	dep	110	SENT_127	21390/21395
66	of	IN	O	of	dep	110	SENT_127	21396/21398
67	geometric	JJ	O	geometric	dep	110	SENT_127	21399/21408
68	means	NNS	O	means	dep	110	SENT_127	21409/21414
69	0.97	CD	NUMBER	0.97	dep	110	SENT_127	21416/21420
70	1.02	CD	NUMBER	1.02	dep	110	SENT_127	21422/21426
71	1.00	CD	NUMBER	1.00	dep	110	SENT_127	21428/21432
72	0.83	CD	NUMBER	0.83	dep	110	SENT_127	21434/21438
73	a	DT	O	a	dep	110	SENT_127	21438/21439
74	90	CD	PERCENT	90	dep	110	SENT_127	21441/21443
75	%	NN	PERCENT	%	dep	110	SENT_127	21443/21444
76	confidence	NN	O	confidence	dep	110	SENT_127	21445/21455
77	interval	NN	O	interval	dep	110	SENT_127	21456/21464
78	0.85-1	CD	NUMBER	0.85-1	dep	110	SENT_127	21466/21472
79	.11	CD	NUMBER	.11	dep	110	SENT_127	21472/21475
80	0.87-1	CD	NUMBER	0.87-1	dep	110	SENT_127	21477/21483
81	.19	CD	NUMBER	.19	dep	110	SENT_127	21483/21486
82	0.89-1	CD	NUMBER	0.89-1	dep	110	SENT_127	21488/21494
83	.12	CD	NUMBER	.12	dep	110	SENT_127	21494/21497
84	0.73-0	CD	NUMBER	0.73-0	dep	110	SENT_127	21499/21505
85	.94	CD	NUMBER	.94	dep	110	SENT_127	21505/21508
86	ACT-373898	NN	O	act-373898	dep	110	SENT_127	21510/21520
87	Ratio	NN	O	ratio	dep	110	SENT_127	21522/21527
88	of	IN	O	of	dep	110	SENT_127	21528/21530
89	geometric	JJ	O	geometric	dep	110	SENT_127	21531/21540
90	means	NNS	O	means	dep	110	SENT_127	21541/21546
91	1.07	CD	NUMBER	1.07	dep	110	SENT_127	21548/21552
92	a	DT	O	a	dep	110	SENT_127	21552/21553
93	1.12	CD	NUMBER	1.12	dep	110	SENT_127	21555/21559
94	a	DT	O	a	dep	110	SENT_127	21559/21560
95	0.36	CD	NUMBER	0.36	dep	110	SENT_127	21562/21566
96	a	DT	O	a	dep	110	SENT_127	21566/21567
97	0.14	CD	NUMBER	0.14	dep	110	SENT_127	21569/21573
98	a	DT	O	a	dep	110	SENT_127	21573/21574
99	90	CD	PERCENT	90	dep	110	SENT_127	21576/21578
100	%	NN	PERCENT	%	dep	110	SENT_127	21578/21579
101	confidence	NN	O	confidence	dep	110	SENT_127	21580/21590
102	interval	NN	O	interval	dep	110	SENT_127	21591/21599
103	0.79-1	CD	NUMBER	0.79-1	dep	110	SENT_127	21601/21607
104	.45	CD	NUMBER	.45	dep	110	SENT_127	21607/21610
105	0.81-1	CD	NUMBER	0.81-1	dep	110	SENT_127	21612/21618
106	.55	CD	NUMBER	.55	dep	110	SENT_127	21618/21621
107	0.27-0	CD	NUMBER	0.27-0	dep	110	SENT_127	21623/21629
108	.50	CD	NUMBER	.50	dep	110	SENT_127	21629/21632
109	0.09-0	CD	NUMBER	0.09-0	dep	110	SENT_127	21634/21640
110	.20	CD	NUMBER	.20		-1	SENT_127	21640/21643

1	Part	NN	O	part	nn	2	SENT_128	21664/21668
2	A	NN	O	a		-1	SENT_128	21669/21670
3	:	:	O	:		-1	SENT_128	21670/21671
4	Ratio	NN	O	ratio	dep	2	SENT_128	21672/21677
5	of	IN	O	of		-1	SENT_128	21678/21680
6	geometric	JJ	O	geometric	amod	7	SENT_128	21681/21690
7	mean	NN	O	mean	prep_of	4	SENT_128	21691/21695
8	of	IN	O	of		-1	SENT_128	21696/21698
9	AUC	NN	O	auc	prep_of	7	SENT_128	21699/21702
10	in	IN	O	in		-1	SENT_128	21705/21707
11	Period	NN	O	period	prep_in	9	SENT_128	21708/21714
12	2	CD	NUMBER	2	num	11	SENT_128	21715/21716
13	versus	CC	O	versus	prep	11	SENT_128	21717/21723
14	Period	NN	O	period	dep	13	SENT_128	21724/21730
15	1	CD	NUMBER	1	num	14	SENT_128	21731/21732
16	:	:	O	:		-1	SENT_128	21732/21733
17	AUC	NN	O	auc	dep	11	SENT_128	21734/21737
18	(	CD	NUMBER	(	num	17	SENT_128	21737/21738
19	384h	SYM	O	384h	dep	9	SENT_128	21738/21742
20	-	:	O	-		-1	SENT_128	21743/21744
21	408h	JJ	O	408h	amod	22	SENT_128	21745/21749
22	)	NN	O	)	dep	9	SENT_128	21749/21750
23	/	:	O	/	punct	2	SENT_128	21753/21754
24	AUC	NN	O	auc	nn	26	SENT_128	21757/21760
25	(	CD	NUMBER	(	num	26	SENT_128	21760/21761
26	96h	NN	O	96h	dep	2	SENT_128	21761/21764
27	-	:	O	-		-1	SENT_128	21765/21766
28	120h	JJ	O	120h	amod	29	SENT_128	21767/21771
29	)	NN	O	)	dep	26	SENT_128	21771/21772
30	.	.	O	.		-1	SENT_128	21772/21773

1	Ratio	NN	O	ratio		-1	SENT_129	21774/21779
2	of	IN	O	of		-1	SENT_129	21780/21782
3	geometric	JJ	O	geometric	amod	4	SENT_129	21783/21792
4	mean	NN	O	mean	prep_of	1	SENT_129	21793/21797
5	of	IN	O	of		-1	SENT_129	21798/21800
6	C	NN	O	c	nn	7	SENT_129	21801/21802
7	tr	NN	O	tr	prep_of	4	SENT_129	21803/21805
8	in	IN	O	in		-1	SENT_129	21806/21808
9	Period	NN	O	period	prep_in	1	SENT_129	21809/21815
10	2	CD	NUMBER	2	num	9	SENT_129	21816/21817
11	versus	CC	O	versus	prep	1	SENT_129	21818/21824
12	Period	NN	O	period	dep	11	SENT_129	21825/21831
13	1	CD	NUMBER	1	num	12	SENT_129	21832/21833
14	.	.	O	.		-1	SENT_129	21833/21834

1	Part	NN	O	part	nn	2	SENT_130	21835/21839
2	B	NN	O	b		-1	SENT_130	21840/21841
3	:	:	O	:		-1	SENT_130	21841/21842
4	Ratio	NN	O	ratio	dep	2	SENT_130	21843/21848
5	of	IN	O	of		-1	SENT_130	21849/21851
6	geometric	JJ	O	geometric	amod	7	SENT_130	21852/21861
7	mean	NN	O	mean	prep_of	4	SENT_130	21862/21866
8	of	IN	O	of		-1	SENT_130	21867/21869
9	AUC	NN	O	auc	prep_of	7	SENT_130	21870/21873
10	in	IN	O	in		-1	SENT_130	21876/21878
11	Period	NN	O	period	prep_in	9	SENT_130	21879/21885
12	2	CD	NUMBER	2	num	11	SENT_130	21886/21887
13	versus	CC	O	versus	prep	11	SENT_130	21888/21894
14	Period	NN	O	period	dep	13	SENT_130	21895/21901
15	1	CD	NUMBER	1	num	14	SENT_130	21902/21903
16	:	:	O	:		-1	SENT_130	21903/21904
17	AUC	NN	O	auc	dep	11	SENT_130	21905/21908
18	(	CD	NUMBER	(	num	17	SENT_130	21908/21909
19	264h	SYM	O	264h	dep	9	SENT_130	21909/21913
20	-	:	O	-		-1	SENT_130	21914/21915
21	288h	JJ	O	288h	amod	22	SENT_130	21916/21920
22	)	NN	O	)	dep	9	SENT_130	21920/21921
23	/	:	O	/	punct	2	SENT_130	21924/21925
24	AUC	NN	O	auc	nn	26	SENT_130	21928/21931
25	(	CD	NUMBER	(	num	26	SENT_130	21931/21932
26	96h	NN	O	96h	dep	2	SENT_130	21932/21935
27	-	:	O	-		-1	SENT_130	21936/21937
28	120h	JJ	O	120h	amod	29	SENT_130	21938/21942
29	)	NN	O	)	dep	26	SENT_130	21942/21943
30	.	.	O	.		-1	SENT_130	21943/21944

1	Ratio	NN	O	ratio		-1	SENT_131	21945/21950
2	of	IN	O	of		-1	SENT_131	21951/21953
3	geometric	JJ	O	geometric	amod	4	SENT_131	21954/21963
4	mean	NN	O	mean	prep_of	1	SENT_131	21964/21968
5	of	IN	O	of		-1	SENT_131	21969/21971
6	C	NN	O	c	nn	7	SENT_131	21972/21973
7	tr	NN	O	tr	prep_of	1	SENT_131	21974/21976
8	in	IN	O	in		-1	SENT_131	21977/21979
9	Period	NN	O	period	prep_in	1	SENT_131	21980/21986
10	2	CD	NUMBER	2	num	9	SENT_131	21987/21988
11	versus	CC	O	versus	prep	1	SENT_131	21989/21995
12	Period	NN	O	period	dep	11	SENT_131	21996/22002
13	1	CD	NUMBER	1	num	12	SENT_131	22003/22004

1	aRatio	NN	O	aratio	nsubj	18	SENT_132	22040/22046
2	of	IN	O	of		-1	SENT_132	22047/22049
3	geometric	JJ	O	geometric	amod	4	SENT_132	22050/22059
4	means	NNS	O	means	prep_of	1	SENT_132	22060/22065
5	and	CC	O	and		-1	SENT_132	22066/22069
6	90	CD	PERCENT	90	number	7	SENT_132	22070/22072
7	%	NN	PERCENT	%	amod	9	SENT_132	22072/22073
8	confidence	NN	O	confidence	nn	9	SENT_132	22074/22084
9	intervals	NNS	O	interval	conj_and	4	SENT_132	22085/22094
10	where	WRB	O	where	advmod	17	SENT_132	22095/22100
11	at	IN	O	at	quantmod	13	SENT_132	22101/22103
12	least	JJS	O	least	mwe	11	SENT_132	22104/22109
13	one	CD	NUMBER	one	nsubj	17	SENT_132	22110/22113
14	of	IN	O	of		-1	SENT_132	22114/22116
15	the	DT	O	the	det	16	SENT_132	22117/22120
16	confidence	NN	O	confidence	prep_of	13	SENT_132	22121/22131
17	limits	VBZ	O	limit	rcmod	9	SENT_132	22132/22138
18	falls	VBZ	O	fall		-1	SENT_132	22139/22144
19	outside	IN	O	outside		-1	SENT_132	22145/22152
20	the	DT	O	the	det	23	SENT_132	22153/22156
21	FDA-accepted	JJ	O	fda-accepted	amod	23	SENT_132	22157/22169
22	bioequivalence	NN	O	bioequivalence	nn	23	SENT_132	22170/22184
23	range	NN	O	range	prep_outside	18	SENT_132	22185/22190
24	of	IN	O	of		-1	SENT_132	22191/22193
25	0.80-1	CD	NUMBER	0.80-1	num	26	SENT_132	22194/22200
26	.25	CD	NUMBER	.25	prep_of	23	SENT_132	22200/22203

1	Part	NN	O	part	nn	2	SENT_133	22258/22262
2	B	NN	O	b		-1	SENT_133	22263/22264

1	Mean	NN	O	mean	nn	3	SENT_134	22300/22304
2	concentration-time	JJ	O	concentration-time	amod	3	SENT_134	22305/22323
3	profiles	NNS	O	profile	nsubjpass	31	SENT_134	22324/22332
4	of	IN	O	of		-1	SENT_134	22333/22335
5	macitentan	NN	O	macitentan	prep_of	3	SENT_134	22336/22346
6	and	CC	O	and		-1	SENT_134	22347/22350
7	its	PRP$	O	its	poss	8	SENT_134	22351/22354
8	metabolites	NNS	O	metabolite	conj_and	3	SENT_134	22355/22366
9	ACT-132577	NN	O	act-132577	nsubj	20	SENT_134	22367/22377
10	and	CC	O	and		-1	SENT_134	22378/22381
11	ACT-373898	NN	O	act-373898	conj_and	9	SENT_134	22382/22392
12	in	IN	O	in		-1	SENT_134	22393/22395
13	period	NN	O	period	prep_in	9	SENT_134	22396/22402
14	1	CD	NUMBER	1	number	15	SENT_134	22403/22404
15	(	CD	NUMBER	(	dep	13	SENT_134	22405/22406
16	multiple-dose	JJ	O	multiple-dose	amod	19	SENT_134	22406/22419
17	macitentan	NN	O	macitentan	nn	19	SENT_134	22420/22430
18	treatment	NN	O	treatment	nn	19	SENT_134	22431/22440
19	)	NN	O	)	dep	15	SENT_134	22440/22441
20	followed	VBN	O	follow	rcmod	8	SENT_134	22442/22450
21	by	IN	O	by		-1	SENT_134	22451/22453
22	period	NN	O	period	prep_by	20	SENT_134	22454/22460
23	2	CD	NUMBER	2	number	24	SENT_134	22461/22462
24	(	CD	NUMBER	(	num	26	SENT_134	22463/22464
25	multiple-dose	JJ	O	multiple-dose	amod	26	SENT_134	22464/22477
26	co-administration	NN	O	co-administration	dobj	20	SENT_134	22478/22495
27	of	IN	O	of		-1	SENT_134	22496/22498
28	rifampin	NN	O	rifampin	nn	29	SENT_134	22499/22507
29	)	NN	O	)	prep_of	26	SENT_134	22507/22508
30	are	VBP	O	be	auxpass	31	SENT_134	22509/22512
31	shown	VBN	O	show		-1	SENT_134	22513/22518
32	in	IN	O	in		-1	SENT_134	22519/22521
33	Fig.	NN	O	fig.	prep_in	31	SENT_134	22522/22526
34	3	CD	NUMBER	3	num	33	SENT_134	22527/22528
35	.	.	O	.		-1	SENT_134	22528/22529

1	Steady-state	JJ	O	steady-state	amod	2	SENT_135	22530/22542
2	conditions	NNS	O	condition	nsubj	3	SENT_135	22543/22553
3	were	VBD	O	be		-1	SENT_135	22554/22558
4	approximately	RB	O	approximately	advmod	3	SENT_135	22559/22572
5	attained	VBN	O	attain	dep	4	SENT_135	22573/22581
6	on	IN	O	on		-1	SENT_135	22582/22584
7	day	NN	DURATION	day	prep_on	5	SENT_135	22585/22588
8	5	CD	NUMBER	5	num	7	SENT_135	22589/22590
9	(	NN	O	(	nn	12	SENT_135	22591/22592
10	96	CD	NUMBER	96	num	12	SENT_135	22592/22594
11	h	NN	O	h	nn	12	SENT_135	22595/22596
12	)	NN	O	)	dobj	5	SENT_135	22596/22597
13	of	IN	O	of		-1	SENT_135	22598/22600
14	dosing	NN	O	dosing	prep_of	12	SENT_135	22601/22607
15	in	IN	O	in		-1	SENT_135	22608/22610
16	the	DT	O	the	det	17	SENT_135	22611/22614
17	absence	NN	O	absence	prep_in	14	SENT_135	22615/22622
18	of	IN	O	of		-1	SENT_135	22623/22625
19	rifampin	NN	O	rifampin	prep_of	17	SENT_135	22626/22634
20	.	.	O	.		-1	SENT_135	22634/22635

1	In	IN	O	in		-1	SENT_136	22636/22638
2	the	DT	O	the	det	3	SENT_136	22639/22642
3	presence	NN	O	presence	prep_in	11	SENT_136	22643/22651
4	of	IN	O	of		-1	SENT_136	22652/22654
5	rifampin	NN	O	rifampin	nn	6	SENT_136	22655/22663
6	treatment	NN	O	treatment	prep_of	3	SENT_136	22664/22673
7	,	,	O	,		-1	SENT_136	22673/22674
8	Ctr	NN	O	ctr	nsubj	11	SENT_136	22675/22678
9	of	IN	O	of		-1	SENT_136	22679/22681
10	macitentan	NN	O	macitentan	prep_of	8	SENT_136	22682/22692
11	decreased	VBD	O	decrease		-1	SENT_136	22693/22702
12	from	IN	O	from		-1	SENT_136	22703/22707
13	days	NNS	DATE	day	prep_from	11	SENT_136	22708/22712
14	6	CD	DATE	6	num	13	SENT_136	22713/22714
15	to	TO	DATE	to	dep	13	SENT_136	22715/22717
16	12	CD	DATE	12	num	13	SENT_136	22718/22720
17	,	,	O	,		-1	SENT_136	22720/22721
18	and	CC	O	and		-1	SENT_136	22722/22725
19	new	JJ	O	new	amod	21	SENT_136	22726/22729
20	steady-state	JJ	O	steady-state	amod	21	SENT_136	22730/22742
21	conditions	NNS	O	condition	nsubjpass	23	SENT_136	22743/22753
22	were	VBD	O	be	auxpass	23	SENT_136	22754/22758
23	approached	VBN	O	approach	conj_and	11	SENT_136	22759/22769
24	on	IN	O	on		-1	SENT_136	22770/22772
25	day	NN	DURATION	day	prep_on	23	SENT_136	22773/22776
26	12	CD	NUMBER	12	num	25	SENT_136	22777/22779
27	(	NN	O	(	nn	30	SENT_136	22780/22781
28	264	CD	NUMBER	264	num	30	SENT_136	22781/22784
29	h	NN	O	h	nn	30	SENT_136	22785/22786
30	)	NN	O	)	dep	25	SENT_136	22786/22787
31	.	.	O	.		-1	SENT_136	22787/22788

1	A	DT	O	a	det	3	SENT_137	22789/22790
2	similar	JJ	O	similar	amod	3	SENT_137	22791/22798
3	situation	NN	O	situation	nsubjpass	5	SENT_137	22799/22808
4	was	VBD	O	be	auxpass	5	SENT_137	22809/22812
5	observed	VBN	O	observe		-1	SENT_137	22813/22821
6	for	IN	O	for		-1	SENT_137	22822/22825
7	ACT-373898	NN	O	act-373898	prep_for	5	SENT_137	22826/22836
8	.	.	O	.		-1	SENT_137	22836/22837

1	The	DT	O	the	det	2	SENT_138	22838/22841
2	start	NN	O	start	nsubj	11	SENT_138	22842/22847
3	of	IN	O	of		-1	SENT_138	22848/22850
4	concomitant	JJ	O	concomitant	amod	5	SENT_138	22851/22862
5	treatment	NN	O	treatment	prep_of	2	SENT_138	22863/22872
6	of	IN	O	of		-1	SENT_138	22873/22875
7	rifampin	NN	O	rifampin	prep_of	5	SENT_138	22876/22884
8	on	IN	O	on		-1	SENT_138	22885/22887
9	day	NN	DURATION	day	prep_on	7	SENT_138	22888/22891
10	6	CD	NUMBER	6	num	9	SENT_138	22892/22893
11	caused	VBD	O	cause		-1	SENT_138	22894/22900
12	an	DT	O	a	det	14	SENT_138	22901/22903
13	initial	JJ	O	initial	amod	14	SENT_138	22904/22911
14	increase	NN	O	increase	dobj	11	SENT_138	22912/22920
15	in	IN	O	in		-1	SENT_138	22921/22923
16	Ctr	NN	O	ctr	prep_in	11	SENT_138	22924/22927
17	of	IN	O	of		-1	SENT_138	22928/22930
18	ACT-132577	NN	O	act-132577	prep_of	16	SENT_138	22931/22941
19	,	,	O	,		-1	SENT_138	22941/22942
20	which	WDT	O	which	nsubj	22	SENT_138	22943/22948
21	gradually	RB	O	gradually	advmod	22	SENT_138	22949/22958
22	decreased	VBD	O	decrease	rcmod	18	SENT_138	22959/22968
23	with	IN	O	with		-1	SENT_138	22969/22973
24	continued	JJ	O	continued	amod	25	SENT_138	22974/22983
25	dosing	NN	O	dosing	prep_with	22	SENT_138	22984/22990
26	and	CC	O	and		-1	SENT_138	22991/22994
27	approached	VBD	O	approach	conj_and	22	SENT_138	22995/23005
28	steady-state	JJ	O	steady-state	amod	29	SENT_138	23006/23018
29	concentrations	NNS	O	concentration	dobj	27	SENT_138	23019/23033
30	on	IN	O	on		-1	SENT_138	23034/23036
31	day	NN	DURATION	day	prep_on	27	SENT_138	23037/23040
32	12	CD	NUMBER	12	num	31	SENT_138	23041/23043
33	(	NN	O	(	nn	36	SENT_138	23044/23045
34	264	CD	NUMBER	264	num	36	SENT_138	23045/23048
35	h	NN	O	h	nn	36	SENT_138	23049/23050
36	)	NN	O	)	dobj	22	SENT_138	23050/23051
37	which	WDT	O	which	nsubj	39	SENT_138	23052/23057
38	were	VBD	O	be	cop	39	SENT_138	23058/23062
39	similar	JJ	O	similar	rcmod	36	SENT_138	23063/23070
40	to	TO	O	to		-1	SENT_138	23071/23073
41	the	DT	O	the	det	44	SENT_138	23074/23077
42	original	JJ	O	original	amod	44	SENT_138	23078/23086
43	steady-state	JJ	O	steady-state	amod	44	SENT_138	23087/23099
44	concentrations	NNS	O	concentration	prep_to	39	SENT_138	23100/23114
45	.	.	O	.		-1	SENT_138	23114/23115

1	The	DT	O	the	det	2	SENT_139	23116/23119
2	comparison	NN	O	comparison	dep	23	SENT_139	23120/23130
3	of	IN	O	of		-1	SENT_139	23131/23133
4	24-h	JJ	O	24-h	amod	7	SENT_139	23134/23138
5	plasma	NN	O	plasma	nn	7	SENT_139	23139/23145
6	concentration-time	NN	O	concentration-time	nn	7	SENT_139	23146/23164
7	profiles	NNS	O	profile	prep_of	2	SENT_139	23165/23173
8	at	IN	O	at		-1	SENT_139	23174/23176
9	steady-state	JJ	O	steady-state	prep_at	2	SENT_139	23177/23189
10	in	IN	O	in		-1	SENT_139	23190/23192
11	the	DT	O	the	det	13	SENT_139	23193/23196
12	two	CD	NUMBER	two	num	13	SENT_139	23197/23200
13	periods	NNS	O	period	prep_in	9	SENT_139	23201/23208
14	,	,	O	,		-1	SENT_139	23208/23209
15	i.e.	FW	O	i.e.	dep	9	SENT_139	23210/23214
16	,	,	O	,		-1	SENT_139	23214/23215
17	on	IN	O	on		-1	SENT_139	23216/23218
18	days	NNS	DURATION	day	prep_on	9	SENT_139	23219/23223
19	5	CD	NUMBER	5	num	18	SENT_139	23224/23225
20	and	CC	O	and		-1	SENT_139	23226/23229
21	12	CD	NUMBER	12	conj_and	18	SENT_139	23230/23232
22	,	,	O	,		-1	SENT_139	23232/23233
23	showed	VBD	O	show		-1	SENT_139	23234/23240
24	that	IN	O	that	mark	35	SENT_139	23241/23245
25	concentrations	NNS	O	concentration	nsubj	35	SENT_139	23246/23260
26	of	IN	O	of		-1	SENT_139	23261/23263
27	macitentan	NN	O	macitentan	prep_of	25	SENT_139	23264/23274
28	and	CC	O	and		-1	SENT_139	23275/23278
29	ACT-373898	NN	O	act-373898	conj_and	27	SENT_139	23279/23289
30	on	IN	O	on		-1	SENT_139	23290/23292
31	day	NN	DURATION	day	prep_on	27	SENT_139	23293/23296
32	12	CD	NUMBER	12	num	31	SENT_139	23297/23299
33	were	VBD	O	be	cop	35	SENT_139	23300/23304
34	considerably	RB	O	considerably	advmod	35	SENT_139	23305/23317
35	lower	JJR	O	lower	ccomp	23	SENT_139	23318/23323
36	than	IN	O	than		-1	SENT_139	23324/23328
37	those	DT	O	those	prep_than	35	SENT_139	23329/23334
38	on	IN	O	on		-1	SENT_139	23335/23337
39	day	NN	DURATION	day	prep_on	37	SENT_139	23338/23341
40	5	CD	NUMBER	5	num	39	SENT_139	23342/23343
41	(	CD	NUMBER	(	num	44	SENT_139	23344/23345
42	Fig.	NN	O	fig.	nn	44	SENT_139	23345/23349
43	4	CD	NUMBER	4	num	44	SENT_139	23350/23351
44	)	NN	O	)	nsubj	23	SENT_139	23351/23352
45	.	.	O	.		-1	SENT_139	23352/23353

1	The	DT	O	the	det	2	SENT_140	23354/23357
2	differences	NNS	O	difference	nsubj	14	SENT_140	23358/23369
3	in	IN	O	in		-1	SENT_140	23370/23372
4	concentrations	NNS	O	concentration	prep_in	2	SENT_140	23373/23387
5	of	IN	O	of		-1	SENT_140	23388/23390
6	ACT-132577	NN	O	act-132577	prep_of	4	SENT_140	23391/23401
7	between	IN	O	between		-1	SENT_140	23402/23409
8	days	NNS	DURATION	day	prep_between	6	SENT_140	23410/23414
9	5	CD	NUMBER	5	num	8	SENT_140	23415/23416
10	and	CC	O	and		-1	SENT_140	23417/23420
11	12	CD	NUMBER	12	conj_and	8	SENT_140	23421/23423
12	were	VBD	O	be	cop	14	SENT_140	23424/23428
13	much	RB	O	much	advmod	14	SENT_140	23429/23433
14	smaller	JJR	O	smaller		-1	SENT_140	23434/23441
15	compared	VBN	O	compare		-1	SENT_140	23442/23450
16	to	TO	O	to	prepc_compared_to	14	SENT_140	23451/23453
17	those	DT	O	those	pobj	14	SENT_140	23454/23459
18	of	IN	O	of		-1	SENT_140	23460/23462
19	macitentan	NN	O	macitentan	prep_of	17	SENT_140	23463/23473
20	and	CC	O	and		-1	SENT_140	23474/23477
21	ACT-373898	NN	O	act-373898	conj_and	19	SENT_140	23478/23488
22	.	.	O	.		-1	SENT_140	23488/23489

1	Fig.	NN	O	fig.		-1	SENT_141	23489/23493
2	3	CD	NUMBER	3	num	1	SENT_141	23494/23495

1	Part	NN	O	part	nn	2	SENT_142	23512/23516
2	B	NN	O	b		-1	SENT_142	23517/23518
3	:	:	O	:		-1	SENT_142	23518/23519
4	Arithmetic	NNP	O	Arithmetic	nsubj	5	SENT_142	23520/23530
5	mean	VB	O	mean	dep	2	SENT_142	23531/23535
6	SD	NN	O	sd	nn	8	SENT_142	23539/23541
7	plasma	NN	O	plasma	nn	8	SENT_142	23542/23548
8	concentration	NN	O	concentration	dobj	5	SENT_142	23549/23562
9	versus	CC	O	versus	prep	8	SENT_142	23563/23569
10	time	NN	O	time	nn	11	SENT_142	23570/23574
11	profiles	NNS	O	profile	dep	9	SENT_142	23575/23583
12	of	IN	O	of		-1	SENT_142	23584/23586
13	macitentan	NN	O	macitentan	prep_of	11	SENT_142	23587/23597
14	,	,	O	,		-1	SENT_142	23597/23598
15	ACT-132577	NN	O	act-132577	conj_and	13	SENT_142	23599/23609
16	,	,	O	,		-1	SENT_142	23609/23610
17	and	CC	O	and		-1	SENT_142	23611/23614
18	ACT-373898	NN	O	act-373898	conj_and	13	SENT_142	23615/23625
19	from	IN	O	from		-1	SENT_142	23626/23630
20	days	NNS	DATE	day	prep_from	13	SENT_142	23631/23635
21	1	CD	DATE	1	num	20	SENT_142	23636/23637
22	to	TO	DATE	to	dep	20	SENT_142	23638/23640
23	12	CD	DATE	12	num	20	SENT_142	23641/23643
24	.	.	O	.		-1	SENT_142	23643/23644

1	The	DT	DATE	the	det	3	SENT_143	23645/23648
2	last	JJ	DATE	last	amod	3	SENT_143	23649/23653
3	day	NN	DATE	day	dep	12	SENT_143	23654/23657
4	of	IN	O	of		-1	SENT_143	23658/23660
5	treatment	NN	O	treatment	prep_of	3	SENT_143	23661/23670
6	with	IN	O	with		-1	SENT_143	23671/23675
7	macitentan	NN	O	macitentan	prep_with	5	SENT_143	23676/23686
8	in	IN	O	in		-1	SENT_143	23687/23689
9	period	NN	O	period	prep_in	7	SENT_143	23690/23696
10	1	CD	NUMBER	1	dep	12	SENT_143	23697/23698
11	(	CD	NUMBER	(	num	12	SENT_143	23699/23700
12	day	NN	NUMBER	day	dep	28	SENT_143	23700/23703
13	5	CD	NUMBER	5	num	14	SENT_143	23704/23705
14	)	NN	O	)	dep	12	SENT_143	23705/23706
15	and	CC	O	and		-1	SENT_143	23707/23710
16	last	JJ	DATE	last	amod	17	SENT_143	23711/23715
17	day	NN	DATE	day	conj_and	12	SENT_143	23716/23719
18	of	IN	O	of		-1	SENT_143	23720/23722
19	treatment	NN	O	treatment	prep_of	17	SENT_143	23723/23732
20	with	IN	O	with		-1	SENT_143	23733/23737
21	macitentan	NN	O	macitentan	prep_with	19	SENT_143	23738/23748
22	+	CC	O	+		-1	SENT_143	23751/23752
23	rifampin	NN	O	rifampin	conj_+	17	SENT_143	23755/23763
24	in	IN	O	in		-1	SENT_143	23764/23766
25	period	NN	O	period	prep_in	23	SENT_143	23767/23773
26	2	CD	NUMBER	2	num	28	SENT_143	23774/23775
27	(	CD	NUMBER	(	num	28	SENT_143	23776/23777
28	day	NN	NUMBER	day		-1	SENT_143	23777/23780
29	12	CD	NUMBER	12	num	30	SENT_143	23781/23783
30	)	NN	O	)	nsubjpass	32	SENT_143	23783/23784
31	are	VBP	O	be	auxpass	32	SENT_143	23785/23788
32	indicated	VBN	O	indicate	rcmod	28	SENT_143	23789/23798
33	in	IN	O	in		-1	SENT_143	23799/23801
34	the	DT	O	the	det	35	SENT_143	23802/23805
35	figure	NN	O	figure	prep_in	32	SENT_143	23806/23812

1	Fig.	NN	O	fig.		-1	SENT_144	23829/23833
2	4	CD	NUMBER	4	num	1	SENT_144	23834/23835

1	Part	NN	O	part	nn	2	SENT_145	23852/23856
2	B	NN	O	b		-1	SENT_145	23857/23858
3	:	:	O	:		-1	SENT_145	23858/23859
4	Arithmetic	NNP	O	Arithmetic	nsubj	5	SENT_145	23860/23870
5	mean	VB	O	mean	dep	2	SENT_145	23871/23875
6	SD	NN	O	sd	nn	8	SENT_145	23879/23881
7	plasma	NN	O	plasma	nn	8	SENT_145	23882/23888
8	concentration	NN	O	concentration	dobj	5	SENT_145	23889/23902
9	versus	CC	O	versus	prep	8	SENT_145	23903/23909
10	time	NN	O	time	nn	11	SENT_145	23910/23914
11	profiles	NNS	O	profile	dep	9	SENT_145	23915/23923
12	of	IN	O	of		-1	SENT_145	23924/23926
13	macitentan	NN	O	macitentan	prep_of	11	SENT_145	23927/23937
14	,	,	O	,		-1	SENT_145	23937/23938
15	ACT-132577	NN	O	act-132577	conj_and	13	SENT_145	23939/23949
16	,	,	O	,		-1	SENT_145	23949/23950
17	and	CC	O	and		-1	SENT_145	23951/23954
18	ACT-373898	NN	O	act-373898	conj_and	13	SENT_145	23955/23965
19	on	IN	O	on		-1	SENT_145	23966/23968
20	day	NN	DURATION	day	nn	23	SENT_145	23969/23972
21	5	CD	NUMBER	5	num	23	SENT_145	23973/23974
22	(	NN	O	(	nn	23	SENT_145	23975/23976
23	period	NN	O	period	prep_on	13	SENT_145	23976/23982
24	1	CD	NUMBER	1	dep	8	SENT_145	23983/23984
25	:	:	O	:		-1	SENT_145	23984/23985
26	macitentan	NN	O	macitentan	nn	27	SENT_145	23986/23996
27	)	NN	O	)	dep	8	SENT_145	23996/23997
28	compared	VBN	O	compare		-1	SENT_145	23998/24006
29	to	TO	O	to	prepc_compared_to	27	SENT_145	24007/24009
30	day	NN	DURATION	day	nn	33	SENT_145	24010/24013
31	12	CD	NUMBER	12	num	33	SENT_145	24014/24016
32	(	NN	O	(	nn	33	SENT_145	24017/24018
33	period	NN	O	period	pobj	27	SENT_145	24018/24024
34	2	CD	NUMBER	2	dep	33	SENT_145	24025/24026
35	:	:	O	:		-1	SENT_145	24026/24027
36	macitentan	NN	O	macitentan	dep	27	SENT_145	24028/24038
37	+	CC	O	+		-1	SENT_145	24041/24042
38	rifampin	NN	O	rifampin	nn	39	SENT_145	24045/24053
39	)	NN	O	)	conj_+	36	SENT_145	24053/24054

1	Geometric	JJ	O	geometric	amod	2	SENT_146	24109/24118
2	means	NNS	O	means	nsubj	18	SENT_146	24119/24124
3	of	IN	O	of		-1	SENT_146	24125/24127
4	steady-state	JJ	O	steady-state	amod	5	SENT_146	24128/24140
5	AUC	NN	O	auc	prep_of	2	SENT_146	24141/24144
6	for	IN	O	for		-1	SENT_146	24147/24150
7	macitentan	NN	O	macitentan	prep_for	5	SENT_146	24151/24161
8	,	,	O	,		-1	SENT_146	24161/24162
9	ACT-132577	NN	O	act-132577	conj_and	7	SENT_146	24163/24173
10	,	,	O	,		-1	SENT_146	24173/24174
11	and	CC	O	and		-1	SENT_146	24175/24178
12	ACT-373898	NN	O	act-373898	conj_and	7	SENT_146	24179/24189
13	from	IN	O	from		-1	SENT_146	24190/24194
14	periods	NNS	O	period	prep_from	7	SENT_146	24195/24202
15	1	CD	NUMBER	1	num	14	SENT_146	24203/24204
16	to	TO	O	to	dep	14	SENT_146	24205/24207
17	2	CD	NUMBER	2	num	14	SENT_146	24208/24209
18	decreased	VBN	O	decrease	dep	58	SENT_146	24210/24219
19	from	IN	O	from		-1	SENT_146	24220/24224
20	5,775	CD	NUMBER	5,775	prep_from	18	SENT_146	24225/24230
21	to	TO	NUMBER	to		-1	SENT_146	24231/24233
22	1,240	CD	NUMBER	1,240	num	23	SENT_146	24234/24239
23	(	CD	NUMBER	(	prep_to	18	SENT_146	24240/24241
24	a	DT	O	a	det	28	SENT_146	24241/24242
25	79	CD	PERCENT	79	number	26	SENT_146	24243/24245
26	%	NN	PERCENT	%	amod	28	SENT_146	24245/24246
27	decrease	NN	O	decrease	nn	28	SENT_146	24247/24255
28	)	NN	O	)	dep	23	SENT_146	24255/24256
29	,	,	O	,		-1	SENT_146	24256/24257
30	14,846	CD	NUMBER	14,846	advmod	38	SENT_146	24258/24264
31	to	TO	O	to		-1	SENT_146	24265/24267
32	14,798	CD	NUMBER	14,798	number	33	SENT_146	24268/24274
33	(	CD	NUMBER	(	prep_to	30	SENT_146	24275/24276
34	a	DT	O	a	det	38	SENT_146	24276/24277
35	0.3	CD	PERCENT	0.3	number	36	SENT_146	24278/24281
36	%	NN	PERCENT	%	amod	38	SENT_146	24281/24282
37	decrease	NN	O	decrease	nn	38	SENT_146	24283/24291
38	)	NN	O	)	conj_and	28	SENT_146	24291/24292
39	,	,	O	,		-1	SENT_146	24292/24293
40	and	CC	O	and		-1	SENT_146	24294/24297
41	484	CD	NUMBER	484	number	43	SENT_146	24298/24301
42	to	TO	O	to	dep	43	SENT_146	24302/24304
43	176	CD	NUMBER	176	num	45	SENT_146	24305/24308
44	ng	NN	O	ng	nn	45	SENT_146	24309/24311
45	*	NN	O	*	conj_and	28	SENT_146	24311/24312
46	h/mL	NN	O	h/ml	dep	23	SENT_146	24312/24316
47	(	CD	NUMBER	(	num	46	SENT_146	24317/24318
48	a	DT	O	a	det	52	SENT_146	24318/24319
49	64	CD	PERCENT	64	num	52	SENT_146	24320/24322
50	%	NN	PERCENT	%	nn	52	SENT_146	24322/24323
51	decrease	NN	O	decrease	nn	52	SENT_146	24324/24332
52	)	NN	O	)	dep	46	SENT_146	24332/24333
53	,	,	O	,		-1	SENT_146	24333/24334
54	respectively	RB	O	respectively	advmod	23	SENT_146	24335/24347
55	(	CD	NUMBER	(	dep	23	SENT_146	24348/24349
56	Table	NNP	O	Table	dep	55	SENT_146	24349/24354
57	I	PRP	O	I	nsubj	58	SENT_146	24355/24356
58	)	VBP	O	)		-1	SENT_146	24356/24357
59	.	.	O	.		-1	SENT_146	24357/24358

1	The	DT	O	the	det	2	SENT_147	24359/24362
2	ratio	NN	O	ratio	nsubj	16	SENT_147	24363/24368
3	of	IN	O	of		-1	SENT_147	24369/24371
4	geometric	JJ	O	geometric	amod	5	SENT_147	24372/24381
5	means	NNS	O	means	prep_of	2	SENT_147	24382/24387
6	and	CC	O	and		-1	SENT_147	24388/24391
7	their	PRP$	O	they	poss	11	SENT_147	24392/24397
8	90	CD	PERCENT	90	number	9	SENT_147	24398/24400
9	%	NN	PERCENT	%	amod	11	SENT_147	24400/24401
10	confidence	NN	O	confidence	nn	11	SENT_147	24402/24412
11	limits	NNS	O	limit	conj_and	2	SENT_147	24413/24419
12	of	IN	O	of		-1	SENT_147	24420/24422
13	AUC	NN	O	auc	prep_of	11	SENT_147	24423/24426
14	for	IN	O	for		-1	SENT_147	24429/24432
15	ACT-132577	NN	O	act-132577	prep_for	13	SENT_147	24433/24443
16	fell	VBD	O	fall		-1	SENT_147	24444/24448
17	entirely	RB	O	entirely	advmod	16	SENT_147	24449/24457
18	within	IN	O	within		-1	SENT_147	24458/24464
19	the	DT	O	the	det	22	SENT_147	24465/24468
20	FDA-recommended	JJ	O	fda-recommended	amod	22	SENT_147	24469/24484
21	bioequivalence	NN	O	bioequivalence	nn	22	SENT_147	24485/24499
22	range	NN	O	range	prep_within	16	SENT_147	24500/24505
23	of	IN	O	of		-1	SENT_147	24506/24508
24	0.80-1	CD	NUMBER	0.80-1	num	25	SENT_147	24509/24515
25	.25	CD	NUMBER	.25	prep_of	22	SENT_147	24515/24518
26	,	,	O	,		-1	SENT_147	24518/24519
27	whereas	IN	O	whereas	mark	34	SENT_147	24520/24527
28	for	IN	O	for		-1	SENT_147	24528/24531
29	macitentan	NN	O	macitentan	prep_for	34	SENT_147	24532/24542
30	and	CC	O	and		-1	SENT_147	24543/24546
31	ACT-373898	NN	O	act-373898	conj_and	29	SENT_147	24547/24557
32	,	,	O	,		-1	SENT_147	24557/24558
33	they	PRP	O	they	nsubj	34	SENT_147	24559/24563
34	were	VBD	O	be	advcl	16	SENT_147	24564/24568
35	completely	RB	O	completely	advmod	34	SENT_147	24569/24579
36	outside	JJ	O	outside		-1	SENT_147	24580/24587
37	of	IN	O	of		-1	SENT_147	24588/24590
38	this	DT	O	this	det	39	SENT_147	24591/24595
39	range	NN	O	range	prep_outside_of	34	SENT_147	24596/24601
40	(	CD	NUMBER	(	num	43	SENT_147	24602/24603
41	Table	NNP	O	Table	nn	43	SENT_147	24603/24608
42	II	NNP	O	II	nn	43	SENT_147	24609/24611
43	)	NN	O	)	dep	39	SENT_147	24611/24612
44	.	.	O	.		-1	SENT_147	24612/24613

1	Tolerability	NN	O	tolerability		-1	SENT_148	24649/24661
2	and	CC	O	and		-1	SENT_148	24662/24665
3	Safety	NN	O	safety	conj_and	1	SENT_148	24666/24672

1	There	EX	O	there	expl	2	SENT_149	24708/24713
2	were	VBD	O	be		-1	SENT_149	24714/24718
3	no	DT	O	no	det	4	SENT_149	24719/24721
4	deaths	NNS	O	death	nsubj	2	SENT_149	24722/24728
5	,	,	O	,		-1	SENT_149	24728/24729
6	SAEs	NNS	O	sae	conj_or	4	SENT_149	24730/24734
7	,	,	O	,		-1	SENT_149	24734/24735
8	or	CC	O	or		-1	SENT_149	24736/24738
9	AEs	NNS	O	ae	conj_or	4	SENT_149	24739/24742
10	leading	VBG	O	lead	partmod	9	SENT_149	24743/24750
11	to	TO	O	to		-1	SENT_149	24751/24753
12	treatment	NN	O	treatment	nn	13	SENT_149	24754/24763
13	discontinuation	NN	O	discontinuation	prep_to	10	SENT_149	24764/24779
14	.	.	O	.		-1	SENT_149	24779/24780

1	None	NN	O	none	nsubj	5	SENT_150	24781/24785
2	of	IN	O	of		-1	SENT_150	24786/24788
3	the	DT	O	the	det	4	SENT_150	24789/24792
4	AEs	NNS	O	ae	prep_of	1	SENT_150	24793/24796
5	led	VBD	O	lead		-1	SENT_150	24797/24800
6	to	TO	O	to		-1	SENT_150	24801/24803
7	a	DT	O	a	det	8	SENT_150	24804/24805
8	withdrawal	NN	O	withdrawal	prep_to	5	SENT_150	24806/24816
9	or	CC	O	or		-1	SENT_150	24817/24819
10	any	DT	O	any	det	11	SENT_150	24820/24823
11	change	NN	O	change	conj_or	8	SENT_150	24824/24830
12	in	IN	O	in		-1	SENT_150	24831/24833
13	the	DT	O	the	det	14	SENT_150	24834/24837
14	conduct	NN	O	conduct	prep_in	5	SENT_150	24838/24845
15	of	IN	O	of		-1	SENT_150	24846/24848
16	the	DT	O	the	det	17	SENT_150	24849/24852
17	study	NN	O	study	prep_of	14	SENT_150	24853/24858
18	.	.	O	.		-1	SENT_150	24858/24859

1	All	DT	O	all	det	2	SENT_151	24860/24863
2	AEs	NNS	O	ae	nsubj	3	SENT_151	24864/24867
3	were	VBD	O	be		-1	SENT_151	24868/24872
4	of	IN	O	of		-1	SENT_151	24873/24875
5	mild	JJ	O	mild	amod	8	SENT_151	24876/24880
6	or	CC	O	or		-1	SENT_151	24881/24883
7	moderate	JJ	O	moderate	conj_or	5	SENT_151	24884/24892
8	severity	NN	O	severity	prep_of	3	SENT_151	24893/24901
9	and	CC	O	and		-1	SENT_151	24902/24905
10	were	VBD	O	be	auxpass	11	SENT_151	24906/24910
11	resolved	VBN	O	resolve	conj_and	3	SENT_151	24911/24919
12	at	IN	O	at		-1	SENT_151	24920/24922
13	the	DT	O	the	det	14	SENT_151	24923/24926
14	end	NN	O	end	prep_at	11	SENT_151	24927/24930
15	of	IN	O	of		-1	SENT_151	24931/24933
16	the	DT	O	the	det	17	SENT_151	24934/24937
17	study	NN	O	study	prep_of	14	SENT_151	24938/24943
18	with	IN	O	with		-1	SENT_151	24944/24948
19	no	DT	O	no	det	20	SENT_151	24949/24951
20	sequelae	NN	O	sequela	prep_with	17	SENT_151	24952/24960
21	.	.	O	.		-1	SENT_151	24960/24961

1	In	IN	O	in		-1	SENT_152	24997/24999
2	part	NN	O	part	nn	3	SENT_152	25000/25004
3	A	NN	O	a	prep_in	14	SENT_152	25005/25006
4	of	IN	O	of		-1	SENT_152	25007/25009
5	the	DT	O	the	det	6	SENT_152	25010/25013
6	study	NN	O	study	prep_of	3	SENT_152	25014/25019
7	,	,	O	,		-1	SENT_152	25019/25020
8	a	DT	O	a	det	9	SENT_152	25021/25022
9	total	NN	O	total	nsubj	14	SENT_152	25023/25028
10	of	IN	O	of		-1	SENT_152	25029/25031
11	12	CD	NUMBER	12	num	13	SENT_152	25032/25034
12	treatment-emergent	JJ	O	treatment-emergent	amod	13	SENT_152	25035/25053
13	AEs	NNS	O	ae	prep_of	9	SENT_152	25054/25057
14	(	VBP	O	(		-1	SENT_152	25058/25059
15	TEAEs	NNS	O	teae	dobj	14	SENT_152	25059/25064
16	)	CD	NUMBER	)	nsubj	17	SENT_152	25064/25065
17	occurred	VBD	O	occur	rcmod	15	SENT_152	25066/25074
18	,	,	O	,		-1	SENT_152	25074/25075
19	of	IN	O	of		-1	SENT_152	25076/25078
20	which	WDT	O	which	prep_of	22	SENT_152	25079/25084
21	three	CD	NUMBER	three	nsubj	22	SENT_152	25085/25090
22	occurred	VBD	O	occur	rcmod	15	SENT_152	25091/25099
23	during	IN	O	during		-1	SENT_152	25100/25106
24	period	NN	O	period	prep_during	22	SENT_152	25107/25113
25	1	CD	NUMBER	1	num	24	SENT_152	25114/25115
26	,	,	O	,		-1	SENT_152	25115/25116
27	affecting	VBG	O	affect	xcomp	22	SENT_152	25117/25126
28	three	CD	NUMBER	three	num	29	SENT_152	25127/25132
29	subjects	NNS	O	subject	npadvmod	30	SENT_152	25133/25141
30	(	JJ	O	(	acomp	27	SENT_152	25142/25143
31	30	CD	PERCENT	30	num	32	SENT_152	25143/25145
32	%	NN	PERCENT	%	dep	30	SENT_152	25145/25146
33	)	CD	NUMBER	)	dep	32	SENT_152	25146/25147
34	,	,	O	,		-1	SENT_152	25147/25148
35	and	CC	O	and		-1	SENT_152	25149/25152
36	nine	CD	NUMBER	nine	conj_and	15	SENT_152	25153/25157
37	affecting	VBG	O	affect	partmod	36	SENT_152	25158/25167
38	six	CD	NUMBER	six	num	39	SENT_152	25168/25171
39	subjects	NNS	O	subject	dobj	37	SENT_152	25172/25180
40	(	JJ	O	(	dep	42	SENT_152	25181/25182
41	60	CD	PERCENT	60	number	42	SENT_152	25182/25184
42	%	NN	PERCENT	%	amod	39	SENT_152	25184/25185
43	)	CD	NUMBER	)	nsubj	44	SENT_152	25185/25186
44	occurred	VBD	O	occur	rcmod	39	SENT_152	25187/25195
45	during	IN	O	during		-1	SENT_152	25196/25202
46	period	NN	O	period	prep_during	44	SENT_152	25203/25209
47	2	CD	NUMBER	2	num	46	SENT_152	25210/25211
48	.	.	O	.		-1	SENT_152	25211/25212

1	The	DT	O	the	det	5	SENT_153	25213/25216
2	most	RBS	O	most	advmod	3	SENT_153	25217/25221
3	frequently	RB	O	frequently	advmod	4	SENT_153	25222/25232
4	reported	VBN	O	report	amod	5	SENT_153	25233/25241
5	TEAE	NN	ORGANIZATION	tea	nsubj	7	SENT_153	25242/25246
6	was	VBD	O	be	cop	7	SENT_153	25247/25250
7	headache	NN	O	headache		-1	SENT_153	25251/25259
8	,	,	O	,		-1	SENT_153	25259/25260
9	which	WDT	O	which	nsubj	10	SENT_153	25261/25266
10	affected	VBD	O	affect	rcmod	7	SENT_153	25267/25275
11	one	CD	NUMBER	one	num	12	SENT_153	25276/25279
12	subject	NN	O	subject	dobj	10	SENT_153	25280/25287
13	in	IN	O	in		-1	SENT_153	25288/25290
14	period	NN	O	period	prep_in	10	SENT_153	25291/25297
15	1	CD	NUMBER	1	num	14	SENT_153	25298/25299
16	and	CC	O	and		-1	SENT_153	25300/25303
17	three	CD	NUMBER	three	num	18	SENT_153	25304/25309
18	subjects	NNS	O	subject	conj_and	14	SENT_153	25310/25318
19	in	IN	O	in		-1	SENT_153	25319/25321
20	period	NN	O	period	prep_in	10	SENT_153	25322/25328
21	2	CD	NUMBER	2	num	20	SENT_153	25329/25330
22	.	.	O	.		-1	SENT_153	25330/25331

1	In	IN	O	in		-1	SENT_154	25367/25369
2	part	NN	O	part	nn	3	SENT_154	25370/25374
3	B	NN	O	b	prep_in	13	SENT_154	25375/25376
4	of	IN	O	of		-1	SENT_154	25377/25379
5	the	DT	O	the	det	6	SENT_154	25380/25383
6	study	NN	O	study	prep_of	3	SENT_154	25384/25389
7	,	,	O	,		-1	SENT_154	25389/25390
8	a	DT	O	a	det	9	SENT_154	25391/25392
9	total	NN	O	total	nsubj	13	SENT_154	25393/25398
10	of	IN	O	of		-1	SENT_154	25399/25401
11	eight	CD	NUMBER	eight	num	12	SENT_154	25402/25407
12	TEAEs	NNS	O	teae	prep_of	9	SENT_154	25408/25413
13	occurred	VBD	O	occur		-1	SENT_154	25414/25422
14	,	,	O	,		-1	SENT_154	25422/25423
15	of	IN	O	of		-1	SENT_154	25424/25426
16	which	WDT	O	which	prep_of	18	SENT_154	25427/25432
17	six	CD	NUMBER	six	nsubj	18	SENT_154	25433/25436
18	occurred	VBD	O	occur	ccomp	13	SENT_154	25437/25445
19	during	IN	O	during		-1	SENT_154	25446/25452
20	period	NN	O	period	prep_during	18	SENT_154	25453/25459
21	1	CD	NUMBER	1	num	20	SENT_154	25460/25461
22	,	,	O	,		-1	SENT_154	25461/25462
23	affecting	VBG	O	affect	xcomp	18	SENT_154	25463/25472
24	six	CD	NUMBER	six	num	25	SENT_154	25473/25476
25	subjects	NNS	O	subject	npadvmod	26	SENT_154	25477/25485
26	(	JJ	O	(	acomp	23	SENT_154	25486/25487
27	60	CD	PERCENT	60	num	28	SENT_154	25487/25489
28	%	NN	PERCENT	%	dep	26	SENT_154	25489/25490
29	)	CD	NUMBER	)	dep	28	SENT_154	25490/25491
30	,	,	O	,		-1	SENT_154	25491/25492
31	and	CC	O	and		-1	SENT_154	25493/25496
32	two	CD	NUMBER	two	nsubj	40	SENT_154	25497/25500
33	affecting	VBG	O	affect	partmod	32	SENT_154	25501/25510
34	two	CD	NUMBER	two	num	35	SENT_154	25511/25514
35	subjects	NNS	O	subject	npadvmod	36	SENT_154	25515/25523
36	(	JJ	O	(	acomp	33	SENT_154	25524/25525
37	20	CD	PERCENT	20	num	38	SENT_154	25525/25527
38	%	NN	PERCENT	%	dep	36	SENT_154	25527/25528
39	)	CD	NUMBER	)	dep	38	SENT_154	25528/25529
40	occurred	VBD	O	occur	conj_and	13	SENT_154	25530/25538
41	during	IN	O	during		-1	SENT_154	25539/25545
42	period	NN	O	period	prep_during	40	SENT_154	25546/25552
43	2	CD	NUMBER	2	num	42	SENT_154	25553/25554
44	.	.	O	.		-1	SENT_154	25554/25555

1	The	DT	O	the	det	5	SENT_155	25556/25559
2	most	RBS	O	most	advmod	3	SENT_155	25560/25564
3	frequently	RB	O	frequently	advmod	4	SENT_155	25565/25575
4	reported	VBN	O	report	amod	5	SENT_155	25576/25584
5	TEAE	NN	ORGANIZATION	tea	nsubj	7	SENT_155	25585/25589
6	was	VBD	O	be	cop	7	SENT_155	25590/25593
7	headache	NN	O	headache		-1	SENT_155	25594/25602
8	,	,	O	,		-1	SENT_155	25602/25603
9	which	WDT	O	which	nsubj	10	SENT_155	25604/25609
10	affected	VBD	O	affect	rcmod	7	SENT_155	25610/25618
11	five	CD	NUMBER	five	num	12	SENT_155	25619/25623
12	subjects	NNS	O	subject	dobj	10	SENT_155	25624/25632
13	in	IN	O	in		-1	SENT_155	25633/25635
14	period	NN	O	period	prep_in	10	SENT_155	25636/25642
15	1	CD	NUMBER	1	num	14	SENT_155	25643/25644
16	and	CC	O	and		-1	SENT_155	25645/25648
17	two	CD	NUMBER	two	num	18	SENT_155	25649/25652
18	subjects	NNS	O	subject	conj_and	14	SENT_155	25653/25661
19	in	IN	O	in		-1	SENT_155	25662/25664
20	period	NN	O	period	prep_in	10	SENT_155	25665/25671
21	2	CD	NUMBER	2	num	20	SENT_155	25672/25673
22	.	.	O	.		-1	SENT_155	25673/25674

1	No	DT	O	no	det	5	SENT_156	25710/25712
2	clinically	RB	O	clinically	advmod	3	SENT_156	25713/25723
3	relevant	JJ	O	relevant	amod	5	SENT_156	25724/25732
4	treatment-related	JJ	O	treatment-related	amod	5	SENT_156	25733/25750
5	effects	NNS	O	effect	nsubjpass	18	SENT_156	25751/25758
6	on	IN	O	on		-1	SENT_156	25759/25761
7	vital	JJ	O	vital	amod	8	SENT_156	25762/25767
8	signs	NNS	O	sign	prep_on	5	SENT_156	25768/25773
9	,	,	O	,		-1	SENT_156	25773/25774
10	ECG	NN	O	ecg	nn	11	SENT_156	25775/25778
11	variables	NNS	O	variable	conj_or	8	SENT_156	25779/25788
12	,	,	O	,		-1	SENT_156	25788/25789
13	or	CC	O	or		-1	SENT_156	25790/25792
14	clinical	JJ	O	clinical	amod	16	SENT_156	25793/25801
15	laboratory	NN	O	laboratory	nn	16	SENT_156	25802/25812
16	variables	NNS	O	variable	conj_or	8	SENT_156	25813/25822
17	were	VBD	O	be	auxpass	18	SENT_156	25823/25827
18	detected	VBN	O	detect		-1	SENT_156	25828/25836
19	in	IN	O	in		-1	SENT_156	25837/25839
20	either	CC	O	either	dep	21	SENT_156	25840/25846
21	part	NN	O	part	prep_in	18	SENT_156	25847/25851
22	of	IN	O	of		-1	SENT_156	25852/25854
23	the	DT	O	the	det	24	SENT_156	25855/25858
24	study	NN	O	study	prep_of	21	SENT_156	25859/25864
25	.	.	O	.		-1	SENT_156	25864/25865

1	In	IN	O	in		-1	SENT_157	25901/25903
2	Vitro	NNP	O	Vitro	nn	3	SENT_157	25904/25909
3	Experiments	NNS	O	experiment	pobj	1	SENT_157	25910/25921

1	To	TO	O	to	aux	2	SENT_158	25957/25959
2	assess	VB	O	assess		-1	SENT_158	25960/25966
3	whether	IN	O	whether	mark	11	SENT_158	25967/25974
4	macitentan	NN	O	macitentan	nsubj	11	SENT_158	25975/25985
5	and	CC	O	and		-1	SENT_158	25986/25989
6	its	PRP$	O	its	poss	9	SENT_158	25990/25993
7	active	JJ	O	active	amod	9	SENT_158	25994/26000
8	metabolite	NN	O	metabolite	nn	9	SENT_158	26001/26011
9	ACT-132577	NN	O	act-132577	conj_and	4	SENT_158	26012/26022
10	are	VBP	O	be	cop	11	SENT_158	26023/26026
11	substrates	NNS	O	substrate	ccomp	2	SENT_158	26027/26037
12	of	IN	O	of		-1	SENT_158	26038/26040
13	human	JJ	O	human	amod	14	SENT_158	26041/26046
14	OATPs	NNS	O	oatp	prep_of	11	SENT_158	26047/26052
15	,	,	O	,		-1	SENT_158	26052/26053
16	time	NN	O	time	appos	14	SENT_158	26054/26058
17	-	:	O	-		-1	SENT_158	26058/26059
18	and	CC	O	and		-1	SENT_158	26060/26063
19	concentration-dependence	NN	O	concentration-dependence	nn	20	SENT_158	26064/26088
20	assessments	NNS	O	assessment	nsubjpass	22	SENT_158	26089/26100
21	were	VBD	O	be	auxpass	22	SENT_158	26101/26105
22	performed	VBN	O	perform	conj_and	2	SENT_158	26106/26115
23	in	FW	O	in	nn	24	SENT_158	26116/26118
24	vitro	FW	O	vitro	advmod	22	SENT_158	26119/26124
25	.	.	O	.		-1	SENT_158	26124/26125

1	Rapid	JJ	O	rapid	amod	4	SENT_159	26126/26131
2	and	CC	O	and		-1	SENT_159	26132/26135
3	comparable	JJ	O	comparable	conj_and	1	SENT_159	26136/26146
4	uptake	NN	O	uptake	nsubjpass	10	SENT_159	26147/26153
5	of	IN	O	of		-1	SENT_159	26154/26156
6	macitentan	NN	O	macitentan	prep_of	4	SENT_159	26157/26167
7	and	CC	O	and		-1	SENT_159	26168/26171
8	ACT-132577	NN	O	act-132577	conj_and	6	SENT_159	26172/26182
9	was	VBD	O	be	auxpass	10	SENT_159	26183/26186
10	observed	VBN	O	observe		-1	SENT_159	26187/26195
11	in	IN	O	in		-1	SENT_159	26196/26198
12	wild-type	JJ	O	wild-type	prep_in	10	SENT_159	26199/26208
13	and	CC	O	and		-1	SENT_159	26209/26212
14	OATP1B1	NN	O	oatp1b1	conj_and	12	SENT_159	26213/26220
15	as	RB	O	as		-1	SENT_159	26221/26223
16	well	RB	O	well		-1	SENT_159	26224/26228
17	as	IN	O	as		-1	SENT_159	26229/26231
18	OATP1B3	NN	O	oatp1b3	nn	19	SENT_159	26232/26239
19	over-expressing	NN	O	over-expressing	conj_and	12	SENT_159	26240/26255
20	CHO	NN	O	cho	nn	21	SENT_159	26256/26259
21	cells	NNS	O	cell	nsubj	22	SENT_159	26260/26265
22	(	VBP	O	(	rcmod	19	SENT_159	26266/26267
23	Fig.	NN	O	fig.	nn	25	SENT_159	26267/26271
24	5	CD	NUMBER	5	num	25	SENT_159	26272/26273
25	)	NN	O	)	dobj	22	SENT_159	26273/26274
26	.	.	O	.		-1	SENT_159	26274/26275

1	The	DT	O	the	det	2	SENT_160	26276/26279
2	uptake	NN	O	uptake	nsubj	24	SENT_160	26280/26286
3	of	IN	O	of		-1	SENT_160	26287/26289
4	macitentan	NN	O	macitentan	prep_of	2	SENT_160	26290/26300
5	into	IN	O	into		-1	SENT_160	26301/26305
6	the	DT	O	the	det	7	SENT_160	26306/26309
7	wild-type	JJ	O	wild-type	prep_into	4	SENT_160	26310/26319
8	,	,	O	,		-1	SENT_160	26319/26320
9	OATP1B1	NN	O	oatp1b1	conj_and	7	SENT_160	26321/26328
10	,	,	O	,		-1	SENT_160	26328/26329
11	and	CC	O	and		-1	SENT_160	26330/26333
12	OATP1B3	NN	O	oatp1b3	nn	14	SENT_160	26334/26341
13	over-expressing	NN	O	over-expressing	nn	14	SENT_160	26342/26357
14	cells	NNS	O	cell	conj_and	7	SENT_160	26358/26363
15	after	IN	O	after		-1	SENT_160	26364/26369
16	incubation	NN	O	incubation	prep_after	14	SENT_160	26370/26380
17	for	IN	O	for		-1	SENT_160	26381/26384
18	40	CD	NUMBER	40	num	19	SENT_160	26385/26387
19	s	NNS	O	s	prep_for	16	SENT_160	26388/26389
20	was	VBD	O	be	cop	24	SENT_160	26390/26393
21	(	CD	NUMBER	(	num	24	SENT_160	26394/26395
22	mean	NN	O	mean	nn	24	SENT_160	26395/26399
23	SD	NN	O	sd	nn	24	SENT_160	26403/26405
24	)	NN	O	)		-1	SENT_160	26405/26406
25	346	CD	NUMBER	346	num	26	SENT_160	26407/26410
26	3	CD	NUMBER	3	dep	24	SENT_160	26416/26417
27	,	,	O	,		-1	SENT_160	26417/26418
28	362	CD	NUMBER	362	number	29	SENT_160	26419/26422
29	6	CD	NUMBER	6	appos	24	SENT_160	26430/26431
30	,	,	O	,		-1	SENT_160	26431/26432
31	and	CC	NUMBER	and		-1	SENT_160	26433/26436
32	387	CD	NUMBER	387	number	33	SENT_160	26437/26440
33	11	CD	NUMBER	11	conj_and	29	SENT_160	26448/26450
34	pmol/mg	NN	O	pmol/mg	dep	33	SENT_160	26451/26458
35	,	,	O	,		-1	SENT_160	26458/26459
36	respectively	RB	O	respectively	advmod	24	SENT_160	26460/26472
37	,	,	O	,		-1	SENT_160	26472/26473
38	and	CC	O	and		-1	SENT_160	26474/26477
39	the	DT	O	the	det	40	SENT_160	26478/26481
40	uptake	NN	O	uptake	nsubj	45	SENT_160	26482/26488
41	of	IN	O	of		-1	SENT_160	26489/26491
42	ACT-132577	NN	O	act-132577	prep_of	40	SENT_160	26492/26502
43	was	VBD	O	be	cop	45	SENT_160	26503/26506
44	214	CD	NUMBER	214	number	45	SENT_160	26507/26510
45	11	CD	NUMBER	11	conj_and	24	SENT_160	26518/26520
46	,	,	O	,		-1	SENT_160	26520/26521
47	237	CD	NUMBER	237	number	48	SENT_160	26522/26525
48	7	CD	NUMBER	7	appos	45	SENT_160	26533/26534
49	,	,	O	,		-1	SENT_160	26534/26535
50	and	CC	NUMBER	and		-1	SENT_160	26536/26539
51	288	CD	NUMBER	288	conj_and	48	SENT_160	26540/26543
52	10	CD	NUMBER	10	num	53	SENT_160	26551/26553
53	pmol/mg	NN	O	pmol/mg	dep	51	SENT_160	26554/26561
54	,	,	O	,		-1	SENT_160	26561/26562
55	respectively	RB	O	respectively	advmod	51	SENT_160	26563/26575
56	.	.	O	.		-1	SENT_160	26575/26576

1	No	DT	O	no	det	3	SENT_161	26577/26579
2	marked	JJ	O	marked	amod	3	SENT_161	26580/26586
3	difference	NN	O	difference	nsubjpass	18	SENT_161	26587/26597
4	in	IN	O	in		-1	SENT_161	26598/26600
5	uptake	NN	O	uptake	nn	6	SENT_161	26601/26607
6	rate	NN	O	rate	prep_in	3	SENT_161	26608/26612
7	of	IN	O	of		-1	SENT_161	26613/26615
8	macitentan	NN	O	macitentan	prep_of	6	SENT_161	26616/26626
9	and	CC	O	and		-1	SENT_161	26627/26630
10	ACT-132577	NN	O	act-132577	conj_and	8	SENT_161	26631/26641
11	between	IN	O	between		-1	SENT_161	26642/26649
12	wild-type	JJ	O	wild-type	amod	16	SENT_161	26650/26659
13	and	CC	O	and		-1	SENT_161	26660/26663
14	OATP	NN	O	oatp	conj_and	12	SENT_161	26664/26668
15	over-expressing	NN	O	over-expressing	nn	16	SENT_161	26669/26684
16	cells	NNS	O	cell	prep_between	8	SENT_161	26685/26690
17	was	VBD	O	be	auxpass	18	SENT_161	26691/26694
18	observed	VBN	O	observe		-1	SENT_161	26695/26703
19	when	WRB	O	when	advmod	26	SENT_161	26704/26708
20	the	DT	O	the	det	21	SENT_161	26709/26712
21	effect	NN	O	effect	nsubjpass	26	SENT_161	26713/26719
22	of	IN	O	of		-1	SENT_161	26720/26722
23	different	JJ	O	different	amod	24	SENT_161	26723/26732
24	concentrations	NNS	O	concentration	prep_of	21	SENT_161	26733/26747
25	was	VBD	O	be	auxpass	26	SENT_161	26748/26751
26	tested	VBN	O	test	advcl	18	SENT_161	26752/26758
27	(	CD	NUMBER	(	num	28	SENT_161	26759/26760
28	Fig.	NN	O	fig.	dobj	26	SENT_161	26760/26764
29	6	CD	NUMBER	6	num	30	SENT_161	26765/26766
30	)	NN	O	)	dep	28	SENT_161	26766/26767
31	.	.	O	.		-1	SENT_161	26767/26768

1	Fig.	NN	O	fig.		-1	SENT_162	26768/26772
2	5	CD	NUMBER	5	num	1	SENT_162	26773/26774

1	Time	NNP	O	Time		-1	SENT_163	26791/26795
2	course	NN	O	course	dep	1	SENT_163	26796/26802
3	of	IN	O	of		-1	SENT_163	26803/26805
4	cellular	JJ	O	cellular	amod	5	SENT_163	26806/26814
5	uptake	NN	O	uptake	prep_of	2	SENT_163	26815/26821
6	of	IN	O	of		-1	SENT_163	26822/26824
7	3	CD	NUMBER	3	prep_of	5	SENT_163	26825/26826
8	M	NN	O	m	nn	9	SENT_163	26829/26830
9	macitentan	NN	O	macitentan	dep	1	SENT_163	26831/26841
10	(	CD	NUMBER	(	dep	9	SENT_163	26842/26843
11	a	DT	O	a	det	12	SENT_163	26843/26844
12	)	NN	O	)	dep	1	SENT_163	26844/26845
13	and	CC	O	and		-1	SENT_163	26846/26849
14	3	CD	NUMBER	3	num	15	SENT_163	26850/26851
15	M	NN	O	m	conj_and	12	SENT_163	26854/26855
16	ACT-132577	NN	O	act-132577	nn	19	SENT_163	26856/26866
17	(	CD	NUMBER	(	num	19	SENT_163	26867/26868
18	b	NN	O	b	nn	19	SENT_163	26868/26869
19	)	NN	O	)	dep	1	SENT_163	26869/26870
20	in	IN	O	in		-1	SENT_163	26871/26873
21	wild-type	JJ	O	wild-type	amod	23	SENT_163	26874/26883
22	(	NN	O	(	nn	23	SENT_163	26884/26885
23	circles	NNS	O	circle	prep_in	19	SENT_163	26885/26892
24	)	CD	NUMBER	)	dep	1	SENT_163	26892/26893
25	and	CC	O	and		-1	SENT_163	26894/26897
26	human	JJ	O	human	amod	29	SENT_163	26898/26903
27	OATP1B1	NN	O	oatp1b1	nn	29	SENT_163	26904/26911
28	(	NN	O	(	nn	29	SENT_163	26912/26913
29	squares	NNS	O	square	conj_and	24	SENT_163	26913/26920
30	)	NN	O	)	dep	1	SENT_163	26920/26921
31	and	CC	O	and		-1	SENT_163	26922/26925
32	OATP1B3	NN	O	oatp1b3	conj_and	30	SENT_163	26926/26933
33	(	CD	NUMBER	(	num	34	SENT_163	26934/26935
34	triangles	NNS	O	triangle	dep	1	SENT_163	26935/26944
35	)	CD	NUMBER	)	num	38	SENT_163	26944/26945
36	over-expressing	NN	O	over-expressing	nn	38	SENT_163	26946/26961
37	CHO	NN	O	cho	nn	38	SENT_163	26962/26965
38	cells	NNS	O	cell	dep	34	SENT_163	26966/26971
39	.	.	O	.		-1	SENT_163	26971/26972

1	Values	NNS	O	value	nsubj	2	SENT_164	26973/26979
2	represent	VBP	O	represent		-1	SENT_164	26980/26989
3	the	DT	O	the	det	5	SENT_164	26990/26993
4	mean	NN	O	mean	nn	5	SENT_164	26994/26998
5	SD	NN	O	sd	dobj	2	SENT_164	27006/27008
6	of	IN	O	of		-1	SENT_164	27009/27011
7	one	CD	NUMBER	one	num	8	SENT_164	27012/27015
8	experiment	NN	O	experiment	prep_of	5	SENT_164	27016/27026
9	performed	VBN	O	perform	partmod	8	SENT_164	27027/27036
10	in	IN	O	in		-1	SENT_164	27037/27039
11	triplicate	NN	O	triplicate	prep_in	9	SENT_164	27040/27050

1	Fig.	NN	O	fig.		-1	SENT_165	27067/27071
2	6	CD	NUMBER	6	num	1	SENT_165	27072/27073

1	Concentration	NN	O	concentration		-1	SENT_166	27090/27103
2	dependence	NN	O	dependence	dep	1	SENT_166	27104/27114
3	of	IN	O	of		-1	SENT_166	27115/27117
4	cellular	JJ	O	cellular	amod	5	SENT_166	27118/27126
5	uptake	NN	O	uptake	prep_of	2	SENT_166	27127/27133
6	of	IN	O	of		-1	SENT_166	27134/27136
7	macitentan	NN	O	macitentan	prep_of	5	SENT_166	27137/27147
8	(	CD	NUMBER	(	num	9	SENT_166	27148/27149
9	panels	NNS	O	panel	dep	1	SENT_166	27149/27155
10	a	DT	O	a	dep	9	SENT_166	27156/27157
11	and	CC	O	and		-1	SENT_166	27158/27161
12	b	NN	O	b	conj_and	10	SENT_166	27162/27163
13	)	NN	O	)	dep	1	SENT_166	27163/27164
14	and	CC	O	and		-1	SENT_166	27165/27168
15	ACT-132577	NN	O	act-132577	conj_and	13	SENT_166	27169/27179
16	(	CD	NUMBER	(	num	17	SENT_166	27180/27181
17	panels	NNS	O	panel	dep	13	SENT_166	27181/27187
18	c	NN	O	c	nn	21	SENT_166	27188/27189
19	and	CC	O	and		-1	SENT_166	27190/27193
20	d	NN	O	d	conj_and	18	SENT_166	27194/27195
21	)	NN	O	)	dep	1	SENT_166	27195/27196
22	in	IN	O	in		-1	SENT_166	27197/27199
23	wild-type	JJ	O	wild-type	amod	25	SENT_166	27200/27209
24	(	NN	O	(	nn	25	SENT_166	27210/27211
25	circles	NNS	O	circle	prep_in	21	SENT_166	27211/27218
26	)	CD	NUMBER	)	dep	1	SENT_166	27218/27219
27	and	CC	O	and		-1	SENT_166	27220/27223
28	human	JJ	O	human	amod	29	SENT_166	27224/27229
29	OATP1B1	NN	O	oatp1b1	conj_and	26	SENT_166	27230/27237
30	(	CD	NUMBER	(	num	29	SENT_166	27238/27239
31	a	DT	O	a	det	41	SENT_166	27239/27240
32	,	,	O	,		-1	SENT_166	27240/27241
33	c	NN	O	c	nn	34	SENT_166	27242/27243
34	)	NN	O	)	dep	41	SENT_166	27243/27244
35	and	CC	O	and		-1	SENT_166	27245/27248
36	OATP1B3	NN	O	oatp1b3	nn	38	SENT_166	27249/27256
37	(	NN	O	(	nn	38	SENT_166	27257/27258
38	b	NN	O	b	conj_and	34	SENT_166	27258/27259
39	,	,	O	,		-1	SENT_166	27259/27260
40	d	NN	O	d	nn	41	SENT_166	27261/27262
41	)	NN	O	)	dep	1	SENT_166	27262/27263
42	,	,	O	,		-1	SENT_166	27263/27264
43	over-expressing	NN	O	over-expressing	nn	45	SENT_166	27265/27280
44	CHO	NN	O	cho	nn	45	SENT_166	27281/27284
45	cells	NNS	O	cell	appos	41	SENT_166	27285/27290
46	(	CD	NUMBER	(	num	47	SENT_166	27291/27292
47	squares	NNS	O	square	dep	1	SENT_166	27292/27299
48	)	CD	NUMBER	)	dep	47	SENT_166	27299/27300
49	.	.	O	.		-1	SENT_166	27300/27301

1	Values	NNS	O	value	nsubj	2	SENT_167	27302/27308
2	represent	VBP	O	represent		-1	SENT_167	27309/27318
3	the	DT	O	the	det	5	SENT_167	27319/27322
4	mean	NN	O	mean	nn	5	SENT_167	27323/27327
5	SD	NN	O	sd	dobj	2	SENT_167	27335/27337
6	of	IN	O	of		-1	SENT_167	27338/27340
7	one	CD	NUMBER	one	num	8	SENT_167	27341/27344
8	experiment	NN	O	experiment	prep_of	5	SENT_167	27345/27355
9	performed	VBN	O	perform	partmod	8	SENT_167	27356/27365
10	in	IN	O	in		-1	SENT_167	27366/27368
11	triplicate	NN	O	triplicate	prep_in	9	SENT_167	27369/27379

1	The	DT	O	the	det	3	SENT_168	27434/27437
2	inhibitory	JJ	O	inhibitory	amod	3	SENT_168	27438/27448
3	potential	NN	O	potential	nsubj	19	SENT_168	27449/27458
4	of	IN	O	of		-1	SENT_168	27459/27461
5	macitentan	NN	O	macitentan	prep_of	3	SENT_168	27462/27472
6	and	CC	O	and		-1	SENT_168	27473/27476
7	ACT-132577	NN	O	act-132577	conj_and	5	SENT_168	27477/27487
8	on	IN	O	on		-1	SENT_168	27488/27490
9	OATPs	NNS	O	oatp	prep_on	5	SENT_168	27491/27496
10	was	VBD	O	be	auxpass	11	SENT_168	27497/27500
11	investigated	VBN	O	investigate	rcmod	9	SENT_168	27501/27513
12	over	IN	O	over		-1	SENT_168	27514/27518
13	a	DT	O	a	det	15	SENT_168	27519/27520
14	wide	JJ	O	wide	amod	15	SENT_168	27521/27525
15	range	NN	O	range	prep_over	11	SENT_168	27526/27531
16	of	IN	O	of		-1	SENT_168	27532/27534
17	inhibitor	NN	O	inhibitor	nn	18	SENT_168	27535/27544
18	concentrations	NNS	O	concentration	prep_of	15	SENT_168	27545/27559
19	(	VBP	O	(		-1	SENT_168	27560/27561
20	0.01	CD	NUMBER	0.01	dobj	19	SENT_168	27561/27565
21	to	TO	O	to		-1	SENT_168	27566/27568
22	300	CD	NUMBER	300	num	24	SENT_168	27569/27572
23	M	NN	O	m	nn	24	SENT_168	27575/27576
24	)	NN	O	)	prep_to	19	SENT_168	27576/27577
25	.	.	O	.		-1	SENT_168	27577/27578

1	Macitentan	NN	O	macitentan	nsubj	2	SENT_169	27579/27589
2	inhibited	VBD	O	inhibit		-1	SENT_169	27590/27599
3	OATP1B1-mediated	JJ	O	oatp1b1-mediated	amod	4	SENT_169	27600/27616
4	uptake	NN	O	uptake	dobj	2	SENT_169	27617/27623
5	of	IN	O	of		-1	SENT_169	27624/27626
6	atorvastatin	NN	O	atorvastatin	prep_of	4	SENT_169	27627/27639
7	and	CC	O	and		-1	SENT_169	27640/27643
8	OATP1B3-mediated	JJ	O	oatp1b3-mediated	amod	9	SENT_169	27644/27660
9	uptake	NN	O	uptake	conj_and	4	SENT_169	27661/27667
10	of	IN	O	of		-1	SENT_169	27668/27670
11	estrone-3-sulfate	NN	O	estrone-3-sulfate	prep_of	9	SENT_169	27671/27688
12	with	IN	O	with		-1	SENT_169	27689/27693
13	IC50	NN	O	ic50	nn	15	SENT_169	27694/27698
14	SE	NN	O	se	nn	15	SENT_169	27706/27708
15	values	NNS	O	value	prep_with	2	SENT_169	27709/27715
16	of	IN	O	of		-1	SENT_169	27716/27718
17	6.3	CD	NUMBER	6.3	num	18	SENT_169	27719/27722
18	0.7	CD	NUMBER	0.7	prep_of	15	SENT_169	27728/27731
19	and	CC	O	and		-1	SENT_169	27732/27735
20	11.8	CD	NUMBER	11.8	num	22	SENT_169	27736/27740
21	5.0	CD	NUMBER	5.0	num	22	SENT_169	27748/27751
22	M	NN	O	m	conj_and	15	SENT_169	27754/27755
23	,	,	O	,		-1	SENT_169	27755/27756
24	respectively	RB	O	respectively	advmod	15	SENT_169	27757/27769
25	(	CD	NUMBER	(	num	26	SENT_169	27770/27771
26	Fig.	NN	O	fig.	dep	15	SENT_169	27771/27775
27	7	CD	NUMBER	7	num	28	SENT_169	27776/27777
28	)	NN	O	)	dep	26	SENT_169	27777/27778
29	.	.	O	.		-1	SENT_169	27778/27779

1	For	IN	O	for		-1	SENT_170	27780/27783
2	ACT-132577	NN	O	act-132577	prep_for	8	SENT_170	27784/27794
3	,	,	O	,		-1	SENT_170	27794/27795
4	these	DT	O	these	det	5	SENT_170	27796/27801
5	values	NNS	O	value	nsubj	8	SENT_170	27802/27808
6	were	VBD	O	be	cop	8	SENT_170	27809/27813
7	19.9	CD	NUMBER	19.9	number	8	SENT_170	27814/27818
8	1.4	CD	NUMBER	1.4		-1	SENT_170	27826/27829
9	and	CC	O	and		-1	SENT_170	27830/27833
10	51.6	CD	NUMBER	51.6	num	12	SENT_170	27834/27838
11	3.0	CD	NUMBER	3.0	num	12	SENT_170	27846/27849
12	M	NN	O	m	conj_and	8	SENT_170	27852/27853
13	,	,	O	,		-1	SENT_170	27853/27854
14	respectively	RB	O	respectively	advmod	16	SENT_170	27855/27867
15	(	CD	NUMBER	(	num	16	SENT_170	27868/27869
16	Fig.	NN	O	fig.	rcmod	12	SENT_170	27869/27873
17	7	CD	NUMBER	7	num	18	SENT_170	27874/27875
18	)	NN	O	)	dep	16	SENT_170	27875/27876
19	.	.	O	.		-1	SENT_170	27876/27877

1	Fig.	NN	O	fig.		-1	SENT_171	27877/27881
2	7	CD	NUMBER	7	num	1	SENT_171	27882/27883

1	Concentration-dependent	JJ	O	concentration-dependent	amod	2	SENT_172	27900/27923
2	inhibition	NN	O	inhibition		-1	SENT_172	27924/27934
3	of	IN	O	of		-1	SENT_172	27935/27937
4	OATP1B1-mediated	JJ	O	oatp1b1-mediated	amod	6	SENT_172	27938/27954
5	net	JJ	O	net	amod	6	SENT_172	27955/27958
6	uptake	NN	O	uptake	prep_of	2	SENT_172	27959/27965
7	of	IN	O	of		-1	SENT_172	27966/27968
8	atorvastatin	NN	O	atorvastatin	prep_of	6	SENT_172	27969/27981
9	(	CD	NUMBER	(	num	8	SENT_172	27982/27983
10	a	DT	O	a	det	23	SENT_172	27983/27984
11	,	,	O	,		-1	SENT_172	27984/27985
12	c	NN	O	c	nn	13	SENT_172	27986/27987
13	)	NN	O	)	dep	23	SENT_172	27987/27988
14	and	CC	O	and		-1	SENT_172	27989/27992
15	OATP1B3-mediated	JJ	O	oatp1b3-mediated	amod	16	SENT_172	27993/28009
16	uptake	NN	O	uptake	conj_and	13	SENT_172	28010/28016
17	of	IN	O	of		-1	SENT_172	28017/28019
18	estrone-3-sulfate	JJ	O	estrone-3-sulfate	amod	20	SENT_172	28020/28037
19	(	NN	O	(	nn	20	SENT_172	28038/28039
20	b	NN	O	b	prep_of	13	SENT_172	28039/28040
21	,	,	O	,		-1	SENT_172	28040/28041
22	d	NN	O	d	nn	23	SENT_172	28042/28043
23	)	NN	O	)	dep	2	SENT_172	28043/28044
24	by	IN	O	by		-1	SENT_172	28045/28047
25	macitentan	NN	O	macitentan	prep_by	23	SENT_172	28048/28058
26	and	CC	O	and		-1	SENT_172	28059/28062
27	ACT-132577	NN	O	act-132577	conj_and	25	SENT_172	28063/28073
28	.	.	O	.		-1	SENT_172	28073/28074

1	Values	NNS	O	value	nsubj	2	SENT_173	28075/28081
2	represent	VBP	O	represent		-1	SENT_173	28082/28091
3	the	DT	O	the	det	5	SENT_173	28092/28095
4	mean	NN	O	mean	nn	5	SENT_173	28096/28100
5	SD	NN	O	sd	dobj	2	SENT_173	28108/28110
6	of	IN	O	of		-1	SENT_173	28111/28113
7	one	CD	NUMBER	one	num	8	SENT_173	28114/28117
8	experiment	NN	O	experiment	prep_of	5	SENT_173	28118/28128
9	done	VBN	O	do	partmod	8	SENT_173	28129/28133
10	in	IN	O	in		-1	SENT_173	28134/28136
11	triplicate	NN	O	triplicate	prep_in	9	SENT_173	28137/28147
12	,	,	O	,		-1	SENT_173	28147/28148
13	and	CC	O	and		-1	SENT_173	28149/28152
14	the	DT	O	the	det	16	SENT_173	28153/28156
15	solid	JJ	O	solid	amod	16	SENT_173	28157/28162
16	line	NN	O	line	nsubjpass	19	SENT_173	28163/28167
17	is	VBZ	O	be	auxpass	19	SENT_173	28168/28170
18	best	RB	O	best	advmod	19	SENT_173	28171/28175
19	fit	VBN	O	fit	conj_and	2	SENT_173	28176/28179
20	to	TO	O	to		-1	SENT_173	28180/28182
21	the	DT	O	the	det	22	SENT_173	28183/28186
22	data	NNS	O	datum	prep_to	19	SENT_173	28187/28191

1	DISCUSSION	NN	O	discussion		-1	SENT_174	28246/28256

1	The	DT	O	the	det	3	SENT_175	28292/28295
2	clinical	JJ	O	clinical	amod	3	SENT_175	28296/28304
3	study	NN	O	study	nsubjpass	5	SENT_175	28305/28310
4	was	VBD	O	be	auxpass	5	SENT_175	28311/28314
5	conducted	VBN	O	conduct		-1	SENT_175	28315/28324
6	in	IN	O	in		-1	SENT_175	28325/28327
7	two	CD	NUMBER	two	num	8	SENT_175	28328/28331
8	parts	NNS	O	part	prep_in	5	SENT_175	28332/28337
9	.	.	O	.		-1	SENT_175	28337/28338

1	In	IN	O	in		-1	SENT_176	28339/28341
2	both	DT	O	both	det	3	SENT_176	28342/28346
3	parts	NNS	O	part	prep_in	12	SENT_176	28347/28352
4	,	,	O	,		-1	SENT_176	28352/28353
5	Ctr	NN	O	ctr	nsubj	12	SENT_176	28354/28357
6	of	IN	O	of		-1	SENT_176	28358/28360
7	macitentan	NN	O	macitentan	prep_of	5	SENT_176	28361/28371
8	and	CC	O	and		-1	SENT_176	28372/28375
9	its	PRP$	O	its	poss	10	SENT_176	28376/28379
10	metabolites	NNS	O	metabolite	conj_and	7	SENT_176	28380/28391
11	were	VBD	O	be	cop	12	SENT_176	28392/28396
12	comparable	JJ	O	comparable		-1	SENT_176	28397/28407
13	in	IN	O	in		-1	SENT_176	28408/28410
14	the	DT	O	the	det	15	SENT_176	28411/28414
15	absence	NN	O	absence	prep_in	12	SENT_176	28415/28422
16	of	IN	O	of		-1	SENT_176	28423/28425
17	Cs	NNS	O	c	prep_of	15	SENT_176	28426/28428
18	or	CC	O	or		-1	SENT_176	28429/28431
19	rifampin	NN	O	rifampin	conj_or	17	SENT_176	28432/28440
20	,	,	O	,		-1	SENT_176	28440/28441
21	and	CC	O	and		-1	SENT_176	28442/28445
22	they	PRP	O	they	nsubj	24	SENT_176	28446/28450
23	were	VBD	O	be	cop	24	SENT_176	28451/28455
24	consistent	JJ	O	consistent	conj_and	12	SENT_176	28456/28466
25	with	IN	O	with	mark	28	SENT_176	28467/28471
26	previous	JJ	O	previous	amod	27	SENT_176	28472/28480
27	results	NNS	O	result	nsubj	28	SENT_176	28481/28488
28	(	VBP	O	(	advcl	24	SENT_176	28489/28490
29	16	CD	NUMBER	16	num	30	SENT_176	28490/28492
30	)	CD	NUMBER	)	dobj	28	SENT_176	28492/28493
31	.	.	O	.		-1	SENT_176	28493/28494

1	Part	NNP	O	Part	nn	2	SENT_177	28530/28534
2	A	NNP	O	A		-1	SENT_177	28535/28536

1	It	PRP	O	it	nsubjpass	4	SENT_178	28572/28574
2	has	VBZ	O	have	aux	4	SENT_178	28575/28578
3	been	VBN	O	be	auxpass	4	SENT_178	28579/28583
4	shown	VBN	O	show		-1	SENT_178	28584/28589
5	that	IN	O	that	mark	8	SENT_178	28590/28594
6	Cs	NNS	O	c	nsubj	8	SENT_178	28595/28597
7	may	MD	O	may	aux	8	SENT_178	28598/28601
8	affect	VB	O	affect	ccomp	4	SENT_178	28602/28608
9	the	DT	O	the	det	10	SENT_178	28609/28612
10	PK	NN	O	pk	dobj	8	SENT_178	28613/28615
11	of	IN	O	of		-1	SENT_178	28616/28618
12	numerous	JJ	O	numerous	amod	13	SENT_178	28619/28627
13	compounds	NNS	O	compound	prep_of	10	SENT_178	28628/28637
14	through	IN	O	through		-1	SENT_178	28638/28645
15	its	PRP$	O	its	poss	17	SENT_178	28646/28649
16	inhibitory	JJ	O	inhibitory	amod	17	SENT_178	28650/28660
17	effect	NN	O	effect	prep_through	8	SENT_178	28661/28667
18	on	IN	O	on		-1	SENT_178	28668/28670
19	CYP3A4	NN	O	cyp3a4	nn	22	SENT_178	28671/28677
20	or	CC	O	or		-1	SENT_178	28678/28680
21	OATP	NN	O	oatp	conj_or	19	SENT_178	28681/28685
22	transporters	NNS	O	transporter	prep_on	17	SENT_178	28686/28698
23	(	VBP	O	(	dep	22	SENT_178	28699/28700
24	11,12,17-19	CD	NUMBER	11,12,17-19	num	25	SENT_178	28700/28711
25	)	CD	NUMBER	)	dobj	23	SENT_178	28711/28712
26	.	.	O	.		-1	SENT_178	28712/28713

1	The	DT	O	the	det	2	SENT_179	28714/28717
2	results	NNS	O	result	nsubj	21	SENT_179	28718/28725
3	of	IN	O	of		-1	SENT_179	28726/28728
4	a	DT	O	a	det	7	SENT_179	28729/28730
5	previously	RB	DATE	previously	advmod	6	SENT_179	28731/28741
6	performed	VBN	O	perform	amod	7	SENT_179	28742/28751
7	study	NN	O	study	prep_of	2	SENT_179	28752/28757
8	investigating	VBG	O	investigate	partmod	7	SENT_179	28758/28771
9	the	DT	O	the	det	10	SENT_179	28772/28775
10	interaction	NN	O	interaction	dobj	8	SENT_179	28776/28787
11	between	IN	O	between		-1	SENT_179	28788/28795
12	macitentan	NN	O	macitentan	prep_between	10	SENT_179	28796/28806
13	and	CC	O	and		-1	SENT_179	28807/28810
14	ketoconazole	NN	O	ketoconazole	conj_and	12	SENT_179	28811/28823
15	,	,	O	,		-1	SENT_179	28823/28824
16	a	DT	O	a	det	19	SENT_179	28825/28826
17	strong	JJ	O	strong	amod	19	SENT_179	28827/28833
18	CYP3A4	NN	O	cyp3a4	nn	19	SENT_179	28834/28840
19	inhibitor	NN	O	inhibitor	appos	12	SENT_179	28841/28850
20	,	,	O	,		-1	SENT_179	28850/28851
21	showed	VBD	O	show		-1	SENT_179	28852/28858
22	a	DT	O	a	det	24	SENT_179	28859/28860
23	small	JJ	O	small	amod	24	SENT_179	28861/28866
24	effect	NN	O	effect	dobj	21	SENT_179	28867/28873
25	of	IN	O	of		-1	SENT_179	28874/28876
26	ketoconazole	NN	O	ketoconazole	prep_of	24	SENT_179	28877/28889
27	on	IN	O	on		-1	SENT_179	28890/28892
28	the	DT	O	the	det	29	SENT_179	28893/28896
29	exposure	NN	O	exposure	prep_on	26	SENT_179	28897/28905
30	to	TO	O	to	aux	31	SENT_179	28906/28908
31	macitentan	VB	O	macitentan	infmod	29	SENT_179	28909/28919
32	(	CD	NUMBER	(	num	35	SENT_179	28920/28921
33	approximately	RB	O	approximately	advmod	35	SENT_179	28921/28934
34	two-fold	JJ	O	two-fold	amod	35	SENT_179	28935/28943
35	increase	NN	O	increase	dobj	31	SENT_179	28944/28952
36	of	IN	O	of		-1	SENT_179	28953/28955
37	the	DT	O	the	det	38	SENT_179	28956/28959
38	area	NN	O	area	prep_of	35	SENT_179	28960/28964
39	under	IN	O	under		-1	SENT_179	28965/28970
40	the	DT	O	the	det	43	SENT_179	28971/28974
41	plasma	NN	O	plasma	nn	43	SENT_179	28975/28981
42	concentration-time	NN	O	concentration-time	nn	43	SENT_179	28982/29000
43	curve	NN	O	curve	prep_under	31	SENT_179	29001/29006
44	from	IN	O	from		-1	SENT_179	29007/29011
45	zero	CD	NUMBER	zero	prep_from	31	SENT_179	29012/29016
46	to	TO	O	to		-1	SENT_179	29017/29019
47	infinity	NN	O	infinity	nn	49	SENT_179	29020/29028
48	[	CD	NUMBER	[	num	49	SENT_179	29029/29030
49	AUC0	NN	O	auc0	prep_to	21	SENT_179	29030/29034
50	-	:	O	-		-1	SENT_179	29034/29035
51	]	CD	NUMBER	]	num	52	SENT_179	29038/29039
52	)	NN	O	)	dobj	21	SENT_179	29039/29040
53	,	,	O	,		-1	SENT_179	29040/29041
54	which	WDT	O	which	nsubjpass	57	SENT_179	29042/29047
55	was	VBD	O	be	auxpass	57	SENT_179	29048/29051
56	not	RB	O	not	neg	57	SENT_179	29052/29055
57	considered	VBN	O	consider	rcmod	52	SENT_179	29056/29066
58	clinically	RB	O	clinically	advmod	59	SENT_179	29067/29077
59	relevant	JJ	O	relevant	acomp	57	SENT_179	29078/29086
60	(	IN	O	(		-1	SENT_179	29087/29088
61	10	CD	NUMBER	10	num	62	SENT_179	29088/29090
62	)	NN	O	)	prep_(	57	SENT_179	29090/29091
63	.	.	O	.		-1	SENT_179	29091/29092

1	Since	IN	O	since	mark	7	SENT_180	29093/29098
2	Cs	NNP	O	Cs	nsubj	7	SENT_180	29099/29101
3	is	VBZ	O	be	cop	7	SENT_180	29102/29104
4	a	DT	O	a	det	7	SENT_180	29105/29106
5	weaker	JJR	O	weaker	amod	7	SENT_180	29107/29113
6	CYP3A4	NN	O	cyp3a4	nn	7	SENT_180	29114/29120
7	inhibitor	NN	O	inhibitor	advcl	26	SENT_180	29121/29130
8	than	IN	O	than		-1	SENT_180	29131/29135
9	ketoconazole	NN	O	ketoconazole	prep_than	7	SENT_180	29136/29148
10	,	,	O	,		-1	SENT_180	29148/29149
11	a	DT	O	a	det	13	SENT_180	29150/29151
12	large	JJ	O	large	amod	13	SENT_180	29152/29157
13	effect	NN	O	effect	nsubjpass	26	SENT_180	29158/29164
14	of	IN	O	of		-1	SENT_180	29165/29167
15	Cs	NNS	O	c	prep_of	13	SENT_180	29168/29170
16	on	IN	O	on		-1	SENT_180	29171/29173
17	the	DT	O	the	det	18	SENT_180	29174/29177
18	exposure	NN	O	exposure	prep_on	15	SENT_180	29178/29186
19	to	TO	O	to		-1	SENT_180	29187/29189
20	macitentan	NN	O	macitentan	prep_to	18	SENT_180	29190/29200
21	through	IN	O	through		-1	SENT_180	29201/29208
22	CYP3A4	NN	O	cyp3a4	nn	23	SENT_180	29209/29215
23	inhibition	NN	O	inhibition	prep_through	20	SENT_180	29216/29226
24	was	VBD	O	be	auxpass	26	SENT_180	29227/29230
25	not	RB	O	not	neg	26	SENT_180	29231/29234
26	expected	VBN	O	expect		-1	SENT_180	29235/29243
27	.	.	O	.		-1	SENT_180	29243/29244

1	However	RB	O	however	advmod	24	SENT_181	29245/29252
2	,	,	O	,		-1	SENT_181	29252/29253
3	in	IN	O	in		-1	SENT_181	29254/29256
4	this	DT	O	this	det	5	SENT_181	29257/29261
5	study	NN	O	study	prep_in	24	SENT_181	29262/29267
6	,	,	O	,		-1	SENT_181	29267/29268
7	the	DT	O	the	det	8	SENT_181	29269/29272
8	investigation	NN	O	investigation	nsubj	24	SENT_181	29273/29286
9	of	IN	O	of		-1	SENT_181	29287/29289
10	a	DT	O	a	det	12	SENT_181	29290/29291
11	potential	JJ	O	potential	amod	12	SENT_181	29292/29301
12	increase	NN	O	increase	prep_of	8	SENT_181	29302/29310
13	in	IN	O	in		-1	SENT_181	29311/29313
14	exposure	NN	O	exposure	prep_in	12	SENT_181	29314/29322
15	to	TO	O	to		-1	SENT_181	29323/29325
16	macitentan	NN	O	macitentan	prep_to	14	SENT_181	29326/29336
17	through	IN	O	through		-1	SENT_181	29337/29344
18	inhibition	NN	O	inhibition	prep_through	14	SENT_181	29345/29355
19	of	IN	O	of		-1	SENT_181	29356/29358
20	OATP	NN	O	oatp	nn	21	SENT_181	29359/29363
21	transporters	NNS	O	transporter	prep_of	18	SENT_181	29364/29376
22	by	IN	O	by		-1	SENT_181	29377/29379
23	Cs	NNS	O	c	prep_by	14	SENT_181	29380/29382
24	was	VBD	O	be		-1	SENT_181	29383/29386
25	of	IN	O	of		-1	SENT_181	29387/29389
26	greater	JJR	O	greater	amod	27	SENT_181	29390/29397
27	interest	NN	O	interest	prep_of	24	SENT_181	29398/29406
28	.	.	O	.		-1	SENT_181	29406/29407

1	The	DT	O	the	det	2	SENT_182	29408/29411
2	results	NNS	O	result	nsubj	3	SENT_182	29412/29419
3	showed	VBD	O	show		-1	SENT_182	29420/29426
4	that	IN	O	that	mark	20	SENT_182	29427/29431
5	in	IN	O	in		-1	SENT_182	29432/29434
6	the	DT	O	the	det	7	SENT_182	29435/29438
7	presence	NN	O	presence	prep_in	20	SENT_182	29439/29447
8	of	IN	O	of		-1	SENT_182	29448/29450
9	Cs	NNP	O	Cs	prep_of	7	SENT_182	29451/29453
10	,	,	O	,		-1	SENT_182	29453/29454
11	the	DT	O	the	det	12	SENT_182	29455/29458
12	exposure	NN	O	exposure	nsubj	20	SENT_182	29459/29467
13	to	TO	O	to		-1	SENT_182	29468/29470
14	macitentan	NN	O	macitentan	prep_to	12	SENT_182	29471/29481
15	and	CC	O	and		-1	SENT_182	29482/29485
16	its	PRP$	O	its	poss	17	SENT_182	29486/29489
17	metabolites	NNS	O	metabolite	conj_and	14	SENT_182	29490/29501
18	did	VBD	O	do	aux	20	SENT_182	29502/29505
19	not	RB	O	not	neg	20	SENT_182	29506/29509
20	change	VB	O	change	ccomp	3	SENT_182	29510/29516
21	to	TO	O	to		-1	SENT_182	29517/29519
22	a	DT	O	a	det	25	SENT_182	29520/29521
23	clinically	RB	O	clinically	advmod	24	SENT_182	29522/29532
24	relevant	JJ	O	relevant	amod	25	SENT_182	29533/29541
25	extent	NN	O	extent	prep_to	20	SENT_182	29542/29548
26	,	,	O	,		-1	SENT_182	29548/29549
27	which	WDT	O	which	nsubj	28	SENT_182	29550/29555
28	indicates	VBZ	O	indicate	rcmod	25	SENT_182	29556/29565
29	no	DT	O	no	det	31	SENT_182	29566/29568
30	significant	JJ	O	significant	amod	31	SENT_182	29569/29580
31	interaction	NN	O	interaction	dobj	28	SENT_182	29581/29592
32	between	IN	O	between		-1	SENT_182	29593/29600
33	these	DT	O	these	det	35	SENT_182	29601/29606
34	two	CD	NUMBER	two	num	35	SENT_182	29607/29610
35	drugs	NNS	O	drug	prep_between	31	SENT_182	29611/29616
36	at	IN	O	at		-1	SENT_182	29617/29619
37	the	DT	O	the	det	38	SENT_182	29620/29623
38	level	NN	O	level	prep_at	28	SENT_182	29624/29629
39	of	IN	O	of		-1	SENT_182	29630/29632
40	metabolizing	VBG	O	metabolize	prepc_of	38	SENT_182	29633/29645
41	enzymes	NNS	O	enzyme	nsubj	43	SENT_182	29646/29653
42	and/or	JJ	O	and/or	amod	43	SENT_182	29654/29660
43	transporters	NNS	O	transporter	xcomp	40	SENT_182	29661/29673
44	such	JJ	O	such		-1	SENT_182	29674/29678
45	as	IN	O	as		-1	SENT_182	29679/29681
46	OATP	NN	O	oatp	prep_such_as	43	SENT_182	29682/29686
47	.	.	O	.		-1	SENT_182	29686/29687

1	This	DT	O	this	det	2	SENT_183	29723/29727
2	finding	NN	O	finding	nsubj	4	SENT_183	29728/29735
3	is	VBZ	O	be	cop	4	SENT_183	29736/29738
4	different	JJ	O	different		-1	SENT_183	29739/29748
5	from	IN	O	from		-1	SENT_183	29749/29753
6	that	DT	O	that	det	32	SENT_183	29754/29758
7	reported	VBN	O	report	amod	32	SENT_183	29759/29767
8	for	IN	O	for		-1	SENT_183	29768/29771
9	other	JJ	O	other	amod	10	SENT_183	29772/29777
10	ERAs	NNS	O	era	prep_for	7	SENT_183	29778/29782
11	,	,	O	,		-1	SENT_183	29782/29783
12	such	JJ	O	such		-1	SENT_183	29784/29788
13	as	IN	O	as		-1	SENT_183	29789/29791
14	ambrisentan	NN	O	ambrisentan	prep_such_as	10	SENT_183	29792/29803
15	or	CC	O	or		-1	SENT_183	29804/29806
16	bosentan	NN	O	bosentan	conj_or	14	SENT_183	29807/29815
17	,	,	O	,		-1	SENT_183	29815/29816
18	which	WDT	O	which	nsubj	19	SENT_183	29817/29822
19	showed	VBD	O	show	rcmod	14	SENT_183	29823/29829
20	OATP	NN	O	oatp	nn	21	SENT_183	29830/29834
21	involvement	NN	O	involvement	dobj	19	SENT_183	29835/29846
22	in	IN	O	in		-1	SENT_183	29847/29849
23	the	DT	O	the	det	24	SENT_183	29850/29853
24	interaction	NN	O	interaction	prep_in	19	SENT_183	29854/29865
25	of	IN	O	of		-1	SENT_183	29866/29868
26	those	DT	O	those	det	27	SENT_183	29869/29874
27	ERAs	NNS	O	era	prep_of	24	SENT_183	29875/29879
28	with	IN	O	with		-1	SENT_183	29880/29884
29	Cs	NN	O	c	prep_with	19	SENT_183	29885/29887
30	(	CD	NUMBER	(	number	31	SENT_183	29888/29889
31	11,12,19	CD	NUMBER	11,12,19	num	32	SENT_183	29889/29897
32	)	NN	O	)	prep_from	4	SENT_183	29897/29898
33	.	.	O	.		-1	SENT_183	29898/29899

1	The	DT	O	the	det	4	SENT_184	29900/29903
2	significant	JJ	O	significant	amod	4	SENT_184	29904/29915
3	initial	JJ	O	initial	amod	4	SENT_184	29916/29923
4	increase	NN	O	increase	nsubj	17	SENT_184	29924/29932
5	in	IN	O	in		-1	SENT_184	29933/29935
6	exposure	NN	O	exposure	prep_in	4	SENT_184	29936/29944
7	to	TO	O	to	aux	8	SENT_184	29945/29947
8	bosentan	VB	O	bosentan	infmod	6	SENT_184	29948/29956
9	seen	VBN	O	see	dep	8	SENT_184	29957/29961
10	in	IN	O	in		-1	SENT_184	29962/29964
11	the	DT	O	the	det	12	SENT_184	29965/29968
12	presence	NN	O	presence	prep_in	9	SENT_184	29969/29977
13	of	IN	O	of		-1	SENT_184	29978/29980
14	Cs	NNP	O	Cs	prep_of	12	SENT_184	29981/29983
15	in	IN	O	in		-1	SENT_184	29984/29986
16	humans	NNS	O	human	prep_in	9	SENT_184	29987/29993
17	(	VBP	O	(		-1	SENT_184	29994/29995
18	a	DT	O	a	det	20	SENT_184	29995/29996
19	30-fold	JJ	O	30-fold	amod	20	SENT_184	29997/30004
20	increase	NN	O	increase	dobj	17	SENT_184	30005/30013
21	after	IN	O	after	mark	31	SENT_184	30014/30019
22	the	DT	DURATION	the	det	24	SENT_184	30020/30023
23	first	JJ	DURATION	first	amod	24	SENT_184	30024/30029
24	day	NN	DURATION	day	nsubjpass	31	SENT_184	30030/30033
25	of	IN	O	of		-1	SENT_184	30034/30036
26	co-administration	NN	O	co-administration	prep_of	24	SENT_184	30037/30054
27	of	IN	O	of		-1	SENT_184	30055/30057
28	Cs	NNP	O	Cs	nn	29	SENT_184	30058/30060
29	)	NN	O	)	prep_of	26	SENT_184	30060/30061
30	was	VBD	O	be	auxpass	31	SENT_184	30062/30065
31	attributed	VBN	O	attribute	advcl	17	SENT_184	30066/30076
32	not	RB	O	not	neg	31	SENT_184	30077/30080
33	only	RB	O	only	advmod	31	SENT_184	30081/30085
34	to	TO	O	to		-1	SENT_184	30086/30088
35	the	DT	O	the	det	36	SENT_184	30089/30092
36	inhibition	NN	O	inhibition	prep_to	31	SENT_184	30093/30103
37	of	IN	O	of		-1	SENT_184	30104/30106
38	metabolizing	VBG	O	metabolize	prepc_of	36	SENT_184	30107/30119
39	enzymes	NNS	O	enzyme	dobj	38	SENT_184	30120/30127
40	but	CC	O	but		-1	SENT_184	30128/30131
41	mainly	RB	O	mainly	advmod	38	SENT_184	30132/30138
42	to	TO	O	to	aux	44	SENT_184	30139/30141
43	the	DT	O	the	det	44	SENT_184	30142/30145
44	inhibition	NN	O	inhibition	conj_but	38	SENT_184	30146/30156
45	of	IN	O	of		-1	SENT_184	30157/30159
46	OATP	NN	O	oatp	prep_of	44	SENT_184	30160/30164
47	by	IN	O	by		-1	SENT_184	30165/30167
48	Cs	NNS	O	c	prep_by	44	SENT_184	30168/30170
49	and	CC	O	and		-1	SENT_184	30171/30174
50	consequently	RB	O	consequently	advmod	51	SENT_184	30175/30187
51	reduced	VBN	O	reduce	conj_and	38	SENT_184	30188/30195
52	hepatic	JJ	O	hepatic	amod	56	SENT_184	30196/30203
53	uptake	NN	O	uptake	nn	56	SENT_184	30204/30210
54	(	NN	O	(	nn	56	SENT_184	30211/30212
55	17	CD	NUMBER	17	num	56	SENT_184	30212/30214
56	)	NN	O	)	dobj	51	SENT_184	30214/30215
57	.	.	O	.		-1	SENT_184	30215/30216

1	Cs	NNS	O	c	nsubjpass	4	SENT_185	30217/30219
2	may	MD	O	may	aux	4	SENT_185	30220/30223
3	be	VB	O	be	auxpass	4	SENT_185	30224/30226
4	used	VBN	O	use		-1	SENT_185	30227/30231
5	concomitantly	RB	O	concomitantly	advmod	4	SENT_185	30232/30245
6	with	IN	O	with		-1	SENT_185	30246/30250
7	pulmonary	JJ	O	pulmonary	amod	10	SENT_185	30251/30260
8	arterial	JJ	O	arterial	amod	10	SENT_185	30261/30269
9	hypertension	NN	O	hypertension	nn	10	SENT_185	30270/30282
10	therapies	NNS	O	therapy	prep_with	4	SENT_185	30283/30292
11	,	,	O	,		-1	SENT_185	30292/30293
12	particularly	RB	O	particularly	dep	4	SENT_185	30294/30306
13	in	IN	O	in		-1	SENT_185	30307/30309
14	those	DT	O	those	det	15	SENT_185	30310/30315
15	patients	NNS	O	patient	prep_in	4	SENT_185	30316/30324
16	with	IN	O	with		-1	SENT_185	30325/30329
17	connective	JJ	O	connective	amod	19	SENT_185	30330/30340
18	tissue	NN	O	tissue	nn	19	SENT_185	30341/30347
19	disease	NN	O	disease	prep_with	15	SENT_185	30348/30355
20	.	.	O	.		-1	SENT_185	30355/30356

1	In	IN	O	in		-1	SENT_186	30357/30359
2	addition	NN	O	addition	prep_in	11	SENT_186	30360/30368
3	,	,	O	,		-1	SENT_186	30368/30369
4	calcineurin	NN	O	calcineurin	nn	5	SENT_186	30370/30381
5	inhibitors	NNS	O	inhibitor	nsubjpass	11	SENT_186	30382/30392
6	,	,	O	,		-1	SENT_186	30392/30393
7	including	VBG	O	include		-1	SENT_186	30394/30403
8	Cs	NNP	O	Cs	prep_including	5	SENT_186	30404/30406
9	,	,	O	,		-1	SENT_186	30406/30407
10	are	VBP	O	be	auxpass	11	SENT_186	30408/30411
11	used	VBN	O	use		-1	SENT_186	30412/30416
12	to	TO	O	to	aux	13	SENT_186	30417/30419
13	prevent	VB	O	prevent	xcomp	11	SENT_186	30420/30427
14	host	NN	O	host	nn	16	SENT_186	30428/30432
15	organ	NN	O	organ	nn	16	SENT_186	30433/30438
16	rejection	NN	O	rejection	dobj	13	SENT_186	30439/30448
17	during	IN	O	during		-1	SENT_186	30449/30455
18	solid	JJ	O	solid	amod	21	SENT_186	30456/30461
19	organ	NN	O	organ	nn	21	SENT_186	30462/30467
20	transplantation	NN	O	transplantation	nn	21	SENT_186	30468/30483
21	procedures	NNS	O	procedure	prep_during	13	SENT_186	30484/30494
22	.	.	O	.		-1	SENT_186	30494/30495

1	However	RB	O	however	advmod	6	SENT_187	30496/30503
2	,	,	O	,		-1	SENT_187	30503/30504
3	calcineurin	NN	O	calcineurin	nn	4	SENT_187	30505/30516
4	inhibitors	NNS	O	inhibitor	nsubj	6	SENT_187	30517/30527
5	can	MD	O	can	aux	6	SENT_187	30528/30531
6	limit	VB	O	limit		-1	SENT_187	30532/30537
7	the	DT	O	the	det	8	SENT_187	30538/30541
8	success	NN	O	success	nsubj	12	SENT_187	30542/30549
9	of	IN	O	of		-1	SENT_187	30550/30552
10	kidney	NN	O	kidney	nn	11	SENT_187	30553/30559
11	transplantation	NN	O	transplantation	prep_of	8	SENT_187	30560/30575
12	due	JJ	O	due	xcomp	6	SENT_187	30576/30579
13	to	TO	O	to		-1	SENT_187	30580/30582
14	calcineurin	NN	O	calcineurin	nn	16	SENT_187	30583/30594
15	inhibitor-mediated	JJ	O	inhibitor-mediated	amod	16	SENT_187	30595/30613
16	nephrotoxicity	NN	O	nephrotoxicity	prep_to	12	SENT_187	30614/30628
17	.	.	O	.		-1	SENT_187	30628/30629

1	Data	NNS	O	datum	nsubj	5	SENT_188	30630/30634
2	from	IN	O	from		-1	SENT_188	30635/30639
3	previous	JJ	O	previous	amod	4	SENT_188	30640/30648
4	studies	NNS	O	study	prep_from	1	SENT_188	30649/30656
5	suggest	VBP	O	suggest		-1	SENT_188	30657/30664
6	that	IN	O	that	mark	10	SENT_188	30665/30669
7	some	DT	O	some	det	8	SENT_188	30670/30674
8	ERAs	NNS	O	era	nsubj	10	SENT_188	30675/30679
9	may	MD	O	may	aux	10	SENT_188	30680/30683
10	attenuate	VB	O	attenuate	ccomp	5	SENT_188	30684/30693
11	Cs	NNP	O	Cs	nn	12	SENT_188	30694/30696
12	toxicity	NN	O	toxicity	dobj	10	SENT_188	30697/30705
13	and	CC	O	and		-1	SENT_188	30706/30709
14	may	MD	O	may	aux	16	SENT_188	30710/30713
15	be	VB	O	be	cop	16	SENT_188	30714/30716
16	useful	JJ	O	useful	conj_and	5	SENT_188	30717/30723
17	in	IN	O	in	mark	22	SENT_188	30724/30726
18	solid	JJ	O	solid	amod	21	SENT_188	30727/30732
19	organ	NN	O	organ	nn	21	SENT_188	30733/30738
20	transplantation	NN	O	transplantation	nn	21	SENT_188	30739/30754
21	studies	NNS	O	study	nsubj	22	SENT_188	30755/30762
22	(	VBP	O	(	advcl	16	SENT_188	30763/30764
23	20-22	CD	NUMBER	20-22	num	24	SENT_188	30764/30769
24	)	CD	NUMBER	)	dobj	22	SENT_188	30769/30770
25	;	:	O	;		-1	SENT_188	30770/30771
26	in	IN	O	in		-1	SENT_188	30772/30774
27	contrast	NN	O	contrast	prep_in	35	SENT_188	30775/30783
28	to	TO	O	to		-1	SENT_188	30784/30786
29	other	JJ	O	other	amod	30	SENT_188	30787/30792
30	ERAs	NNS	O	era	prep_to	27	SENT_188	30793/30797
31	,	,	O	,		-1	SENT_188	30797/30798
32	macitentan	NN	O	macitentan	nsubj	35	SENT_188	30799/30809
33	does	VBZ	O	do	aux	35	SENT_188	30810/30814
34	not	RB	O	not	neg	35	SENT_188	30815/30818
35	show	VB	O	show	parataxis	5	SENT_188	30819/30823
36	any	DT	O	any	det	37	SENT_188	30824/30827
37	interaction	NN	O	interaction	dobj	35	SENT_188	30828/30839
38	with	IN	O	with		-1	SENT_188	30840/30844
39	Cs	NNS	O	c	prep_with	37	SENT_188	30845/30847
40	either	CC	O	either	preconj	35	SENT_188	30848/30854
41	at	IN	O	at		-1	SENT_188	30855/30857
42	the	DT	O	the	det	43	SENT_188	30858/30861
43	level	NN	O	level	prep_at	35	SENT_188	30862/30867
44	of	IN	O	of		-1	SENT_188	30868/30870
45	CYP	NN	O	cyp	nn	46	SENT_188	30871/30874
46	enzymes	NNS	O	enzyme	prep_of	43	SENT_188	30875/30882
47	or	CC	O	or		-1	SENT_188	30883/30885
48	at	IN	O	at		-1	SENT_188	30886/30888
49	the	DT	O	the	det	50	SENT_188	30889/30892
50	level	NN	O	level	conj_or	43	SENT_188	30893/30898
51	of	IN	O	of		-1	SENT_188	30899/30901
52	OATP	NN	O	oatp	nn	53	SENT_188	30902/30906
53	transporters	NNS	O	transporter	prep_of	50	SENT_188	30907/30919
54	.	.	O	.		-1	SENT_188	30919/30920

1	Therefore	RB	O	therefore	advmod	8	SENT_189	30921/30930
2	,	,	O	,		-1	SENT_189	30930/30931
3	macitentan	NN	O	macitentan	nsubj	8	SENT_189	30932/30942
4	in	IN	O	in		-1	SENT_189	30943/30945
5	combination	NN	O	combination	prep_in	3	SENT_189	30946/30957
6	with	IN	O	with		-1	SENT_189	30958/30962
7	Cs	NNP	O	Cs	prep_with	5	SENT_189	30963/30965
8	has	VBZ	O	have		-1	SENT_189	30966/30969
9	potential	JJ	O	potential	dobj	8	SENT_189	30970/30979
10	to	TO	O	to	aux	12	SENT_189	30980/30982
11	be	VB	O	be	cop	12	SENT_189	30983/30985
12	successful	JJ	O	successful	dep	9	SENT_189	30986/30996
13	in	IN	O	in		-1	SENT_189	30997/30999
14	organ	NN	O	organ	nn	15	SENT_189	31000/31005
15	transplantation	NN	O	transplantation	prep_in	12	SENT_189	31006/31021
16	without	IN	O	without		-1	SENT_189	31022/31029
17	the	DT	O	the	det	18	SENT_189	31030/31033
18	need	NN	O	need	prep_without	12	SENT_189	31034/31038
19	for	IN	O	for		-1	SENT_189	31039/31042
20	macitentan	NN	O	macitentan	nn	22	SENT_189	31043/31053
21	dose	NN	O	dose	nn	22	SENT_189	31054/31058
22	adjustment	NN	O	adjustment	prep_for	18	SENT_189	31059/31069
23	.	.	O	.		-1	SENT_189	31069/31070

1	Part	NN	O	part	nn	2	SENT_190	31106/31110
2	B	NN	O	b		-1	SENT_190	31111/31112

1	In	IN	O	in		-1	SENT_191	31148/31150
2	the	DT	O	the	det	3	SENT_191	31151/31154
3	presence	NN	O	presence	prep_in	10	SENT_191	31155/31163
4	of	IN	O	of		-1	SENT_191	31164/31166
5	rifampin	NN	O	rifampin	prep_of	3	SENT_191	31167/31175
6	,	,	O	,		-1	SENT_191	31175/31176
7	exposure	NN	O	exposure	nsubj	10	SENT_191	31177/31185
8	to	TO	O	to		-1	SENT_191	31186/31188
9	macitentan	NN	O	macitentan	prep_to	7	SENT_191	31189/31199
10	decreased	VBD	O	decrease		-1	SENT_191	31200/31209
11	markedly	RB	O	markedly	advmod	10	SENT_191	31210/31218
12	.	.	O	.		-1	SENT_191	31218/31219

1	This	DT	O	this	nsubj	2	SENT_192	31220/31224
2	indicates	VBZ	O	indicate		-1	SENT_192	31225/31234
3	that	IN	O	that	mark	9	SENT_192	31235/31239
4	the	DT	O	the	det	5	SENT_192	31240/31243
5	metabolism	NN	O	metabolism	nsubjpass	9	SENT_192	31244/31254
6	of	IN	O	of		-1	SENT_192	31255/31257
7	macitentan	NN	O	macitentan	prep_of	5	SENT_192	31258/31268
8	is	VBZ	O	be	auxpass	9	SENT_192	31269/31271
9	induced	VBN	O	induce	ccomp	2	SENT_192	31272/31279
10	in	IN	O	in		-1	SENT_192	31280/31282
11	the	DT	O	the	det	12	SENT_192	31283/31286
12	presence	NN	O	presence	prep_in	9	SENT_192	31287/31295
13	of	IN	O	of		-1	SENT_192	31296/31298
14	rifampin	NN	O	rifampin	prep_of	12	SENT_192	31299/31307
15	,	,	O	,		-1	SENT_192	31307/31308
16	a	DT	O	a	det	18	SENT_192	31309/31310
17	strong	JJ	O	strong	amod	18	SENT_192	31311/31317
18	inducer	NN	O	inducer	appos	14	SENT_192	31318/31325
19	of	IN	O	of		-1	SENT_192	31326/31328
20	CYP3A4	NN	O	cyp3a4	prep_of	18	SENT_192	31329/31335
21	.	.	O	.		-1	SENT_192	31335/31336

1	Complex	NN	O	complex	nn	2	SENT_193	31337/31344
2	interactions	NNS	O	interaction	nsubjpass	5	SENT_193	31345/31357
3	have	VBP	O	have	aux	5	SENT_193	31358/31362
4	been	VBN	O	be	auxpass	5	SENT_193	31363/31367
5	observed	VBN	O	observe		-1	SENT_193	31368/31376
6	between	IN	O	between		-1	SENT_193	31377/31384
7	rifampin	NN	O	rifampin	prep_between	5	SENT_193	31385/31393
8	and	CC	O	and		-1	SENT_193	31394/31397
9	a	DT	O	a	det	10	SENT_193	31398/31399
10	number	NN	O	number	conj_and	7	SENT_193	31400/31406
11	of	IN	O	of		-1	SENT_193	31407/31409
12	drugs	NNS	O	drug	prep_of	10	SENT_193	31410/31415
13	,	,	O	,		-1	SENT_193	31415/31416
14	including	VBG	O	include		-1	SENT_193	31417/31426
15	ERAs	NNS	O	era	prep_including	5	SENT_193	31427/31431
16	,	,	O	,		-1	SENT_193	31431/31432
17	which	WDT	O	which	nsubj	19	SENT_193	31433/31438
18	are	VBP	O	be	cop	19	SENT_193	31439/31442
19	subject	JJ	O	subject	rcmod	15	SENT_193	31443/31450
20	to	TO	O	to		-1	SENT_193	31451/31453
21	both	DT	O	both	det	23	SENT_193	31454/31458
22	CYP3A4-mediated	JJ	O	cyp3a4-mediated	amod	23	SENT_193	31459/31474
23	oxidation	NN	O	oxidation	prep_to	19	SENT_193	31475/31484
24	and	CC	O	and		-1	SENT_193	31485/31488
25	OATP-mediated	JJ	O	oatp-mediated	amod	27	SENT_193	31489/31502
26	hepatic	JJ	O	hepatic	amod	27	SENT_193	31503/31510
27	uptake	NN	O	uptake	conj_and	23	SENT_193	31511/31517
28	.	.	O	.		-1	SENT_193	31517/31518

1	These	DT	O	these	det	2	SENT_194	31519/31524
2	studies	NNS	O	study	nsubj	5	SENT_194	31525/31532
3	have	VBP	O	have	aux	5	SENT_194	31533/31537
4	typically	RB	O	typically	advmod	5	SENT_194	31538/31547
5	revealed	VBN	O	reveal		-1	SENT_194	31548/31556
6	a	DT	O	a	det	8	SENT_194	31557/31558
7	biphasic	JJ	O	biphasic	amod	8	SENT_194	31559/31567
8	response	NN	O	response	dobj	5	SENT_194	31568/31576
9	characterized	VBN	O	characterize	partmod	8	SENT_194	31577/31590
10	by	IN	O	by		-1	SENT_194	31591/31593
11	an	DT	O	a	det	15	SENT_194	31594/31596
12	initial	JJ	O	initial	amod	15	SENT_194	31597/31604
13	,	,	O	,		-1	SENT_194	31604/31605
14	transient	JJ	O	transient	amod	15	SENT_194	31606/31615
15	increase	NN	O	increase	agent	9	SENT_194	31616/31624
16	in	IN	O	in		-1	SENT_194	31625/31627
17	ERA	NN	O	era	nn	19	SENT_194	31628/31631
18	plasma	NN	O	plasma	nn	19	SENT_194	31632/31638
19	concentration	NN	O	concentration	prep_in	15	SENT_194	31639/31652
20	with	IN	O	with		-1	SENT_194	31653/31657
21	acute	JJ	O	acute	amod	23	SENT_194	31658/31663
22	rifampin	NN	O	rifampin	nn	23	SENT_194	31664/31672
23	administration	NN	O	administration	prep_with	19	SENT_194	31673/31687
24	,	,	O	,		-1	SENT_194	31687/31688
25	presumably	RB	O	presumably	dep	8	SENT_194	31689/31699
26	due	JJ	O	due		-1	SENT_194	31700/31703
27	to	TO	O	to		-1	SENT_194	31704/31706
28	OATP	NN	O	oatp	nn	29	SENT_194	31707/31711
29	inhibition	NN	O	inhibition	prep_due_to	8	SENT_194	31712/31722
30	,	,	O	,		-1	SENT_194	31722/31723
31	followed	VBN	O	follow	partmod	29	SENT_194	31724/31732
32	by	IN	O	by		-1	SENT_194	31733/31735
33	reduction	NN	O	reduction	agent	31	SENT_194	31736/31745
34	in	IN	O	in		-1	SENT_194	31746/31748
35	exposure	NN	O	exposure	prep_in	31	SENT_194	31749/31757
36	attributed	VBN	O	attribute	partmod	35	SENT_194	31758/31768
37	to	TO	O	to		-1	SENT_194	31769/31771
38	CYP3A4	NN	O	cyp3a4	nn	39	SENT_194	31772/31778
39	induction	NN	O	induction	prep_to	36	SENT_194	31779/31788
40	(	CD	NUMBER	(	num	42	SENT_194	31789/31790
41	23-26	CD	NUMBER	23-26	num	42	SENT_194	31790/31795
42	)	NN	O	)	dep	8	SENT_194	31795/31796
43	.	.	O	.		-1	SENT_194	31796/31797

1	Such	JJ	O	such	amod	3	SENT_195	31798/31802
2	biphasic	JJ	O	biphasic	amod	3	SENT_195	31803/31811
3	effects	NNS	O	effect	nsubjpass	8	SENT_195	31812/31819
4	of	IN	O	of		-1	SENT_195	31820/31822
5	rifampin	NN	O	rifampin	prep_of	3	SENT_195	31823/31831
6	are	VBP	O	be	auxpass	8	SENT_195	31832/31835
7	not	RB	O	not	neg	8	SENT_195	31836/31839
8	observed	VBN	O	observe		-1	SENT_195	31840/31848
9	with	IN	O	with		-1	SENT_195	31849/31853
10	macitentan	NN	O	macitentan	prep_with	8	SENT_195	31854/31864
11	,	,	O	,		-1	SENT_195	31864/31865
12	which	WDT	O	which	nsubj	14	SENT_195	31866/31871
13	further	RB	O	further	advmod	14	SENT_195	31872/31879
14	demonstrates	VBZ	O	demonstrate	rcmod	10	SENT_195	31880/31892
15	the	DT	O	the	det	16	SENT_195	31893/31896
16	absence	NN	O	absence	dobj	14	SENT_195	31897/31904
17	of	IN	O	of		-1	SENT_195	31905/31907
18	a	DT	O	a	det	19	SENT_195	31908/31909
19	contribution	NN	O	contribution	prep_of	16	SENT_195	31910/31922
20	from	IN	O	from		-1	SENT_195	31923/31927
21	OATP	NN	ORGANIZATION	oatp	prep_from	19	SENT_195	31928/31932
22	to	TO	O	to		-1	SENT_195	31933/31935
23	the	DT	O	the	det	24	SENT_195	31936/31939
24	disposition	NN	O	disposition	prep_to	14	SENT_195	31940/31951
25	of	IN	O	of		-1	SENT_195	31952/31954
26	macitentan	NN	O	macitentan	prep_of	24	SENT_195	31955/31965
27	.	.	O	.		-1	SENT_195	31965/31966

1	The	DT	O	the	det	3	SENT_196	31967/31970
2	initial	JJ	O	initial	amod	3	SENT_196	31971/31978
3	increase	NN	O	increase	nsubjpass	18	SENT_196	31979/31987
4	seen	VBN	O	see	partmod	3	SENT_196	31988/31992
5	in	IN	O	in		-1	SENT_196	31993/31995
6	trough	NN	O	trough	nn	7	SENT_196	31996/32002
7	concentrations	NNS	O	concentration	prep_in	4	SENT_196	32003/32017
8	of	IN	O	of		-1	SENT_196	32018/32020
9	ACT-132577	NN	O	act-132577	prep_of	7	SENT_196	32021/32031
10	after	IN	O	after		-1	SENT_196	32032/32037
11	the	DT	O	the	det	13	SENT_196	32038/32041
12	first	JJ	ORDINAL	first	amod	13	SENT_196	32042/32047
13	doses	NNS	O	dose	prep_after	4	SENT_196	32048/32053
14	of	IN	O	of		-1	SENT_196	32054/32056
15	rifampin	NN	O	rifampin	prep_of	13	SENT_196	32057/32065
16	could	MD	O	could	aux	18	SENT_196	32066/32071
17	be	VB	O	be	auxpass	18	SENT_196	32072/32074
18	explained	VBN	O	explain		-1	SENT_196	32075/32084
19	by	IN	O	by		-1	SENT_196	32085/32087
20	an	DT	O	a	det	21	SENT_196	32088/32090
21	increase	NN	O	increase	agent	18	SENT_196	32091/32099
22	in	IN	O	in		-1	SENT_196	32100/32102
23	macitentan	NN	O	macitentan	nn	24	SENT_196	32103/32113
24	metabolism	NN	O	metabolism	prep_in	21	SENT_196	32114/32124
25	at	IN	O	at		-1	SENT_196	32125/32127
26	the	DT	O	the	det	27	SENT_196	32128/32131
27	level	NN	O	level	prep_at	18	SENT_196	32132/32137
28	of	IN	O	of		-1	SENT_196	32138/32140
29	CYP3A4	NN	O	cyp3a4	prep_of	27	SENT_196	32141/32147
30	,	,	O	,		-1	SENT_196	32147/32148
31	resulting	VBG	O	result	xcomp	18	SENT_196	32149/32158
32	in	IN	O	in		-1	SENT_196	32159/32161
33	an	DT	O	a	det	36	SENT_196	32162/32164
34	increased	VBN	O	increase	amod	36	SENT_196	32165/32174
35	transformation	NN	O	transformation	nn	36	SENT_196	32175/32189
36	rate	NN	O	rate	prep_in	31	SENT_196	32190/32194
37	to	TO	O	to		-1	SENT_196	32195/32197
38	ACT-132577	NN	O	act-132577	prep_to	36	SENT_196	32198/32208
39	.	.	O	.		-1	SENT_196	32208/32209

1	Rifampin	NNP	O	Rifampin	nsubjpass	5	SENT_197	32210/32218
2	has	VBZ	O	have	aux	5	SENT_197	32219/32222
3	also	RB	O	also	advmod	5	SENT_197	32223/32227
4	been	VBN	O	be	auxpass	5	SENT_197	32228/32232
5	reported	VBN	O	report		-1	SENT_197	32233/32241
6	to	TO	O	to	aux	9	SENT_197	32242/32244
7	be	VB	O	be	cop	9	SENT_197	32245/32247
8	an	DT	O	a	det	9	SENT_197	32248/32250
9	inducer	NN	O	inducer	xcomp	5	SENT_197	32251/32258
10	of	IN	O	of		-1	SENT_197	32259/32261
11	conjugation	NN	O	conjugation	nn	12	SENT_197	32262/32273
12	enzymes	NNS	O	enzyme	prep_of	9	SENT_197	32274/32281
13	,	,	O	,		-1	SENT_197	32281/32282
14	which	WDT	O	which	nsubj	15	SENT_197	32283/32288
15	render	VBP	O	render	rcmod	12	SENT_197	32289/32295
16	drugs	NNS	O	drug	nsubj	18	SENT_197	32296/32301
17	more	RBR	O	more	advmod	18	SENT_197	32302/32306
18	polar	JJ	O	polar	xcomp	15	SENT_197	32307/32312
19	and	CC	O	and		-1	SENT_197	32313/32316
20	facilitate	VB	O	facilitate	conj_and	9	SENT_197	32317/32327
21	their	PRP$	O	they	poss	25	SENT_197	32328/32333
22	excretion	NN	O	excretion	nn	25	SENT_197	32334/32343
23	(	NN	O	(	nn	25	SENT_197	32344/32345
24	7	CD	NUMBER	7	num	25	SENT_197	32345/32346
25	)	NN	O	)	dobj	20	SENT_197	32346/32347
26	.	.	O	.		-1	SENT_197	32347/32348

1	In	IN	O	in		-1	SENT_198	32349/32351
2	humans	NNS	O	human	prep_in	7	SENT_198	32352/32358
3	,	,	O	,		-1	SENT_198	32358/32359
4	conjugation	NN	O	conjugation	nn	5	SENT_198	32360/32371
5	enzymes	NNS	O	enzyme	nsubjpass	7	SENT_198	32372/32379
6	are	VBP	O	be	auxpass	7	SENT_198	32380/32383
7	involved	VBN	O	involve		-1	SENT_198	32384/32392
8	in	IN	O	in		-1	SENT_198	32393/32395
9	the	DT	O	the	det	10	SENT_198	32396/32399
10	elimination	NN	O	elimination	prep_in	7	SENT_198	32400/32411
11	of	IN	O	of		-1	SENT_198	32412/32414
12	ACT-132577	NN	O	act-132577	prep_of	10	SENT_198	32415/32425
13	,	,	O	,		-1	SENT_198	32425/32426
14	which	WDT	O	which	nsubjpass	19	SENT_198	32427/32432
15	could	MD	O	could	aux	19	SENT_198	32433/32438
16	in	IN	O	in		-1	SENT_198	32439/32441
17	turn	NN	O	turn	prep_in	19	SENT_198	32442/32446
18	be	VB	O	be	auxpass	19	SENT_198	32447/32449
19	induced	VBN	O	induce	rcmod	12	SENT_198	32450/32457
20	by	IN	O	by		-1	SENT_198	32458/32460
21	rifampin	NN	O	rifampin	agent	19	SENT_198	32461/32469
22	,	,	O	,		-1	SENT_198	32469/32470
23	accelerating	VBG	O	accelerate	xcomp	19	SENT_198	32471/32483
24	the	DT	O	the	det	25	SENT_198	32484/32487
25	elimination	NN	O	elimination	dobj	23	SENT_198	32488/32499
26	of	IN	O	of		-1	SENT_198	32500/32502
27	ACT-132577	NN	O	act-132577	prep_of	25	SENT_198	32503/32513
28	.	.	O	.		-1	SENT_198	32513/32514

1	This	DT	O	this	det	2	SENT_199	32515/32519
2	hypothesis	NN	O	hypothesis	nsubjpass	4	SENT_199	32520/32530
3	is	VBZ	O	be	auxpass	4	SENT_199	32531/32533
4	supported	VBN	O	support		-1	SENT_199	32534/32543
5	by	IN	O	by		-1	SENT_199	32544/32546
6	the	DT	O	the	det	7	SENT_199	32547/32550
7	observation	NN	O	observation	agent	4	SENT_199	32551/32562
8	that	IN	O	that	mark	22	SENT_199	32563/32567
9	the	DT	O	the	det	10	SENT_199	32568/32571
10	exposure	NN	O	exposure	nsubj	22	SENT_199	32572/32580
11	to	TO	O	to		-1	SENT_199	32581/32583
12	ACT-132577	NN	O	act-132577	prep_to	10	SENT_199	32584/32594
13	after	IN	O	after		-1	SENT_199	32595/32600
14	continued	JJ	O	continued	amod	19	SENT_199	32601/32610
15	dosing	NN	O	dosing	nn	19	SENT_199	32611/32617
16	(	NN	O	(	nn	19	SENT_199	32618/32619
17	day	NN	DURATION	day	nn	19	SENT_199	32619/32622
18	12	CD	NUMBER	12	num	19	SENT_199	32623/32625
19	)	NN	O	)	prep_after	12	SENT_199	32625/32626
20	was	VBD	O	be	cop	22	SENT_199	32627/32630
21	very	RB	O	very	advmod	22	SENT_199	32631/32635
22	similar	JJ	O	similar	ccomp	4	SENT_199	32636/32643
23	to	TO	O	to		-1	SENT_199	32644/32646
24	that	DT	O	that	prep_to	22	SENT_199	32647/32651
25	without	IN	O	without		-1	SENT_199	32652/32659
26	rifampin	NN	O	rifampin	prep_without	22	SENT_199	32660/32668
27	.	.	O	.		-1	SENT_199	32668/32669

1	OATP	NN	O	oatp	nsubj	3	SENT_200	32670/32674
2	is	VBZ	O	be	cop	3	SENT_200	32675/32677
3	unlikely	JJ	O	unlikely		-1	SENT_200	32678/32686
4	to	TO	O	to	aux	6	SENT_200	32687/32689
5	be	VB	O	be	auxpass	6	SENT_200	32690/32692
6	involved	VBN	O	involve	xcomp	3	SENT_200	32693/32701
7	in	IN	O	in		-1	SENT_200	32702/32704
8	the	DT	O	the	det	10	SENT_200	32705/32708
9	initial	JJ	O	initial	amod	10	SENT_200	32709/32716
10	increase	NN	O	increase	prep_in	6	SENT_200	32717/32725
11	of	IN	O	of		-1	SENT_200	32726/32728
12	exposure	NN	O	exposure	prep_of	10	SENT_200	32729/32737
13	to	TO	O	to		-1	SENT_200	32738/32740
14	ACT-132577	NN	O	act-132577	prep_to	6	SENT_200	32741/32751
15	based	VBN	O	base	partmod	14	SENT_200	32752/32757
16	on	IN	O	on		-1	SENT_200	32758/32760
17	the	DT	O	the	det	18	SENT_200	32761/32764
18	fact	NN	O	fact	prep_on	15	SENT_200	32765/32769
19	that	IN	O	that	mark	34	SENT_200	32770/32774
20	concomitant	JJ	O	concomitant	amod	21	SENT_200	32775/32786
21	treatment	NN	O	treatment	nsubj	34	SENT_200	32787/32796
22	with	IN	O	with		-1	SENT_200	32797/32801
23	Cs	NNS	O	c	prep_with	21	SENT_200	32802/32804
24	,	,	O	,		-1	SENT_200	32804/32805
25	also	RB	O	also	advmod	21	SENT_200	32806/32810
26	a	DT	O	a	det	28	SENT_200	32811/32812
27	major	JJ	O	major	amod	28	SENT_200	32813/32818
28	inhibitor	NN	O	inhibitor	dep	21	SENT_200	32819/32828
29	of	IN	O	of		-1	SENT_200	32829/32831
30	OATP	NN	O	oatp	prep_of	28	SENT_200	32832/32836
31	,	,	O	,		-1	SENT_200	32836/32837
32	did	VBD	O	do	aux	34	SENT_200	32838/32841
33	not	RB	O	not	neg	34	SENT_200	32842/32845
34	show	VB	O	show	ccomp	15	SENT_200	32846/32850
35	the	DT	O	the	det	37	SENT_200	32851/32854
36	same	JJ	O	same	amod	37	SENT_200	32855/32859
37	effect	NN	O	effect	dobj	34	SENT_200	32860/32866
38	.	.	O	.		-1	SENT_200	32866/32867

1	Since	IN	O	since	mark	8	SENT_201	32868/32873
2	both	DT	O	both	preconj	3	SENT_201	32874/32878
3	rifampin	NN	O	rifampin	nsubjpass	8	SENT_201	32879/32887
4	and	CC	O	and		-1	SENT_201	32888/32891
5	macitentan	NN	O	macitentan	conj_and	3	SENT_201	32892/32902
6	would	MD	O	would	aux	8	SENT_201	32903/32908
7	be	VB	O	be	auxpass	8	SENT_201	32909/32911
8	administered	VBN	O	administer	advcl	30	SENT_201	32912/32924
9	on	IN	O	on		-1	SENT_201	32925/32927
10	a	DT	O	a	det	12	SENT_201	32928/32929
11	multiple-dose	JJ	O	multiple-dose	amod	12	SENT_201	32930/32943
12	basis	NN	O	basis	prep_on	8	SENT_201	32944/32949
13	if	IN	O	if	mark	14	SENT_201	32950/32952
14	used	VBN	O	use	advcl	8	SENT_201	32953/32957
15	together	RB	O	together	advmod	14	SENT_201	32958/32966
16	,	,	O	,		-1	SENT_201	32966/32967
17	the	DT	O	the	det	18	SENT_201	32968/32971
18	exposure	NN	O	exposure	nsubjpass	30	SENT_201	32972/32980
19	at	IN	O	at		-1	SENT_201	32981/32983
20	steady-state	JJ	O	steady-state	amod	22	SENT_201	32984/32996
21	(	NN	O	(	nn	22	SENT_201	32997/32998
22	day	NN	DURATION	day	prep_at	30	SENT_201	32998/33001
23	5	CD	NUMBER	5	nsubjpass	30	SENT_201	33002/33003
24	compared	VBN	O	compare		-1	SENT_201	33004/33012
25	to	TO	O	to	prepc_compared_to	23	SENT_201	33013/33015
26	day	NN	DURATION	day	nn	28	SENT_201	33016/33019
27	12	CD	NUMBER	12	num	28	SENT_201	33020/33022
28	)	NN	O	)	pobj	23	SENT_201	33022/33023
29	is	VBZ	O	be	auxpass	30	SENT_201	33024/33026
30	considered	VBN	O	consider		-1	SENT_201	33027/33037
31	to	TO	O	to	aux	36	SENT_201	33038/33040
32	be	VB	O	be	cop	36	SENT_201	33041/33043
33	the	DT	O	the	det	36	SENT_201	33044/33047
34	most	RBS	O	most	advmod	35	SENT_201	33048/33052
35	relevant	JJ	O	relevant	amod	36	SENT_201	33053/33061
36	comparison	NN	O	comparison	xcomp	30	SENT_201	33062/33072
37	between	IN	O	between		-1	SENT_201	33073/33080
38	the	DT	O	the	det	41	SENT_201	33081/33084
39	two	CD	NUMBER	two	num	41	SENT_201	33085/33088
40	treatment	NN	O	treatment	nn	41	SENT_201	33089/33098
41	conditions	NNS	O	condition	prep_between	36	SENT_201	33099/33109
42	.	.	O	.		-1	SENT_201	33109/33110

1	Macitentan	NNP	O	Macitentan	nsubj	10	SENT_202	33146/33156
2	and	CC	O	and		-1	SENT_202	33157/33160
3	its	PRP$	O	its	poss	5	SENT_202	33161/33164
4	metabolite	NN	O	metabolite	nn	5	SENT_202	33165/33175
5	ACT-132577	NN	O	act-132577	conj_and	1	SENT_202	33176/33186
6	are	VBP	O	be	cop	10	SENT_202	33187/33190
7	both	DT	O	both	det	10	SENT_202	33191/33195
8	potent	JJ	O	potent	amod	10	SENT_202	33196/33202
9	dual	JJ	O	dual	amod	10	SENT_202	33203/33207
10	ERAs	NNS	O	era		-1	SENT_202	33208/33212
11	,	,	O	,		-1	SENT_202	33212/33213
12	and	CC	O	and		-1	SENT_202	33214/33217
13	both	DT	O	both	nsubj	14	SENT_202	33218/33222
14	contribute	VBP	O	contribute	conj_and	10	SENT_202	33223/33233
15	to	TO	O	to		-1	SENT_202	33234/33236
16	the	DT	O	the	det	19	SENT_202	33237/33240
17	overall	JJ	O	overall	amod	19	SENT_202	33241/33248
18	pharmacological	JJ	O	pharmacological	amod	19	SENT_202	33249/33264
19	effect	NN	O	effect	prep_to	14	SENT_202	33265/33271
20	of	IN	O	of		-1	SENT_202	33272/33274
21	macitentan	NN	O	macitentan	prep_of	19	SENT_202	33275/33285
22	in	FW	O	in	prep	21	SENT_202	33286/33288
23	vivo	FW	O	vivo	pobj	22	SENT_202	33289/33293
24	.	.	O	.		-1	SENT_202	33293/33294

1	ACT-132577	NN	O	act-132577	nsubj	5	SENT_203	33295/33305
2	is	VBZ	O	be	cop	5	SENT_203	33306/33308
3	approximately	RB	O	approximately	advmod	4	SENT_203	33309/33322
4	five-fold	JJ	O	five-fold	amod	5	SENT_203	33323/33332
5	less	JJR	O	less		-1	SENT_203	33333/33337
6	potent	JJ	O	potent	amod	5	SENT_203	33338/33344
7	than	IN	O	than		-1	SENT_203	33345/33349
8	macitentan	NN	O	macitentan	prep_than	6	SENT_203	33350/33360
9	in	FW	O	in	nn	10	SENT_203	33361/33363
10	vitro	FW	O	vitro	advmod	5	SENT_203	33364/33369
11	.	.	O	.		-1	SENT_203	33369/33370

1	However	RB	O	however	advmod	11	SENT_204	33371/33378
2	,	,	O	,		-1	SENT_204	33378/33379
3	systemic	JJ	O	systemic	amod	4	SENT_204	33380/33388
4	exposure	NN	O	exposure	nsubj	11	SENT_204	33389/33397
5	in	IN	O	in		-1	SENT_204	33398/33400
6	humans	NNS	O	human	prep_in	4	SENT_204	33401/33407
7	to	TO	O	to		-1	SENT_204	33408/33410
8	ACT-132577	NN	O	act-132577	prep_to	6	SENT_204	33411/33421
9	is	VBZ	O	be	cop	11	SENT_204	33422/33424
10	2.5-fold	RB	O	2.5-fold	advmod	11	SENT_204	33425/33433
11	higher	JJR	O	higher		-1	SENT_204	33434/33440
12	than	IN	O	than	mark	14	SENT_204	33441/33445
13	to	TO	O	to	aux	14	SENT_204	33446/33448
14	macitentan	VB	O	macitentan	ccomp	11	SENT_204	33449/33459
15	.	.	O	.		-1	SENT_204	33459/33460

1	Although	IN	O	although	mark	10	SENT_205	33461/33469
2	the	DT	O	the	det	3	SENT_205	33470/33473
3	exposure	NN	O	exposure	nsubjpass	10	SENT_205	33474/33482
4	to	TO	O	to		-1	SENT_205	33483/33485
5	ACT-132577	NN	O	act-132577	prep_to	3	SENT_205	33486/33496
6	at	IN	O	at		-1	SENT_205	33497/33499
7	steady-state	NN	O	steady-state	prep_at	5	SENT_205	33500/33512
8	was	VBD	O	be	auxpass	10	SENT_205	33513/33516
9	not	RB	O	not	neg	10	SENT_205	33517/33520
10	affected	VBN	O	affect	advcl	31	SENT_205	33521/33529
11	by	IN	O	by		-1	SENT_205	33530/33532
12	concomitant	JJ	O	concomitant	amod	13	SENT_205	33533/33544
13	treatment	NN	O	treatment	agent	10	SENT_205	33545/33554
14	with	IN	O	with		-1	SENT_205	33555/33559
15	rifampin	NN	O	rifampin	prep_with	10	SENT_205	33560/33568
16	,	,	O	,		-1	SENT_205	33568/33569
17	the	DT	O	the	det	20	SENT_205	33570/33573
18	approximately	RB	O	approximately	advmod	19	SENT_205	33574/33587
19	four-fold	JJ	O	four-fold	amod	20	SENT_205	33588/33597
20	reduction	NN	O	reduction	nsubj	31	SENT_205	33598/33607
21	in	IN	O	in		-1	SENT_205	33608/33610
22	exposure	NN	O	exposure	prep_in	20	SENT_205	33611/33619
23	to	TO	O	to	aux	24	SENT_205	33620/33622
24	macitentan	VB	O	macitentan	infmod	22	SENT_205	33623/33633
25	in	IN	O	in		-1	SENT_205	33634/33636
26	the	DT	O	the	det	27	SENT_205	33637/33640
27	presence	NN	O	presence	prep_in	24	SENT_205	33641/33649
28	of	IN	O	of		-1	SENT_205	33650/33652
29	rifampin	NN	O	rifampin	prep_of	27	SENT_205	33653/33661
30	might	MD	O	might	aux	31	SENT_205	33662/33667
31	affect	VB	O	affect		-1	SENT_205	33668/33674
32	the	DT	O	the	det	35	SENT_205	33675/33678
33	overall	JJ	O	overall	amod	35	SENT_205	33679/33686
34	pharmacological	JJ	O	pharmacological	amod	35	SENT_205	33687/33702
35	effect	NN	O	effect	dobj	31	SENT_205	33703/33709
36	of	IN	O	of		-1	SENT_205	33710/33712
37	the	DT	O	the	det	38	SENT_205	33713/33716
38	drug	NN	O	drug	prep_of	35	SENT_205	33717/33721
39	.	.	O	.		-1	SENT_205	33721/33722

1	Thus	RB	O	thus	advmod	17	SENT_206	33723/33727
2	,	,	O	,		-1	SENT_206	33727/33728
3	reduced	VBD	O	reduce	csubjpass	17	SENT_206	33729/33736
4	efficacy	NN	O	efficacy	dobj	3	SENT_206	33737/33745
5	of	IN	O	of		-1	SENT_206	33746/33748
6	macitentan	NN	O	macitentan	prep_of	4	SENT_206	33749/33759
7	in	IN	O	in		-1	SENT_206	33760/33762
8	the	DT	O	the	det	9	SENT_206	33763/33766
9	presence	NN	O	presence	prep_in	3	SENT_206	33767/33775
10	of	IN	O	of		-1	SENT_206	33776/33778
11	concomitant	JJ	O	concomitant	amod	12	SENT_206	33779/33790
12	treatment	NN	O	treatment	prep_of	9	SENT_206	33791/33800
13	with	IN	O	with		-1	SENT_206	33801/33805
14	rifampin	NN	O	rifampin	prep_with	3	SENT_206	33806/33814
15	should	MD	O	should	aux	17	SENT_206	33815/33821
16	be	VB	O	be	auxpass	17	SENT_206	33822/33824
17	considered	VBN	O	consider		-1	SENT_206	33825/33835
18	.	.	O	.		-1	SENT_206	33835/33836

1	The	DT	O	the	det	2	SENT_207	33872/33875
2	results	NNS	O	result	nsubj	8	SENT_207	33876/33883
3	from	IN	O	from	prep	2	SENT_207	33884/33888
4	in	FW	O	in	nn	5	SENT_207	33889/33891
5	vitro	FW	O	vitro	dep	7	SENT_207	33892/33897
6	OATP	NN	O	oatp	nn	7	SENT_207	33898/33902
7	studies	NNS	O	study	dep	3	SENT_207	33903/33910
8	support	VBP	O	support		-1	SENT_207	33911/33918
9	the	DT	O	the	det	10	SENT_207	33919/33922
10	observations	NNS	O	observation	dobj	8	SENT_207	33923/33935
11	from	IN	O	from		-1	SENT_207	33936/33940
12	the	DT	O	the	det	14	SENT_207	33941/33944
13	clinical	JJ	O	clinical	amod	14	SENT_207	33945/33953
14	study	NN	O	study	prep_from	8	SENT_207	33954/33959
15	.	.	O	.		-1	SENT_207	33959/33960

1	High	JJ	O	high	amod	4	SENT_208	33961/33965
2	cellular	JJ	O	cellular	amod	4	SENT_208	33966/33974
3	uptake	NN	O	uptake	nn	4	SENT_208	33975/33981
4	rates	NNS	O	rate	nsubj	19	SENT_208	33982/33987
5	of	IN	O	of		-1	SENT_208	33988/33990
6	macitentan	NN	O	macitentan	prep_of	4	SENT_208	33991/34001
7	and	CC	O	and		-1	SENT_208	34002/34005
8	ACT-132577	NN	O	act-132577	conj_and	6	SENT_208	34006/34016
9	in	IN	O	in		-1	SENT_208	34017/34019
10	wild-type	JJ	O	wild-type	amod	11	SENT_208	34020/34029
11	cells	NNS	O	cell	prep_in	6	SENT_208	34030/34035
12	as	RB	O	as		-1	SENT_208	34036/34038
13	well	RB	O	well		-1	SENT_208	34039/34043
14	as	IN	O	as		-1	SENT_208	34044/34046
15	OATP	NN	O	oatp	nn	18	SENT_208	34047/34051
16	over-expressing	NN	O	over-expressing	nn	18	SENT_208	34052/34067
17	CHO	NN	O	cho	nn	18	SENT_208	34068/34071
18	cells	NNS	O	cell	conj_and	6	SENT_208	34072/34077
19	suggest	VBP	O	suggest		-1	SENT_208	34078/34085
20	that	IN	O	that	mark	26	SENT_208	34086/34090
21	their	PRP$	O	they	poss	23	SENT_208	34091/34096
22	cellular	JJ	O	cellular	amod	23	SENT_208	34097/34105
23	uptake	NN	O	uptake	nsubj	26	SENT_208	34106/34112
24	does	VBZ	O	do	aux	26	SENT_208	34113/34117
25	not	RB	O	not	neg	26	SENT_208	34118/34121
26	depend	VB	O	depend	ccomp	19	SENT_208	34122/34128
27	on	IN	O	on		-1	SENT_208	34129/34131
28	human	JJ	O	human	amod	30	SENT_208	34132/34137
29	OATP	NN	O	oatp	nn	30	SENT_208	34138/34142
30	transporters	NNS	O	transporter	prep_on	26	SENT_208	34143/34155
31	but	CC	O	but		-1	SENT_208	34156/34159
32	is	VBZ	O	be	cop	33	SENT_208	34160/34162
33	likely	JJ	O	likely	conj_but	26	SENT_208	34163/34169
34	to	TO	O	to	aux	36	SENT_208	34170/34172
35	be	VB	O	be	auxpass	36	SENT_208	34173/34175
36	driven	VBN	O	drive	xcomp	33	SENT_208	34176/34182
37	by	IN	O	by		-1	SENT_208	34183/34185
38	passive	NN	O	passive	nn	39	SENT_208	34186/34193
39	diffusion	NN	O	diffusion	agent	36	SENT_208	34194/34203
40	.	.	O	.		-1	SENT_208	34203/34204

1	A	DT	O	a	det	3	SENT_209	34205/34206
2	small	JJ	O	small	amod	3	SENT_209	34207/34212
3	contribution	NN	O	contribution	nsubjpass	11	SENT_209	34213/34225
4	from	IN	O	from		-1	SENT_209	34226/34230
5	active	JJ	O	active	amod	6	SENT_209	34231/34237
6	uptake	NN	O	uptake	prep_from	3	SENT_209	34238/34244
7	could	MD	O	could	aux	11	SENT_209	34245/34250
8	not	RB	O	not	neg	11	SENT_209	34251/34254
9	be	VB	O	be	auxpass	11	SENT_209	34255/34257
10	totally	RB	O	totally	advmod	11	SENT_209	34258/34265
11	excluded	VBN	O	exclude		-1	SENT_209	34266/34274
12	,	,	O	,		-1	SENT_209	34274/34275
13	however	RB	O	however	advmod	11	SENT_209	34276/34283
14	,	,	O	,		-1	SENT_209	34283/34284
15	although	IN	O	although	mark	25	SENT_209	34285/34293
16	compared	VBN	O	compare		-1	SENT_209	34294/34302
17	to	TO	O	to	prepc_compared_to	25	SENT_209	34303/34305
18	the	DT	O	the	det	21	SENT_209	34306/34309
19	high	JJ	O	high	amod	21	SENT_209	34310/34314
20	passive	NN	O	passive	nn	21	SENT_209	34315/34322
21	component	NN	O	component	pobj	25	SENT_209	34323/34332
22	,	,	O	,		-1	SENT_209	34332/34333
23	it	PRP	O	it	nsubjpass	25	SENT_209	34334/34336
24	is	VBZ	O	be	auxpass	25	SENT_209	34337/34339
25	considered	VBN	O	consider	advcl	11	SENT_209	34340/34350
26	not	RB	O	not	neg	29	SENT_209	34351/34354
27	to	TO	O	to	aux	29	SENT_209	34355/34357
28	be	VB	O	be	cop	29	SENT_209	34358/34360
29	relevant	JJ	O	relevant	xcomp	25	SENT_209	34361/34369
30	.	.	O	.		-1	SENT_209	34369/34370

1	The	DT	O	the	det	2	SENT_210	34371/34374
2	present	JJ	DATE	present	nsubj	6	SENT_210	34375/34382
3	in	FW	O	in	nn	5	SENT_210	34383/34385
4	vitro	FW	O	vitro	dep	5	SENT_210	34386/34391
5	data	NNS	O	datum	advmod	6	SENT_210	34392/34396
6	give	VBP	O	give		-1	SENT_210	34397/34401
7	a	DT	O	a	det	10	SENT_210	34402/34403
8	possible	JJ	O	possible	amod	10	SENT_210	34404/34412
9	mechanistic	JJ	O	mechanistic	amod	10	SENT_210	34413/34424
10	explanation	NN	O	explanation	dobj	6	SENT_210	34425/34436
11	why	WRB	O	why	advmod	23	SENT_210	34437/34440
12	the	DT	O	the	det	14	SENT_210	34441/34444
13	concomitant	JJ	O	concomitant	amod	14	SENT_210	34445/34456
14	administration	NN	O	administration	nsubj	23	SENT_210	34457/34471
15	of	IN	O	of		-1	SENT_210	34472/34474
16	the	DT	O	the	det	20	SENT_210	34475/34478
17	potent	JJ	O	potent	amod	20	SENT_210	34479/34485
18	OATP	NN	O	oatp	nn	20	SENT_210	34486/34490
19	inhibitor	NN	O	inhibitor	nn	20	SENT_210	34491/34500
20	Cs	NN	O	c	prep_of	14	SENT_210	34501/34503
21	did	VBD	O	do	aux	23	SENT_210	34504/34507
22	not	RB	O	not	neg	23	SENT_210	34508/34511
23	increase	VB	O	increase	advcl	6	SENT_210	34512/34520
24	the	DT	O	the	det	25	SENT_210	34521/34524
25	exposure	NN	O	exposure	dobj	23	SENT_210	34525/34533
26	to	TO	O	to		-1	SENT_210	34534/34536
27	macitentan	NN	O	macitentan	prep_to	23	SENT_210	34537/34547
28	and	CC	O	and		-1	SENT_210	34548/34551
29	ACT-132577	NN	O	act-132577	conj_and	27	SENT_210	34552/34562
30	to	TO	O	to		-1	SENT_210	34563/34565
31	a	DT	O	a	det	34	SENT_210	34566/34567
32	clinically	RB	O	clinically	advmod	33	SENT_210	34568/34578
33	relevant	JJ	O	relevant	amod	34	SENT_210	34579/34587
34	extent	NN	O	extent	prep_to	23	SENT_210	34588/34594
35	and	CC	O	and		-1	SENT_210	34595/34598
36	explain	VB	O	explain	conj_and	23	SENT_210	34599/34606
37	why	WRB	O	why	advmod	43	SENT_210	34607/34610
38	Ctr	NN	O	ctr	nsubj	43	SENT_210	34611/34614
39	of	IN	O	of		-1	SENT_210	34615/34617
40	macitentan	NN	O	macitentan	prep_of	38	SENT_210	34618/34628
41	did	VBD	O	do	aux	43	SENT_210	34629/34632
42	not	RB	O	not	neg	43	SENT_210	34633/34636
43	show	VB	O	show	advcl	36	SENT_210	34637/34641
44	any	DT	O	any	det	46	SENT_210	34642/34645
45	immediate	JJ	O	immediate	amod	46	SENT_210	34646/34655
46	increase	NN	O	increase	dobj	43	SENT_210	34656/34664
47	in	IN	O	in		-1	SENT_210	34665/34667
48	the	DT	O	the	det	49	SENT_210	34668/34671
49	presence	NN	O	presence	prep_in	43	SENT_210	34672/34680
50	of	IN	O	of		-1	SENT_210	34681/34683
51	rifampin	NN	O	rifampin	prep_of	49	SENT_210	34684/34692
52	.	.	O	.		-1	SENT_210	34692/34693

1	The	DT	O	the	det	2	SENT_211	34729/34732
2	question	NN	O	question	nsubjpass	19	SENT_211	34733/34741
3	whether	IN	O	whether	mark	11	SENT_211	34742/34749
4	macitentan	NN	O	macitentan	nsubj	11	SENT_211	34750/34760
5	and	CC	O	and		-1	SENT_211	34761/34764
6	its	PRP$	O	its	poss	9	SENT_211	34765/34768
7	active	JJ	O	active	amod	9	SENT_211	34769/34775
8	metabolite	NN	O	metabolite	nn	9	SENT_211	34776/34786
9	ACT-132577	NN	O	act-132577	conj_and	4	SENT_211	34787/34797
10	could	MD	O	could	aux	11	SENT_211	34798/34803
11	act	VB	O	act	dep	2	SENT_211	34804/34807
12	as	IN	O	as		-1	SENT_211	34808/34810
13	a	DT	O	a	det	14	SENT_211	34811/34812
14	perpetrator	NN	O	perpetrator	prep_as	11	SENT_211	34813/34824
15	in	IN	O	in		-1	SENT_211	34825/34827
16	DDIs	NNS	O	ddi	prep_in	14	SENT_211	34828/34832
17	was	VBD	O	be	auxpass	19	SENT_211	34833/34836
18	also	RB	O	also	advmod	19	SENT_211	34837/34841
19	assessed	VBN	O	assess		-1	SENT_211	34842/34850
20	in	IN	O	in	prep	19	SENT_211	34851/34853
21	in	FW	O	in	nn	23	SENT_211	34854/34856
22	vitro	FW	O	vitro	dep	23	SENT_211	34857/34862
23	studies	NNS	O	study	advmod	19	SENT_211	34863/34870
24	.	.	O	.		-1	SENT_211	34870/34871

1	Macitentan	NNP	O	Macitentan	nsubj	4	SENT_212	34872/34882
2	and	CC	O	and		-1	SENT_212	34883/34886
3	ACT-132577	NNP	O	ACT-132577	conj_and	1	SENT_212	34887/34897
4	exhibited	VBD	O	exhibit		-1	SENT_212	34898/34907
5	an	DT	O	a	det	7	SENT_212	34908/34910
6	inhibitory	JJ	O	inhibitory	amod	7	SENT_212	34911/34921
7	potency	NN	O	potency	dobj	4	SENT_212	34922/34929
8	on	IN	O	on		-1	SENT_212	34930/34932
9	OATP1B1-mediated	JJ	O	oatp1b1-mediated	amod	10	SENT_212	34933/34949
10	uptake	NN	O	uptake	prep_on	4	SENT_212	34950/34956
11	of	IN	O	of		-1	SENT_212	34957/34959
12	atorvastatin	NN	O	atorvastatin	prep_of	10	SENT_212	34960/34972
13	,	,	O	,		-1	SENT_212	34972/34973
14	as	RB	O	as		-1	SENT_212	34974/34976
15	well	RB	O	well		-1	SENT_212	34977/34981
16	as	IN	O	as		-1	SENT_212	34982/34984
17	OATP1B3-mediated	JJ	O	oatp1b3-mediated	amod	18	SENT_212	34985/35001
18	uptake	NN	O	uptake	conj_and	10	SENT_212	35002/35008
19	of	IN	O	of		-1	SENT_212	35009/35011
20	estrone-3-sulfate	NN	O	estrone-3-sulfate	prep_of	18	SENT_212	35012/35029
21	.	.	O	.		-1	SENT_212	35029/35030

1	Comparing	VBG	O	compare	dep	53	SENT_213	35031/35040
2	the	DT	O	the	det	4	SENT_213	35041/35044
3	IC50	NN	O	ic50	nn	4	SENT_213	35045/35049
4	values	NNS	O	value	dobj	1	SENT_213	35050/35056
5	and	CC	O	and		-1	SENT_213	35057/35060
6	total	JJ	O	total	amod	8	SENT_213	35061/35066
7	plasma	NN	O	plasma	nn	8	SENT_213	35067/35073
8	concentrations	NNS	O	concentration	conj_and	4	SENT_213	35074/35088
9	of	IN	O	of		-1	SENT_213	35089/35091
10	macitentan	NN	O	macitentan	prep_of	8	SENT_213	35092/35102
11	and	CC	O	and		-1	SENT_213	35103/35106
12	ACT-132577	NN	O	act-132577	conj_and	10	SENT_213	35107/35117
13	at	IN	O	at		-1	SENT_213	35118/35120
14	steady-state	JJ	O	steady-state	amod	23	SENT_213	35121/35133
15	in	IN	O	in		-1	SENT_213	35134/35136
16	healthy	JJ	O	healthy	amod	17	SENT_213	35137/35144
17	subjects	NNS	O	subject	prep_in	14	SENT_213	35145/35153
18	(	JJ	O	(	amod	23	SENT_213	35154/35155
19	approximately	RB	O	approximately	advmod	20	SENT_213	35155/35168
20	0.63	CD	NUMBER	0.63	dep	18	SENT_213	35169/35173
21	and	CC	O	and		-1	SENT_213	35174/35177
22	1.5	CD	NUMBER	1.5	conj_and	20	SENT_213	35178/35181
23	M	NN	O	m	prep_at	4	SENT_213	35184/35185
24	,	,	O	,		-1	SENT_213	35185/35186
25	respectively	RB	O	respectively	advmod	4	SENT_213	35187/35199
26	)	CD	NUMBER	)	dep	4	SENT_213	35199/35200
27	during	IN	O	during		-1	SENT_213	35201/35207
28	a	DT	O	a	det	31	SENT_213	35208/35209
29	10-mg	JJ	O	10-mg	amod	31	SENT_213	35210/35215
30	once-daily	JJ	O	once-daily	amod	31	SENT_213	35216/35226
31	regimen	NN	O	regimen	prep_during	26	SENT_213	35227/35234
32	and	CC	O	and		-1	SENT_213	35235/35238
33	binding	NN	O	binding	conj_and	4	SENT_213	35239/35246
34	of	IN	O	of		-1	SENT_213	35247/35249
35	macitentan	NN	O	macitentan	prep_of	33	SENT_213	35250/35260
36	and	CC	O	and		-1	SENT_213	35261/35264
37	ACT-132577	NN	O	act-132577	conj_and	35	SENT_213	35265/35275
38	to	TO	O	to		-1	SENT_213	35276/35278
39	human	JJ	O	human	amod	41	SENT_213	35279/35284
40	plasma	NN	O	plasma	nn	41	SENT_213	35285/35291
41	proteins	NNS	O	protein	prep_to	1	SENT_213	35292/35300
42	in	FW	O	in	prep	41	SENT_213	35301/35303
43	vitro	FW	O	vitro	amod	46	SENT_213	35304/35309
44	(	FW	O	(	dep	43	SENT_213	35310/35311
45	99.6	CD	PERCENT	99.6	num	46	SENT_213	35311/35315
46	%	NN	PERCENT	%	pobj	42	SENT_213	35315/35316
47	and	CC	O	and		-1	SENT_213	35317/35320
48	99.5	CD	PERCENT	99.5	num	49	SENT_213	35321/35325
49	%	NN	PERCENT	%	conj_and	46	SENT_213	35325/35326
50	,	,	O	,		-1	SENT_213	35326/35327
51	respectively	RB	O	respectively	advmod	53	SENT_213	35328/35340
52	)	CD	NUMBER	)	nsubj	53	SENT_213	35340/35341
53	indicates	VBZ	O	indicate		-1	SENT_213	35342/35351
54	that	IN	O	that	mark	68	SENT_213	35352/35356
55	the	DT	O	the	det	58	SENT_213	35357/35360
56	free	JJ	O	free	amod	58	SENT_213	35361/35365
57	steady-state	JJ	O	steady-state	amod	58	SENT_213	35366/35378
58	concentration	NN	O	concentration	nsubj	68	SENT_213	35379/35392
59	of	IN	O	of		-1	SENT_213	35393/35395
60	macitentan	NN	O	macitentan	prep_of	58	SENT_213	35396/35406
61	and	CC	O	and		-1	SENT_213	35407/35410
62	ACT-132577	NN	O	act-132577	conj_and	60	SENT_213	35411/35421
63	is	VBZ	O	be	cop	68	SENT_213	35422/35424
64	around	IN	O	around	amod	65	SENT_213	35425/35431
65	2.5	CD	NUMBER	2.5	num	68	SENT_213	35432/35435
66	and	CC	O	and		-1	SENT_213	35436/35439
67	7.3	CD	NUMBER	7.3	conj_and	65	SENT_213	35440/35443
68	nM	NN	O	nm	ccomp	53	SENT_213	35444/35446
69	,	,	O	,		-1	SENT_213	35446/35447
70	respectively	RB	O	respectively	advmod	68	SENT_213	35448/35460
71	.	.	O	.		-1	SENT_213	35460/35461

1	Since	IN	O	since	mark	12	SENT_214	35462/35467
2	free	JJ	O	free	amod	4	SENT_214	35468/35472
3	steady-state	JJ	O	steady-state	amod	4	SENT_214	35473/35485
4	macitentan	NN	O	macitentan	nsubj	12	SENT_214	35486/35496
5	and	CC	O	and		-1	SENT_214	35497/35500
6	ACT-132577	NN	O	act-132577	nn	8	SENT_214	35501/35511
7	plasma	NN	O	plasma	nn	8	SENT_214	35512/35518
8	concentrations	NNS	O	concentration	conj_and	4	SENT_214	35519/35533
9	are	VBP	O	be	cop	12	SENT_214	35534/35537
10	around	IN	O	around	advmod	12	SENT_214	35538/35544
11	2,490-fold	RB	O	2,490-fold	advmod	12	SENT_214	35545/35555
12	lower	JJR	O	lower	advcl	21	SENT_214	35556/35561
13	than	IN	O	than	mark	17	SENT_214	35562/35566
14	the	DT	O	the	det	16	SENT_214	35567/35570
15	lowest	JJS	O	lowest	amod	16	SENT_214	35571/35577
16	IC50	NN	O	ic50	nsubj	17	SENT_214	35578/35582
17	determined	VBD	O	determine	ccomp	12	SENT_214	35583/35593
18	,	,	O	,		-1	SENT_214	35593/35594
19	it	PRP	O	it	nsubj	21	SENT_214	35595/35597
20	appears	VBZ	O	appear	cop	21	SENT_214	35598/35605
21	unlikely	JJ	O	unlikely		-1	SENT_214	35606/35614
22	that	IN	O	that	mark	27	SENT_214	35615/35619
23	treatment	NN	O	treatment	nsubj	27	SENT_214	35620/35629
24	with	IN	O	with		-1	SENT_214	35630/35634
25	macitentan	NN	O	macitentan	prep_with	23	SENT_214	35635/35645
26	will	MD	O	will	aux	27	SENT_214	35646/35650
27	affect	VB	O	affect	ccomp	21	SENT_214	35651/35657
28	the	DT	O	the	det	29	SENT_214	35658/35661
29	PK	NN	O	pk	dobj	27	SENT_214	35662/35664
30	of	IN	O	of		-1	SENT_214	35665/35667
31	co-administered	JJ	O	co-administered	amod	33	SENT_214	35668/35683
32	OATP	NN	O	oatp	nn	33	SENT_214	35684/35688
33	substrates	NNS	O	substrate	prep_of	29	SENT_214	35689/35699
34	.	.	O	.		-1	SENT_214	35699/35700

1	Based	VBN	O	base		-1	SENT_215	35736/35741
2	on	IN	O	on	prepc_based_on	36	SENT_215	35742/35744
3	the	DT	O	the	det	4	SENT_215	35745/35748
4	guidance	NN	O	guidance	pobj	36	SENT_215	35749/35757
5	for	IN	O	for		-1	SENT_215	35758/35761
6	industry	NN	O	industry	prep_for	4	SENT_215	35762/35770
7	issued	VBN	O	issue	partmod	6	SENT_215	35771/35777
8	in	IN	O	in		-1	SENT_215	35778/35780
9	2008	CD	DATE	2008	prep_in	7	SENT_215	35781/35785
10	by	IN	O	by		-1	SENT_215	35786/35788
11	the	DT	O	the	det	12	SENT_215	35789/35792
12	Center	NNP	ORGANIZATION	Center	agent	7	SENT_215	35793/35799
13	for	IN	ORGANIZATION	for		-1	SENT_215	35800/35803
14	Drug	NNP	ORGANIZATION	Drug	nn	15	SENT_215	35804/35808
15	Evaluation	NN	ORGANIZATION	evaluation	prep_for	7	SENT_215	35809/35819
16	and	CC	ORGANIZATION	and		-1	SENT_215	35820/35823
17	Research	NN	ORGANIZATION	research	conj_and	15	SENT_215	35824/35832
18	,	,	O	,		-1	SENT_215	35832/35833
19	ACT-373898	NN	O	act-373898	nsubjpass	36	SENT_215	35834/35844
20	,	,	O	,		-1	SENT_215	35844/35845
21	identified	VBN	O	identify	partmod	19	SENT_215	35846/35856
22	in	IN	O	in		-1	SENT_215	35857/35859
23	the	DT	O	the	det	29	SENT_215	35860/35863
24	human	JJ	O	human	amod	29	SENT_215	35864/35869
25	absorption	NN	O	absorption	nn	29	SENT_215	35870/35880
26	,	,	O	,		-1	SENT_215	35880/35881
27	distribution	NN	O	distribution	dep	29	SENT_215	35882/35894
28	,	,	O	,		-1	SENT_215	35894/35895
29	metabolism	NN	O	metabolism	prep_in	21	SENT_215	35896/35906
30	,	,	O	,		-1	SENT_215	35906/35907
31	and	CC	O	and		-1	SENT_215	35908/35911
32	excretion	NN	O	excretion	nn	33	SENT_215	35912/35921
33	study	NN	O	study	conj_and	29	SENT_215	35922/35927
34	,	,	O	,		-1	SENT_215	35927/35928
35	was	VBD	O	be	auxpass	36	SENT_215	35929/35932
36	considered	VBN	O	consider		-1	SENT_215	35933/35943
37	as	IN	O	as		-1	SENT_215	35944/35946
38	a	DT	DURATION	a	det	40	SENT_215	35947/35948
39	second	JJ	DURATION	second	amod	40	SENT_215	35949/35955
40	major	JJ	O	major	prep_as	36	SENT_215	35956/35961
41	circulating	VBG	O	circulate	partmod	40	SENT_215	35962/35973
42	metabolite	NN	O	metabolite	dobj	41	SENT_215	35974/35984
43	of	IN	O	of		-1	SENT_215	35985/35987
44	macitentan	NN	O	macitentan	prep_of	42	SENT_215	35988/35998
45	(	CD	NUMBER	(	num	44	SENT_215	35999/36000
46	27,28	CD	NUMBER	27,28	num	47	SENT_215	36000/36005
47	)	NN	O	)	dep	44	SENT_215	36005/36006
48	and	CC	O	and		-1	SENT_215	36007/36010
49	,	,	O	,		-1	SENT_215	36010/36011
50	therefore	RB	O	therefore	dep	36	SENT_215	36012/36021
51	,	,	O	,		-1	SENT_215	36021/36022
52	was	VBD	O	be	auxpass	54	SENT_215	36023/36026
53	also	RB	O	also	advmod	54	SENT_215	36027/36031
54	analyzed	VBN	O	analyze	conj_and	36	SENT_215	36032/36040
55	in	IN	O	in		-1	SENT_215	36041/36043
56	the	DT	O	the	det	58	SENT_215	36044/36047
57	present	JJ	DATE	present	amod	58	SENT_215	36048/36055
58	study	NN	O	study	prep_in	54	SENT_215	36056/36061
59	.	.	O	.		-1	SENT_215	36061/36062

1	However	RB	O	however	advmod	27	SENT_216	36063/36070
2	,	,	O	,		-1	SENT_216	36070/36071
3	in	IN	O	in		-1	SENT_216	36072/36074
4	view	NN	O	view	prep_in	27	SENT_216	36075/36079
5	of	IN	O	of		-1	SENT_216	36080/36082
6	the	DT	O	the	det	10	SENT_216	36083/36086
7	more	RBR	O	more	advmod	9	SENT_216	36087/36091
8	recently	RB	DATE	recently	advmod	9	SENT_216	36092/36100
9	issued	VBN	O	issue	amod	10	SENT_216	36101/36107
10	guidance	NN	O	guidance	prep_of	4	SENT_216	36108/36116
11	by	IN	O	by		-1	SENT_216	36117/36119
12	the	DT	O	the	det	14	SENT_216	36120/36123
13	International	NNP	ORGANIZATION	International	nn	14	SENT_216	36124/36137
14	Conference	NNP	ORGANIZATION	Conference	prep_by	10	SENT_216	36138/36148
15	on	IN	ORGANIZATION	on		-1	SENT_216	36149/36151
16	Harmonization	NNP	ORGANIZATION	Harmonization	prep_on	14	SENT_216	36152/36165
17	in	IN	O	in		-1	SENT_216	36166/36168
18	2010	CD	DATE	2010	num	19	SENT_216	36169/36173
19	(	CD	NUMBER	(	prep_in	14	SENT_216	36174/36175
20	29	CD	NUMBER	29	num	21	SENT_216	36175/36177
21	)	NN	O	)	dep	14	SENT_216	36177/36178
22	,	,	O	,		-1	SENT_216	36178/36179
23	ACT-373898	NN	O	act-373898	nsubjpass	27	SENT_216	36180/36190
24	is	VBZ	O	be	auxpass	27	SENT_216	36191/36193
25	no	RB	O	no	advmod	26	SENT_216	36194/36196
26	longer	RB	O	longer	advmod	27	SENT_216	36197/36203
27	considered	VBN	O	consider		-1	SENT_216	36204/36214
28	a	DT	O	a	det	30	SENT_216	36215/36216
29	major	JJ	O	major	amod	30	SENT_216	36217/36222
30	metabolite	NN	O	metabolite	dobj	27	SENT_216	36223/36233
31	.	.	O	.		-1	SENT_216	36233/36234

1	Similar	JJ	O	similar	nsubj	15	SENT_217	36270/36277
2	to	TO	O	to		-1	SENT_217	36278/36280
3	previous	JJ	O	previous	amod	6	SENT_217	36281/36289
4	phase	NN	O	phase	nn	6	SENT_217	36290/36295
5	1	CD	NUMBER	1	num	6	SENT_217	36296/36297
6	studies	NNS	O	study	prep_to	1	SENT_217	36298/36305
7	with	IN	O	with		-1	SENT_217	36306/36310
8	macitentan	NN	O	macitentan	prep_with	6	SENT_217	36311/36321
9	,	,	O	,		-1	SENT_217	36321/36322
10	the	DT	O	the	det	13	SENT_217	36323/36326
11	most	RBS	O	most	advmod	12	SENT_217	36327/36331
12	frequent	JJ	O	frequent	amod	13	SENT_217	36332/36340
13	TEAE	NN	ORGANIZATION	tea	appos	8	SENT_217	36341/36345
14	was	VBD	O	be	cop	15	SENT_217	36346/36349
15	headache	NN	O	headache		-1	SENT_217	36350/36358
16	(	CD	NUMBER	(	num	15	SENT_217	36359/36360
17	2,4,10	CD	NUMBER	2,4,10	num	18	SENT_217	36360/36366
18	)	NN	O	)	dep	15	SENT_217	36366/36367
19	.	.	O	.		-1	SENT_217	36367/36368

1	In	IN	O	in		-1	SENT_218	36369/36371
2	part	NN	O	part	nn	3	SENT_218	36372/36376
3	A	NN	O	a	prep_in	22	SENT_218	36377/36378
4	,	,	O	,		-1	SENT_218	36378/36379
5	no	DT	O	no	det	6	SENT_218	36380/36382
6	hypertension	NN	O	hypertension	nsubjpass	22	SENT_218	36383/36395
7	or	CC	O	or		-1	SENT_218	36396/36398
8	AEs	NNS	O	ae	conj_or	6	SENT_218	36399/36402
9	relating	VBG	O	relate	partmod	6	SENT_218	36403/36411
10	to	TO	O	to		-1	SENT_218	36412/36414
11	renal	JJ	O	renal	amod	12	SENT_218	36415/36420
12	function	NN	O	function	prep_to	9	SENT_218	36421/36429
13	,	,	O	,		-1	SENT_218	36429/36430
14	which	WDT	O	which	nsubjpass	16	SENT_218	36431/36436
15	are	VBP	O	be	auxpass	16	SENT_218	36437/36440
16	associated	VBN	O	associate	rcmod	12	SENT_218	36441/36451
17	with	IN	O	with		-1	SENT_218	36452/36456
18	Cs	NN	O	c	nn	19	SENT_218	36457/36459
19	treatment	NN	O	treatment	prep_with	16	SENT_218	36460/36469
20	,	,	O	,		-1	SENT_218	36469/36470
21	were	VBD	O	be	auxpass	22	SENT_218	36471/36475
22	reported	VBN	O	report		-1	SENT_218	36476/36484
23	(	CD	NUMBER	(	num	25	SENT_218	36485/36486
24	13	CD	NUMBER	13	num	25	SENT_218	36486/36488
25	)	NN	O	)	dobj	22	SENT_218	36488/36489
26	.	.	O	.		-1	SENT_218	36489/36490

1	Similarly	RB	O	similarly	advmod	13	SENT_219	36491/36500
2	in	IN	O	in		-1	SENT_219	36501/36503
3	part	NN	O	part	nn	4	SENT_219	36504/36508
4	B	NN	O	b	prep_in	13	SENT_219	36509/36510
5	,	,	O	,		-1	SENT_219	36510/36511
6	no	DT	O	no	det	7	SENT_219	36512/36514
7	AEs	NNS	O	ae	nsubjpass	13	SENT_219	36515/36518
8	associated	VBN	O	associate	partmod	7	SENT_219	36519/36529
9	with	IN	O	with		-1	SENT_219	36530/36534
10	rifampin	NN	O	rifampin	nn	11	SENT_219	36535/36543
11	treatment	NN	O	treatment	prep_with	8	SENT_219	36544/36553
12	were	VBD	O	be	auxpass	13	SENT_219	36554/36558
13	reported	VBN	O	report		-1	SENT_219	36559/36567
14	(	NN	O	(	nn	16	SENT_219	36568/36569
15	14	CD	NUMBER	14	num	16	SENT_219	36569/36571
16	)	NN	O	)	dobj	13	SENT_219	36571/36572
17	.	.	O	.		-1	SENT_219	36572/36573

1	Overall	RB	O	overall	advmod	14	SENT_220	36574/36581
2	,	,	O	,		-1	SENT_220	36581/36582
3	tolerability	NN	O	tolerability	nsubj	14	SENT_220	36583/36595
4	of	IN	O	of		-1	SENT_220	36596/36598
5	macitentan	NN	O	macitentan	prep_of	3	SENT_220	36599/36609
6	when	WRB	O	when	advmod	7	SENT_220	36610/36614
7	administered	VBN	O	administer	rcmod	5	SENT_220	36615/36627
8	concomitantly	RB	O	concomitantly	advmod	7	SENT_220	36628/36641
9	with	IN	O	with		-1	SENT_220	36642/36646
10	Cs	NNS	O	c	prep_with	7	SENT_220	36647/36649
11	or	CC	O	or		-1	SENT_220	36650/36652
12	rifampin	NN	O	rifampin	conj_or	10	SENT_220	36653/36661
13	was	VBD	O	be	cop	14	SENT_220	36662/36665
14	good	JJ	O	good		-1	SENT_220	36666/36670
15	.	.	O	.		-1	SENT_220	36670/36671

1	However	RB	O	however	advmod	8	SENT_221	36672/36679
2	,	,	O	,		-1	SENT_221	36679/36680
3	the	DT	O	the	det	5	SENT_221	36681/36684
4	small	JJ	O	small	amod	5	SENT_221	36685/36690
5	number	NN	O	number	nsubj	8	SENT_221	36691/36697
6	of	IN	O	of		-1	SENT_221	36698/36700
7	subjects	NNS	O	subject	prep_of	5	SENT_221	36701/36709
8	limits	VBZ	O	limit		-1	SENT_221	36710/36716
9	the	DT	O	the	det	10	SENT_221	36717/36720
10	interpretation	NN	O	interpretation	nsubj	30	SENT_221	36721/36735
11	of	IN	O	of		-1	SENT_221	36736/36738
12	safety	NN	O	safety	nn	13	SENT_221	36739/36745
13	data	NNS	O	datum	prep_of	10	SENT_221	36746/36750
14	in	IN	O	in		-1	SENT_221	36751/36753
15	both	DT	O	both	det	16	SENT_221	36754/36758
16	parts	NNS	O	part	prep_in	13	SENT_221	36759/36764
17	of	IN	O	of		-1	SENT_221	36765/36767
18	the	DT	O	the	det	19	SENT_221	36768/36771
19	study	NN	O	study	prep_of	16	SENT_221	36772/36777
20	,	,	O	,		-1	SENT_221	36777/36778
21	and	CC	O	and	cc	22	SENT_221	36779/36782
22	more	RBR	O	more	num	23	SENT_221	36783/36787
23	data	NNS	O	datum	appos	19	SENT_221	36788/36792
24	in	IN	O	in		-1	SENT_221	36793/36795
25	a	DT	O	a	det	28	SENT_221	36796/36797
26	larger	JJR	O	larger	amod	28	SENT_221	36798/36804
27	patient	NN	O	patient	nn	28	SENT_221	36805/36812
28	population	NN	O	population	prep_in	23	SENT_221	36813/36823
29	are	VBP	O	be	cop	30	SENT_221	36824/36827
30	necessary	JJ	O	necessary	ccomp	8	SENT_221	36828/36837
31	to	TO	O	to	aux	32	SENT_221	36838/36840
32	evaluate	VB	O	evaluate	xcomp	30	SENT_221	36841/36849
33	adequately	RB	O	adequately	advmod	32	SENT_221	36850/36860
34	the	DT	O	the	det	35	SENT_221	36861/36864
35	safety	NN	O	safety	dobj	32	SENT_221	36865/36871
36	of	IN	O	of		-1	SENT_221	36872/36874
37	macitentan	NN	O	macitentan	prep_of	35	SENT_221	36875/36885
38	in	IN	O	in		-1	SENT_221	36886/36888
39	combination	NN	O	combination	prep_in	32	SENT_221	36889/36900
40	with	IN	O	with		-1	SENT_221	36901/36905
41	Cs	NNS	O	c	prep_with	32	SENT_221	36906/36908
42	and	CC	O	and		-1	SENT_221	36909/36912
43	rifampin	NN	O	rifampin	conj_and	41	SENT_221	36913/36921
44	.	.	O	.		-1	SENT_221	36921/36922

1	CONCLUSION	NN	O	conclusion		-1	SENT_222	36958/36968

1	The	DT	O	the	det	3	SENT_223	37004/37007
2	observed	VBN	O	observe	amod	3	SENT_223	37008/37016
3	effect	NN	O	effect	nsubjpass	22	SENT_223	37017/37023
4	of	IN	O	of		-1	SENT_223	37024/37026
5	Cs	NNS	O	c	prep_of	3	SENT_223	37027/37029
6	on	IN	O	on		-1	SENT_223	37030/37032
7	the	DT	O	the	det	8	SENT_223	37033/37036
8	exposure	NN	O	exposure	prep_on	5	SENT_223	37037/37045
9	to	TO	O	to		-1	SENT_223	37046/37048
10	macitentan	NN	O	macitentan	prep_to	8	SENT_223	37049/37059
11	and	CC	O	and		-1	SENT_223	37060/37063
12	its	PRP$	O	its	poss	14	SENT_223	37064/37067
13	metabolites	NNS	O	metabolite	nn	14	SENT_223	37068/37079
14	ACT-132577	NN	O	act-132577	conj_and	10	SENT_223	37080/37090
15	and	CC	O	and		-1	SENT_223	37091/37094
16	ACT-373898	NN	O	act-373898	conj_and	8	SENT_223	37095/37105
17	under	IN	O	under		-1	SENT_223	37106/37111
18	steady-state	JJ	O	steady-state	amod	19	SENT_223	37112/37124
19	conditions	NNS	O	condition	prep_under	16	SENT_223	37125/37135
20	is	VBZ	O	be	auxpass	22	SENT_223	37136/37138
21	not	RB	O	not	neg	22	SENT_223	37139/37142
22	considered	VBN	O	consider		-1	SENT_223	37143/37153
23	clinically	RB	O	clinically	advmod	24	SENT_223	37154/37164
24	relevant	JJ	O	relevant	acomp	22	SENT_223	37165/37173
25	.	.	O	.		-1	SENT_223	37173/37174

1	Concomitant	JJ	O	concomitant	amod	2	SENT_224	37175/37186
2	treatment	NN	O	treatment	nsubj	5	SENT_224	37187/37196
3	with	IN	O	with		-1	SENT_224	37197/37201
4	rifampin	NN	O	rifampin	prep_with	2	SENT_224	37202/37210
5	reduced	VBD	O	reduce		-1	SENT_224	37211/37218
6	significantly	RB	O	significantly	advmod	5	SENT_224	37219/37232
7	the	DT	O	the	det	8	SENT_224	37233/37236
8	exposure	NN	O	exposure	pobj	6	SENT_224	37237/37245
9	to	TO	O	to		-1	SENT_224	37246/37248
10	macitentan	NN	O	macitentan	prep_to	6	SENT_224	37249/37259
11	and	CC	O	and		-1	SENT_224	37260/37263
12	its	PRP$	O	its	poss	14	SENT_224	37264/37267
13	metabolite	NN	O	metabolite	nn	14	SENT_224	37268/37278
14	ACT-373898	NN	O	act-373898	conj_and	10	SENT_224	37279/37289
15	at	IN	O	at		-1	SENT_224	37290/37292
16	steady-state	JJ	O	steady-state	prep_at	5	SENT_224	37293/37305
17	but	CC	O	but		-1	SENT_224	37306/37309
18	did	VBD	O	do	aux	20	SENT_224	37310/37313
19	not	RB	O	not	neg	20	SENT_224	37314/37317
20	affect	VB	O	affect	conj_but	5	SENT_224	37318/37324
21	the	DT	O	the	det	22	SENT_224	37325/37328
22	exposure	NN	O	exposure	dobj	20	SENT_224	37329/37337
23	to	TO	O	to		-1	SENT_224	37338/37340
24	the	DT	O	the	det	27	SENT_224	37341/37344
25	active	JJ	O	active	amod	27	SENT_224	37345/37351
26	metabolite	NN	O	metabolite	nn	27	SENT_224	37352/37362
27	ACT-132577	NN	O	act-132577	prep_to	20	SENT_224	37363/37373
28	to	TO	O	to		-1	SENT_224	37374/37376
29	a	DT	O	a	det	32	SENT_224	37377/37378
30	clinically	RB	O	clinically	advmod	31	SENT_224	37379/37389
31	relevant	JJ	O	relevant	amod	32	SENT_224	37390/37398
32	extent	NN	O	extent	prep_to	20	SENT_224	37399/37405
33	.	.	O	.		-1	SENT_224	37405/37406

1	Reduced	VBN	O	reduce	amod	2	SENT_225	37407/37414
2	efficacy	NN	O	efficacy	nsubjpass	12	SENT_225	37415/37423
3	of	IN	O	of		-1	SENT_225	37424/37426
4	macitentan	NN	O	macitentan	prep_of	2	SENT_225	37427/37437
5	in	IN	O	in		-1	SENT_225	37438/37440
6	the	DT	O	the	det	7	SENT_225	37441/37444
7	presence	NN	O	presence	prep_in	4	SENT_225	37445/37453
8	of	IN	O	of		-1	SENT_225	37454/37456
9	rifampin	NN	O	rifampin	prep_of	7	SENT_225	37457/37465
10	should	MD	O	should	aux	12	SENT_225	37466/37472
11	be	VB	O	be	auxpass	12	SENT_225	37473/37475
12	considered	VBN	O	consider		-1	SENT_225	37476/37486
13	.	.	O	.		-1	SENT_225	37486/37487

1	Hepatic	JJ	O	hepatic	amod	2	SENT_226	37488/37495
2	uptake	NN	O	uptake	nsubj	12	SENT_226	37496/37502
3	of	IN	O	of		-1	SENT_226	37503/37505
4	macitentan	NN	O	macitentan	prep_of	2	SENT_226	37506/37516
5	and	CC	O	and		-1	SENT_226	37517/37520
6	its	PRP$	O	its	poss	9	SENT_226	37521/37524
7	active	JJ	O	active	amod	9	SENT_226	37525/37531
8	metabolite	NN	O	metabolite	nn	9	SENT_226	37532/37542
9	ACT-132577	NN	O	act-132577	conj_and	4	SENT_226	37543/37553
10	does	VBZ	O	do	aux	12	SENT_226	37554/37558
11	not	RB	O	not	neg	12	SENT_226	37559/37562
12	depend	VB	O	depend		-1	SENT_226	37563/37569
13	on	IN	O	on		-1	SENT_226	37570/37572
14	OATP	NN	O	oatp	prep_on	12	SENT_226	37573/37577
15	.	.	O	.		-1	SENT_226	37577/37578

1	ACKNOWLEDGMENTS	NNS	O	acknowledgment		-1	SENT_227	37614/37629

1	All	DT	O	all	det	2	SENT_228	37665/37668
2	authors	NNS	O	author	nsubj	4	SENT_228	37669/37676
3	are	VBP	O	be	cop	4	SENT_228	37677/37680
4	employees	NNS	O	employee		-1	SENT_228	37681/37690
5	of	IN	O	of		-1	SENT_228	37691/37693
6	Actelion	NNP	ORGANIZATION	Actelion	nn	8	SENT_228	37694/37702
7	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	8	SENT_228	37703/37718
8	Ltd.	NNP	ORGANIZATION	Ltd.	prep_of	4	SENT_228	37719/37723
9	,	,	O	,		-1	SENT_228	37723/37724
10	except	IN	O	except		-1	SENT_228	37725/37731
11	for	IN	O	for		-1	SENT_228	37732/37735
12	Dr.	NNP	O	Dr.	nn	13	SENT_228	37736/37739
13	Homery	NNP	PERSON	Homery	prep_except_for	4	SENT_228	37740/37746
14	who	WP	O	who	nsubj	18	SENT_228	37747/37750
15	was	VBD	O	be	cop	18	SENT_228	37751/37754
16	the	DT	O	the	det	18	SENT_228	37755/37758
17	principal	JJ	O	principal	amod	18	SENT_228	37759/37768
18	investigator	NN	O	investigator	rcmod	13	SENT_228	37769/37781
19	of	IN	O	of		-1	SENT_228	37782/37784
20	the	DT	O	the	det	22	SENT_228	37785/37788
21	clinical	JJ	O	clinical	amod	22	SENT_228	37789/37797
22	trial	NN	O	trial	prep_of	18	SENT_228	37798/37803
23	and	CC	O	and		-1	SENT_228	37804/37807
24	was	VBD	O	be	cop	25	SENT_228	37808/37811
25	employee	NN	O	employee	conj_and	18	SENT_228	37812/37820
26	of	IN	O	of		-1	SENT_228	37821/37823
27	the	DT	O	the	det	32	SENT_228	37824/37827
28	contract	NN	O	contract	nn	32	SENT_228	37828/37836
29	research	NN	O	research	nn	32	SENT_228	37837/37845
30	organization	NN	O	organization	nn	32	SENT_228	37846/37858
31	BIOTRIAL	NNP	O	BIOTRIAL	nn	32	SENT_228	37859/37867
32	RENNES	NNP	ORGANIZATION	RENNES	prep_of	25	SENT_228	37868/37874
33	.	.	O	.		-1	SENT_228	37874/37875

1	BIOTRIAL	NNP	ORGANIZATION	BIOTRIAL	nsubj	2	SENT_229	37876/37884
2	received	VBD	O	receive		-1	SENT_229	37885/37893
3	financial	JJ	O	financial	amod	4	SENT_229	37894/37903
4	compensation	NN	O	compensation	dobj	2	SENT_229	37904/37916
5	for	IN	O	for		-1	SENT_229	37917/37920
6	the	DT	O	the	det	8	SENT_229	37921/37924
7	clinical	JJ	O	clinical	amod	8	SENT_229	37925/37933
8	conduct	NN	O	conduct	prep_for	2	SENT_229	37934/37941
9	of	IN	O	of		-1	SENT_229	37942/37944
10	the	DT	O	the	det	11	SENT_229	37945/37948
11	study	NN	O	study	prep_of	8	SENT_229	37949/37954
12	.	.	O	.		-1	SENT_229	37954/37955

1	This	DT	O	this	det	2	SENT_230	37956/37960
2	study	NN	O	study	nsubjpass	4	SENT_230	37961/37966
3	was	VBD	O	be	auxpass	4	SENT_230	37967/37970
4	funded	VBN	O	fund		-1	SENT_230	37971/37977
5	by	IN	O	by		-1	SENT_230	37978/37980
6	Actelion	NNP	ORGANIZATION	Actelion	nn	8	SENT_230	37981/37989
7	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	8	SENT_230	37990/38005
8	Ltd.	NNP	ORGANIZATION	Ltd.	agent	4	SENT_230	38006/38010
9	,	,	O	,		-1	SENT_230	38010/38011
10	Allschwil	NNP	PERSON	Allschwil	nn	12	SENT_230	38012/38021
11	,	,	O	,		-1	SENT_230	38021/38022
12	Switzerland	NNP	LOCATION	Switzerland	appos	8	SENT_230	38023/38034
13	.	.	O	.		-1	SENT_230	38034/38035

1	The	DT	O	the	det	2	SENT_231	38036/38039
2	authors	NNS	O	author	nsubj	3	SENT_231	38040/38047
3	acknowledge	VBP	O	acknowledge		-1	SENT_231	38048/38059
4	Dr.	NNP	O	Dr.	nn	8	SENT_231	38060/38063
5	Urs	NNP	PERSON	Urs	nn	8	SENT_231	38064/38067
6	Simmen	NNP	PERSON	Simmen	nn	8	SENT_231	38068/38074
7	(	NNP	O	(	nn	8	SENT_231	38075/38076
8	Schotzau	NNP	ORGANIZATION	Schotzau	dobj	3	SENT_231	38076/38084
9	&	CC	ORGANIZATION	&		-1	SENT_231	38085/38086
10	Simmen	NNP	ORGANIZATION	Simmen	conj_and	8	SENT_231	38087/38093
11	,	,	O	,		-1	SENT_231	38093/38094
12	Statistische	NNP	PERSON	Statistische	nn	13	SENT_231	38095/38107
13	Beratungen	NNP	PERSON	Beratungen	appos	8	SENT_231	38108/38118
14	,	,	O	,		-1	SENT_231	38118/38119
15	Switzerland	NNP	LOCATION	Switzerland	nn	16	SENT_231	38120/38131
16	)	NNP	O	)	appos	8	SENT_231	38131/38132
17	for	IN	O	for		-1	SENT_231	38133/38136
18	his	PRP$	O	he	poss	19	SENT_231	38137/38140
19	assistance	NN	O	assistance	prep_for	16	SENT_231	38141/38151
20	in	IN	O	in		-1	SENT_231	38152/38154
21	statistical	JJ	O	statistical	amod	22	SENT_231	38155/38166
22	work	NN	O	work	prep_in	19	SENT_231	38167/38171
23	.	.	O	.		-1	SENT_231	38171/38172

1	Open	NNP	O	Open		-1	SENT_232	38208/38212
2	Access	NN	O	access	dep	1	SENT_232	38213/38219

1	This	DT	O	this	det	2	SENT_233	38255/38259
2	article	NN	O	article	nsubjpass	4	SENT_233	38260/38267
3	is	VBZ	O	be	auxpass	4	SENT_233	38268/38270
4	distributed	VBN	O	distribute		-1	SENT_233	38271/38282
5	under	IN	O	under		-1	SENT_233	38283/38288
6	the	DT	O	the	det	7	SENT_233	38289/38292
7	terms	NNS	O	term	prep_under	4	SENT_233	38293/38298
8	of	IN	O	of		-1	SENT_233	38299/38301
9	the	DT	O	the	det	14	SENT_233	38302/38305
10	Creative	NNP	O	Creative	nn	14	SENT_233	38306/38314
11	Commons	NNPS	O	Commons	nn	14	SENT_233	38315/38322
12	Attribution	NNP	O	Attribution	nn	14	SENT_233	38323/38334
13	Noncommercial	NNP	O	Noncommercial	nn	14	SENT_233	38335/38348
14	License	NNP	O	License	prep_of	7	SENT_233	38349/38356
15	which	WDT	O	which	nsubj	16	SENT_233	38357/38362
16	permits	VBZ	O	permit	rcmod	14	SENT_233	38363/38370
17	any	DT	O	any	det	19	SENT_233	38371/38374
18	noncommercial	JJ	O	noncommercial	amod	19	SENT_233	38375/38388
19	use	NN	O	use	nsubj	29	SENT_233	38389/38392
20	,	,	O	,		-1	SENT_233	38392/38393
21	distribution	NN	O	distribution	appos	19	SENT_233	38394/38406
22	,	,	O	,		-1	SENT_233	38406/38407
23	and	CC	O	and		-1	SENT_233	38408/38411
24	reproduction	NN	O	reproduction	conj_and	21	SENT_233	38412/38424
25	in	IN	O	in		-1	SENT_233	38425/38427
26	any	DT	O	any	det	27	SENT_233	38428/38431
27	medium	NN	O	medium	prep_in	24	SENT_233	38432/38438
28	,	,	O	,		-1	SENT_233	38438/38439
29	provided	VBD	O	provide	ccomp	16	SENT_233	38440/38448
30	the	DT	O	the	det	32	SENT_233	38449/38452
31	original	JJ	O	original	amod	32	SENT_233	38453/38461
32	author	NN	O	author	iobj	29	SENT_233	38462/38468
33	(	CD	NUMBER	(	num	34	SENT_233	38468/38469
34	s	NNS	O	s	dobj	29	SENT_233	38469/38470
35	)	CD	NUMBER	)	nsubjpass	39	SENT_233	38470/38471
36	and	CC	O	and		-1	SENT_233	38472/38475
37	source	NN	O	source	conj_and	35	SENT_233	38476/38482
38	are	VBP	O	be	auxpass	39	SENT_233	38483/38486
39	credited	VBN	O	credit	rcmod	34	SENT_233	38487/38495
40	.	.	O	.		-1	SENT_233	38495/38496

1	REFERENCES	NNS	O	reference		-1	SENT_234	38532/38542

1	1	LS	NUMBER	1		-1	SENT_235	38559/38560
2	.	.	O	.		-1	SENT_235	38560/38561

1	IglarzMBinkertCMorrisonKFischliWGatfieldJTreiberAPharmacology	NN	O	iglarzmbinkertcmorrisonkfischliwgatfieldjtreiberapharmacology	dep	12	SENT_236	38561/38622
2	of	IN	O	of		-1	SENT_236	38623/38625
3	macitentan	NN	O	macitentan	prep_of	1	SENT_236	38626/38636
4	,	,	O	,		-1	SENT_236	38636/38637
5	an	DT	O	a	det	10	SENT_236	38638/38640
6	orally	RB	O	orally	advmod	7	SENT_236	38641/38647
7	active	JJ	O	active	amod	10	SENT_236	38648/38654
8	tissue-targeting	JJ	O	tissue-targeting	amod	10	SENT_236	38655/38671
9	dual	JJ	O	dual	amod	10	SENT_236	38672/38676
10	endothelin	NN	O	endothelin	appos	3	SENT_236	38677/38687
11	receptor	NN	O	receptor	dep	12	SENT_236	38688/38696
12	antagonistJ	NN	O	antagonistj	dep	16	SENT_236	38697/38708
13	Pharmacol	NNP	O	Pharmacol	nn	15	SENT_236	38709/38718
14	Exp	NNP	O	Exp	nn	15	SENT_236	38719/38722
15	Ther200832737364510	NNP	O	Ther200832737364510	dep	12	SENT_236	38723/38742
16	.1124	CD	NUMBER	.1124		-1	SENT_236	38742/38747
17	/	:	O	/	punct	16	SENT_236	38747/38748
18	jpet	NN	O	jpet	nn	19	SENT_236	38748/38752
19	.108.142976187808302	NN	O	.108.142976187808302	dep	16	SENT_236	38752/38772
20	.	.	O	.		-1	SENT_236	38772/38773

1	SidhartaPNvan	NNP	O	SidhartaPNvan	nn	2	SENT_237	38773/38786
2	GiersbergenPLHalabiADingemanseJMacitentan	NNP	O	GiersbergenPLHalabiADingemanseJMacitentan		-1	SENT_237	38787/38828
3	:	:	O	:		-1	SENT_237	38828/38829
4	entry-into-humans	JJ	O	entry-into-humans	amod	5	SENT_237	38830/38847
5	study	NN	O	study	dep	12	SENT_237	38848/38853
6	with	IN	O	with		-1	SENT_237	38854/38858
7	a	DT	O	a	det	9	SENT_237	38859/38860
8	new	JJ	O	new	amod	9	SENT_237	38861/38864
9	endothelin	NN	O	endothelin	prep_with	5	SENT_237	38865/38875
10	receptor	NN	O	receptor	dep	12	SENT_237	38876/38884
11	antagonistEur	NN	O	antagonisteur	nn	12	SENT_237	38885/38898
12	J	NN	O	j	dep	15	SENT_237	38899/38900
13	Clin	NN	O	clin	nn	14	SENT_237	38901/38905
14	Pharmacol2011671097798410	NN	O	pharmacol2011671097798410	dep	12	SENT_237	38906/38931
15	.1007	CD	NUMBER	.1007	dep	2	SENT_237	38931/38936
16	/	:	O	/	punct	15	SENT_237	38936/38937
17	s00228	CD	NUMBER	s00228	num	18	SENT_237	38937/38943
18	-011	CD	NUMBER	-011	dep	15	SENT_237	38944/38948
19	-1043	CD	NUMBER	-1043	num	20	SENT_237	38948/38953
20	-2215417813	CD	NUMBER	-2215417813	dep	18	SENT_237	38953/38964
21	.	.	O	.		-1	SENT_237	38964/38965

1	BrudererSSidhartaPDingemanseJPharmacokinetics	NNS	O	brudererssidhartapdingemansejpharmacokinetic		-1	SENT_238	38965/39010
2	,	,	O	,		-1	SENT_238	39010/39011
3	tolerability	NN	O	tolerability	conj_and	1	SENT_238	39012/39024
4	,	,	O	,		-1	SENT_238	39024/39025
5	and	CC	O	and		-1	SENT_238	39026/39029
6	safety	NN	O	safety	conj_and	1	SENT_238	39030/39036
7	of	IN	O	of		-1	SENT_238	39037/39039
8	the	DT	O	the	det	11	SENT_238	39040/39043
9	dual	JJ	O	dual	amod	11	SENT_238	39044/39048
10	endothelin	NN	O	endothelin	nn	11	SENT_238	39049/39059
11	receptor	NN	O	receptor	prep_of	6	SENT_238	39060/39068
12	antagonist	NN	O	antagonist	nn	13	SENT_238	39069/39079
13	macitentan	NN	O	macitentan	dep	1	SENT_238	39080/39090
14	in	IN	O	in		-1	SENT_238	39091/39093
15	Japanese	JJ	O	japanese	prep_in	13	SENT_238	39094/39102
16	and	CC	O	and		-1	SENT_238	39103/39106
17	Caucasian	JJ	O	caucasian	conj_and	15	SENT_238	39107/39116
18	healthy	JJ	O	healthy	amod	21	SENT_238	39117/39124
19	subjectsClin	NN	O	subjectsclin	nn	21	SENT_238	39125/39137
20	Pharmacol	NN	O	pharmacol	nn	21	SENT_238	39138/39147
21	Ther201189Suppl	NN	O	ther201189suppl	dep	1	SENT_238	39148/39163
22	1834	CD	DATE	1834	dep	21	SENT_238	39164/39168
23	.	.	O	.		-1	SENT_238	39168/39169

1	KummerOHaschkeMHammannFBodmerMBrudererSRegnaultYComparison	NN	O	kummerohaschkemhammannfbodmermbruderersregnaultycomparison	dep	18	SENT_239	39169/39227
2	of	IN	O	of		-1	SENT_239	39228/39230
3	the	DT	O	the	det	4	SENT_239	39231/39234
4	dissolution	NN	O	dissolution	prep_of	1	SENT_239	39235/39246
5	and	CC	O	and		-1	SENT_239	39247/39250
6	pharmacokinetic	JJ	O	pharmacokinetic	amod	7	SENT_239	39251/39266
7	profiles	NNS	O	profile	conj_and	1	SENT_239	39267/39275
8	of	IN	O	of		-1	SENT_239	39276/39278
9	two	CD	NUMBER	two	num	11	SENT_239	39279/39282
10	galenical	JJ	O	galenical	amod	11	SENT_239	39283/39292
11	formulations	NNS	O	formulation	prep_of	7	SENT_239	39293/39305
12	of	IN	O	of		-1	SENT_239	39306/39308
13	the	DT	O	the	det	15	SENT_239	39309/39312
14	endothelin	NN	O	endothelin	nn	15	SENT_239	39313/39323
15	receptor	NN	O	receptor	prep_of	11	SENT_239	39324/39332
16	antagonist	NN	O	antagonist	dep	18	SENT_239	39333/39343
17	macitentanEur	NN	O	macitentaneur	nn	18	SENT_239	39344/39357
18	J	NN	O	j	dep	21	SENT_239	39358/39359
19	Pharm	NN	O	pharm	nn	20	SENT_239	39360/39365
20	Sci2009384384810	NN	O	sci2009384384810	dep	18	SENT_239	39366/39382
21	.1016	CD	NUMBER	.1016		-1	SENT_239	39382/39387
22	/	:	O	/	punct	21	SENT_239	39387/39388
23	j.	NN	O	j.	nn	24	SENT_239	39388/39390
24	ejps	NNS	O	ejp	dep	21	SENT_239	39390/39394
25	.2009.09.005197656555	CD	NUMBER	.2009.09.005197656555	dep	24	SENT_239	39394/39415
26	.	.	O	.		-1	SENT_239	39415/39416

1	KimRBOrganic	JJ	O	kimrborganic	amod	2	SENT_240	39416/39428
2	anion	NN	O	anion		-1	SENT_240	39429/39434
3	-	:	O	-		-1	SENT_240	39434/39435
4	transporting	VBG	O	transport	dep	2	SENT_240	39436/39448
5	polypeptide	NN	O	polypeptide	dobj	4	SENT_240	39449/39460
6	(	CD	NUMBER	(	num	5	SENT_240	39461/39462
7	OATP	NN	O	oatp	nn	10	SENT_240	39462/39466
8	)	CD	NUMBER	)	num	10	SENT_240	39466/39467
9	transporter	NN	O	transporter	nn	10	SENT_240	39468/39479
10	family	NN	O	family	dep	5	SENT_240	39480/39486
11	and	CC	O	and		-1	SENT_240	39487/39490
12	drug	NN	O	drug	nn	16	SENT_240	39491/39495
13	dispositionEur	NN	O	dispositioneur	nn	16	SENT_240	39496/39510
14	J	NN	O	j	nn	16	SENT_240	39511/39512
15	Clin	NN	O	clin	nn	16	SENT_240	39513/39517
16	Invest20033321510	NN	O	invest20033321510	conj_and	5	SENT_240	39518/39535
17	.1046	CD	NUMBER	.1046	dep	16	SENT_240	39535/39540
18	/	:	O	/	punct	19	SENT_240	39540/39541
19	j.1365-2362	NN	DURATION	j.1365-2362	dep	17	SENT_240	39541/39552
20	.33	CD	NUMBER	.33	num	19	SENT_240	39552/39555
21	.	.	O	.		-1	SENT_240	39555/39556

1	s2	NN	O	s2		-1	SENT_241	39556/39558
2	.5	CD	NUMBER	.5	dep	1	SENT_241	39558/39560
3	.	.	O	.		-1	SENT_241	39560/39561

1	x146415496	NN	O	x146415496		-1	SENT_242	39561/39571
2	.	.	O	.		-1	SENT_242	39571/39572

1	International	NNP	O	International	nn	4	SENT_243	39572/39585
2	Transporter	NNP	O	Transporter	nn	4	SENT_243	39586/39597
3	ConsortiumMembrane	NNP	O	ConsortiumMembrane	nn	4	SENT_243	39598/39616
4	transporters	NNS	O	transporter	dep	9	SENT_243	39617/39629
5	in	IN	O	in		-1	SENT_243	39630/39632
6	drug	NN	O	drug	prep_in	4	SENT_243	39633/39637
7	developmentNat	NNP	O	developmentNat	dep	9	SENT_243	39638/39652
8	Rev	NN	O	rev	nn	9	SENT_243	39653/39656
9	Drug	NN	O	drug	dep	12	SENT_243	39657/39661
10	Di	NNP	O	Di	dep	9	SENT_243	39662/39664
11	scov2010932153610	CD	NUMBER	scov2010932153610	num	12	SENT_243	39665/39682
12	.1038	CD	NUMBER	.1038		-1	SENT_243	39682/39687
13	/	:	O	/	punct	12	SENT_243	39687/39688
14	nrd3028201907877	CD	NUMBER	nrd3028201907877	dep	12	SENT_243	39688/39704
15	.	.	O	.		-1	SENT_243	39704/39705

1	NiemiMBackmanJTFrommMFNeuvonenPJKivist	NN	O	niemimbackmanjtfrommmfneuvonenpjkivist		-1	SENT_244	39705/39743
2	oKTPharmacokinetic	JJ	O	oktpharmacokinetic	amod	3	SENT_244	39744/39762
3	interactions	NNS	O	interaction	dep	1	SENT_244	39763/39775
4	with	IN	O	with		-1	SENT_244	39776/39780
5	rifampin	NN	O	rifampin	prep_with	3	SENT_244	39781/39789
6	:	:	O	:		-1	SENT_244	39789/39790
7	clinical	JJ	O	clinical	amod	10	SENT_244	39791/39799
8	relevanceClin	NNP	O	relevanceClin	nn	10	SENT_244	39800/39813
9	Pharmaco	NNP	ORGANIZATION	Pharmaco	nn	10	SENT_244	39814/39822
10	kinet20034298195010	NN	O	kinet20034298195010	dep	3	SENT_244	39823/39842
11	.2165	CD	NUMBER	.2165	dep	10	SENT_244	39842/39847
12	/	:	O	/	punct	1	SENT_244	39847/39848
13	00003088-200342090-00003128825888	CD	NUMBER	00003088-200342090-00003128825888	dep	1	SENT_244	39848/39881
14	.	.	O	.		-1	SENT_244	39881/39882

1	VavrickaSRVan	NNP	O	VavrickaSRVan	nn	2	SENT_245	39882/39895
2	MontfoortJHaHRMeierPJFattingerKInteractions	NNPS	O	MontfoortJHaHRMeierPJFattingerKInteractions		-1	SENT_245	39896/39939
3	of	IN	O	of		-1	SENT_245	39940/39942
4	rifamycin	NN	O	rifamycin	nn	5	SENT_245	39943/39952
5	SV	NN	O	sv	prep_of	2	SENT_245	39953/39955
6	and	CC	O	and		-1	SENT_245	39956/39959
7	rifampin	NN	O	rifampin	conj_and	5	SENT_245	39960/39968
8	with	IN	O	with		-1	SENT_245	39969/39973
9	organic	JJ	O	organic	amod	12	SENT_245	39974/39981
10	anion	NN	O	anion	nn	12	SENT_245	39982/39987
11	uptake	NN	O	uptake	nn	12	SENT_245	39988/39994
12	systems	NNS	O	system	prep_with	2	SENT_245	39995/40002
13	of	IN	O	of		-1	SENT_245	40003/40005
14	human	JJ	O	human	amod	15	SENT_245	40006/40011
15	liverHepatology20023611647210	NN	O	liverhepatology20023611647210	prep_of	12	SENT_245	40012/40041
16	.1053	CD	NUMBER	.1053	tmod	2	SENT_245	40041/40046
17	/	:	O	/	punct	2	SENT_245	40046/40047
18	jhep	NN	O	jhep	dep	2	SENT_245	40047/40051
19	.	.	O	.		-1	SENT_245	40051/40052

1	2002.34133120853619	CD	NUMBER	2002.34133120853619		-1	SENT_246	40053/40072
2	.	.	O	.		-1	SENT_246	40072/40073

1	BaciewiczAMChrismanCRFinchCKSelfTHUpdate	NN	O	baciewiczamchrismancrfinchckselfthupdate	nsubj	8	SENT_247	40073/40113
2	on	IN	O	on		-1	SENT_247	40114/40116
3	rifampin	NN	O	rifampin	nn	7	SENT_247	40117/40125
4	and	CC	O	and		-1	SENT_247	40126/40129
5	rifabutin	NN	O	rifabutin	conj_and	3	SENT_247	40130/40139
6	drug	NN	O	drug	nn	7	SENT_247	40140/40144
7	interactionsAm	NN	O	interactionsam	prep_on	1	SENT_247	40145/40159
8	J	NN	O	j		-1	SENT_247	40160/40161
9	Sci200833521263610	NN	O	sci200833521263610	dobj	8	SENT_247	40162/40180
10	.	.	O	.		-1	SENT_247	40180/40181

1	SidhartaPNAtsmonJDingemanseJInvestigation	NN	O	sidhartapnatsmonjdingemansejinvestigation		-1	SENT_248	40181/40222
2	of	IN	O	of		-1	SENT_248	40223/40225
3	the	DT	O	the	det	4	SENT_248	40226/40229
4	effect	NN	O	effect	prep_of	1	SENT_248	40230/40236
5	of	IN	O	of		-1	SENT_248	40237/40239
6	ketoconazole	NN	O	ketoconazole	prep_of	4	SENT_248	40240/40252
7	on	IN	O	on		-1	SENT_248	40253/40255
8	the	DT	O	the	det	9	SENT_248	40256/40259
9	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_248	40260/40276
10	of	IN	O	of		-1	SENT_248	40277/40279
11	macitentan	NN	O	macitentan	prep_of	9	SENT_248	40280/40290
12	in	IN	O	in		-1	SENT_248	40291/40293
13	healthy	JJ	O	healthy	amod	18	SENT_248	40294/40301
14	male	JJ	O	male	amod	18	SENT_248	40302/40306
15	subjectsBr	NN	O	subjectsbr	nn	18	SENT_248	40307/40317
16	J	NN	O	j	nn	18	SENT_248	40318/40319
17	Clin	NN	O	clin	nn	18	SENT_248	40320/40324
18	Pharmacol201070730111	NN	O	pharmacol201070730111	prep_in	1	SENT_248	40325/40346
19	.	.	O	.		-1	SENT_248	40346/40347

1	van	NN	O	van	nn	2	SENT_249	40347/40350
2	GiersbergenPLMBodinFDingemanseJCyclosporin	NNP	O	GiersbergenPLMBodinFDingemanseJCyclosporin	nsubj	3	SENT_249	40351/40393
3	increases	VBZ	O	increase		-1	SENT_249	40394/40403
4	the	DT	O	the	det	5	SENT_249	40404/40407
5	exposure	NN	O	exposure	dobj	3	SENT_249	40408/40416
6	to	TO	O	to		-1	SENT_249	40417/40419
7	tezosentan	NN	O	tezosentan	prep_to	3	SENT_249	40420/40430
8	,	,	O	,		-1	SENT_249	40430/40431
9	an	DT	O	a	det	13	SENT_249	40432/40434
10	intravenous	JJ	O	intravenous	amod	13	SENT_249	40435/40446
11	dual	JJ	O	dual	amod	13	SENT_249	40447/40451
12	endothelin	NN	O	endothelin	nn	13	SENT_249	40452/40462
13	receptor	NN	O	receptor	dep	17	SENT_249	40463/40471
14	antagonistEur	NN	O	antagonisteur	dep	13	SENT_249	40472/40485
15	J	NN	O	j	dep	17	SENT_249	40486/40487
16	Clin	NN	O	clin	nn	17	SENT_249	40488/40492
17	Pharmacol2002584243510	NN	O	pharmacol2002584243510	dep	20	SENT_249	40493/40515
18	.1007	CD	NUMBER	.1007	dep	17	SENT_249	40515/40520
19	/	:	O	/	punct	20	SENT_249	40520/40521
20	s00228-002-0459-01213636912	NN	O	s00228-002-0459-01213636912	dep	3	SENT_249	40521/40548
21	.	.	O	.		-1	SENT_249	40548/40549

1	B	NN	O	b		-1	SENT_250	40549/40550
2	inetIWallnoferAWeberCJonesRThielGRenal	JJ	O	inetiwallnoferawebercjonesrthielgrenal	amod	3	SENT_250	40551/40589
3	hemodynamics	NNS	O	hemodynamic	dep	1	SENT_250	40590/40602
4	and	CC	O	and		-1	SENT_250	40603/40606
5	pharmaco-kinetics	NNS	O	pharmaco-kinetics	conj_and	3	SENT_250	40607/40624
6	of	IN	O	of		-1	SENT_250	40625/40627
7	bosentan	NN	O	bosentan	prep_of	3	SENT_250	40628/40636
8	with	IN	O	with		-1	SENT_250	40637/40641
9	and	CC	O	and		-1	SENT_250	40642/40645
10	without	IN	O	without		-1	SENT_250	40646/40653
11	CsAKidney	NNP	O	CsAKidney	nn	12	SENT_250	40654/40663
12	Int20005712243110	NNP	O	Int20005712243110	prep_without	3	SENT_250	40664/40681
13	.1046	CD	NUMBER	.1046	num	12	SENT_250	40681/40686
14	/	:	O	/	punct	1	SENT_250	40686/40687
15	j.1523-1755	CD	DURATION	j.1523-1755	num	16	SENT_250	40687/40698
16	.2000.00838	CD	NUMBER	.2000.00838	dep	1	SENT_250	40698/40709
17	.	.	O	.		-1	SENT_250	40709/40710

1	x1062020313	NN	O	x1062020313		-1	SENT_251	40710/40721
2	.	.	O	.		-1	SENT_251	40721/40722

1	Novartis	NNP	ORGANIZATION	Novartis		-1	SENT_252	40722/40730
2	.	.	O	.		-1	SENT_252	40730/40731

1	Neoral	NNP	O	Neoral		-1	SENT_253	40732/40738
2	,	,	O	,		-1	SENT_253	40738/40739
3	summary	NN	O	summary	appos	1	SENT_253	40740/40747
4	of	IN	O	of		-1	SENT_253	40748/40750
5	product	NN	O	product	nn	6	SENT_253	40751/40758
6	characteristics	NNS	O	characteristic	prep_of	3	SENT_253	40759/40774
7	of	IN	O	of		-1	SENT_253	40775/40777
8	Cs	NNS	O	c	prep_of	6	SENT_253	40778/40780
9	.	.	O	.		-1	SENT_253	40780/40781

1	2009.14.Sanofi-aventis	NN	O	2009.14.sanofi-aventi		-1	SENT_254	40782/40804
2	.	.	O	.		-1	SENT_254	40804/40805

1	Rifadin	NNP	PERSON	Rifadin		-1	SENT_255	40806/40813
2	,	,	O	,		-1	SENT_255	40813/40814
3	summary	NN	O	summary	appos	1	SENT_255	40815/40822
4	of	IN	O	of		-1	SENT_255	40823/40825
5	product	NN	O	product	nn	6	SENT_255	40826/40833
6	characteristics	NNS	O	characteristic	prep_of	3	SENT_255	40834/40849
7	of	IN	O	of		-1	SENT_255	40850/40852
8	rifampin	NN	O	rifampin	prep_of	6	SENT_255	40853/40861
9	.	.	O	.		-1	SENT_255	40861/40862

1	2009.15	CD	NUMBER	2009.15		-1	SENT_256	40863/40870
2	.	.	O	.		-1	SENT_256	40870/40871

1	U.S.	NNP	ORGANIZATION	U.S.	nn	2	SENT_257	40871/40875
2	Department	NNP	ORGANIZATION	Department		-1	SENT_257	40876/40886
3	of	IN	ORGANIZATION	of		-1	SENT_257	40887/40889
4	Health	NNP	ORGANIZATION	Health	nn	7	SENT_257	40890/40896
5	and	CC	ORGANIZATION	and		-1	SENT_257	40897/40900
6	Human	NNP	ORGANIZATION	Human	conj_and	4	SENT_257	40901/40906
7	Services	NNPS	ORGANIZATION	Services	prep_of	2	SENT_257	40907/40915
8	,	,	ORGANIZATION	,		-1	SENT_257	40915/40916
9	Food	NNP	ORGANIZATION	Food	appos	2	SENT_257	40917/40921
10	and	CC	ORGANIZATION	and		-1	SENT_257	40922/40925
11	Drug	NNP	ORGANIZATION	Drug	nn	12	SENT_257	40926/40930
12	Administration	NNP	ORGANIZATION	Administration	conj_and	9	SENT_257	40931/40945
13	,	,	O	,		-1	SENT_257	40945/40946
14	Center	NNP	ORGANIZATION	Center	appos	2	SENT_257	40947/40953
15	for	IN	ORGANIZATION	for		-1	SENT_257	40954/40957
16	Drug	NNP	ORGANIZATION	Drug	nn	17	SENT_257	40958/40962
17	Evaluation	NN	ORGANIZATION	evaluation	prep_for	14	SENT_257	40963/40973
18	and	CC	ORGANIZATION	and		-1	SENT_257	40974/40977
19	Research	NN	ORGANIZATION	research	nn	22	SENT_257	40978/40986
20	(	CD	NUMBER	(	num	22	SENT_257	40987/40988
21	CDER	NN	O	cder	nn	22	SENT_257	40988/40992
22	)	NN	O	)	conj_and	17	SENT_257	40992/40993
23	,	,	O	,		-1	SENT_257	40993/40994
24	Center	NNP	O	Center	appos	2	SENT_257	40995/41001
25	for	IN	O	for		-1	SENT_257	41002/41005
26	Biologics	NNP	ORGANIZATION	Biologics	nn	27	SENT_257	41006/41015
27	Evaluation	NN	ORGANIZATION	evaluation	prep_for	24	SENT_257	41016/41026
28	and	CC	ORGANIZATION	and		-1	SENT_257	41027/41030
29	Research	NN	ORGANIZATION	research	nn	32	SENT_257	41031/41039
30	(	CD	NUMBER	(	num	32	SENT_257	41040/41041
31	CBER	NN	O	cber	nn	32	SENT_257	41041/41045
32	)	NN	O	)	conj_and	27	SENT_257	41045/41046
33	.	.	O	.		-1	SENT_257	41046/41047

1	Draft	NN	O	draft	nn	2	SENT_258	41048/41053
2	guidance	NN	O	guidance		-1	SENT_258	41054/41062
3	for	IN	O	for		-1	SENT_258	41063/41066
4	industry	NN	O	industry	nn	9	SENT_258	41067/41075
5	,	,	O	,		-1	SENT_258	41075/41076
6	drug	NN	O	drug	dep	9	SENT_258	41077/41081
7	interaction	NN	O	interaction	nn	9	SENT_258	41082/41093
8	studies-study	JJ	O	studies-study	amod	9	SENT_258	41094/41107
9	design	NN	O	design	prep_for	2	SENT_258	41108/41114
10	,	,	O	,		-1	SENT_258	41114/41115
11	data	NN	O	datum	nn	12	SENT_258	41116/41120
12	analysis	NN	O	analysis	conj_and	9	SENT_258	41121/41129
13	,	,	O	,		-1	SENT_258	41129/41130
14	and	CC	O	and		-1	SENT_258	41131/41134
15	implications	NNS	O	implication	conj_and	9	SENT_258	41135/41147
16	for	IN	O	for		-1	SENT_258	41148/41151
17	dosing	NN	O	dosing	prep_for	15	SENT_258	41152/41158
18	and	CC	O	and		-1	SENT_258	41159/41162
19	labeling	NN	O	labeling	conj_and	17	SENT_258	41163/41171
20	.	.	O	.		-1	SENT_258	41171/41172

1	2006.16	CD	NUMBER	2006.16		-1	SENT_259	41173/41180
2	.	.	O	.		-1	SENT_259	41181/41182

1	SidhartaPNDingemanseJMultiple-dose	JJ	O	sidhartapndingemansejmultiple-dose	amod	2	SENT_260	41182/41216
2	tolerability	NN	O	tolerability		-1	SENT_260	41217/41229
3	,	,	O	,		-1	SENT_260	41229/41230
4	safety	NN	O	safety	conj_and	2	SENT_260	41231/41237
5	,	,	O	,		-1	SENT_260	41237/41238
6	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	2	SENT_260	41239/41255
7	,	,	O	,		-1	SENT_260	41255/41256
8	and	CC	O	and		-1	SENT_260	41257/41260
9	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	2	SENT_260	41261/41277
10	of	IN	O	of		-1	SENT_260	41278/41280
11	the	DT	O	the	det	14	SENT_260	41281/41284
12	dual	JJ	O	dual	amod	14	SENT_260	41285/41289
13	endothelin	NN	O	endothelin	nn	14	SENT_260	41290/41300
14	receptor	NN	O	receptor	prep_of	9	SENT_260	41301/41309
15	antagonist	NN	O	antagonist	nn	16	SENT_260	41310/41320
16	ACT-064992	NN	O	act-064992	dep	2	SENT_260	41321/41331
17	in	IN	O	in		-1	SENT_260	41332/41334
18	healthy	JJ	O	healthy	amod	20	SENT_260	41335/41342
19	human	JJ	O	human	amod	20	SENT_260	41343/41348
20	subjects	NNS	O	subject	prep_in	16	SENT_260	41349/41357
21	.	.	O	.		-1	SENT_260	41357/41358

1	(	NN	O	(		-1	SENT_261	41359/41360
2	Abstract	JJ	O	abstract	amod	6	SENT_261	41360/41368
3	)	NN	O	)	nn	6	SENT_261	41368/41369
4	J	NN	O	j	nn	6	SENT_261	41369/41370
5	Clin	NN	O	clin	nn	6	SENT_261	41371/41375
6	Pharmacol200848111417	NN	O	pharmacol200848111417	dep	1	SENT_261	41376/41397
7	.	.	O	.		-1	SENT_261	41397/41398

1	TreiberASchneiterRHauserSStiegerBBosentan	NNP	O	TreiberASchneiterRHauserSStiegerBBosentan	nsubj	4	SENT_262	41398/41439
2	is	VBZ	O	be	cop	4	SENT_262	41440/41442
3	a	DT	O	a	det	4	SENT_262	41443/41444
4	substrate	NN	O	substrate		-1	SENT_262	41445/41454
5	of	IN	O	of		-1	SENT_262	41455/41457
6	human	JJ	O	human	amod	7	SENT_262	41458/41463
7	OATP1B1	NN	O	oatp1b1	prep_of	4	SENT_262	41464/41471
8	and	CC	O	and		-1	SENT_262	41472/41475
9	OATP1B3	NN	O	oatp1b3	conj_and	7	SENT_262	41476/41483
10	:	:	O	:		-1	SENT_262	41483/41484
11	inhibition	NN	O	inhibition	conj_and	4	SENT_262	41485/41495
12	of	IN	O	of		-1	SENT_262	41496/41498
13	hepatic	JJ	O	hepatic	amod	14	SENT_262	41499/41506
14	uptake	NN	O	uptake	prep_of	11	SENT_262	41507/41513
15	as	IN	O	as		-1	SENT_262	41514/41516
16	the	DT	O	the	det	18	SENT_262	41517/41520
17	common	JJ	O	common	amod	18	SENT_262	41521/41527
18	mechanism	NN	O	mechanism	prep_as	14	SENT_262	41528/41537
19	of	IN	O	of		-1	SENT_262	41538/41540
20	its	PRP$	O	its	poss	21	SENT_262	41541/41544
21	interactions	NNS	O	interaction	prep_of	18	SENT_262	41545/41557
22	with	IN	O	with		-1	SENT_262	41558/41562
23	cyclosporin	NN	O	cyclosporin	nn	24	SENT_262	41563/41574
24	A	NN	O	a	prep_with	21	SENT_262	41575/41576
25	,	,	O	,		-1	SENT_262	41576/41577
26	rifampin	NN	O	rifampin	appos	24	SENT_262	41578/41586
27	,	,	O	,		-1	SENT_262	41586/41587
28	and	CC	O	and		-1	SENT_262	41588/41591
29	sildenafilDrug	NN	O	sildenafildrug	nn	31	SENT_262	41592/41606
30	Metab	NN	O	metab	nn	31	SENT_262	41607/41612
31	Dispos200735814000710	NN	O	dispos200735814000710	conj_and	4	SENT_262	41613/41634
32	.1124	CD	NUMBER	.1124	dep	31	SENT_262	41634/41639
33	/	:	O	/	punct	34	SENT_262	41639/41640
34	dmd	NN	O	dmd	dep	32	SENT_262	41640/41643
35	.106.0136151749620818	CD	NUMBER	.106.0136151749620818	num	34	SENT_262	41643/41664
36	.	.	O	.		-1	SENT_262	41664/41665

1	Actelion	NNP	ORGANIZATION	Actelion	nn	3	SENT_263	41665/41673
2	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	3	SENT_263	41674/41689
3	Ltd.	NNP	ORGANIZATION	Ltd.		-1	SENT_263	41690/41693
4	.	.	O	.		-1	SENT_263	41693/41694

1	Tracleer	NNP	O	Tracleer		-1	SENT_264	41695/41703
2	(	CD	NUMBER	(	num	5	SENT_264	41704/41705
3	bosentan	NN	O	bosentan	nn	5	SENT_264	41705/41713
4	)	NN	O	)	nn	5	SENT_264	41713/41714
5	tablets	NNS	O	tablet	dep	1	SENT_264	41715/41722
6	.	.	O	.		-1	SENT_264	41722/41723

1	United	NNP	ORGANIZATION	United	nn	3	SENT_265	41724/41730
2	States	NNPS	ORGANIZATION	States	nn	3	SENT_265	41731/41737
3	Food	NNP	ORGANIZATION	Food	nsubj	9	SENT_265	41738/41742
4	and	CC	ORGANIZATION	and		-1	SENT_265	41743/41746
5	Drug	NNP	ORGANIZATION	Drug	nn	8	SENT_265	41747/41751
6	Administration	NNP	ORGANIZATION	Administration	nn	8	SENT_265	41752/41766
7	Drug	NNP	ORGANIZATION	Drug	nn	8	SENT_265	41767/41771
8	Product	NNP	ORGANIZATION	Product	conj_and	3	SENT_265	41772/41779
9	Label	NN	ORGANIZATION	label		-1	SENT_265	41780/41785
10	2009.19	CD	NUMBER	2009.19	dobj	9	SENT_265	41786/41793
11	.	.	O	.		-1	SENT_265	41793/41794

1	SpenceRMandagereARichardsDBMageeMHDuftonCBoinpallyRPotential	NNP	O	SpenceRMandagereARichardsDBMageeMHDuftonCBoinpallyRPotential	dep	10	SENT_266	41794/41854
2	for	IN	O	for		-1	SENT_266	41855/41858
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_266	41859/41874
4	interactions	NNS	O	interaction	prep_for	1	SENT_266	41875/41887
5	between	IN	O	between		-1	SENT_266	41888/41895
6	ambrisentan	NN	O	ambrisentan	prep_between	4	SENT_266	41896/41907
7	and	CC	O	and		-1	SENT_266	41908/41911
8	cyclosporineClin	NN	O	cyclosporineclin	conj_and	6	SENT_266	41912/41928
9	Pharmacol	NN	O	pharmacol	dep	10	SENT_266	41929/41938
10	Ther20108845132010	NN	O	ther20108845132010	dep	14	SENT_266	41939/41957
11	.1038	CD	NUMBER	.1038	dep	10	SENT_266	41957/41962
12	/	:	O	/	punct	14	SENT_266	41962/41963
13	clpt	JJ	O	clpt	amod	14	SENT_266	41963/41967
14	.2010.1202081134620	NN	O	.2010.1202081134620		-1	SENT_266	41967/41986
15	.	.	O	.		-1	SENT_266	41986/41987

1	KonVSugiuraMInagamiT	NN	O	konvsugiuraminagamit	nn	2	SENT_267	41987/42007
2	HarvieBRIchikawaIHooverRLRole	NN	O	harviebrichikawaihooverrlrole		-1	SENT_267	42008/42037
3	of	IN	O	of		-1	SENT_267	42038/42040
4	endothelin	NN	O	endothelin	prep_of	2	SENT_267	42041/42051
5	in	IN	O	in		-1	SENT_267	42052/42054
6	cyclosporine-induced	JJ	O	cyclosporine-induced	amod	9	SENT_267	42055/42075
7	glomerular	JJ	O	glomerular	amod	9	SENT_267	42076/42086
8	dysfunctionKidney	NN	O	dysfunctionkidney	nn	9	SENT_267	42087/42104
9	Int199037614879110	NN	O	int199037614879110	prep_in	2	SENT_267	42105/42123
10	.1038	CD	NUMBER	.1038	dep	9	SENT_267	42123/42128
11	/	:	O	/	punct	2	SENT_267	42128/42129
12	ki	FW	O	ki	nn	13	SENT_267	42129/42131
13	.1990.139219406721	FW	O	.1990.139219406721	dep	2	SENT_267	42131/42149
14	.	.	O	.		-1	SENT_267	42149/42150

1	PericoNDadanJRemuzziGEndothelin	NN	O	pericondadanjremuzzigendothelin	nsubj	2	SENT_268	42150/42181
2	mediates	VBZ	O	mediate		-1	SENT_268	42182/42190
3	the	DT	O	the	det	5	SENT_268	42191/42194
4	renal	JJ	O	renal	amod	5	SENT_268	42195/42200
5	vasoconstriction	NN	O	vasoconstriction	dobj	2	SENT_268	42201/42217
6	induced	VBN	O	induce	partmod	5	SENT_268	42218/42225
7	by	IN	O	by		-1	SENT_268	42226/42228
8	cyclosporine	NN	O	cyclosporine	agent	6	SENT_268	42229/42241
9	in	IN	O	in		-1	SENT_268	42242/42244
10	the	DT	O	the	det	11	SENT_268	42245/42248
11	ratJ	NNP	O	ratJ	prep_in	8	SENT_268	42249/42253
12	Am	VBP	O	be	dep	13	SENT_268	42254/42256
13	Soc	JJ	O	soc	dobj	6	SENT_268	42257/42260
14	Nephrol1990117683210425422	NN	O	nephrol1990117683210425422	dep	13	SENT_268	42261/42287
15	.	.	O	.		-1	SENT_268	42287/42288

1	FogoAHellingsSEInagamiTKonVEndothelin	NN	O	fogoahellingsseinagamitkonvendothelin	nn	3	SENT_269	42288/42325
2	receptor	NN	O	receptor	nn	3	SENT_269	42326/42334
3	antagonism	NN	O	antagonism	nsubj	5	SENT_269	42335/42345
4	is	VBZ	O	be	cop	5	SENT_269	42346/42348
5	protective	JJ	O	protective		-1	SENT_269	42349/42359
6	in	IN	O	in		-1	SENT_269	42360/42362
7	in-vivo	JJ	O	in-vivo	amod	11	SENT_269	42363/42370
8	acute	JJ	O	acute	amod	11	SENT_269	42371/42376
9	cyclosporine	NN	O	cyclosporine	nn	11	SENT_269	42377/42389
10	toxicityKidney	NN	O	toxicitykidney	nn	11	SENT_269	42390/42404
11	Int1992423770410	NN	O	int1992423770410	prep_in	5	SENT_269	42405/42421
12	.1038	CD	NUMBER	.1038	tmod	5	SENT_269	42421/42426
13	/	:	O	/	punct	14	SENT_269	42426/42427
14	ki	FW	O	ki	dep	5	SENT_269	42427/42429
15	.1992.346140535523	FW	O	.1992.346140535523	dep	14	SENT_269	42429/42447
16	.	.	O	.		-1	SENT_269	42447/42448

1	van	NN	PERSON	van		-1	SENT_270	42448/42451
2	GiersbergenPLMTreiberASchneiterRDietrichHDingemanseJInhibitory	NNP	PERSON	GiersbergenPLMTreiberASchneiterRDietrichHDingemanseJInhibitory	dep	1	SENT_270	42452/42514
3	and	CC	O	and		-1	SENT_270	42515/42518
4	inductive	JJ	O	inductive	amod	5	SENT_270	42519/42528
5	effects	NNS	O	effect	conj_and	1	SENT_270	42529/42536
6	of	IN	O	of		-1	SENT_270	42537/42539
7	rifampin	NN	O	rifampin	prep_of	5	SENT_270	42540/42548
8	on	IN	O	on		-1	SENT_270	42549/42551
9	the	DT	O	the	det	10	SENT_270	42552/42555
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_270	42556/42572
11	of	IN	O	of		-1	SENT_270	42573/42575
12	bosentan	NN	O	bosentan	prep_of	10	SENT_270	42576/42584
13	in	IN	O	in		-1	SENT_270	42585/42587
14	healthy	JJ	O	healthy	amod	17	SENT_270	42588/42595
15	subjectsClin	NN	O	subjectsclin	nn	17	SENT_270	42596/42608
16	Pharmacol	NN	O	pharmacol	nn	17	SENT_270	42609/42618
17	Ther2007813414910	NN	O	ther2007813414910	prep_in	1	SENT_270	42619/42636
18	.1038	CD	NUMBER	.1038	dep	17	SENT_270	42636/42641
19	/	:	O	/	punct	1	SENT_270	42641/42642
20	sj	NN	O	sj	dep	1	SENT_270	42642/42644
21	.	.	O	.		-1	SENT_270	42644/42645

1	clpt	JJ	O	clpt	amod	2	SENT_271	42645/42649
2	.61000751725198224	NN	NUMBER	.61000751725198224		-1	SENT_271	42649/42667
3	.	.	O	.		-1	SENT_271	42667/42668

1	Harris	NNP	PERSON	Harris	nn	2	SENT_272	42668/42674
2	onBMageeMHMandagereAWalkerGDuftonCHendersonLSBoinpallyREffects	NNS	O	onbmageemhmandagereawalkergduftonchendersonlsboinpallyreffect	dep	7	SENT_272	42675/42737
3	of	IN	O	of		-1	SENT_272	42738/42740
4	rifampin	NN	O	rifampin	prep_of	2	SENT_272	42741/42749
5	(	CD	NUMBER	(	num	6	SENT_272	42750/42751
6	rifampin	NN	O	rifampin	dep	7	SENT_272	42751/42759
7	)	NN	O	)	dep	26	SENT_272	42759/42760
8	on	IN	O	on		-1	SENT_272	42761/42763
9	the	DT	O	the	det	10	SENT_272	42764/42767
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	7	SENT_272	42768/42784
11	and	CC	O	and		-1	SENT_272	42785/42788
12	safety	NN	O	safety	conj_and	7	SENT_272	42789/42795
13	of	IN	O	of		-1	SENT_272	42796/42798
14	ambrisentan	NN	O	ambrisentan	prep_of	12	SENT_272	42799/42810
15	in	IN	O	in		-1	SENT_272	42811/42813
16	healthy	JJ	O	healthy	amod	17	SENT_272	42814/42821
17	subjects	NNS	O	subject	prep_in	14	SENT_272	42822/42830
18	:	:	O	:		-1	SENT_272	42830/42831
19	a	DT	O	a	det	20	SENT_272	42832/42833
20	single-sequence	NN	O	single-sequence	dep	12	SENT_272	42834/42849
21	,	,	O	,		-1	SENT_272	42849/42850
22	open-label	JJ	O	open-label	amod	25	SENT_272	42851/42861
23	studyClin	NN	O	studyclin	nn	25	SENT_272	42862/42871
24	Drug	NN	O	drug	nn	25	SENT_272	42872/42876
25	Investig201030128758510	NN	O	investig201030128758510	appos	20	SENT_272	42877/42900
26	.2165	CD	NUMBER	.2165		-1	SENT_272	42901/42906
27	/	:	O	/	punct	26	SENT_272	42906/42907
28	11539110-000000000-000002092324525	CD	NUMBER	11539110-000000000-000002092324525	dep	26	SENT_272	42907/42941
29	.	.	O	.		-1	SENT_272	42941/42942

1	XiongHCarrRALockeCSKatzDAAchariRDoanT	NN	O	xionghcarrralockecskatzdaacharirdoant		-1	SENT_273	42942/42979
2	TDual	JJ	O	tdual	amod	3	SENT_273	42980/42985
3	effects	NNS	O	effect	dep	1	SENT_273	42986/42993
4	of	IN	O	of		-1	SENT_273	42994/42996
5	rifampin	NN	O	rifampin	prep_of	3	SENT_273	42997/43005
6	on	IN	O	on		-1	SENT_273	43006/43008
7	the	DT	O	the	det	8	SENT_273	43009/43012
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	3	SENT_273	43013/43029
9	of	IN	O	of		-1	SENT_273	43030/43032
10	atrasentanJ	NN	O	atrasentanj	nn	12	SENT_273	43033/43044
11	Clin	NNP	O	Clin	nn	12	SENT_273	43045/43049
12	Pharmaco	NNP	O	Pharmaco	prep_of	8	SENT_273	43050/43058
13	l2007474423910	NN	O	l2007474423910	dep	12	SENT_273	43059/43073
14	.1177	CD	NUMBER	.1177	num	13	SENT_273	43073/43078
15	/	:	O	/	punct	1	SENT_273	43078/43079
16	00912700072999281738955126	CD	NUMBER	00912700072999281738955126	dep	1	SENT_273	43079/43105
17	.	.	O	.		-1	SENT_273	43105/43106

1	ZhengHXHuangYFrassettoLABenetLZ	NNP	O	ZhengHXHuangYFrassettoLABenetLZ	nn	2	SENT_274	43106/43137
2	Elucidating	NNP	O	Elucidating		-1	SENT_274	43138/43149
3	rifampin	NN	O	rifampin	poss	2	SENT_274	43150/43158
4	's	POS	O	's		-1	SENT_274	43158/43160
5	inducing	VBG	O	induce	partmod	2	SENT_274	43161/43169
6	and	CC	O	and		-1	SENT_274	43170/43173
7	inhibiting	VBG	O	inhibit	conj_and	5	SENT_274	43174/43184
8	effects	NNS	O	effect	dobj	5	SENT_274	43185/43192
9	on	IN	O	on		-1	SENT_274	43193/43195
10	glyburide	NN	O	glyburide	nn	11	SENT_274	43196/43205
11	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	8	SENT_274	43206/43222
12	and	CC	O	and		-1	SENT_274	43223/43226
13	blood	NN	O	blood	nn	14	SENT_274	43227/43232
14	glucose	NN	O	glucose	conj_and	11	SENT_274	43233/43240
15	in	IN	O	in		-1	SENT_274	43241/43243
16	healthy	JJ	O	healthy	amod	17	SENT_274	43244/43251
17	volunteers	NNS	O	volunteer	prep_in	5	SENT_274	43252/43262
18	:	:	O	:		-1	SENT_274	43262/43263
19	unmasking	VBG	O	unmask	dep	17	SENT_274	43264/43273
20	the	DT	O	the	det	22	SENT_274	43274/43277
21	differential	JJ	O	differential	amod	22	SENT_274	43278/43290
22	effects	NNS	O	effect	dobj	19	SENT_274	43291/43298
23	of	IN	O	of		-1	SENT_274	43299/43301
24	enzyme	NN	O	enzyme	nn	25	SENT_274	43302/43308
25	induction	NN	O	induction	prep_of	22	SENT_274	43309/43318
26	and	CC	O	and		-1	SENT_274	43319/43322
27	transporter	NN	O	transporter	nn	28	SENT_274	43323/43334
28	inhibition	NN	O	inhibition	conj_and	25	SENT_274	43335/43345
29	for	IN	O	for		-1	SENT_274	43346/43349
30	a	DT	O	a	det	31	SENT_274	43350/43351
31	drug	NN	O	drug	prep_for	25	SENT_274	43352/43356
32	and	CC	O	and		-1	SENT_274	43357/43360
33	its	PRP$	O	its	poss	37	SENT_274	43361/43364
34	primary	JJ	O	primary	amod	37	SENT_274	43365/43372
35	metaboliteClin	NN	O	metaboliteclin	nn	37	SENT_274	43373/43387
36	Pharmacol	NN	O	pharmacol	nn	37	SENT_274	43388/43397
37	Ther2009851788510	NN	O	ther2009851788510	conj_and	25	SENT_274	43398/43415
38	.1038	CD	NUMBER	.1038	dep	37	SENT_274	43415/43420
39	/	:	O	/	punct	41	SENT_274	43420/43421
40	clpt	JJ	O	clpt	amod	41	SENT_274	43421/43425
41	.2008.1861884326327	NN	O	.2008.1861884326327	dep	38	SENT_274	43425/43444
42	.	.	O	.		-1	SENT_274	43444/43445

1	Bruderer	NNP	O	Bruderer	nn	2	SENT_275	43445/43453
2	S	NN	O	s		-1	SENT_275	43454/43455
3	,	,	O	,		-1	SENT_275	43455/43456
4	Hopfgartner	NNP	O	Hopfgartner	nn	5	SENT_275	43457/43468
5	G	NNP	O	G	appos	2	SENT_275	43469/43470
6	,	,	O	,		-1	SENT_275	43470/43471
7	Seiberling	NNP	PERSON	Seiberling	nn	8	SENT_275	43472/43482
8	M	NNP	O	M	appos	2	SENT_275	43483/43484
9	,	,	O	,		-1	SENT_275	43484/43485
10	Wank	NNP	PERSON	Wank	nn	11	SENT_275	43486/43490
11	J	NNP	PERSON	J	appos	2	SENT_275	43491/43492
12	,	,	O	,		-1	SENT_275	43492/43493
13	Sidharta	NNP	O	Sidharta	nn	14	SENT_275	43494/43502
14	P	NN	O	p	appos	2	SENT_275	43503/43504
15	,	,	O	,		-1	SENT_275	43504/43505
16	Treiber	NNP	O	Treiber	nn	17	SENT_275	43506/43513
17	A	NNP	O	A	appos	2	SENT_275	43514/43515
18	,	,	O	,		-1	SENT_275	43515/43516
19	Dingemanse	NNP	O	Dingemanse	nn	21	SENT_275	43517/43527
20	J.	NNP	O	J.	nn	21	SENT_275	43528/43530
21	Allschwil	NNP	O	Allschwil	appos	2	SENT_275	43531/43540
22	:	:	O	:		-1	SENT_275	43540/43541
23	Actelion	NNP	ORGANIZATION	Actelion	nn	25	SENT_275	43542/43550
24	Pharmaceuticals	NNPS	ORGANIZATION	Pharmaceuticals	nn	25	SENT_275	43551/43566
25	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_275	43567/43571
26	2011	CD	DATE	2011	dep	25	SENT_275	43572/43576
27	.	.	O	.		-1	SENT_275	43576/43577

1	(	NNP	O	(	nn	2	SENT_276	43578/43579
2	Data	NNP	O	Data		-1	SENT_276	43579/43583
3	on	IN	O	on		-1	SENT_276	43584/43586
4	file	NN	O	file	prep_on	2	SENT_276	43587/43591
5	)	CD	NUMBER	)	number	6	SENT_276	43591/43592
6	28	CD	NUMBER	28	num	4	SENT_276	43592/43594
7	.	.	O	.		-1	SENT_276	43594/43595

1	US	NNP	ORGANIZATION	US	nn	2	SENT_277	43595/43597
2	Food	NNP	ORGANIZATION	Food		-1	SENT_277	43598/43602
3	and	CC	ORGANIZATION	and		-1	SENT_277	43603/43606
4	Drug	NNP	ORGANIZATION	Drug	nn	5	SENT_277	43607/43611
5	Administration	NNP	ORGANIZATION	Administration	conj_and	2	SENT_277	43612/43626
6	.	.	O	.		-1	SENT_277	43626/43627

1	Guidance	NN	O	guidance		-1	SENT_278	43628/43636
2	for	IN	O	for		-1	SENT_278	43637/43640
3	industry	NN	O	industry	prep_for	1	SENT_278	43641/43649
4	2008	CD	DATE	2008	num	3	SENT_278	43650/43654
5	,	,	O	,		-1	SENT_278	43654/43655
6	safety	NN	O	safety	nn	7	SENT_278	43656/43662
7	testing	NN	O	testing	appos	1	SENT_278	43663/43670
8	of	IN	O	of		-1	SENT_278	43671/43673
9	drug	NN	O	drug	nn	10	SENT_278	43674/43678
10	metabolites	NNS	O	metabolite	prep_of	7	SENT_278	43679/43690
11	.	.	O	.		-1	SENT_278	43690/43691

1	US	NNP	ORGANIZATION	US	nn	2	SENT_279	43692/43694
2	Department	NNP	ORGANIZATION	Department		-1	SENT_279	43695/43705
3	of	IN	ORGANIZATION	of		-1	SENT_279	43706/43708
4	Health	NNP	ORGANIZATION	Health	nn	7	SENT_279	43709/43715
5	and	CC	ORGANIZATION	and		-1	SENT_279	43716/43719
6	Human	NNP	ORGANIZATION	Human	conj_and	4	SENT_279	43720/43725
7	Services	NNPS	ORGANIZATION	Services	prep_of	2	SENT_279	43726/43734
8	.	.	O	.		-1	SENT_279	43734/43735

1	Food	NNP	O	Food	nn	4	SENT_280	43736/43740
2	and	CC	O	and		-1	SENT_280	43741/43744
3	Drug	NNP	O	Drug	conj_and	1	SENT_280	43745/43749
4	Administration	NNP	O	Administration		-1	SENT_280	43750/43764
5	,	,	O	,		-1	SENT_280	43764/43765
6	Center	NNP	ORGANIZATION	Center	appos	4	SENT_280	43766/43772
7	for	IN	ORGANIZATION	for		-1	SENT_280	43773/43776
8	Drug	NNP	ORGANIZATION	Drug	nn	9	SENT_280	43777/43781
9	Evaluation	NN	ORGANIZATION	evaluation	prep_for	6	SENT_280	43782/43792
10	and	CC	ORGANIZATION	and		-1	SENT_280	43793/43796
11	Research	NN	ORGANIZATION	research	nn	14	SENT_280	43797/43805
12	(	CD	NUMBER	(	num	14	SENT_280	43806/43807
13	CDER	NN	O	cder	nn	14	SENT_280	43807/43811
14	)	NN	O	)	conj_and	9	SENT_280	43811/43812
15	.	.	O	.		-1	SENT_280	43812/43813

1	February	NNP	DATE	February		-1	SENT_281	43814/43822
2	2008	CD	DATE	2008	dep	1	SENT_281	43823/43827
3	.	.	O	.		-1	SENT_281	43827/43828

1	Pharmacology	NN	O	pharmacology		-1	SENT_282	43829/43841
2	and	CC	O	and		-1	SENT_282	43842/43845
3	Toxicology	NN	O	toxicology	conj_and	1	SENT_282	43846/43856
4	.29	CD	NUMBER	.29	dep	1	SENT_282	43856/43859
5	.	.	O	.		-1	SENT_282	43859/43860

1	US	NNP	ORGANIZATION	US	nn	2	SENT_283	43860/43862
2	Department	NNP	ORGANIZATION	Department		-1	SENT_283	43863/43873
3	of	IN	ORGANIZATION	of		-1	SENT_283	43874/43876
4	Health	NNP	ORGANIZATION	Health	nn	7	SENT_283	43877/43883
5	and	CC	ORGANIZATION	and		-1	SENT_283	43884/43887
6	Human	NNP	ORGANIZATION	Human	conj_and	4	SENT_283	43888/43893
7	Services	NNPS	ORGANIZATION	Services	prep_of	2	SENT_283	43894/43902
8	,	,	ORGANIZATION	,		-1	SENT_283	43902/43903
9	Food	NNP	ORGANIZATION	Food	appos	2	SENT_283	43904/43908
10	and	CC	ORGANIZATION	and		-1	SENT_283	43909/43912
11	Drug	NNP	ORGANIZATION	Drug	nn	12	SENT_283	43913/43917
12	Administration	NNP	ORGANIZATION	Administration	conj_and	9	SENT_283	43918/43932
13	,	,	O	,		-1	SENT_283	43932/43933
14	Center	NNP	ORGANIZATION	Center	appos	2	SENT_283	43934/43940
15	for	IN	ORGANIZATION	for		-1	SENT_283	43941/43944
16	Drug	NNP	ORGANIZATION	Drug	nn	17	SENT_283	43945/43949
17	Evaluation	NN	ORGANIZATION	evaluation	prep_for	14	SENT_283	43950/43960
18	and	CC	ORGANIZATION	and		-1	SENT_283	43961/43964
19	Research	NN	ORGANIZATION	research	nn	22	SENT_283	43965/43973
20	(	CD	NUMBER	(	num	22	SENT_283	43974/43975
21	CDER	NN	O	cder	nn	22	SENT_283	43975/43979
22	)	NN	O	)	conj_and	17	SENT_283	43979/43980
23	,	,	O	,		-1	SENT_283	43980/43981
24	Center	NNP	O	Center	appos	2	SENT_283	43982/43988
25	for	IN	O	for		-1	SENT_283	43989/43992
26	Biologics	NNP	ORGANIZATION	Biologics	nn	27	SENT_283	43993/44002
27	Evaluation	NN	ORGANIZATION	evaluation	prep_for	24	SENT_283	44003/44013
28	and	CC	ORGANIZATION	and		-1	SENT_283	44014/44017
29	Research	NN	ORGANIZATION	research	nn	32	SENT_283	44018/44026
30	(	CD	NUMBER	(	num	32	SENT_283	44027/44028
31	CBER	NN	O	cber	nn	32	SENT_283	44028/44032
32	)	NN	O	)	conj_and	27	SENT_283	44032/44033
33	.	.	O	.		-1	SENT_283	44033/44034

1	Guidance	NN	O	guidance	nsubj	4	SENT_284	44035/44043
2	for	IN	O	for		-1	SENT_284	44044/44047
3	industry	NN	O	industry	prep_for	1	SENT_284	44048/44056
4	M3	NN	O	m3		-1	SENT_284	44057/44059
5	(	CD	NUMBER	(	num	6	SENT_284	44059/44060
6	R2	NN	O	r2	dobj	4	SENT_284	44060/44062
7	)	CD	NUMBER	)	num	8	SENT_284	44062/44063
8	2010	CD	DATE	2010	dep	6	SENT_284	44064/44068
9	,	,	O	,		-1	SENT_284	44068/44069
10	nonclinical	JJ	O	nonclinical	amod	12	SENT_284	44070/44081
11	safety	NN	O	safety	nn	12	SENT_284	44082/44088
12	studies	NNS	O	study	conj_and	6	SENT_284	44089/44096
13	for	IN	O	for		-1	SENT_284	44097/44100
14	the	DT	O	the	det	15	SENT_284	44101/44104
15	conduct	NN	O	conduct	prep_for	12	SENT_284	44105/44112
16	of	IN	O	of		-1	SENT_284	44113/44115
17	human	JJ	O	human	amod	19	SENT_284	44116/44121
18	clinical	JJ	O	clinical	amod	19	SENT_284	44122/44130
19	trials	NNS	O	trial	prep_of	15	SENT_284	44131/44137
20	and	CC	O	and		-1	SENT_284	44138/44141
21	marketing	NN	O	marketing	nn	22	SENT_284	44142/44151
22	authorization	NN	O	authorization	conj_and	6	SENT_284	44152/44165
23	for	IN	O	for		-1	SENT_284	44166/44169
24	pharmaceuticals	NNS	O	pharmaceutical	prep_for	22	SENT_284	44170/44185
25	.	.	O	.		-1	SENT_284	44185/44186

1	2010	CD	DATE	2010	num	2	SENT_285	44187/44191
2	(	CD	NUMBER	(	nsubj	5	SENT_285	44192/44193
3	Revision	NNP	O	Revision	dep	5	SENT_285	44193/44201
4	1	CD	NUMBER	1	num	5	SENT_285	44202/44203
5	)	CD	NUMBER	)		-1	SENT_285	44203/44204
6	.	.	O	.		-1	SENT_285	44204/44205

